<!DOCTYPE html>
<html class="client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled" lang="en" dir="ltr">
<head>
<meta charset="UTF-8">
<title>Multiple sclerosis - Wikipedia</title>
<script>document.documentElement.className="client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled";(function(){var cookie=document.cookie.match(/(?:^|; )enwikimwclientprefs=([^;]+)/);if(cookie){var featureName=cookie[1];document.documentElement.className=document.documentElement.className.replace(featureName+'-enabled',featureName+'-disabled');}}());RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"575f6576-d0cc-4fb9-94f2-b54f72bbd973","wgCSPNonce":false,
"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Multiple_sclerosis","wgTitle":"Multiple sclerosis","wgCurRevisionId":1162037993,"wgRevisionId":1162037993,"wgArticleId":50603,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["All articles with unsourced statements","Articles with unsourced statements from July 2022","Webarchive template wayback links","CS1 Japanese-language sources (ja)","Articles with short description","Short description is different from Wikidata","Articles needing additional medical references from July 2022","All articles needing additional references","Articles requiring reliable medical sources","Use dmy dates from March 2023","Articles with unsourced statements from May 2023","Articles containing potentially dated statements from 2017","All articles containing potentially dated statements","Wikipedia articles in need of updating from July 2022",
"All Wikipedia articles in need of updating","Articles with unsourced statements from December 2022","All articles lacking reliable references","Articles lacking reliable references from December 2022","Commons category link is on Wikidata","Articles with Curlie links","Articles with BNF identifiers","Articles with BNFdata identifiers","Articles with GND identifiers","Articles with J9U identifiers","Articles with LCCN identifiers","Articles with NDL identifiers","Articles with NKC identifiers","Wikipedia neurology articles ready to translate","Wikipedia medicine articles ready to translate (full)","Multiple sclerosis","Ailments of unknown cause","Epstein–Barr virus–associated diseases","Myelin disorders"],"wgPageViewLanguage":"en","wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Multiple_sclerosis","wgRelevantArticleId":50603,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],
"wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":100000,"wgNoticeProject":"wikipedia","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":10,"wgULSCurrentAutonym":"English","wgEditSubmitButtonLabelPublish":true,"wgCentralAuthMobileDomain":false,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":true,"wgULSisLanguageSelectorEmpty":false,"wgWikibaseItemId":"Q8277","GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,"wgGEStructuredTaskRejectionReasonTextInputEnabled":false,"wgGELevelingUpEnabledForUser":false};RLSTATE={"skins.vector.user.styles":"ready","ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","skins.vector.user":"ready",
"ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","codex-search-styles":"ready","skins.vector.styles":"ready","skins.vector.icons":"ready","jquery.makeCollapsible.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.wikimediaBadges":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","site","mediawiki.page.ready","jquery.makeCollapsible","mediawiki.toc","skins.vector.js","mmv.head","mmv.bootstrap.autostart","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.cx.eventlogging.campaigns","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.gadget.ReferenceTooltips","ext.gadget.charinsert","ext.gadget.extra-toolbar-buttons","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","ext.echo.centralauth",
"ext.uls.compactlinks","ext.uls.interface","ext.cx.uls.quick.actions","wikibase.client.vector-2022","ext.growthExperiments.SuggestedEditSession"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=codex-search-styles%7Cext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cskins.vector.icons%2Cstyles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector-2022">
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector-2022"></script>
<meta name="ResourceLoaderDynamicStyles" content="">
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector-2022">
<meta name="generator" content="MediaWiki 1.41.0-wmf.13">
<meta name="referrer" content="origin">
<meta name="referrer" content="origin-when-crossorigin">
<meta name="referrer" content="origin-when-cross-origin">
<meta name="robots" content="max-image-preview:standard">
<meta name="format-detection" content="telephone=no">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/5/59/MS_Demyelinisation_CD68_10xv2.jpg/1200px-MS_Demyelinisation_CD68_10xv2.jpg">
<meta property="og:image:width" content="1200">
<meta property="og:image:height" content="891">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/5/59/MS_Demyelinisation_CD68_10xv2.jpg/800px-MS_Demyelinisation_CD68_10xv2.jpg">
<meta property="og:image:width" content="800">
<meta property="og:image:height" content="594">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/5/59/MS_Demyelinisation_CD68_10xv2.jpg/640px-MS_Demyelinisation_CD68_10xv2.jpg">
<meta property="og:image:width" content="640">
<meta property="og:image:height" content="475">
<meta name="viewport" content="width=1000">
<meta property="og:title" content="Multiple sclerosis - Wikipedia">
<meta property="og:type" content="website">
<link rel="preconnect" href="//upload.wikimedia.org">
<link rel="alternate" media="only screen and (max-width: 720px)" href="//en.m.wikipedia.org/wiki/Multiple_sclerosis">
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Multiple_sclerosis&amp;action=edit">
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png">
<link rel="icon" href="/static/favicon/wikipedia.ico">
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)">
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd">
<link rel="canonical" href="https://en.wikipedia.org/wiki/Multiple_sclerosis">
<link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en">
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom">
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<link rel="dns-prefetch" href="//login.wikimedia.org">
</head>
<body class="skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Multiple_sclerosis rootpage-Multiple_sclerosis skin-vector-2022 action-view"><a class="mw-jump-link" href="#bodyContent">Jump to content</a>
<div class="vector-header-container">
	<header class="vector-header mw-header">
		<div class="vector-header-start">
			<nav class="vector-main-menu-landmark" aria-label="Site" role="navigation">
				
<div id="vector-main-menu-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-main-menu-dropdown vector-button-flush-left vector-button-flush-right"  >
	<input type="checkbox"
		id="vector-main-menu-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-main-menu-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Main menu"
		
	/>
	<label
		id="vector-main-menu-dropdown-label"
		for="vector-main-menu-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-menu mw-ui-icon-wikimedia-menu"></span>


		<span class="vector-menu-heading-label">Main menu</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


				<div id="vector-main-menu-unpinned-container" class="vector-unpinned-container">
		
<div id="vector-main-menu" class="vector-main-menu vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned"
	data-feature-name="main-menu-pinned"
	data-pinnable-element-id="vector-main-menu"
	data-pinned-container-id="vector-main-menu-pinned-container"
	data-unpinned-container-id="vector-main-menu-unpinned-container"
>
	<div class="vector-pinnable-header-label">Main menu</div>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-main-menu.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-main-menu.unpin">hide</button>
</div>

	
<div id="p-navigation" class="vector-menu mw-portlet mw-portlet-navigation"  >
	<div class="vector-menu-heading">
		Navigation
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"><span>Main page</span></a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia"><span>Contents</span></a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events"><span>Current events</span></a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x"><span>Random article</span></a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works"><span>About Wikipedia</span></a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia"><span>Contact us</span></a></li><li id="n-sitesupport" class="mw-list-item"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us by donating to the Wikimedia Foundation"><span>Donate</span></a></li></ul>
		
	</div>
</div>

	
	
<div id="p-interaction" class="vector-menu mw-portlet mw-portlet-interaction"  >
	<div class="vector-menu-heading">
		Contribute
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia"><span>Help</span></a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia"><span>Learn to edit</span></a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors"><span>Community portal</span></a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r"><span>Recent changes</span></a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_upload_wizard" title="Add images or other media for use on Wikipedia"><span>Upload file</span></a></li></ul>
		
	</div>
</div>

	
<div class="vector-main-menu-action vector-main-menu-action-lang-alert">
	<div class="vector-main-menu-action-item">
		<div class="vector-main-menu-action-heading vector-menu-heading">Languages</div>
		<div class="vector-main-menu-action-content vector-menu-content">
			<div class="mw-message-box-notice vector-language-sidebar-alert mw-message-box">Language links are at the top of the page across from the title.</div>
		</div>
	</div>
</div>

</div>

				</div>

	</div>
</div>
		</nav>
			
<a href="/wiki/Main_Page" class="mw-logo">
	<img class="mw-logo-icon" src="/static/images/icons/wikipedia.png" alt=""
		aria-hidden="true" height="50" width="50">
	<span class="mw-logo-container">
		<img class="mw-logo-wordmark" alt="Wikipedia"
			src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" style="width: 7.5em; height: 1.125em;">
		<img class="mw-logo-tagline"
			alt="The Free Encyclopedia"
			src="/static/images/mobile/copyright/wikipedia-tagline-en.svg" width="117" height="13" style="width: 7.3125em; height: 0.8125em;">
	</span>
</a>

		</div>
		<div class="vector-header-end">
			
<div id="p-search" role="search" class="vector-search-box-vue  vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box">
	<a href="/wiki/Special:Search"
	
		id=""
		class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only search-toggle"
		title="Search Wikipedia [f]"accesskey="f"><span class="vector-icon mw-ui-icon-search mw-ui-icon-wikimedia-search"></span>

<span>Search</span>
	</a>
	
	<div class="vector-typeahead-search-container">
		<div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail cdx-typeahead-search--auto-expand-width">
			<form action="/w/index.php" id="searchform" class="cdx-search-input cdx-search-input--has-end-button">
				<div id="simpleSearch" class="cdx-search-input__input-wrapper"  data-search-loc="header-moved">
					<div class="cdx-text-input cdx-text-input--has-start-icon">
						<input
							class="cdx-text-input__input"
							 type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput"
							
						>
						<span class="cdx-text-input__icon cdx-text-input__start-icon"></span>
					</div>
					<input type="hidden" name="title" value="Special:Search">
				</div>
				<button class="cdx-button cdx-search-input__end-button">Search</button>
			</form>
		</div>
	</div>
</div>

			<nav class="vector-user-links" aria-label="Personal tools" role="navigation" >
	
<div id="p-vector-user-menu-overflow" class="vector-menu mw-portlet mw-portlet-vector-user-menu-overflow"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-createaccount-2" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Multiple+sclerosis" title="You are encouraged to create an account and log in; however, it is not mandatory"><span>Create account</span></a></li><li id="pt-login-2" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Multiple+sclerosis" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span>Log in</span></a></li></ul>
		
	</div>
</div>

	
<div id="vector-user-links-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-user-menu vector-button-flush-right vector-user-menu-logged-out"  title="Log in and more options" >
	<input type="checkbox"
		id="vector-user-links-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-user-links-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Personal tools"
		
	/>
	<label
		id="vector-user-links-dropdown-label"
		for="vector-user-links-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-ellipsis mw-ui-icon-wikimedia-ellipsis"></span>


		<span class="vector-menu-heading-label">Personal tools</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


		
<div id="p-personal" class="vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item"  title="User menu" >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-createaccount" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Multiple+sclerosis" title="You are encouraged to create an account and log in; however, it is not mandatory"><span class="vector-icon mw-ui-icon-userAdd mw-ui-icon-wikimedia-userAdd"></span> <span>Create account</span></a></li><li id="pt-login" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Multiple+sclerosis" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span class="vector-icon mw-ui-icon-logIn mw-ui-icon-wikimedia-logIn"></span> <span>Log in</span></a></li></ul>
		
	</div>
</div>

<div id="p-user-menu-anon-editor" class="vector-menu mw-portlet mw-portlet-user-menu-anon-editor"  >
	<div class="vector-menu-heading">
		Pages for logged out editors <a href="/wiki/Help:Introduction" aria-label="Learn more about editing"><span>learn more</span></a>
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y"><span>Contributions</span></a></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n"><span>Talk</span></a></li></ul>
		
	</div>
</div>

	
	</div>
</div>
</nav>

		</div>
	</header>
</div>
<div class="mw-page-container">
	<div class="mw-page-container-inner">
		<div class="vector-main-menu-container ">
			<div id="mw-navigation">
				<nav id="mw-panel" class="vector-main-menu-landmark" aria-label="Site" role="navigation">
					<div id="vector-main-menu-pinned-container" class="vector-pinned-container">
				
					</div>
		</nav>
			</div>
		</div>
		<div class="vector-sitenotice-container">
			<div id="siteNotice"><!-- CentralNotice --></div>
		</div>
		<input type="checkbox" id="vector-toc-collapsed-checkbox" class="vector-menu-checkbox">
		<nav id="mw-panel-toc" role="navigation" aria-label="Contents" data-event-name="ui.sidebar-toc" class="mw-table-of-contents-container vector-toc-landmark vector-sticky-pinned-container">
			<div id="vector-toc-pinned-container" class="vector-pinned-container">
					<div id="vector-toc" class="vector-toc vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned"
	data-feature-name="toc-pinned"
	data-pinnable-element-id="vector-toc"
	
	
>
	<h2 class="vector-pinnable-header-label">Contents</h2>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-toc.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-toc.unpin">hide</button>
</div>


	<ul class="vector-toc-contents" id="mw-panel-toc-list">
		<li id="toc-mw-content-text"
			class="vector-toc-list-item vector-toc-level-1">
			<a href="#" class="vector-toc-link">
				<div class="vector-toc-text">(Top)</div>
			</a>
		</li>
		<li id="toc-Signs_and_symptoms"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Signs_and_symptoms">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">1</span>Signs and symptoms</div>
		</a>
		
			<button aria-controls="toc-Signs_and_symptoms-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Signs and symptoms subsection</span>
			</button>
		
		<ul id="toc-Signs_and_symptoms-sublist" class="vector-toc-list">
			<li id="toc-Prodromal_phase"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Prodromal_phase">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">1.1</span>Prodromal phase</div>
			</a>
			
			<ul id="toc-Prodromal_phase-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Causes"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Causes">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">2</span>Causes</div>
		</a>
		
			<button aria-controls="toc-Causes-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Causes subsection</span>
			</button>
		
		<ul id="toc-Causes-sublist" class="vector-toc-list">
			<li id="toc-Infectious_agents"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Infectious_agents">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.1</span>Infectious agents</div>
			</a>
			
			<ul id="toc-Infectious_agents-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Genetics"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Genetics">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.2</span>Genetics</div>
			</a>
			
			<ul id="toc-Genetics-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Geography"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Geography">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.3</span>Geography</div>
			</a>
			
			<ul id="toc-Geography-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Other"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Other">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.4</span>Other</div>
			</a>
			
			<ul id="toc-Other-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Pathophysiology"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Pathophysiology">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">3</span>Pathophysiology</div>
		</a>
		
			<button aria-controls="toc-Pathophysiology-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Pathophysiology subsection</span>
			</button>
		
		<ul id="toc-Pathophysiology-sublist" class="vector-toc-list">
			<li id="toc-Lesions"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Lesions">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">3.1</span>Lesions</div>
			</a>
			
			<ul id="toc-Lesions-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Inflammation"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Inflammation">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">3.2</span>Inflammation</div>
			</a>
			
			<ul id="toc-Inflammation-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Blood–brain_barrier"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Blood–brain_barrier">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">3.3</span>Blood–brain barrier</div>
			</a>
			
			<ul id="toc-Blood–brain_barrier-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Diagnosis"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Diagnosis">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">4</span>Diagnosis</div>
		</a>
		
			<button aria-controls="toc-Diagnosis-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Diagnosis subsection</span>
			</button>
		
		<ul id="toc-Diagnosis-sublist" class="vector-toc-list">
			<li id="toc-Differential_diagnosis"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Differential_diagnosis">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">4.1</span>Differential diagnosis</div>
			</a>
			
			<ul id="toc-Differential_diagnosis-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Types_and_variants"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Types_and_variants">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">5</span>Types and variants</div>
		</a>
		
			<button aria-controls="toc-Types_and_variants-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Types and variants subsection</span>
			</button>
		
		<ul id="toc-Types_and_variants-sublist" class="vector-toc-list">
			<li id="toc-Special_courses"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Special_courses">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">5.1</span>Special courses</div>
			</a>
			
			<ul id="toc-Special_courses-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Variants"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Variants">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">5.2</span>Variants</div>
			</a>
			
			<ul id="toc-Variants-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Management"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Management">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">6</span>Management</div>
		</a>
		
			<button aria-controls="toc-Management-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Management subsection</span>
			</button>
		
		<ul id="toc-Management-sublist" class="vector-toc-list">
			<li id="toc-Initial_management_of_acute_flare"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Initial_management_of_acute_flare">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.1</span>Initial management of acute flare</div>
			</a>
			
			<ul id="toc-Initial_management_of_acute_flare-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Chronic_management"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Chronic_management">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.2</span>Chronic management</div>
			</a>
			
			<ul id="toc-Chronic_management-sublist" class="vector-toc-list">
				<li id="toc-Relapsing_remitting_multiple_sclerosis"
			class="vector-toc-list-item vector-toc-level-3">
			<a class="vector-toc-link" href="#Relapsing_remitting_multiple_sclerosis">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.2.1</span>Relapsing remitting multiple sclerosis</div>
			</a>
			
			<ul id="toc-Relapsing_remitting_multiple_sclerosis-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Progressive_multiple_sclerosis"
			class="vector-toc-list-item vector-toc-level-3">
			<a class="vector-toc-link" href="#Progressive_multiple_sclerosis">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.2.2</span>Progressive multiple sclerosis</div>
			</a>
			
			<ul id="toc-Progressive_multiple_sclerosis-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Adverse_effects"
			class="vector-toc-list-item vector-toc-level-3">
			<a class="vector-toc-link" href="#Adverse_effects">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.2.3</span>Adverse effects</div>
			</a>
			
			<ul id="toc-Adverse_effects-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
		</li>
		<li id="toc-Associated_symptoms"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Associated_symptoms">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.3</span>Associated symptoms</div>
			</a>
			
			<ul id="toc-Associated_symptoms-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Non-pharmaceutical"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Non-pharmaceutical">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.4</span>Non-pharmaceutical</div>
			</a>
			
			<ul id="toc-Non-pharmaceutical-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Alternative_treatments"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Alternative_treatments">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.5</span>Alternative treatments</div>
			</a>
			
			<ul id="toc-Alternative_treatments-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Prognosis"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Prognosis">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">7</span>Prognosis</div>
		</a>
		
		<ul id="toc-Prognosis-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Epidemiology"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Epidemiology">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">8</span>Epidemiology</div>
		</a>
		
		<ul id="toc-Epidemiology-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-History"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#History">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">9</span>History</div>
		</a>
		
			<button aria-controls="toc-History-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle History subsection</span>
			</button>
		
		<ul id="toc-History-sublist" class="vector-toc-list">
			<li id="toc-Medical_discovery"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Medical_discovery">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">9.1</span>Medical discovery</div>
			</a>
			
			<ul id="toc-Medical_discovery-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Diagnosis_history"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Diagnosis_history">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">9.2</span>Diagnosis history</div>
			</a>
			
			<ul id="toc-Diagnosis_history-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Historical_cases"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Historical_cases">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">9.3</span>Historical cases</div>
			</a>
			
			<ul id="toc-Historical_cases-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Research"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Research">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">10</span>Research</div>
		</a>
		
			<button aria-controls="toc-Research-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Research subsection</span>
			</button>
		
		<ul id="toc-Research-sublist" class="vector-toc-list">
			<li id="toc-Epstein-Barr_virus_ongoing_studies"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Epstein-Barr_virus_ongoing_studies">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">10.1</span>Epstein-Barr virus ongoing studies</div>
			</a>
			
			<ul id="toc-Epstein-Barr_virus_ongoing_studies-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Human_endogenous_retroviruses"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Human_endogenous_retroviruses">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">10.2</span>Human endogenous retroviruses</div>
			</a>
			
			<ul id="toc-Human_endogenous_retroviruses-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Medications"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Medications">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">10.3</span>Medications</div>
			</a>
			
			<ul id="toc-Medications-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Pathogenesis"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Pathogenesis">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">10.4</span>Pathogenesis</div>
			</a>
			
			<ul id="toc-Pathogenesis-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Disease_biomarkers"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Disease_biomarkers">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">10.5</span>Disease biomarkers</div>
			</a>
			
			<ul id="toc-Disease_biomarkers-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-COVID-19"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#COVID-19">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">10.6</span>COVID-19</div>
			</a>
			
			<ul id="toc-COVID-19-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Other_emerging_theories"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Other_emerging_theories">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">10.7</span>Other emerging theories</div>
			</a>
			
			<ul id="toc-Other_emerging_theories-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-See_also"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#See_also">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">11</span>See also</div>
		</a>
		
		<ul id="toc-See_also-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-References"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#References">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">12</span>References</div>
		</a>
		
		<ul id="toc-References-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-External_links"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#External_links">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">13</span>External links</div>
		</a>
		
		<ul id="toc-External_links-sublist" class="vector-toc-list">
		</ul>
	</li>
</ul>
</div>

			</div>
		</nav>
		<div class="mw-content-container">
			<main id="content" class="mw-body" role="main">
				<header class="mw-body-header vector-page-titlebar">
					<label
						id="vector-toc-collapsed-button"
						class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet vector-button-flush-left cdx-button--icon-only"
						for="vector-toc-collapsed-checkbox"
						role="button"
						aria-controls="vector-toc"
						tabindex="0"
						title="Table of Contents">
						<span class="vector-icon mw-ui-icon-wikimedia-listBullet"></span>
						<span>Toggle the table of contents</span>
					</label>
				
					<nav role="navigation" aria-label="Contents" class="vector-toc-landmark">
						
<div id="vector-page-titlebar-toc" class="vector-menu vector-dropdown vector-menu-dropdown vector-page-titlebar-toc vector-button-flush-left"  >
	<input type="checkbox"
		id="vector-page-titlebar-toc-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-page-titlebar-toc"
		class="vector-menu-checkbox "
		
		aria-label="Toggle the table of contents"
		
	/>
	<label
		id="vector-page-titlebar-toc-label"
		for="vector-page-titlebar-toc-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet"></span>


		<span class="vector-menu-heading-label">Toggle the table of contents</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


							<div id="vector-page-titlebar-toc-unpinned-container" class="vector-unpinned-container">
			</div>
		
	</div>
</div>
					</nav>
					<h1 id="firstHeading" class="firstHeading mw-first-heading"><span class="mw-page-title-main">Multiple sclerosis</span></h1>
				
							
<div id="p-lang-btn" class="vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-lang"  >
	<input type="checkbox"
		id="p-lang-btn-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-lang-btn"
		class="vector-menu-checkbox mw-interlanguage-selector"
		aria-label="Go to an article in another language. Available in 71 languages"
		
		
	/>
	<label
		id="p-lang-btn-label"
		for="p-lang-btn-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive mw-portlet-lang-heading-71"
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-language-progressive mw-ui-icon-wikimedia-language-progressive"></span>


		<span class="vector-menu-heading-label">71 languages</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">

		<div class="vector-menu-content">
			
			<ul class="vector-menu-content-list"><li class="interlanguage-link interwiki-af mw-list-item"><a href="https://af.wikipedia.org/wiki/Veelvuldige_sklerose" title="Veelvuldige sklerose – Afrikaans" lang="af" hreflang="af" class="interlanguage-link-target"><span>Afrikaans</span></a></li><li class="interlanguage-link interwiki-ar mw-list-item"><a href="https://ar.wikipedia.org/wiki/%D8%AA%D8%B5%D9%84%D8%A8_%D9%85%D8%AA%D8%B9%D8%AF%D8%AF" title="تصلب متعدد – Arabic" lang="ar" hreflang="ar" class="interlanguage-link-target"><span>العربية</span></a></li><li class="interlanguage-link interwiki-an mw-list-item"><a href="https://an.wikipedia.org/wiki/Esclerosi_multiple" title="Esclerosi multiple – Aragonese" lang="an" hreflang="an" class="interlanguage-link-target"><span>Aragonés</span></a></li><li class="interlanguage-link interwiki-ast mw-list-item"><a href="https://ast.wikipedia.org/wiki/Esclerosis_m%C3%BAltiple" title="Esclerosis múltiple – Asturian" lang="ast" hreflang="ast" class="interlanguage-link-target"><span>Asturianu</span></a></li><li class="interlanguage-link interwiki-az mw-list-item"><a href="https://az.wikipedia.org/wiki/Da%C4%9F%C4%B1n%C4%B1q_skleroz" title="Dağınıq skleroz – Azerbaijani" lang="az" hreflang="az" class="interlanguage-link-target"><span>Azərbaycanca</span></a></li><li class="interlanguage-link interwiki-bn mw-list-item"><a href="https://bn.wikipedia.org/wiki/%E0%A6%AE%E0%A6%BE%E0%A6%B2%E0%A7%8D%E0%A6%9F%E0%A6%BF%E0%A6%AA%E0%A6%B2_%E0%A6%B8%E0%A7%8D%E0%A6%95%E0%A7%8D%E0%A6%B2%E0%A7%87%E0%A6%B0%E0%A7%8B%E0%A6%B8%E0%A6%BF%E0%A6%B8" title="মাল্টিপল স্ক্লেরোসিস – Bangla" lang="bn" hreflang="bn" class="interlanguage-link-target"><span>বাংলা</span></a></li><li class="interlanguage-link interwiki-bg badge-Q17437796 badge-featuredarticle mw-list-item" title="featured article badge"><a href="https://bg.wikipedia.org/wiki/%D0%9C%D0%BD%D0%BE%D0%B6%D0%B5%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%B0_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7%D0%B0" title="Множествена склероза – Bulgarian" lang="bg" hreflang="bg" class="interlanguage-link-target"><span>Български</span></a></li><li class="interlanguage-link interwiki-bs badge-Q17437796 badge-featuredarticle mw-list-item" title="featured article badge"><a href="https://bs.wikipedia.org/wiki/Multipla_skleroza" title="Multipla skleroza – Bosnian" lang="bs" hreflang="bs" class="interlanguage-link-target"><span>Bosanski</span></a></li><li class="interlanguage-link interwiki-ca mw-list-item"><a href="https://ca.wikipedia.org/wiki/Esclerosi_m%C3%BAltiple" title="Esclerosi múltiple – Catalan" lang="ca" hreflang="ca" class="interlanguage-link-target"><span>Català</span></a></li><li class="interlanguage-link interwiki-cs badge-Q17437796 badge-featuredarticle mw-list-item" title="featured article badge"><a href="https://cs.wikipedia.org/wiki/Roztrou%C5%A1en%C3%A1_skler%C3%B3za" title="Roztroušená skleróza – Czech" lang="cs" hreflang="cs" class="interlanguage-link-target"><span>Čeština</span></a></li><li class="interlanguage-link interwiki-cy mw-list-item"><a href="https://cy.wikipedia.org/wiki/Sglerosis_ymledol" title="Sglerosis ymledol – Welsh" lang="cy" hreflang="cy" class="interlanguage-link-target"><span>Cymraeg</span></a></li><li class="interlanguage-link interwiki-da badge-Q17559452 badge-recommendedarticle mw-list-item" title="recommended article"><a href="https://da.wikipedia.org/wiki/Multipel_sklerose" title="Multipel sklerose – Danish" lang="da" hreflang="da" class="interlanguage-link-target"><span>Dansk</span></a></li><li class="interlanguage-link interwiki-de badge-Q17437796 badge-featuredarticle mw-list-item" title="featured article badge"><a href="https://de.wikipedia.org/wiki/Multiple_Sklerose" title="Multiple Sklerose – German" lang="de" hreflang="de" class="interlanguage-link-target"><span>Deutsch</span></a></li><li class="interlanguage-link interwiki-et mw-list-item"><a href="https://et.wikipedia.org/wiki/Pol%C3%BCskleroos" title="Polüskleroos – Estonian" lang="et" hreflang="et" class="interlanguage-link-target"><span>Eesti</span></a></li><li class="interlanguage-link interwiki-el mw-list-item"><a href="https://el.wikipedia.org/wiki/%CE%A0%CE%BF%CE%BB%CE%BB%CE%B1%CF%80%CE%BB%CE%AE_%CF%83%CE%BA%CE%BB%CE%AE%CF%81%CF%85%CE%BD%CF%83%CE%B7" title="Πολλαπλή σκλήρυνση – Greek" lang="el" hreflang="el" class="interlanguage-link-target"><span>Ελληνικά</span></a></li><li class="interlanguage-link interwiki-es mw-list-item"><a href="https://es.wikipedia.org/wiki/Esclerosis_m%C3%BAltiple" title="Esclerosis múltiple – Spanish" lang="es" hreflang="es" class="interlanguage-link-target"><span>Español</span></a></li><li class="interlanguage-link interwiki-eo mw-list-item"><a href="https://eo.wikipedia.org/wiki/Multloka_sklerozo" title="Multloka sklerozo – Esperanto" lang="eo" hreflang="eo" class="interlanguage-link-target"><span>Esperanto</span></a></li><li class="interlanguage-link interwiki-eu mw-list-item"><a href="https://eu.wikipedia.org/wiki/Esklerosi_anizkoitz" title="Esklerosi anizkoitz – Basque" lang="eu" hreflang="eu" class="interlanguage-link-target"><span>Euskara</span></a></li><li class="interlanguage-link interwiki-fa mw-list-item"><a href="https://fa.wikipedia.org/wiki/%D8%AA%D8%B5%D9%84%D8%A8_%D9%BE%D8%B1%D8%A7%DA%A9%D9%86%D8%AF%D9%87" title="تصلب پراکنده – Persian" lang="fa" hreflang="fa" class="interlanguage-link-target"><span>فارسی</span></a></li><li class="interlanguage-link interwiki-fr mw-list-item"><a href="https://fr.wikipedia.org/wiki/Scl%C3%A9rose_en_plaques" title="Sclérose en plaques – French" lang="fr" hreflang="fr" class="interlanguage-link-target"><span>Français</span></a></li><li class="interlanguage-link interwiki-ga mw-list-item"><a href="https://ga.wikipedia.org/wiki/Scl%C3%A9ar%C3%B3is_iolrach" title="Scléaróis iolrach – Irish" lang="ga" hreflang="ga" class="interlanguage-link-target"><span>Gaeilge</span></a></li><li class="interlanguage-link interwiki-gl mw-list-item"><a href="https://gl.wikipedia.org/wiki/Esclerose_m%C3%BAltiple" title="Esclerose múltiple – Galician" lang="gl" hreflang="gl" class="interlanguage-link-target"><span>Galego</span></a></li><li class="interlanguage-link interwiki-ko mw-list-item"><a href="https://ko.wikipedia.org/wiki/%EB%8B%A4%EB%B0%9C%EC%84%B1_%EA%B2%BD%ED%99%94%EC%A6%9D" title="다발성 경화증 – Korean" lang="ko" hreflang="ko" class="interlanguage-link-target"><span>한국어</span></a></li><li class="interlanguage-link interwiki-ha mw-list-item"><a href="https://ha.wikipedia.org/wiki/Sclerosis_da_yawa" title="Sclerosis da yawa – Hausa" lang="ha" hreflang="ha" class="interlanguage-link-target"><span>Hausa</span></a></li><li class="interlanguage-link interwiki-hy mw-list-item"><a href="https://hy.wikipedia.org/wiki/%D5%91%D6%80%D5%BE%D5%A1%D5%AE_%D5%BD%D5%AF%D5%AC%D5%A5%D6%80%D5%B8%D5%A6" title="Ցրված սկլերոզ – Armenian" lang="hy" hreflang="hy" class="interlanguage-link-target"><span>Հայերեն</span></a></li><li class="interlanguage-link interwiki-hi mw-list-item"><a href="https://hi.wikipedia.org/wiki/%E0%A4%AC%E0%A4%B9%E0%A5%81%E0%A4%B8%E0%A5%83%E0%A4%A4_%E0%A4%95%E0%A4%BE%E0%A4%A0%E0%A4%BF%E0%A4%A8%E0%A5%8D%E0%A4%AF" title="बहुसृत काठिन्य – Hindi" lang="hi" hreflang="hi" class="interlanguage-link-target"><span>हिन्दी</span></a></li><li class="interlanguage-link interwiki-hr badge-Q17437796 badge-featuredarticle mw-list-item" title="featured article badge"><a href="https://hr.wikipedia.org/wiki/Multipla_skleroza" title="Multipla skleroza – Croatian" lang="hr" hreflang="hr" class="interlanguage-link-target"><span>Hrvatski</span></a></li><li class="interlanguage-link interwiki-id mw-list-item"><a href="https://id.wikipedia.org/wiki/Sklerosis_multipel" title="Sklerosis multipel – Indonesian" lang="id" hreflang="id" class="interlanguage-link-target"><span>Bahasa Indonesia</span></a></li><li class="interlanguage-link interwiki-is mw-list-item"><a href="https://is.wikipedia.org/wiki/MS_(sj%C3%BAkd%C3%B3mur)" title="MS (sjúkdómur) – Icelandic" lang="is" hreflang="is" class="interlanguage-link-target"><span>Íslenska</span></a></li><li class="interlanguage-link interwiki-it badge-Q17437796 badge-featuredarticle mw-list-item" title="featured article badge"><a href="https://it.wikipedia.org/wiki/Sclerosi_multipla" title="Sclerosi multipla – Italian" lang="it" hreflang="it" class="interlanguage-link-target"><span>Italiano</span></a></li><li class="interlanguage-link interwiki-he mw-list-item"><a href="https://he.wikipedia.org/wiki/%D7%98%D7%A8%D7%A9%D7%AA_%D7%A0%D7%A4%D7%95%D7%A6%D7%94" title="טרשת נפוצה – Hebrew" lang="he" hreflang="he" class="interlanguage-link-target"><span>עברית</span></a></li><li class="interlanguage-link interwiki-sw mw-list-item"><a href="https://sw.wikipedia.org/wiki/Sklerosisi_ya_sehemu_nyingi" title="Sklerosisi ya sehemu nyingi – Swahili" lang="sw" hreflang="sw" class="interlanguage-link-target"><span>Kiswahili</span></a></li><li class="interlanguage-link interwiki-ku mw-list-item"><a href="https://ku.wikipedia.org/wiki/Skleroza_en%C3%AEfireh" title="Skleroza enîfireh – Kurdish" lang="ku" hreflang="ku" class="interlanguage-link-target"><span>Kurdî</span></a></li><li class="interlanguage-link interwiki-la mw-list-item"><a href="https://la.wikipedia.org/wiki/Encephalomyelitis_disseminata" title="Encephalomyelitis disseminata – Latin" lang="la" hreflang="la" class="interlanguage-link-target"><span>Latina</span></a></li><li class="interlanguage-link interwiki-lv mw-list-item"><a href="https://lv.wikipedia.org/wiki/Izkais%C4%ABt%C4%81_skleroze" title="Izkaisītā skleroze – Latvian" lang="lv" hreflang="lv" class="interlanguage-link-target"><span>Latviešu</span></a></li><li class="interlanguage-link interwiki-lt mw-list-item"><a href="https://lt.wikipedia.org/wiki/I%C5%A1s%C4%97tin%C4%97_skleroz%C4%97" title="Išsėtinė sklerozė – Lithuanian" lang="lt" hreflang="lt" class="interlanguage-link-target"><span>Lietuvių</span></a></li><li class="interlanguage-link interwiki-lfn mw-list-item"><a href="https://lfn.wikipedia.org/wiki/Sclerose_multiple" title="Sclerose multiple – Lingua Franca Nova" lang="lfn" hreflang="lfn" class="interlanguage-link-target"><span>Lingua Franca Nova</span></a></li><li class="interlanguage-link interwiki-hu badge-Q17437798 badge-goodarticle mw-list-item" title="good article badge"><a href="https://hu.wikipedia.org/wiki/Sclerosis_multiplex" title="Sclerosis multiplex – Hungarian" lang="hu" hreflang="hu" class="interlanguage-link-target"><span>Magyar</span></a></li><li class="interlanguage-link interwiki-mk mw-list-item"><a href="https://mk.wikipedia.org/wiki/%D0%9C%D1%83%D0%BB%D1%82%D0%B8%D0%BF%D0%BB%D0%B0_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7%D0%B0" title="Мултипла склероза – Macedonian" lang="mk" hreflang="mk" class="interlanguage-link-target"><span>Македонски</span></a></li><li class="interlanguage-link interwiki-ml mw-list-item"><a href="https://ml.wikipedia.org/wiki/%E0%B4%AE%E0%B5%BE%E0%B4%9F%E0%B5%8D%E0%B4%9F%E0%B4%BF%E0%B4%AA%E0%B5%8D%E0%B4%AA%E0%B4%BF%E0%B5%BE_%E0%B4%B8%E0%B5%8D%E0%B4%95%E0%B5%8D%E0%B4%B2%E0%B5%80%E0%B4%B1%E0%B5%8B%E0%B4%B8%E0%B4%BF%E0%B4%B8%E0%B5%8D" title="മൾട്ടിപ്പിൾ സ്ക്ലീറോസിസ് – Malayalam" lang="ml" hreflang="ml" class="interlanguage-link-target"><span>മലയാളം</span></a></li><li class="interlanguage-link interwiki-mr mw-list-item"><a href="https://mr.wikipedia.org/wiki/%E0%A4%AE%E0%A4%B2%E0%A5%8D%E0%A4%9F%E0%A4%BF%E0%A4%AA%E0%A4%B2_%E0%A4%B8%E0%A5%8D%E0%A4%95%E0%A5%8D%E0%A4%B2%E0%A5%87%E0%A4%B0%E0%A5%89%E0%A4%B8%E0%A4%BF%E0%A4%B8" title="मल्टिपल स्क्लेरॉसिस – Marathi" lang="mr" hreflang="mr" class="interlanguage-link-target"><span>मराठी</span></a></li><li class="interlanguage-link interwiki-ms mw-list-item"><a href="https://ms.wikipedia.org/wiki/Sklerosis_berbilang" title="Sklerosis berbilang – Malay" lang="ms" hreflang="ms" class="interlanguage-link-target"><span>Bahasa Melayu</span></a></li><li class="interlanguage-link interwiki-nl mw-list-item"><a href="https://nl.wikipedia.org/wiki/Multiple_sclerose" title="Multiple sclerose – Dutch" lang="nl" hreflang="nl" class="interlanguage-link-target"><span>Nederlands</span></a></li><li class="interlanguage-link interwiki-ja mw-list-item"><a href="https://ja.wikipedia.org/wiki/%E5%A4%9A%E7%99%BA%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87" title="多発性硬化症 – Japanese" lang="ja" hreflang="ja" class="interlanguage-link-target"><span>日本語</span></a></li><li class="interlanguage-link interwiki-no mw-list-item"><a href="https://no.wikipedia.org/wiki/Multippel_sklerose" title="Multippel sklerose – Norwegian Bokmål" lang="nb" hreflang="nb" class="interlanguage-link-target"><span>Norsk bokmål</span></a></li><li class="interlanguage-link interwiki-nn mw-list-item"><a href="https://nn.wikipedia.org/wiki/Multippel_sklerose" title="Multippel sklerose – Norwegian Nynorsk" lang="nn" hreflang="nn" class="interlanguage-link-target"><span>Norsk nynorsk</span></a></li><li class="interlanguage-link interwiki-oc mw-list-item"><a href="https://oc.wikipedia.org/wiki/Escler%C3%B2si_multipla" title="Escleròsi multipla – Occitan" lang="oc" hreflang="oc" class="interlanguage-link-target"><span>Occitan</span></a></li><li class="interlanguage-link interwiki-or mw-list-item"><a href="https://or.wikipedia.org/wiki/%E0%AC%AE%E0%AC%B2%E0%AD%8D%E0%AC%9F%E0%AC%BF%E0%AC%AA%E0%AD%8D%E0%AC%B2_%E0%AC%B8%E0%AD%8D%E0%AC%95%E0%AD%8D%E0%AC%B2%E0%AD%87%E0%AC%B0%E0%AD%8B%E0%AC%B8%E0%AC%BF%E0%AC%B8" title="ମଲ୍ଟିପ୍ଲ ସ୍କ୍ଲେରୋସିସ – Odia" lang="or" hreflang="or" class="interlanguage-link-target"><span>ଓଡ଼ିଆ</span></a></li><li class="interlanguage-link interwiki-pl badge-Q17437798 badge-goodarticle mw-list-item" title="good article badge"><a href="https://pl.wikipedia.org/wiki/Stwardnienie_rozsiane" title="Stwardnienie rozsiane – Polish" lang="pl" hreflang="pl" class="interlanguage-link-target"><span>Polski</span></a></li><li class="interlanguage-link interwiki-pt badge-Q17437796 badge-featuredarticle mw-list-item" title="featured article badge"><a href="https://pt.wikipedia.org/wiki/Esclerose_m%C3%BAltipla" title="Esclerose múltipla – Portuguese" lang="pt" hreflang="pt" class="interlanguage-link-target"><span>Português</span></a></li><li class="interlanguage-link interwiki-ro mw-list-item"><a href="https://ro.wikipedia.org/wiki/Scleroz%C4%83_multipl%C4%83" title="Scleroză multiplă – Romanian" lang="ro" hreflang="ro" class="interlanguage-link-target"><span>Română</span></a></li><li class="interlanguage-link interwiki-ru mw-list-item"><a href="https://ru.wikipedia.org/wiki/%D0%A0%D0%B0%D1%81%D1%81%D0%B5%D1%8F%D0%BD%D0%BD%D1%8B%D0%B9_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7" title="Рассеянный склероз – Russian" lang="ru" hreflang="ru" class="interlanguage-link-target"><span>Русский</span></a></li><li class="interlanguage-link interwiki-sq mw-list-item"><a href="https://sq.wikipedia.org/wiki/Multiple_skleroza" title="Multiple skleroza – Albanian" lang="sq" hreflang="sq" class="interlanguage-link-target"><span>Shqip</span></a></li><li class="interlanguage-link interwiki-simple mw-list-item"><a href="https://simple.wikipedia.org/wiki/Multiple_sclerosis" title="Multiple sclerosis – Simple English" lang="en-simple" hreflang="en-simple" class="interlanguage-link-target"><span>Simple English</span></a></li><li class="interlanguage-link interwiki-sk mw-list-item"><a href="https://sk.wikipedia.org/wiki/Skler%C3%B3za_multiplex" title="Skleróza multiplex – Slovak" lang="sk" hreflang="sk" class="interlanguage-link-target"><span>Slovenčina</span></a></li><li class="interlanguage-link interwiki-sl mw-list-item"><a href="https://sl.wikipedia.org/wiki/Multipla_skleroza" title="Multipla skleroza – Slovenian" lang="sl" hreflang="sl" class="interlanguage-link-target"><span>Slovenščina</span></a></li><li class="interlanguage-link interwiki-ckb mw-list-item"><a href="https://ckb.wikipedia.org/wiki/%D8%A6%DB%8E%D9%85_%D8%A6%DB%8E%D8%B3" title="ئێم ئێس – Central Kurdish" lang="ckb" hreflang="ckb" class="interlanguage-link-target"><span>کوردی</span></a></li><li class="interlanguage-link interwiki-sr badge-Q17437796 badge-featuredarticle mw-list-item" title="featured article badge"><a href="https://sr.wikipedia.org/wiki/Multipla_skleroza" title="Multipla skleroza – Serbian" lang="sr" hreflang="sr" class="interlanguage-link-target"><span>Српски / srpski</span></a></li><li class="interlanguage-link interwiki-sh mw-list-item"><a href="https://sh.wikipedia.org/wiki/Multipla_skleroza" title="Multipla skleroza – Serbo-Croatian" lang="sh" hreflang="sh" class="interlanguage-link-target"><span>Srpskohrvatski / српскохрватски</span></a></li><li class="interlanguage-link interwiki-fi mw-list-item"><a href="https://fi.wikipedia.org/wiki/MS-tauti" title="MS-tauti – Finnish" lang="fi" hreflang="fi" class="interlanguage-link-target"><span>Suomi</span></a></li><li class="interlanguage-link interwiki-sv mw-list-item"><a href="https://sv.wikipedia.org/wiki/Multipel_skleros" title="Multipel skleros – Swedish" lang="sv" hreflang="sv" class="interlanguage-link-target"><span>Svenska</span></a></li><li class="interlanguage-link interwiki-ta mw-list-item"><a href="https://ta.wikipedia.org/wiki/%E0%AE%A4%E0%AE%A3%E0%AF%8D%E0%AE%9F%E0%AF%81%E0%AE%B5%E0%AE%9F_%E0%AE%AE%E0%AE%B0%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%81_%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8D" title="தண்டுவட மரப்பு நோய் – Tamil" lang="ta" hreflang="ta" class="interlanguage-link-target"><span>தமிழ்</span></a></li><li class="interlanguage-link interwiki-tt mw-list-item"><a href="https://tt.wikipedia.org/wiki/%D0%A2%D0%B0%D1%80%D0%BA%D0%B0%D1%83_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7" title="Таркау склероз – Tatar" lang="tt" hreflang="tt" class="interlanguage-link-target"><span>Татарча / tatarça</span></a></li><li class="interlanguage-link interwiki-te mw-list-item"><a href="https://te.wikipedia.org/wiki/%E0%B0%AE%E0%B0%B2%E0%B1%8D%E0%B0%9F%E0%B0%BF%E0%B0%AA%E0%B1%81%E0%B0%B2%E0%B1%8D_%E0%B0%B8%E0%B1%8D%E0%B0%B2%E0%B1%8D%E0%B0%95%E0%B0%BF%E0%B0%B0%E0%B1%8B%E0%B0%B8%E0%B0%BF%E0%B0%B8%E0%B1%8D_(%E0%B0%8E%E0%B0%82.%E0%B0%8E%E0%B0%B8%E0%B1%8D)" title="మల్టిపుల్ స్ల్కిరోసిస్ (ఎం.ఎస్) – Telugu" lang="te" hreflang="te" class="interlanguage-link-target"><span>తెలుగు</span></a></li><li class="interlanguage-link interwiki-th mw-list-item"><a href="https://th.wikipedia.org/wiki/%E0%B9%82%E0%B8%A3%E0%B8%84%E0%B8%9B%E0%B8%A5%E0%B8%AD%E0%B8%81%E0%B8%9B%E0%B8%A3%E0%B8%B0%E0%B8%AA%E0%B8%B2%E0%B8%97%E0%B9%80%E0%B8%AA%E0%B8%B7%E0%B9%88%E0%B8%AD%E0%B8%A1%E0%B9%81%E0%B8%82%E0%B9%87%E0%B8%87" title="โรคปลอกประสาทเสื่อมแข็ง – Thai" lang="th" hreflang="th" class="interlanguage-link-target"><span>ไทย</span></a></li><li class="interlanguage-link interwiki-tr mw-list-item"><a href="https://tr.wikipedia.org/wiki/Multipl_skleroz" title="Multipl skleroz – Turkish" lang="tr" hreflang="tr" class="interlanguage-link-target"><span>Türkçe</span></a></li><li class="interlanguage-link interwiki-uk mw-list-item"><a href="https://uk.wikipedia.org/wiki/%D0%A0%D0%BE%D0%B7%D1%81%D1%96%D1%8F%D0%BD%D0%B8%D0%B9_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7" title="Розсіяний склероз – Ukrainian" lang="uk" hreflang="uk" class="interlanguage-link-target"><span>Українська</span></a></li><li class="interlanguage-link interwiki-vi mw-list-item"><a href="https://vi.wikipedia.org/wiki/%C4%90a_x%C6%A1_c%E1%BB%A9ng" title="Đa xơ cứng – Vietnamese" lang="vi" hreflang="vi" class="interlanguage-link-target"><span>Tiếng Việt</span></a></li><li class="interlanguage-link interwiki-wuu mw-list-item"><a href="https://wuu.wikipedia.org/wiki/%E5%A4%9A%E5%8F%91%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87" title="多发性硬化症 – Wu Chinese" lang="wuu" hreflang="wuu" class="interlanguage-link-target"><span>吴语</span></a></li><li class="interlanguage-link interwiki-zh-yue mw-list-item"><a href="https://zh-yue.wikipedia.org/wiki/%E5%A4%9A%E7%99%BC%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87" title="多發性硬化症 – Cantonese" lang="yue" hreflang="yue" class="interlanguage-link-target"><span>粵語</span></a></li><li class="interlanguage-link interwiki-zh badge-Q17437796 badge-featuredarticle mw-list-item" title="featured article badge"><a href="https://zh.wikipedia.org/wiki/%E5%A4%9A%E5%8F%91%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87" title="多发性硬化症 – Chinese" lang="zh" hreflang="zh" class="interlanguage-link-target"><span>中文</span></a></li></ul>
			<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q8277#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>
		</div>

	</div>
</div>
				</header>
				<div class="vector-page-toolbar">
					<div class="vector-page-toolbar-container">
						<div id="left-navigation">
							<nav aria-label="Namespaces">
								
<div id="p-associated-pages" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			<li id="ca-nstab-main" class="selected vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/Multiple_sclerosis" title="View the content page [c]" accesskey="c" class=""><span>Article</span></a>
</li>
<li id="ca-talk" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/Talk:Multiple_sclerosis" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t" class=""><span>Talk</span></a>
</li>

		</ul>
		
	</div>
</div>

								

<div id="p-variants" class="vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-variants emptyPortlet"  >
	<input type="checkbox"
		id="p-variants-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-variants"
		class="vector-menu-checkbox"
		aria-label="Change language variant"
		
		
	/>
	<label
		id="p-variants-label"
		for="p-variants-checkbox"
		class="vector-menu-heading "
		aria-hidden="true"
		
	>
		
		<span class="vector-menu-heading-label">English</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">

	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"></ul>
		
	</div>

	</div>
</div>
							</nav>
						</div>
						<div id="right-navigation" class="vector-collapsible">
							<nav aria-label="Views">
								
<div id="p-views" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-views"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			<li id="ca-view" class="selected vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/Multiple_sclerosis" class=""><span>Read</span></a>
</li>
<li id="ca-edit" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/w/index.php?title=Multiple_sclerosis&amp;action=edit" title="Edit this page [e]" accesskey="e" class=""><span>Edit</span></a>
</li>
<li id="ca-history" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/w/index.php?title=Multiple_sclerosis&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class=""><span>View history</span></a>
</li>

		</ul>
		
	</div>
</div>

							</nav>
				
							<nav class="vector-page-tools-landmark" aria-label="More options">
								
<div id="vector-page-tools-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-page-tools-dropdown"  >
	<input type="checkbox"
		id="vector-page-tools-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-page-tools-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Tools"
		
	/>
	<label
		id="vector-page-tools-dropdown-label"
		for="vector-page-tools-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet"
		aria-hidden="true"
		
	>
		
		<span class="vector-menu-heading-label">Tools</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


									<div id="vector-page-tools-unpinned-container" class="vector-unpinned-container">
						
<div id="vector-page-tools" class="vector-page-tools vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned"
	data-feature-name="page-tools-pinned"
	data-pinnable-element-id="vector-page-tools"
	data-pinned-container-id="vector-page-tools-pinned-container"
	data-unpinned-container-id="vector-page-tools-unpinned-container"
>
	<div class="vector-pinnable-header-label">Tools</div>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-page-tools.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-page-tools.unpin">hide</button>
</div>

	
<div id="p-cactions" class="vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items"  title="More options" >
	<div class="vector-menu-heading">
		Actions
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="ca-more-view" class="selected vector-more-collapsible-item mw-list-item"><a href="/wiki/Multiple_sclerosis"><span>Read</span></a></li><li id="ca-more-edit" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit"><span>Edit</span></a></li><li id="ca-more-history" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Multiple_sclerosis&amp;action=history"><span>View history</span></a></li></ul>
		
	</div>
</div>

<div id="p-tb" class="vector-menu mw-portlet mw-portlet-tb"  >
	<div class="vector-menu-heading">
		General
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/Multiple_sclerosis" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j"><span>What links here</span></a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/Multiple_sclerosis" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k"><span>Related changes</span></a></li><li id="t-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u"><span>Upload file</span></a></li><li id="t-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q"><span>Special pages</span></a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=Multiple_sclerosis&amp;oldid=1162037993" title="Permanent link to this revision of this page"><span>Permanent link</span></a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=Multiple_sclerosis&amp;action=info" title="More information about this page"><span>Page information</span></a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Multiple_sclerosis&amp;id=1162037993&amp;wpFormIdentifier=titleform" title="Information on how to cite this page"><span>Cite this page</span></a></li><li id="t-wikibase" class="mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q8277" title="Structured data on this page hosted by Wikidata [g]" accesskey="g"><span>Wikidata item</span></a></li></ul>
		
	</div>
</div>

<div id="p-coll-print_export" class="vector-menu mw-portlet mw-portlet-coll-print_export"  >
	<div class="vector-menu-heading">
		Print/export
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&amp;page=Multiple_sclerosis&amp;action=show-download-screen" title="Download this page as a PDF file"><span>Download as PDF</span></a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=Multiple_sclerosis&amp;printable=yes" title="Printable version of this page [p]" accesskey="p"><span>Printable version</span></a></li></ul>
		
	</div>
</div>

<div id="p-wikibase-otherprojects" class="vector-menu mw-portlet mw-portlet-wikibase-otherprojects"  >
	<div class="vector-menu-heading">
		In other projects
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li class="wb-otherproject-link wb-otherproject-commons mw-list-item"><a href="https://commons.wikimedia.org/wiki/Category:Multiple_sclerosis" hreflang="en"><span>Wikimedia Commons</span></a></li></ul>
		
	</div>
</div>

</div>

									</div>
				
	</div>
</div>
							</nav>
						</div>
					</div>
				</div>
				<div class="vector-column-end">
					<nav class="vector-page-tools-landmark vector-sticky-pinned-container" aria-label="More options">
						<div id="vector-page-tools-pinned-container" class="vector-pinned-container">
			
						</div>
	</nav>
				</div>
				<div id="bodyContent" class="vector-body" aria-labelledby="firstHeading" data-mw-ve-target-container>
					<div class="vector-body-before-content">
							<div class="mw-indicators">
		</div>

						<div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div>
					</div>
					<div id="contentSub"><div id="mw-content-subtitle"></div></div>
					
					
					<div id="mw-content-text" class="mw-body-content mw-content-ltr" lang="en" dir="ltr"><div class="mw-parser-output"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Disease that damages the myelin sheaths around nerves</div>
<style data-mw-deduplicate="TemplateStyles:r1097763485">.mw-parser-output .ambox{border:1px solid #a2a9b1;border-left:10px solid #36c;background-color:#fbfbfb;box-sizing:border-box}.mw-parser-output .ambox+link+.ambox,.mw-parser-output .ambox+link+style+.ambox,.mw-parser-output .ambox+link+link+.ambox,.mw-parser-output .ambox+.mw-empty-elt+link+.ambox,.mw-parser-output .ambox+.mw-empty-elt+link+style+.ambox,.mw-parser-output .ambox+.mw-empty-elt+link+link+.ambox{margin-top:-1px}html body.mediawiki .mw-parser-output .ambox.mbox-small-left{margin:4px 1em 4px 0;overflow:hidden;width:238px;border-collapse:collapse;font-size:88%;line-height:1.25em}.mw-parser-output .ambox-speedy{border-left:10px solid #b32424;background-color:#fee7e6}.mw-parser-output .ambox-delete{border-left:10px solid #b32424}.mw-parser-output .ambox-content{border-left:10px solid #f28500}.mw-parser-output .ambox-style{border-left:10px solid #fc3}.mw-parser-output .ambox-move{border-left:10px solid #9932cc}.mw-parser-output .ambox-protection{border-left:10px solid #a2a9b1}.mw-parser-output .ambox .mbox-text{border:none;padding:0.25em 0.5em;width:100%}.mw-parser-output .ambox .mbox-image{border:none;padding:2px 0 2px 0.5em;text-align:center}.mw-parser-output .ambox .mbox-imageright{border:none;padding:2px 0.5em 2px 0;text-align:center}.mw-parser-output .ambox .mbox-empty-cell{border:none;padding:0;width:1px}.mw-parser-output .ambox .mbox-image-div{width:52px}html.client-js body.skin-minerva .mw-parser-output .mbox-text-span{margin-left:23px!important}@media(min-width:720px){.mw-parser-output .ambox{margin:0 10%}}</style><table class="box-Medical_citations_needed plainlinks metadata ambox ambox-content" role="presentation"><tbody><tr><td class="mbox-image"><div class="mbox-image-div"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png" decoding="async" width="40" height="40" srcset="//upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/60px-Ambox_important.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/80px-Ambox_important.svg.png 2x" data-file-width="40" data-file-height="40" /></div></td><td class="mbox-text"><div class="mbox-text-span">This article <b>needs more <a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)">reliable medical references</a> for <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verification</a> or relies too heavily on <a href="/wiki/Wikipedia:Primary_sources" class="mw-redirect" title="Wikipedia:Primary sources">primary sources</a>, specifically: references that do not meet <a href="/wiki/Wikipedia:MEDRS" class="mw-redirect" title="Wikipedia:MEDRS">Wikipedia's guidelines for medical content</a>, or are excessively dated, are contained in this article</b>.<span class="hide-when-compact"> Please review the contents of the article and <a class="external text" href="https://en.wikipedia.org/w/index.php?title=Multiple_sclerosis&amp;action=edit">add the appropriate references</a> if you can. Unsourced or poorly sourced material may be challenged and <a href="/wiki/Wikipedia:Verifiability#Burden_of_evidence" title="Wikipedia:Verifiability">removed</a>.<br /><small><span class="plainlinks"><i>Find sources:</i>&#160;<a rel="nofollow" class="external text" href="https://www.google.com/search?as_eq=wikipedia&amp;q=%22Multiple+sclerosis%22">"Multiple sclerosis"</a>&#160;–&#160;<a rel="nofollow" class="external text" href="https://www.google.com/search?tbm=nws&amp;q=%22Multiple+sclerosis%22+-wikipedia&amp;tbs=ar:1">news</a>&#160;<b>·</b> <a rel="nofollow" class="external text" href="https://www.google.com/search?&amp;q=%22Multiple+sclerosis%22&amp;tbs=bkt:s&amp;tbm=bks">newspapers</a>&#160;<b>·</b> <a rel="nofollow" class="external text" href="https://www.google.com/search?tbs=bks:1&amp;q=%22Multiple+sclerosis%22+-wikipedia">books</a>&#160;<b>·</b> <a rel="nofollow" class="external text" href="https://scholar.google.com/scholar?q=%22Multiple+sclerosis%22">scholar</a>&#160;<b>·</b> <a rel="nofollow" class="external text" href="https://www.jstor.org/action/doBasicSearch?Query=%22Multiple+sclerosis%22&amp;acc=on&amp;wc=on">JSTOR</a></span></small></span>  <span class="date-container"><i>(<span class="date">July 2022</span>)</i></span></div></td><td class="mbox-imageright"><div class="mbox-image-div"><a href="/wiki/File:Rod_of_Asclepius2.svg" class="image"><img alt="Rod of Asclepius2.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Rod_of_Asclepius2.svg/17px-Rod_of_Asclepius2.svg.png" decoding="async" width="17" height="56" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Rod_of_Asclepius2.svg/26px-Rod_of_Asclepius2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Rod_of_Asclepius2.svg/35px-Rod_of_Asclepius2.svg.png 2x" data-file-width="251" data-file-height="804" /></a></div></td></tr></tbody></table>
<p class="mw-empty-elt">
</p>
<div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Medical condition</div><style data-mw-deduplicate="TemplateStyles:r1066479718">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}</style><table class="infobox"><tbody><tr><th colspan="2" class="infobox-above" style="background:#ccc">Multiple sclerosis</th></tr><tr><th scope="row" class="infobox-label">Other names</th><td class="infobox-data">Multiple cerebral sclerosis, multiple cerebro-spinal sclerosis, disseminated sclerosis, encephalomyelitis disseminata</td></tr><tr><td colspan="2" class="infobox-full-data"><a href="/wiki/File:MS_Demyelinisation_CD68_10xv2.jpg" class="image"><img alt="MS Demyelinisation CD68 10xv2.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/MS_Demyelinisation_CD68_10xv2.jpg/300px-MS_Demyelinisation_CD68_10xv2.jpg" decoding="async" width="300" height="223" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/MS_Demyelinisation_CD68_10xv2.jpg/450px-MS_Demyelinisation_CD68_10xv2.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/59/MS_Demyelinisation_CD68_10xv2.jpg/600px-MS_Demyelinisation_CD68_10xv2.jpg 2x" data-file-width="2080" data-file-height="1544" /></a></td></tr><tr><td colspan="2" class="infobox-full-data"><a href="/wiki/CD68" title="CD68">CD68</a>-stained tissue shows several <a href="/wiki/Macrophage" title="Macrophage">macrophages</a> in the area of a demyelinated lesion caused by MS.</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_specialty" title="Medical specialty">Specialty</a></th><td class="infobox-data"><a href="/wiki/Neurology" title="Neurology">Neurology</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Signs_and_symptoms" title="Signs and symptoms">Symptoms</a></th><td class="infobox-data">Variable, including almost any neurological symptom or sign, with <a href="/wiki/Autonomic_nervous_system" title="Autonomic nervous system">autonomic</a>, visual, motor, and sensory problems being the most common.<sup id="cite_ref-pmid18970977_1-0" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Usual onset</th><td class="infobox-data">Age 20–50<sup id="cite_ref-Milo2010_2-0" class="reference"><a href="#cite_note-Milo2010-2">&#91;2&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Duration</th><td class="infobox-data">Long term<sup id="cite_ref-NIH2015_3-0" class="reference"><a href="#cite_note-NIH2015-3">&#91;3&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Causes</th><td class="infobox-data">Unknown<sup id="cite_ref-Nak2012_4-0" class="reference"><a href="#cite_note-Nak2012-4">&#91;4&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_diagnosis" title="Medical diagnosis">Diagnostic method</a></th><td class="infobox-data">Based on symptoms and medical tests<sup id="cite_ref-Tsang2011_5-0" class="reference"><a href="#cite_note-Tsang2011-5">&#91;5&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Treatment</th><td class="infobox-data">Disease-Modifying Therapies<sup id="cite_ref-Liu_2021_6-0" class="reference"><a href="#cite_note-Liu_2021-6">&#91;6&#93;</a></sup>
<p>Physiotherapy<sup id="cite_ref-Alphonsus_2019_7-0" class="reference"><a href="#cite_note-Alphonsus_2019-7">&#91;7&#93;</a></sup>
</p>
Occupational Therapy<sup id="cite_ref-Alphonsus_2019_7-1" class="reference"><a href="#cite_note-Alphonsus_2019-7">&#91;7&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Frequency</th><td class="infobox-data">0.032% (<a href="/wiki/World" title="World">world</a>)</td></tr></tbody></table>
<p><b>Multiple</b> <b>sclerosis</b> (<b>MS</b>) is the most common <a href="/wiki/Demyelinating_disease" title="Demyelinating disease">demyelinating disease</a>,<sup id="cite_ref-Leray2016Epidemiology_8-0" class="reference"><a href="#cite_note-Leray2016Epidemiology-8">&#91;8&#93;</a></sup> in which the <a href="/wiki/Myelin" title="Myelin">insulating covers</a> of <a href="/wiki/Nerve_cells" class="mw-redirect" title="Nerve cells">nerve cells</a> in the brain and <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a> are damaged.<sup id="cite_ref-NIH2015_3-1" class="reference"><a href="#cite_note-NIH2015-3">&#91;3&#93;</a></sup> This damage disrupts the ability of parts of the nervous system to <a href="/wiki/Action_potential" title="Action potential">transmit signals</a>, resulting in a range of <a href="/wiki/Signs_and_symptoms" title="Signs and symptoms">signs and symptoms</a>, including physical, <a href="/wiki/Cognitive_disability" class="mw-redirect" title="Cognitive disability">mental</a>, and sometimes psychiatric problems.<sup id="cite_ref-pmid18970977_1-1" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid11955556_9-0" class="reference"><a href="#cite_note-pmid11955556-9">&#91;9&#93;</a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10">&#91;10&#93;</a></sup> Specific symptoms can include <a href="/wiki/Double_vision" class="mw-redirect" title="Double vision">double vision</a>, visual loss, muscle weakness, and trouble with <a href="/wiki/Sensation_(psychology)" class="mw-redirect" title="Sensation (psychology)">sensation</a> or coordination.<sup id="cite_ref-NIH2015_3-2" class="reference"><a href="#cite_note-NIH2015-3">&#91;3&#93;</a></sup><sup id="cite_ref-Piryonesi-2021_11-0" class="reference"><a href="#cite_note-Piryonesi-2021-11">&#91;11&#93;</a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12">&#91;12&#93;</a></sup> MS takes several forms, with new symptoms either occurring in isolated attacks (relapsing forms) or building up over time (progressive forms).<sup id="cite_ref-13" class="reference"><a href="#cite_note-13">&#91;13&#93;</a></sup><sup id="cite_ref-pmid8780061_14-0" class="reference"><a href="#cite_note-pmid8780061-14">&#91;14&#93;</a></sup> In the relapsing forms of MS, between attacks, symptoms may disappear completely, although some permanent neurological problems often remain, especially as the disease advances.<sup id="cite_ref-pmid8780061_14-1" class="reference"><a href="#cite_note-pmid8780061-14">&#91;14&#93;</a></sup>
</p><p>While the cause is unclear, the underlying mechanism is thought to be either <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">destruction by the immune system</a> or failure of the myelin-producing cells.<sup id="cite_ref-Nak2012_4-1" class="reference"><a href="#cite_note-Nak2012-4">&#91;4&#93;</a></sup> Proposed causes for this include <a href="/wiki/Genetics" title="Genetics">genetics</a> and environmental factors, such as <a href="/wiki/Viral_infection" class="mw-redirect" title="Viral infection">viral infections</a>.<sup id="cite_ref-Aloisi2022_15-0" class="reference"><a href="#cite_note-Aloisi2022-15">&#91;15&#93;</a></sup><sup id="cite_ref-pmid11955556_9-1" class="reference"><a href="#cite_note-pmid11955556-9">&#91;9&#93;</a></sup><sup id="cite_ref-pmid17444504_16-0" class="reference"><a href="#cite_note-pmid17444504-16">&#91;16&#93;</a></sup> MS is usually diagnosed based on the presenting signs and symptoms and the results of supporting medical tests.<sup id="cite_ref-Tsang2011_5-1" class="reference"><a href="#cite_note-Tsang2011-5">&#91;5&#93;</a></sup>
</p><p>No cure for multiple sclerosis is known.<sup id="cite_ref-NIH2015_3-3" class="reference"><a href="#cite_note-NIH2015-3">&#91;3&#93;</a></sup> Treatments attempt to improve function after an attack and prevent new attacks.<sup id="cite_ref-pmid11955556_9-2" class="reference"><a href="#cite_note-pmid11955556-9">&#91;9&#93;</a></sup> <a href="/wiki/Physical_therapy" title="Physical therapy">Physical therapy</a><sup id="cite_ref-Alphonsus_2019_7-2" class="reference"><a href="#cite_note-Alphonsus_2019-7">&#91;7&#93;</a></sup> and <a href="/wiki/Occupational_therapy" title="Occupational therapy">occupational therapy</a><sup id="cite_ref-17" class="reference"><a href="#cite_note-17">&#91;17&#93;</a></sup> can help with people's ability to function. Many people pursue <a href="/wiki/Alternative_treatments" class="mw-redirect" title="Alternative treatments">alternative treatments</a>, despite a lack of evidence of benefit.<sup id="cite_ref-pmid16420779_18-0" class="reference"><a href="#cite_note-pmid16420779-18">&#91;18&#93;</a></sup> The long-term outcome is difficult to predict; better outcomes are more often seen in women, those who develop the disease early in life, those with a relapsing course, and those who initially experienced few attacks.<sup id="cite_ref-pmid8017890_19-0" class="reference"><a href="#cite_note-pmid8017890-19">&#91;19&#93;</a></sup>
</p><p>Multiple sclerosis is the most common <a href="/wiki/Immune_disorder" title="Immune disorder">immune-mediated disorder</a> affecting the <a href="/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a>.<sup id="cite_ref-pmid24746689_20-0" class="reference"><a href="#cite_note-pmid24746689-20">&#91;20&#93;</a></sup> Nearly one million people have MS in the United States in 2022,<sup id="cite_ref-McGinley2021_21-0" class="reference"><a href="#cite_note-McGinley2021-21">&#91;21&#93;</a></sup> and in 2020, about 2.8 million people were affected globally, with rates varying widely in different regions and among different populations.<sup id="cite_ref-Lane2022_22-0" class="reference"><a href="#cite_note-Lane2022-22">&#91;22&#93;</a></sup> The disease usually begins between the ages of 20 and 50 and is twice as common in women as in men.<sup id="cite_ref-Milo2010_2-1" class="reference"><a href="#cite_note-Milo2010-2">&#91;2&#93;</a></sup> MS was first described in 1868 by French neurologist <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a>.<sup id="cite_ref-Charcot1_23-0" class="reference"><a href="#cite_note-Charcot1-23">&#91;23&#93;</a></sup> The name "multiple <a href="/wiki/Sclerosis_(medicine)" title="Sclerosis (medicine)">sclerosis</a>" is short for multiple cerebro-spinal sclerosis, which refers to the numerous <a href="/wiki/Glial_scars" class="mw-redirect" title="Glial scars">glial scars</a> (or sclerae – essentially plaques or lesions) that develop on the <a href="/wiki/White_matter" title="White matter">white matter</a> of the brain and spinal cord.<sup id="cite_ref-Charcot1_23-1" class="reference"><a href="#cite_note-Charcot1-23">&#91;23&#93;</a></sup> 
</p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc" /></div>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1033289096">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}</style><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Multiple_sclerosis_signs_and_symptoms" title="Multiple sclerosis signs and symptoms">Multiple sclerosis signs and symptoms</a></div>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:Symptoms_of_multiple_sclerosis.svg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/b/bf/Symptoms_of_multiple_sclerosis.svg/290px-Symptoms_of_multiple_sclerosis.svg.png" decoding="async" width="290" height="441" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/bf/Symptoms_of_multiple_sclerosis.svg/435px-Symptoms_of_multiple_sclerosis.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/bf/Symptoms_of_multiple_sclerosis.svg/580px-Symptoms_of_multiple_sclerosis.svg.png 2x" data-file-width="828" data-file-height="1260" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Symptoms_of_multiple_sclerosis.svg" class="internal" title="Enlarge"></a></div>Main symptoms of multiple sclerosis</div></div></div>
<p>A person with MS can have almost any neurological symptom or sign, with <a href="/wiki/Autonomic_nervous_system" title="Autonomic nervous system">autonomic</a>, visual, motor, and sensory problems being the most common.<sup id="cite_ref-pmid18970977_1-2" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> The specific symptoms are determined by the locations of the lesions within the nervous system, and may include <a href="/wiki/Hypoesthesia" title="Hypoesthesia">loss of sensitivity</a> or <a href="/wiki/Paresthesia" title="Paresthesia">changes in sensation</a>, such as tingling, pins and needles, or numbness; muscle weakness, <a href="/wiki/Blurred_vision" title="Blurred vision">blurred vision</a>,<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">&#91;24&#93;</a></sup> <a href="/wiki/Clonus" title="Clonus">pronounced reflexes</a>, <a href="/wiki/Muscle_spasms" class="mw-redirect" title="Muscle spasms">muscle spasms</a>, difficulty in moving, difficulties with coordination, and balance (<a href="/wiki/Ataxia" title="Ataxia">ataxia</a>); <a href="/wiki/Dysarthria" title="Dysarthria">problems with speech</a> or <a href="/wiki/Dysphagia" title="Dysphagia">swallowing</a>, visual problems (<a href="/wiki/Nystagmus" title="Nystagmus">nystagmus</a>, <a href="/wiki/Optic_neuritis" title="Optic neuritis">optic neuritis</a>,<sup id="cite_ref-Petzold-2022_25-0" class="reference"><a href="#cite_note-Petzold-2022-25">&#91;25&#93;</a></sup> or <a href="/wiki/Diplopia" title="Diplopia">double vision</a>), <a href="/wiki/Fatigue_(physical)" class="mw-redirect" title="Fatigue (physical)">feeling tired</a>, <a href="/wiki/Acute_pain" class="mw-redirect" title="Acute pain">acute</a> or <a href="/wiki/Chronic_pain" title="Chronic pain">chronic pain</a>; and bladder and bowel difficulties (such as <a href="/wiki/Neurogenic_bladder_dysfunction" title="Neurogenic bladder dysfunction">neurogenic bladder</a>), among others.<sup id="cite_ref-pmid18970977_1-3" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> When multiple sclerosis is more advanced, walking difficulties can occur and the risk of falling increases.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26">&#91;26&#93;</a></sup>
</p><p>Difficulties thinking and emotional problems such as depression or <a href="/wiki/Labile_affect" class="mw-redirect" title="Labile affect">unstable mood</a> are also common.<sup id="cite_ref-pmid18970977_1-4" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> The primary deficit in cognitive function that people with MS experience is slowed information-processing speed, with memory also commonly affected, and <a href="/wiki/Executive_functions" title="Executive functions">executive function</a> less commonly. Intelligence, language, and <a href="/wiki/Semantic_memory" title="Semantic memory">semantic memory</a> are usually preserved, and the level of cognitive impairment varies considerably between people with MS.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">&#91;27&#93;</a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup><sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup>
</p><p><a href="/wiki/Uhthoff%27s_phenomenon" title="Uhthoff&#39;s phenomenon">Uhthoff's phenomenon</a>, a worsening of symptoms due to exposure to higher-than-usual temperatures, and <a href="/wiki/Lhermitte%27s_sign" title="Lhermitte&#39;s sign">Lhermitte's sign</a>, an electrical sensation that runs down the back when bending the neck, are particularly characteristic of MS.<sup id="cite_ref-pmid18970977_1-5" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> The main measure of disability and severity is the <a href="/wiki/Expanded_disability_status_scale" class="mw-redirect" title="Expanded disability status scale">expanded disability status scale</a> (EDSS), with other measures such as the <a href="/wiki/Multiple_sclerosis_functional_composite" title="Multiple sclerosis functional composite">multiple sclerosis functional composite</a> being increasingly used in research.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">&#91;30&#93;</a></sup><sup id="cite_ref-pmid10467378_31-0" class="reference"><a href="#cite_note-pmid10467378-31">&#91;31&#93;</a></sup><sup id="cite_ref-pmid12356200_32-0" class="reference"><a href="#cite_note-pmid12356200-32">&#91;32&#93;</a></sup> EDSS is also correlated with falls in people with MS.<sup id="cite_ref-Piryonesi-2021_11-1" class="reference"><a href="#cite_note-Piryonesi-2021-11">&#91;11&#93;</a></sup> While it is a popular measure, EDSS has been criticized for some of its limitations, such as relying too much on walking.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33">&#91;33&#93;</a></sup><sup id="cite_ref-Piryonesi-2021_11-2" class="reference"><a href="#cite_note-Piryonesi-2021-11">&#91;11&#93;</a></sup>
</p><p>The condition begins in 85% of cases as a <a href="/wiki/Clinically_isolated_syndrome" title="Clinically isolated syndrome">clinically isolated syndrome</a> (CIS) over a number of days with 45% having motor or sensory problems, 20% having optic neuritis,<sup id="cite_ref-Petzold-2022_25-1" class="reference"><a href="#cite_note-Petzold-2022-25">&#91;25&#93;</a></sup> and 10% having symptoms related to <a href="/wiki/Brainstem" title="Brainstem">brainstem</a> dysfunction, while the remaining 25% have more than one of the previous difficulties.<sup id="cite_ref-Tsang2011_5-2" class="reference"><a href="#cite_note-Tsang2011-5">&#91;5&#93;</a></sup> The course of symptoms occurs in two main patterns initially: either as episodes of sudden worsening that last a few days to months (called <a href="/wiki/Relapse" title="Relapse">relapses</a>, exacerbations, bouts, attacks, or flare-ups) followed by improvement (85% of cases) or as a gradual worsening over time without periods of recovery (10–15% of cases).<sup id="cite_ref-Milo2010_2-2" class="reference"><a href="#cite_note-Milo2010-2">&#91;2&#93;</a></sup> A combination of these two patterns may also occur<sup id="cite_ref-pmid8780061_14-2" class="reference"><a href="#cite_note-pmid8780061-14">&#91;14&#93;</a></sup> or people may start in a relapsing and remitting course that then becomes progressive later on.<sup id="cite_ref-Milo2010_2-3" class="reference"><a href="#cite_note-Milo2010-2">&#91;2&#93;</a></sup>
</p><p>Relapses are usually not predictable, occurring without warning.<sup id="cite_ref-pmid18970977_1-6" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> Exacerbations rarely occur more frequently than twice per year.<sup id="cite_ref-pmid18970977_1-7" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> Some relapses, however, are preceded by common triggers and they occur more frequently during spring and summer.<sup id="cite_ref-pmid16804331_34-0" class="reference"><a href="#cite_note-pmid16804331-34">&#91;34&#93;</a></sup> Similarly, viral infections such as the <a href="/wiki/Common_cold" title="Common cold">common cold</a>, <a href="/wiki/Influenza" title="Influenza">influenza</a>, or <a href="/wiki/Gastroenteritis" title="Gastroenteritis">gastroenteritis</a> increase their risk.<sup id="cite_ref-pmid18970977_1-8" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> <a href="/wiki/Stress_(medicine)" class="mw-redirect" title="Stress (medicine)">Stress</a> may also trigger an attack.<sup id="cite_ref-pmid17439878_35-0" class="reference"><a href="#cite_note-pmid17439878-35">&#91;35&#93;</a></sup> Women with MS <a href="/wiki/Intercurrent_disease_in_pregnancy" class="mw-redirect" title="Intercurrent disease in pregnancy">who become pregnant</a> experience fewer relapses; however, during the first months after delivery the risk increases.<sup id="cite_ref-pmid18970977_1-9" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> Overall, pregnancy does not seem to influence long-term disability.<sup id="cite_ref-pmid18970977_1-10" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> Many events have been found not to affect relapse rates including <a href="/wiki/Vaccination" title="Vaccination">vaccination</a>,<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">&#91;36&#93;</a></sup><sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag needs references to reliable medical sources. (May 2023)">medical citation needed</span></a></i>&#93;</sup> <a href="/wiki/Breast_feeding" class="mw-redirect" title="Breast feeding">breast feeding</a>,<sup id="cite_ref-pmid18970977_1-11" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> physical trauma,<sup id="cite_ref-pmid11205361_37-0" class="reference"><a href="#cite_note-pmid11205361-37">&#91;37&#93;</a></sup> and Uhthoff's phenomenon.<sup id="cite_ref-pmid16804331_34-1" class="reference"><a href="#cite_note-pmid16804331-34">&#91;34&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Prodromal_phase">Prodromal phase</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=2" title="Edit section: Prodromal phase">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>MS may have a <a href="/wiki/Prodromal" class="mw-redirect" title="Prodromal">prodromal</a> phase in the years leading up to MS manifestation, characterized by psychiatric issues, cognitive impairment, and increased use of healthcare.<sup id="cite_ref-Makhani2021Prodrome_38-0" class="reference"><a href="#cite_note-Makhani2021Prodrome-38">&#91;38&#93;</a></sup><sup id="cite_ref-Marrie2019_Prodrome_39-0" class="reference"><a href="#cite_note-Marrie2019_Prodrome-39">&#91;39&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=3" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The cause of MS is unknown, but it is believed to occur as a result of some combination of genetic and environmental factors, such as infectious agents.<sup id="cite_ref-pmid18970977_1-12" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Infectious_agents">Infectious agents</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=4" title="Edit section: Infectious agents">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Many <a href="/wiki/Microbes" class="mw-redirect" title="Microbes">microbes</a> have been proposed as triggers of MS.<sup id="cite_ref-pmid11955556_9-3" class="reference"><a href="#cite_note-pmid11955556-9">&#91;9&#93;</a></sup> One hypothesis is that infection by a widespread microbe contributes to disease development, and the geographic distribution of this organism influences the epidemiology of MS.<sup id="cite_ref-pmid17444504_16-1" class="reference"><a href="#cite_note-pmid17444504-16">&#91;16&#93;</a></sup> Two opposing versions of this hypothesis include the <a href="/wiki/Hygiene_hypothesis" title="Hygiene hypothesis">hygiene hypothesis</a> and the prevalence hypothesis, the former being more favored.<sup id="cite_ref-pmid17444504_16-2" class="reference"><a href="#cite_note-pmid17444504-16">&#91;16&#93;</a></sup> The hygiene hypothesis proposes that exposure to certain infectious agents early in life is protective; the disease is a response to a late encounter with such agents.<sup id="cite_ref-pmid18970977_1-13" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> The prevalence hypothesis proposes that an early, persistent, and silent infection increases risk of disease, thus the disease is more common where the infectious agent is more common. Only in a few cases and after many years does it cause demyelination.<sup id="cite_ref-pmid17444504_16-3" class="reference"><a href="#cite_note-pmid17444504-16">&#91;16&#93;</a></sup><sup id="cite_ref-pmid8269393_40-0" class="reference"><a href="#cite_note-pmid8269393-40">&#91;40&#93;</a></sup> Evidence for a virus as a cause include the presence of <a href="/wiki/Oligoclonal_bands" class="mw-redirect" title="Oligoclonal bands">oligoclonal bands</a> in the brain and <a href="/wiki/Cerebrospinal_fluid" title="Cerebrospinal fluid">cerebrospinal fluid</a> of most people with MS, the association of several viruses with human demyelinating <a href="/wiki/Encephalomyelitis" title="Encephalomyelitis">encephalomyelitis</a>, and the occurrence of demyelination in animals caused by some viral infections.<sup id="cite_ref-pmid15721830_41-0" class="reference"><a href="#cite_note-pmid15721830-41">&#91;41&#93;</a></sup>
</p><p><a href="/wiki/Epstein%E2%80%93Barr_virus" title="Epstein–Barr virus">Epstein-Barr</a> <a href="/wiki/Herpesviridae#Human_herpesvirus_types" title="Herpesviridae">herpes virus</a> (EBV) can cause <a href="/wiki/Infectious_mononucleosis" title="Infectious mononucleosis">infectious mononucleosis</a> and infects about 95% of adults. In combination with other genetic and environmental factors, there is "compelling epidemiological and mechanistic evidence for a causal role of EBV in multiple sclerosis", though only a small proportion of those infected with EBV later develop MS.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42">&#91;42&#93;</a></sup><sup id="cite_ref-Aloisi2022_15-1" class="reference"><a href="#cite_note-Aloisi2022-15">&#91;15&#93;</a></sup><sup id="cite_ref-Bjornevik2022_43-0" class="reference"><a href="#cite_note-Bjornevik2022-43">&#91;43&#93;</a></sup> A study of individuals in the United States military between 1993 and 2013 (total population greater than 10 million) compared 801 people who developed MS on or after military service to 1,566 matched controls who did not develop MS during this observation period. The study found a 32-fold increased risk of developing MS after infection with EBV. It did not find an increased risk after infection with other viruses, including the similarly transmitted <a href="/wiki/Cytomegalovirus" title="Cytomegalovirus">cytomegalovirus</a>. The finding strongly suggests that EBV plays a role in the onset of MS, although EBV alone may be insufficient to cause it.<sup id="cite_ref-Aloisi2022_15-2" class="reference"><a href="#cite_note-Aloisi2022-15">&#91;15&#93;</a></sup><sup id="cite_ref-Bjornevik2022_43-1" class="reference"><a href="#cite_note-Bjornevik2022-43">&#91;43&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Genetics">Genetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=5" title="Edit section: Genetics">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:HLA.svg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/HLA.svg/220px-HLA.svg.png" decoding="async" width="220" height="416" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/HLA.svg/330px-HLA.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/HLA.svg/440px-HLA.svg.png 2x" data-file-width="230" data-file-height="435" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:HLA.svg" class="internal" title="Enlarge"></a></div>HLA region of chromosome&#160;6: Changes in this area increase the probability of getting MS.</div></div></div>
<p>MS is not considered a <a href="/wiki/Hereditary_disease" class="mw-redirect" title="Hereditary disease">hereditary disease</a>, but several <a href="/wiki/Genetics" title="Genetics">genetic variations</a> have been shown to increase the risk.<sup id="cite_ref-pmid14747002_44-0" class="reference"><a href="#cite_note-pmid14747002-44">&#91;44&#93;</a></sup> Some of these genes appear to have higher levels of expression in <a href="/wiki/Microglia" title="Microglia">microglial cells</a> than expected by chance.<sup id="cite_ref-SkeneGrant2016_45-0" class="reference"><a href="#cite_note-SkeneGrant2016-45">&#91;45&#93;</a></sup> The probability of developing the disease is higher in relatives of an affected person, with a greater risk among those more closely related.<sup id="cite_ref-pmid11955556_9-4" class="reference"><a href="#cite_note-pmid11955556-9">&#91;9&#93;</a></sup> An <a href="/wiki/Identical_twin" class="mw-redirect" title="Identical twin">identical twin</a> of an affected individual has a 30% chance of developing MS, 5% for a nonidentical twin, 2.5% for a sibling, and an even lower chance for a half sibling.<sup id="cite_ref-pmid18970977_1-14" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid11955556_9-5" class="reference"><a href="#cite_note-pmid11955556-9">&#91;9&#93;</a></sup><sup id="cite_ref-46" class="reference"><a href="#cite_note-46">&#91;46&#93;</a></sup> If both parents are affected, the risk in their children is 10 times that of the general population.<sup id="cite_ref-Milo2010_2-4" class="reference"><a href="#cite_note-Milo2010-2">&#91;2&#93;</a></sup> MS is also more common in some ethnic groups than others.<sup id="cite_ref-pmid11603614_47-0" class="reference"><a href="#cite_note-pmid11603614-47">&#91;47&#93;</a></sup>
</p><p>Specific <a href="/wiki/Gene" title="Gene">genes</a> that have been linked with MS include differences in the <a href="/wiki/Human_leukocyte_antigen" title="Human leukocyte antigen">human leukocyte antigen</a> (HLA) system—a group of genes on <a href="/wiki/Chromosome_6_(human)" class="mw-redirect" title="Chromosome 6 (human)">chromosome 6</a> that serves as the <a href="/wiki/Major_histocompatibility_complex" title="Major histocompatibility complex">major histocompatibility complex</a> (MHC).<sup id="cite_ref-pmid18970977_1-15" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> That differences in the HLA region are related to susceptibility has been known since the 1980s,<sup id="cite_ref-pmid21247752_48-0" class="reference"><a href="#cite_note-pmid21247752-48">&#91;48&#93;</a></sup> and this same region has also been implicated in the development of other autoimmune diseases, such as <a href="/wiki/Diabetes_type_I" class="mw-redirect" title="Diabetes type I">diabetes type I</a> and <a href="/wiki/Systemic_lupus_erythematosus" class="mw-redirect" title="Systemic lupus erythematosus">systemic lupus erythematosus</a>.<sup id="cite_ref-pmid21247752_48-1" class="reference"><a href="#cite_note-pmid21247752-48">&#91;48&#93;</a></sup> The most consistent finding is the association between multiple sclerosis and <a href="/wiki/Allele" title="Allele">alleles</a> of the MHC defined as <i><a href="/wiki/HLA-DR15" title="HLA-DR15">DR15</a></i> and <i><a href="/wiki/HLA-DQ6" title="HLA-DQ6">DQ6</a></i>.<sup id="cite_ref-pmid18970977_1-16" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> Other loci have shown a protective effect, such as <i><a href="/wiki/HLA-C554" class="mw-redirect" title="HLA-C554">HLA-C554</a> </i>and <i><a href="/wiki/HLA-DRB1" title="HLA-DRB1">HLA-DRB1</a>*11</i>.<sup id="cite_ref-pmid18970977_1-17" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> HLA differences account for an estimated 20 to 60% of the <a href="/wiki/Genetic_predisposition" title="Genetic predisposition">genetic predisposition</a>.<sup id="cite_ref-pmid21247752_48-2" class="reference"><a href="#cite_note-pmid21247752-48">&#91;48&#93;</a></sup> Modern genetic methods (<a href="/wiki/Genome-wide_association_study" title="Genome-wide association study">genome-wide association studies</a>) have revealed at least 200 variants outside the HLA <a href="/wiki/Locus_(genetics)" title="Locus (genetics)">locus</a> that modestly increase the probability of MS.<sup id="cite_ref-pmid31604244_49-0" class="reference"><a href="#cite_note-pmid31604244-49">&#91;49&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Geography">Geography</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=6" title="Edit section: Geography">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>MS is more common in people who live farther from the <a href="/wiki/Equator" title="Equator">equator</a>, although exceptions exist.<sup id="cite_ref-pmid18970977_1-18" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid18606967_50-0" class="reference"><a href="#cite_note-pmid18606967-50">&#91;50&#93;</a></sup> These exceptions include ethnic groups that are at low risk and that live far from the equator such as the <a href="/wiki/Sami_people" class="mw-redirect" title="Sami people">Sami</a>, <a href="/wiki/Indigenous_peoples_of_the_Americas" title="Indigenous peoples of the Americas">Amerindians</a>, Canadian <a href="/wiki/Hutterite" class="mw-redirect" title="Hutterite">Hutterites</a>, New Zealand <a href="/wiki/M%C4%81ori_people" title="Māori people">Māori</a>,<sup id="cite_ref-pmid12127652_51-0" class="reference"><a href="#cite_note-pmid12127652-51">&#91;51&#93;</a></sup> and Canada's <a href="/wiki/Inuit" title="Inuit">Inuit</a>,<sup id="cite_ref-Milo2010_2-5" class="reference"><a href="#cite_note-Milo2010-2">&#91;2&#93;</a></sup> as well as groups that have a relatively high risk and that live closer to the equator such as <a href="/wiki/Sardinian_people" title="Sardinian people">Sardinians</a>,<sup id="cite_ref-Milo2010_2-6" class="reference"><a href="#cite_note-Milo2010-2">&#91;2&#93;</a></sup> inland <a href="/wiki/Sicily" title="Sicily">Sicilians</a>,<sup id="cite_ref-52" class="reference"><a href="#cite_note-52">&#91;52&#93;</a></sup> <a href="/wiki/Palestinians" title="Palestinians">Palestinians</a>, and <a href="/wiki/Parsi" class="mw-redirect" title="Parsi">Parsi</a>.<sup id="cite_ref-pmid12127652_51-1" class="reference"><a href="#cite_note-pmid12127652-51">&#91;51&#93;</a></sup> The cause of this geographical pattern is not clear.<sup id="cite_ref-Milo2010_2-7" class="reference"><a href="#cite_note-Milo2010-2">&#91;2&#93;</a></sup> While the north–south gradient of incidence is decreasing,<sup id="cite_ref-pmid18606967_50-1" class="reference"><a href="#cite_note-pmid18606967-50">&#91;50&#93;</a></sup> as of 2010 it is still present.<sup id="cite_ref-Milo2010_2-8" class="reference"><a href="#cite_note-Milo2010-2">&#91;2&#93;</a></sup>
</p><p>MS is more common in regions with northern European populations,<sup id="cite_ref-pmid18970977_1-19" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> so the geographic variation may simply reflect the global distribution of these high-risk populations.<sup id="cite_ref-Milo2010_2-9" class="reference"><a href="#cite_note-Milo2010-2">&#91;2&#93;</a></sup>
</p><p>A relationship between season of birth and MS lends support to this idea, with fewer people born in the Northern Hemisphere in November compared to May being affected later in life.<sup id="cite_ref-pmid19897699_53-0" class="reference"><a href="#cite_note-pmid19897699-53">&#91;53&#93;</a></sup>
</p><p>Environmental factors may play a role during childhood, with several studies finding that people who move to a different region of the world before the age of 15 acquire the new region's risk of MS. If migration takes place after age 15, the persons retain the risk of their home country.<sup id="cite_ref-pmid18970977_1-20" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid15556803_54-0" class="reference"><a href="#cite_note-pmid15556803-54">&#91;54&#93;</a></sup> Some evidence indicates that the effect of moving may still apply to people older than 15.<sup id="cite_ref-pmid18970977_1-21" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Other">Other</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=7" title="Edit section: Other">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Tobacco_smoking" title="Tobacco smoking">Smoking</a> may be an independent risk factor for MS.<sup id="cite_ref-pmid17492755_55-0" class="reference"><a href="#cite_note-pmid17492755-55">&#91;55&#93;</a></sup> <a href="/wiki/Stress_(biological)" class="mw-redirect" title="Stress (biological)">Stress</a> may be a risk factor, although the evidence to support this is weak.<sup id="cite_ref-pmid15556803_54-1" class="reference"><a href="#cite_note-pmid15556803-54">&#91;54&#93;</a></sup> Association with occupational exposures and <a href="/wiki/Toxin" title="Toxin">toxins</a>—mainly organic <a href="/wiki/Solvent" title="Solvent">solvents</a><sup id="cite_ref-56" class="reference"><a href="#cite_note-56">&#91;56&#93;</a></sup>—has been evaluated, but no clear conclusions have been reached.<sup id="cite_ref-pmid15556803_54-2" class="reference"><a href="#cite_note-pmid15556803-54">&#91;54&#93;</a></sup> <a href="/wiki/Vaccine" title="Vaccine">Vaccinations</a> were studied as causal factors; most studies, though, show no association.<sup id="cite_ref-pmid15556803_54-3" class="reference"><a href="#cite_note-pmid15556803-54">&#91;54&#93;</a></sup><sup id="cite_ref-57" class="reference"><a href="#cite_note-57">&#91;57&#93;</a></sup> Several other possible risk factors, such as <a href="/wiki/Diet_(nutrition)" title="Diet (nutrition)">diet</a> and <a href="/wiki/Hormone" title="Hormone">hormone</a> intake, have been evaluated, but evidence on their relation with the disease is "sparse and unpersuasive".<sup id="cite_ref-pmid17492755_55-1" class="reference"><a href="#cite_note-pmid17492755-55">&#91;55&#93;</a></sup> <a href="/wiki/Gout" title="Gout">Gout</a> occurs less than would be expected and lower levels of <a href="/wiki/Uric_acid" title="Uric acid">uric acid</a> have been found in people with MS. This has led to the theory that uric acid is protective, although its exact importance remains unknown.<sup id="cite_ref-pmid18219824_58-0" class="reference"><a href="#cite_note-pmid18219824-58">&#91;58&#93;</a></sup> Obesity during adolescence and young adulthood is a risk factor for MS.<sup id="cite_ref-Nourbakhsh2019RisksPathogenesis_59-0" class="reference"><a href="#cite_note-Nourbakhsh2019RisksPathogenesis-59">&#91;59&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=8" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Pathophysiology_of_multiple_sclerosis" title="Pathophysiology of multiple sclerosis">Pathophysiology of multiple sclerosis</a></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Multiple_Sclerosis.png" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Multiple_Sclerosis.png/220px-Multiple_Sclerosis.png" decoding="async" width="220" height="183" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Multiple_Sclerosis.png/330px-Multiple_Sclerosis.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Multiple_Sclerosis.png/440px-Multiple_Sclerosis.png 2x" data-file-width="1200" data-file-height="1000" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Multiple_Sclerosis.png" class="internal" title="Enlarge"></a></div>Multiple sclerosis</div></div></div>
<p>The three main characteristics of MS are the formation of lesions in the <a href="/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a> (also called plaques), inflammation, and the destruction of <a href="/wiki/Myelin_sheath" class="mw-redirect" title="Myelin sheath">myelin sheaths</a> of <a href="/wiki/Neuron" title="Neuron">neurons</a>. These features interact in a complex and not yet fully understood manner to produce the breakdown of nerve tissue, and in turn, the signs and symptoms of the disease.<sup id="cite_ref-pmid18970977_1-22" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup>
<a href="/wiki/Cholesterol_crystal" title="Cholesterol crystal">Cholesterol crystals</a> are believed both to impair myelin repair and aggravate inflammation.<sup id="cite_ref-pmid29439228_60-0" class="reference"><a href="#cite_note-pmid29439228-60">&#91;60&#93;</a></sup><sup id="cite_ref-pmid29301957_61-0" class="reference"><a href="#cite_note-pmid29301957-61">&#91;61&#93;</a></sup> MS is believed to be an <a href="/wiki/Immune-mediated_inflammatory_diseases" title="Immune-mediated inflammatory diseases">immune-mediated</a> disorder that develops from an interaction of the individual's genetics and as yet unidentified environmental causes.<sup id="cite_ref-pmid11955556_9-6" class="reference"><a href="#cite_note-pmid11955556-9">&#91;9&#93;</a></sup> Damage is believed to be caused, at least in part, by attack on the nervous system by a person's own immune system.<sup id="cite_ref-pmid18970977_1-23" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Lesions">Lesions</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=9" title="Edit section: Lesions">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:MS_Demyelinisation_KB_10x.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e4/MS_Demyelinisation_KB_10x.jpg/220px-MS_Demyelinisation_KB_10x.jpg" decoding="async" width="220" height="163" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e4/MS_Demyelinisation_KB_10x.jpg/330px-MS_Demyelinisation_KB_10x.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e4/MS_Demyelinisation_KB_10x.jpg/440px-MS_Demyelinisation_KB_10x.jpg 2x" data-file-width="2080" data-file-height="1544" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:MS_Demyelinisation_KB_10x.jpg" class="internal" title="Enlarge"></a></div>Demyelination in MS: On <a href="/wiki/Kl%C3%BCver-Barrera" class="mw-redirect" title="Klüver-Barrera">Klüver-Barrera</a> myelin staining, decoloration in the area of the lesion can be appreciated.</div></div></div>
<p>The name multiple sclerosis refers to the scars (sclerae – better known as plaques or lesions) that form in the nervous system. These lesions most commonly affect the <a href="/wiki/White_matter" title="White matter">white matter</a> in the <a href="/wiki/Optic_nerve" title="Optic nerve">optic nerve</a>, <a href="/wiki/Brain_stem" class="mw-redirect" title="Brain stem">brain stem</a>, <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a>, and <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a>, or white matter tracts close to the lateral <a href="/wiki/Ventricular_system" title="Ventricular system">ventricles</a>.<sup id="cite_ref-pmid18970977_1-24" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> The function of white matter cells is to carry signals between <a href="/wiki/Grey_matter" title="Grey matter">grey matter</a> areas, where the processing is done, and the rest of the body. The <a href="/wiki/Peripheral_nervous_system" title="Peripheral nervous system">peripheral nervous system</a> is rarely involved.<sup id="cite_ref-pmid11955556_9-7" class="reference"><a href="#cite_note-pmid11955556-9">&#91;9&#93;</a></sup>
</p><p>To be specific, MS involves the loss of <a href="/wiki/Oligodendrocyte" title="Oligodendrocyte">oligodendrocytes</a>, the cells responsible for creating and maintaining a fatty layer—known as the <a href="/wiki/Myelin" title="Myelin">myelin</a> sheath—which helps the neurons carry <a href="/wiki/Action_potential" title="Action potential">electrical signals</a> (action potentials).<sup id="cite_ref-pmid18970977_1-25" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> This results in a thinning or complete loss of myelin, and as the disease advances, the breakdown of the <a href="/wiki/Axons" class="mw-redirect" title="Axons">axons</a> of neurons. When the myelin is lost, a neuron can no longer effectively conduct electrical signals.<sup id="cite_ref-pmid11955556_9-8" class="reference"><a href="#cite_note-pmid11955556-9">&#91;9&#93;</a></sup> A repair process, called <a href="/wiki/Remyelination" title="Remyelination">remyelination</a>, takes place in early phases of the disease, but the oligodendrocytes are unable to completely rebuild the cell's myelin sheath.<sup id="cite_ref-pmid17531860_62-0" class="reference"><a href="#cite_note-pmid17531860-62">&#91;62&#93;</a></sup> Repeated attacks lead to successively less effective remyelinations, until a scar-like plaque is built up around the damaged axons.<sup id="cite_ref-pmid17531860_62-1" class="reference"><a href="#cite_note-pmid17531860-62">&#91;62&#93;</a></sup> These scars are the origin of the symptoms and during an attack <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">magnetic resonance imaging</a> (MRI) often shows more than 10 new plaques.<sup id="cite_ref-pmid18970977_1-26" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> This could indicate that some number of lesions exist, below which the brain is capable of repairing itself without producing noticeable consequences.<sup id="cite_ref-pmid18970977_1-27" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> Another process involved in the creation of lesions is an abnormal <a href="/wiki/Astrocytosis" class="mw-redirect" title="Astrocytosis">increase in the number of astrocytes</a> due to the destruction of nearby neurons.<sup id="cite_ref-pmid18970977_1-28" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> A number of <a href="/wiki/Pathophysiology_of_multiple_sclerosis#Demyelination_patterns" title="Pathophysiology of multiple sclerosis">lesion patterns</a> have been described.<sup id="cite_ref-pmid17351524_63-0" class="reference"><a href="#cite_note-pmid17351524-63">&#91;63&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Inflammation">Inflammation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=10" title="Edit section: Inflammation">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Apart from demyelination, the other sign of the disease is <a href="/wiki/Inflammation" title="Inflammation">inflammation</a>. Fitting with an <a href="/wiki/Immunological" class="mw-redirect" title="Immunological">immunological</a> explanation, the inflammatory process is caused by <a href="/wiki/T_cell" title="T cell">T cells</a>, a kind of <a href="/wiki/Lymphocyte" title="Lymphocyte">lymphocytes</a> that plays an important role in the body's defenses.<sup id="cite_ref-pmid11955556_9-9" class="reference"><a href="#cite_note-pmid11955556-9">&#91;9&#93;</a></sup> T cells gain entry into the brain as a result of disruptions in the <a href="/wiki/Blood%E2%80%93brain_barrier" title="Blood–brain barrier">blood–brain barrier</a>. The T cells recognize myelin as foreign and attack it, explaining why these cells are also called "autoreactive lymphocytes".<sup id="cite_ref-pmid18970977_1-29" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup>
</p><p>The attack on myelin starts inflammatory processes, which trigger other immune cells and the release of soluble factors like <a href="/wiki/Cytokine" title="Cytokine">cytokines</a> and <a href="/wiki/Antibodies" class="mw-redirect" title="Antibodies">antibodies</a>. A further breakdown of the blood-brain barrier, in turn, causes a number of other damaging effects, such as <a href="/wiki/Oedema" class="mw-redirect" title="Oedema">swelling</a>, activation of <a href="/wiki/Macrophages" class="mw-redirect" title="Macrophages">macrophages</a>, and more activation of cytokines and other destructive proteins.<sup id="cite_ref-pmid11955556_9-10" class="reference"><a href="#cite_note-pmid11955556-9">&#91;9&#93;</a></sup> Inflammation can potentially reduce transmission of information between neurons in at least three ways.<sup id="cite_ref-pmid18970977_1-30" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> The soluble factors released might stop neurotransmission by intact neurons. These factors could lead to or enhance the loss of myelin, or they may cause the axon to break down completely.<sup id="cite_ref-pmid18970977_1-31" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup>
</p>
<h3><span id="Blood.E2.80.93brain_barrier"></span><span class="mw-headline" id="Blood–brain_barrier">Blood–brain barrier</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=11" title="Edit section: Blood–brain barrier">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The blood–brain barrier (BBB) is a part of the <a href="/wiki/Capillary" title="Capillary">capillary</a> system that prevents the entry of T cells into the central nervous system. It may become permeable to these types of cells secondary to an infection by a virus or bacteria. After it repairs itself, typically once the infection has cleared, T cells may remain trapped inside the brain.<sup id="cite_ref-pmid11955556_9-11" class="reference"><a href="#cite_note-pmid11955556-9">&#91;9&#93;</a></sup><sup id="cite_ref-64" class="reference"><a href="#cite_note-64">&#91;64&#93;</a></sup> <a href="/wiki/Gadolinium" title="Gadolinium">Gadolinium</a> cannot cross a normal BBB, so gadolinium-enhanced MRI is used to show BBB breakdowns.<sup id="cite_ref-pmid23088946_65-0" class="reference"><a href="#cite_note-pmid23088946-65">&#91;65&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=12" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Multiple_sclerosis_diagnosis" title="Multiple sclerosis diagnosis">Multiple sclerosis diagnosis</a></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Monthly_multiple_sclerosis_anim_cropped_no_text.gif" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Monthly_multiple_sclerosis_anim_cropped_no_text.gif/220px-Monthly_multiple_sclerosis_anim_cropped_no_text.gif" decoding="async" width="220" height="243" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/6/6c/Monthly_multiple_sclerosis_anim_cropped_no_text.gif 1.5x" data-file-width="240" data-file-height="265" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Monthly_multiple_sclerosis_anim_cropped_no_text.gif" class="internal" title="Enlarge"></a></div>Animation showing dissemination of brain lesions in time and space as demonstrated by monthly MRI studies along a year</div></div></div> <div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:MSMRIMark.png" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/2/28/MSMRIMark.png/220px-MSMRIMark.png" decoding="async" width="220" height="274" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/28/MSMRIMark.png/330px-MSMRIMark.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/28/MSMRIMark.png/440px-MSMRIMark.png 2x" data-file-width="756" data-file-height="942" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:MSMRIMark.png" class="internal" title="Enlarge"></a></div>Multiple sclerosis as seen on MRI</div></div></div>
<p>Multiple sclerosis is typically diagnosed based on the presenting signs and symptoms, in combination with supporting <a href="/wiki/Medical_imaging" title="Medical imaging">medical imaging</a> and laboratory testing.<sup id="cite_ref-Tsang2011_5-3" class="reference"><a href="#cite_note-Tsang2011-5">&#91;5&#93;</a></sup> It can be difficult to confirm, especially early on, since the signs and symptoms may be similar to those of other medical problems.<sup id="cite_ref-pmid18970977_1-32" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid11794488_66-0" class="reference"><a href="#cite_note-pmid11794488-66">&#91;66&#93;</a></sup>
</p><p>The <a href="/wiki/McDonald_criteria" title="McDonald criteria">McDonald criteria</a>, which focus on clinical, laboratory, and radiologic evidence of lesions at different times and in different areas, is the most commonly used method of diagnosis<sup id="cite_ref-Atlas2008_67-0" class="reference"><a href="#cite_note-Atlas2008-67">&#91;67&#93;</a></sup> with the <a href="/wiki/Schumacher_criteria" title="Schumacher criteria">Schumacher</a> and <a href="/wiki/Poser_criteria" title="Poser criteria">Poser criteria</a> being of mostly historical significance.<sup id="cite_ref-pmid15177763_68-0" class="reference"><a href="#cite_note-pmid15177763-68">&#91;68&#93;</a></sup>
</p><p>As of 2017<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Multiple_sclerosis&amp;action=edit">&#91;update&#93;</a></sup>, no single test (including biopsy) can provide a definitive diagnosis.<sup id="cite_ref-69" class="reference"><a href="#cite_note-69">&#91;69&#93;</a></sup>
</p><p>Magnetic resonance imaging (MRI) of the brain and spine may show areas of demyelination (lesions or plaques). Gadolinium can be administered <a href="/wiki/Intravenous" class="mw-redirect" title="Intravenous">intravenously</a> as a <a href="/wiki/Contrast_agent" title="Contrast agent">contrast agent</a> to highlight active plaques, and by elimination, demonstrate the existence of historical lesions not associated with symptoms at the moment of the evaluation.<sup id="cite_ref-pmid11456302_70-0" class="reference"><a href="#cite_note-pmid11456302-70">&#91;70&#93;</a></sup><sup id="cite_ref-pmid18256986_71-0" class="reference"><a href="#cite_note-pmid18256986-71">&#91;71&#93;</a></sup>
</p><p>Central vein signs (CVSs) have been proposed as a good indicator of MS in comparison with other conditions causing white lesions.<sup id="cite_ref-72" class="reference"><a href="#cite_note-72">&#91;72&#93;</a></sup><sup id="cite_ref-73" class="reference"><a href="#cite_note-73">&#91;73&#93;</a></sup><sup id="cite_ref-74" class="reference"><a href="#cite_note-74">&#91;74&#93;</a></sup><sup id="cite_ref-75" class="reference"><a href="#cite_note-75">&#91;75&#93;</a></sup> One small study found fewer CVSs in older and hypertensive people.<sup id="cite_ref-76" class="reference"><a href="#cite_note-76">&#91;76&#93;</a></sup> Further research on CVS as a biomarker for MS is ongoing.<sup id="cite_ref-77" class="reference"><a href="#cite_note-77">&#91;77&#93;</a></sup>
</p><p>Brain atrophy is seen as an indicator of MS.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78">&#91;78&#93;</a></sup><sup id="cite_ref-79" class="reference"><a href="#cite_note-79">&#91;79&#93;</a></sup>
</p><p>Testing of cerebrospinal fluid obtained from a <a href="/wiki/Lumbar_puncture" title="Lumbar puncture">lumbar puncture</a> can provide evidence of chronic inflammation in the central nervous system. The cerebrospinal fluid is tested for <a href="/wiki/Oligoclonal_band" title="Oligoclonal band">oligoclonal bands</a> of IgG on <a href="/wiki/Electrophoresis" title="Electrophoresis">electrophoresis</a>, which are inflammation markers found in 75–85% of people with MS.<sup id="cite_ref-pmid11456302_70-1" class="reference"><a href="#cite_note-pmid11456302-70">&#91;70&#93;</a></sup><sup id="cite_ref-pmid16945427_80-0" class="reference"><a href="#cite_note-pmid16945427-80">&#91;80&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Differential_diagnosis">Differential diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=13" title="Edit section: Differential diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Several diseases present similarly to MS.<sup id="cite_ref-Loscalzo-2022_81-0" class="reference"><a href="#cite_note-Loscalzo-2022-81">&#91;81&#93;</a></sup><sup id="cite_ref-Saguil-2022_82-0" class="reference"><a href="#cite_note-Saguil-2022-82">&#91;82&#93;</a></sup> Medical professionals use a patient's specific presentation, history, and exam findings to make an individualized <a href="/wiki/Differential_diagnosis" title="Differential diagnosis">differential</a>. Red flags are findings that suggest an alternate diagnosis, although they do not rule out MS. Red flags include a patient younger than 15 or older than 60, less than 24 hours of symptoms, involvement of multiple <a href="/wiki/Cranial_nerves" title="Cranial nerves">cranial nerves</a>, involvement of organs outside of the <a href="/wiki/Nervous_system" title="Nervous system">nervous system</a>, and atypical lab and exam findings.<sup id="cite_ref-Loscalzo-2022_81-1" class="reference"><a href="#cite_note-Loscalzo-2022-81">&#91;81&#93;</a></sup><sup id="cite_ref-Saguil-2022_82-1" class="reference"><a href="#cite_note-Saguil-2022-82">&#91;82&#93;</a></sup>
</p><p>In an emergency setting, it is important to rule out a stroke or <a href="/wiki/Intracranial_hemorrhage" title="Intracranial hemorrhage">bleeding</a> in the brain.<sup id="cite_ref-Saguil-2022_82-2" class="reference"><a href="#cite_note-Saguil-2022-82">&#91;82&#93;</a></sup> Intractable vomiting, severe optic neuritis,<sup id="cite_ref-Petzold-2022_25-2" class="reference"><a href="#cite_note-Petzold-2022-25">&#91;25&#93;</a></sup> or bilateral optic neuritis<sup id="cite_ref-Petzold-2022_25-3" class="reference"><a href="#cite_note-Petzold-2022-25">&#91;25&#93;</a></sup> raises suspicion for <a href="/wiki/Neuromyelitis_optica_spectrum_disorder" title="Neuromyelitis optica spectrum disorder">neuromyelitis optica spectrum disorder</a> (NMOSD).<sup id="cite_ref-Solomon2019DiagnosisReview_83-0" class="reference"><a href="#cite_note-Solomon2019DiagnosisReview-83">&#91;83&#93;</a></sup> Infectious diseases that may look similar to multiple sclerosis include HIV, <a href="/wiki/Lyme_disease" title="Lyme disease">Lyme disease</a>, and <a href="/wiki/Neurosyphilis" title="Neurosyphilis">Syphilis</a>. Autoimmune diseases include <a href="/wiki/Neurosarcoidosis" title="Neurosarcoidosis">Sarcoidosis</a>, <a href="/wiki/Lupus" title="Lupus">Lupus</a>, <a href="/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome" title="Guillain–Barré syndrome">Guillain-Barré syndrome</a>, <a href="/wiki/Acute_disseminated_encephalomyelitis" title="Acute disseminated encephalomyelitis">Acute disseminated encephalomyelitis</a>, and <a href="/wiki/Beh%C3%A7et%27s_disease" title="Behçet&#39;s disease">Behçet's disease</a>. Psychiatric conditions such as <a href="/wiki/Generalized_anxiety_disorder" title="Generalized anxiety disorder">Anxiety</a> or <a href="/wiki/Conversion_disorder" title="Conversion disorder">Conversion disorder</a> may also present in a similar way. Other rare diseases on the differential include <a href="/wiki/Primary_central_nervous_system_lymphoma" title="Primary central nervous system lymphoma">CNS lymphoma</a>, <a href="/wiki/Leukodystrophy" title="Leukodystrophy">congenital leukodystrophies</a>, and <a href="/wiki/MOG_antibody_disease" title="MOG antibody disease">anti-MOG-associated myelitis</a>.<sup id="cite_ref-Loscalzo-2022_81-2" class="reference"><a href="#cite_note-Loscalzo-2022-81">&#91;81&#93;</a></sup><sup id="cite_ref-Saguil-2022_82-3" class="reference"><a href="#cite_note-Saguil-2022-82">&#91;82&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Types_and_variants">Types and variants</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=14" title="Edit section: Types and variants">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Several <a href="/wiki/Phenotype_(clinical_medicine)" title="Phenotype (clinical medicine)">phenotypes</a> (commonly termed "types"), or patterns of progression, have been described. Phenotypes use the past course of the disease in an attempt to predict the future course. They are important not only for prognosis, but also for treatment decisions.
</p><p>The International Advisory Committee on Clinical Trials of MS describes four types of MS (revised in 2013) in what is known as the <a href="/wiki/Multiple_sclerosis_research#Lublin_classification" title="Multiple sclerosis research">Lublin classification</a>:<sup id="cite_ref-Lublin_84-0" class="reference"><a href="#cite_note-Lublin-84">&#91;84&#93;</a></sup><sup id="cite_ref-85" class="reference"><a href="#cite_note-85">&#91;85&#93;</a></sup>
</p>
<ol><li>Clinically isolated syndrome (CIS)</li>
<li>Relapsing-remitting MS (RRMS)</li>
<li>Primary progressive MS (PPMS)</li>
<li>Secondary progressive MS (SPMS)</li></ol>
<p>RRMS is characterized by unpredictable relapses followed by periods of months to years of relative quiet (<a href="/wiki/Remission_(medicine)" title="Remission (medicine)">remission</a>) with no new signs of disease activity. Deficits that occur during attacks may either resolve or leave <a href="/wiki/Sequelae" class="mw-redirect" title="Sequelae">problems</a>, the latter in about 40% of attacks and being more common the longer a person has had the disease.<sup id="cite_ref-pmid18970977_1-33" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup><sup id="cite_ref-Tsang2011_5-4" class="reference"><a href="#cite_note-Tsang2011-5">&#91;5&#93;</a></sup> This describes the initial course of 80% of individuals with MS.<sup id="cite_ref-pmid18970977_1-34" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup>
</p><p>The relapsing-remitting subtype usually begins with a clinically isolated syndrome (CIS). In CIS, a person has an attack suggestive of demyelination, but does not fulfill the criteria for multiple sclerosis.<sup id="cite_ref-pmid18970977_1-35" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid15847841_86-0" class="reference"><a href="#cite_note-pmid15847841-86">&#91;86&#93;</a></sup> 30 to 70% of persons who experience CIS, later develop MS.<sup id="cite_ref-pmid15847841_86-1" class="reference"><a href="#cite_note-pmid15847841-86">&#91;86&#93;</a></sup>
</p><p>PPMS occurs in roughly 10–20% of individuals with the disease, with no remission after the initial symptoms.<sup id="cite_ref-Tsang2011_5-5" class="reference"><a href="#cite_note-Tsang2011-5">&#91;5&#93;</a></sup><sup id="cite_ref-pmid17884680_87-0" class="reference"><a href="#cite_note-pmid17884680-87">&#91;87&#93;</a></sup> It is characterized by progression of disability from onset, with no, or only occasional and minor, remissions and improvements.<sup id="cite_ref-pmid8780061_14-3" class="reference"><a href="#cite_note-pmid8780061-14">&#91;14&#93;</a></sup> The usual age of onset for the primary progressive subtype is later than of the relapsing-remitting subtype. It is similar to the age that secondary progressive usually begins in RRMS, around 40 years of age.<sup id="cite_ref-pmid18970977_1-36" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup>
</p><p>SPMS occurs in around 65% of those with initial RRMS, who eventually have progressive neurologic decline between acute attacks without any definite periods of remission.<sup id="cite_ref-pmid18970977_1-37" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid8780061_14-4" class="reference"><a href="#cite_note-pmid8780061-14">&#91;14&#93;</a></sup> Occasional relapses and minor remissions may appear.<sup id="cite_ref-pmid8780061_14-5" class="reference"><a href="#cite_note-pmid8780061-14">&#91;14&#93;</a></sup> The most common length of time between disease onset and conversion from RRMS to SPMS is 19 years.<sup id="cite_ref-pmid16545751_88-0" class="reference"><a href="#cite_note-pmid16545751-88">&#91;88&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Special_courses">Special courses</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=15" title="Edit section: Special courses">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Independently of the types published by the MS associations, regulatory agencies such as the FDA often consider special courses, trying to reflect some clinical trials results on their approval documents. Some examples could be "highly active MS" (HAMS),<sup id="cite_ref-sorensen_89-0" class="reference"><a href="#cite_note-sorensen-89">&#91;89&#93;</a></sup> "active secondary MS" (similar to the old progressive-relapsing)<sup id="cite_ref-novartis.com_90-0" class="reference"><a href="#cite_note-novartis.com-90">&#91;90&#93;</a></sup> and "rapidly progressing PPMS".<sup id="cite_ref-91" class="reference"><a href="#cite_note-91">&#91;91&#93;</a></sup>
</p><p>Also, deficits always resolving between attacks is sometimes referred to as "benign" MS,<sup id="cite_ref-pmid18219812_92-0" class="reference"><a href="#cite_note-pmid18219812-92">&#91;92&#93;</a></sup> although people still build up some degree of disability in the long term.<sup id="cite_ref-pmid18970977_1-38" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> On the other hand, the term <a href="/wiki/Malignant_multiple_sclerosis" title="Malignant multiple sclerosis">malignant multiple sclerosis</a> is used to describe people with MS having reached significant level of disability in a short period.<sup id="cite_ref-93" class="reference"><a href="#cite_note-93">&#91;93&#93;</a></sup>
</p><p>An international panel has published a standardized definition for the course HAMS.<sup id="cite_ref-sorensen_89-1" class="reference"><a href="#cite_note-sorensen-89">&#91;89&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Variants">Variants</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=16" title="Edit section: Variants">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Atypical <a href="/wiki/Idiopathic_inflammatory_demyelinating_diseases" class="mw-redirect" title="Idiopathic inflammatory demyelinating diseases">variants</a> of MS have been described; these include <a href="/wiki/Tumefactive_multiple_sclerosis" title="Tumefactive multiple sclerosis">tumefactive multiple sclerosis</a>, <a href="/wiki/Balo_concentric_sclerosis" title="Balo concentric sclerosis">Balo concentric sclerosis</a>, <a href="/wiki/Diffuse_myelinoclastic_sclerosis" title="Diffuse myelinoclastic sclerosis">Schilder's diffuse sclerosis</a>, and <a href="/wiki/Marburg_multiple_sclerosis" class="mw-redirect" title="Marburg multiple sclerosis">Marburg multiple sclerosis</a>. Debate remains on whether they are MS variants or different diseases.<sup id="cite_ref-pmid15727225_94-0" class="reference"><a href="#cite_note-pmid15727225-94">&#91;94&#93;</a></sup> Some diseases previously considered MS variants, such as <a href="/wiki/Devic%27s_disease" class="mw-redirect" title="Devic&#39;s disease">Devic's disease</a>, are now considered outside the MS spectrum.<sup id="cite_ref-95" class="reference"><a href="#cite_note-95">&#91;95&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=17" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Management_of_multiple_sclerosis" title="Management of multiple sclerosis">Management of multiple sclerosis</a></div>
<p>Although no cure for multiple sclerosis has been found, several therapies have proven helpful. Several effective treatments can decrease the number of attacks and the rate of progression.<sup id="cite_ref-McGinley2021_21-1" class="reference"><a href="#cite_note-McGinley2021-21">&#91;21&#93;</a></sup> The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. Starting medications is generally recommended in people after the first attack when more than two lesions are seen on MRI.<sup id="cite_ref-Neurology2018_96-0" class="reference"><a href="#cite_note-Neurology2018-96">&#91;96&#93;</a></sup>
</p><p>The first approved medications used to treat MS were modestly effective, though were poorly tolerated and had many adverse effects.<sup id="cite_ref-NIH2015_3-4" class="reference"><a href="#cite_note-NIH2015-3">&#91;3&#93;</a></sup> Several treatment options with better safety and tolerability profiles have been introduced,<sup id="cite_ref-McGinley2021_21-2" class="reference"><a href="#cite_note-McGinley2021-21">&#91;21&#93;</a></sup> improving the prognosis of MS.
</p><p>As with any medical treatment, medications used in the management of MS have several <a href="/wiki/Adverse_effect_(medicine)" class="mw-redirect" title="Adverse effect (medicine)">adverse effects</a>. <a href="/wiki/Alternative_medicine" title="Alternative medicine">Alternative treatments</a> are pursued by some people, despite the shortage of supporting evidence of efficacy.
</p>
<h3><span class="mw-headline" id="Initial_management_of_acute_flare">Initial management of acute flare</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=18" title="Edit section: Initial management of acute flare">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>During symptomatic attacks, administration of high doses of <a href="/wiki/Intravenous_therapy" title="Intravenous therapy">intravenous</a> <a href="/wiki/Corticosteroid" title="Corticosteroid">corticosteroids</a>, such as <a href="/wiki/Methylprednisolone" title="Methylprednisolone">methylprednisolone</a>, is the usual therapy,<sup id="cite_ref-pmid18970977_1-39" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> with oral corticosteroids seeming to have a similar efficacy and safety profile.<sup id="cite_ref-97" class="reference"><a href="#cite_note-97">&#91;97&#93;</a></sup> Although effective in the short term for relieving symptoms, corticosteroid treatments do not appear to have a significant impact on long-term recovery.<sup id="cite_ref-98" class="reference"><a href="#cite_note-98">&#91;98&#93;</a></sup><sup id="cite_ref-RCOP_acute_99-0" class="reference"><a href="#cite_note-RCOP_acute-99">&#91;99&#93;</a></sup> The long-term benefit is unclear in optic neuritis as of 2020.<sup id="cite_ref-100" class="reference"><a href="#cite_note-100">&#91;100&#93;</a></sup><sup id="cite_ref-Petzold-2022_25-4" class="reference"><a href="#cite_note-Petzold-2022-25">&#91;25&#93;</a></sup> The consequences of severe attacks that do not respond to corticosteroids might be treatable by <a href="/wiki/Plasmapheresis" title="Plasmapheresis">plasmapheresis</a>.<sup id="cite_ref-pmid18970977_1-40" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Chronic_management">Chronic management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=19" title="Edit section: Chronic management">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<h4><span class="mw-headline" id="Relapsing_remitting_multiple_sclerosis">Relapsing remitting multiple sclerosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=20" title="Edit section: Relapsing remitting multiple sclerosis">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Multiple <a href="/wiki/Management_of_multiple_sclerosis#Disease-modifying_treatments" title="Management of multiple sclerosis">disease-modifying</a> medications were approved by regulatory agencies for RRMS; they are modestly effective at decreasing the number of attacks.<sup id="cite_ref-He2016_101-0" class="reference"><a href="#cite_note-He2016-101">&#91;101&#93;</a></sup> <a href="/wiki/Interferons" class="mw-redirect" title="Interferons">Interferons</a><sup id="cite_ref-Rice2001_102-0" class="reference"><a href="#cite_note-Rice2001-102">&#91;102&#93;</a></sup> and <a href="/wiki/Glatiramer_acetate" title="Glatiramer acetate">glatiramer acetate</a> are first-line treatments<sup id="cite_ref-Tsang2011_5-6" class="reference"><a href="#cite_note-Tsang2011-5">&#91;5&#93;</a></sup> and are roughly equivalent, reducing relapses by approximately 30%.<sup id="cite_ref-Hassan2011_103-0" class="reference"><a href="#cite_note-Hassan2011-103">&#91;103&#93;</a></sup> Early-initiated long-term therapy is safe and improves outcomes.<sup id="cite_ref-pmid21205679_104-0" class="reference"><a href="#cite_note-pmid21205679-104">&#91;104&#93;</a></sup><sup id="cite_ref-pmid22284996_105-0" class="reference"><a href="#cite_note-pmid22284996-105">&#91;105&#93;</a></sup>
</p><p>Treatment of CIS with interferons decreases the chance of progressing to clinical MS.<sup id="cite_ref-pmid18970977_1-41" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid21205678_106-0" class="reference"><a href="#cite_note-pmid21205678-106">&#91;106&#93;</a></sup><sup id="cite_ref-107" class="reference"><a href="#cite_note-107">&#91;107&#93;</a></sup> Efficacy of interferons and glatiramer acetate in children has been estimated to be roughly equivalent to that of adults.<sup id="cite_ref-pmid22642799_108-0" class="reference"><a href="#cite_note-pmid22642799-108">&#91;108&#93;</a></sup> The role of some newer agents such as <a href="/wiki/Fingolimod" title="Fingolimod">fingolimod</a>,<sup id="cite_ref-LaMantia2016_109-0" class="reference"><a href="#cite_note-LaMantia2016-109">&#91;109&#93;</a></sup> <a href="/wiki/Teriflunomide" title="Teriflunomide">teriflunomide</a>, and <a href="/wiki/Dimethyl_fumarate" title="Dimethyl fumarate">dimethyl fumarate</a>,<sup id="cite_ref-Xu2015_110-0" class="reference"><a href="#cite_note-Xu2015-110">&#91;110&#93;</a></sup> is not yet entirely clear.<sup id="cite_ref-pmid22014437_111-0" class="reference"><a href="#cite_note-pmid22014437-111">&#91;111&#93;</a></sup> Making firm conclusions about the best treatment is difficult, especially regarding the long‐term benefit and safety of early treatment, given the lack of studies directly comparing disease-modifying therapies or long-term monitoring of patient outcomes.<sup id="cite_ref-112" class="reference"><a href="#cite_note-112">&#91;112&#93;</a></sup>
</p><p>The relative effectiveness of different treatments is unclear, as most have only been compared to placebo or a small number of other therapies.<sup id="cite_ref-Filippini2013_113-0" class="reference"><a href="#cite_note-Filippini2013-113">&#91;113&#93;</a></sup> Direct comparisons of interferons and glatiramer acetate indicate similar effects or only small differences in effects on relapse rate, disease progression, and MRI measures.<sup id="cite_ref-114" class="reference"><a href="#cite_note-114">&#91;114&#93;</a></sup> Alemtuzumab, natalizumab, and fingolimod may be more effective than other drugs in reducing relapses over the short term in people with RRMS.<sup id="cite_ref-Tramacere2015_115-0" class="reference"><a href="#cite_note-Tramacere2015-115">&#91;115&#93;</a></sup> <a href="/wiki/Natalizumab" title="Natalizumab">Natalizumab</a> and <a href="/wiki/Interferon_beta-1a" title="Interferon beta-1a">interferon beta-1a</a> (<a href="/wiki/Interferon_beta-1a#Brand_names" title="Interferon beta-1a">Rebif</a>) may reduce relapses compared to both placebo and interferon beta-1a (Avonex) while <a href="/wiki/Interferon_beta-1b" title="Interferon beta-1b">Interferon beta-1b</a> (<a href="/wiki/Interferon_beta-1b#Commercial_formulations" title="Interferon beta-1b">Betaseron</a>), <a href="/wiki/Glatiramer_acetate" title="Glatiramer acetate">glatiramer acetate</a>, and <a href="/wiki/Mitoxantrone" title="Mitoxantrone">mitoxantrone</a> may also prevent relapses.<sup id="cite_ref-Filippini2013_113-1" class="reference"><a href="#cite_note-Filippini2013-113">&#91;113&#93;</a></sup> Evidence on relative effectiveness in reducing disability progression is unclear.<sup id="cite_ref-Filippini2013_113-2" class="reference"><a href="#cite_note-Filippini2013-113">&#91;113&#93;</a></sup><sup id="cite_ref-Tramacere2015_115-1" class="reference"><a href="#cite_note-Tramacere2015-115">&#91;115&#93;</a></sup> All medications are associated with adverse effects that may influence their risk to benefit profiles.<sup id="cite_ref-Filippini2013_113-3" class="reference"><a href="#cite_note-Filippini2013-113">&#91;113&#93;</a></sup><sup id="cite_ref-Tramacere2015_115-2" class="reference"><a href="#cite_note-Tramacere2015-115">&#91;115&#93;</a></sup>
</p><p><a href="/wiki/Ublituximab" title="Ublituximab">Ublituximab</a> was approved for medical use in the United States in December 2022.<sup id="cite_ref-116" class="reference"><a href="#cite_note-116">&#91;116&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Progressive_multiple_sclerosis">Progressive multiple sclerosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=21" title="Edit section: Progressive multiple sclerosis">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>In 2011, mitoxantrone was the first medication approved for secondary progressive MS.<sup id="cite_ref-BopeKellerman2011_117-0" class="reference"><a href="#cite_note-BopeKellerman2011-117">&#91;117&#93;</a></sup> In this population, tentative evidence supports mitoxantrone moderately slowing the progression of the disease and decreasing rates of relapses over two years.<sup id="cite_ref-CochMit2013_118-0" class="reference"><a href="#cite_note-CochMit2013-118">&#91;118&#93;</a></sup><sup id="cite_ref-119" class="reference"><a href="#cite_note-119">&#91;119&#93;</a></sup>
</p><p>New approved medications continue to emerge in modern medicine. In March 2017, the FDA approved ocrelizumab as a treatment for primary progressive MS in adults, the first drug to gain that approval,<sup id="cite_ref-pmid31598138_120-0" class="reference"><a href="#cite_note-pmid31598138-120">&#91;120&#93;</a></sup><sup id="cite_ref-STATapproval_121-0" class="reference"><a href="#cite_note-STATapproval-121">&#91;121&#93;</a></sup><sup id="cite_ref-Ocrevus_FDA_label_122-0" class="reference"><a href="#cite_note-Ocrevus_FDA_label-122">&#91;122&#93;</a></sup> with requirements for several <a href="/wiki/Phases_of_clinical_research#Phase_IV" title="Phases of clinical research">Phase IV</a> clinical trials.<sup id="cite_ref-FDABLAapproval_123-0" class="reference"><a href="#cite_note-FDABLAapproval-123">&#91;123&#93;</a></sup> It is also used for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.<sup id="cite_ref-Ocrevus_FDA_label_122-1" class="reference"><a href="#cite_note-Ocrevus_FDA_label-122">&#91;122&#93;</a></sup> According to a 2021 <a href="/wiki/Cochrane_review" class="mw-redirect" title="Cochrane review">Cochrane review</a>, ocrelizumab may reduce worsening of symptoms for primary progressive MS and probably increases unwanted effects but makes little or no difference to the number of serious unwanted effects.<sup id="cite_ref-124" class="reference"><a href="#cite_note-124">&#91;124&#93;</a></sup>
</p><p>In 2019, <a href="/wiki/Siponimod" title="Siponimod">siponimod</a> and <a href="/wiki/Cladribine" title="Cladribine">cladribine</a> were approved in the United States for the treatment of secondary progressive multiple sclerosis (SPMS).<sup id="cite_ref-pmid31598138_120-1" class="reference"><a href="#cite_note-pmid31598138-120">&#91;120&#93;</a></sup> Subsequently, <a href="/wiki/Ozanimod" title="Ozanimod">ozanimod</a> was approved in 2020, and <a href="/wiki/Ponesimod" title="Ponesimod">ponesimod</a> was approved in 2021, which were both approved for management of CIS, relapsing MS, and SPMS in the U.S., and RRMS in Europe.<sup id="cite_ref-125" class="reference"><a href="#cite_note-125">&#91;125&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Adverse_effects">Adverse effects</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=22" title="Edit section: Adverse effects">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Copaxone_Injection_Site_Reaction.JPG" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a0/Copaxone_Injection_Site_Reaction.JPG/220px-Copaxone_Injection_Site_Reaction.JPG" decoding="async" width="220" height="318" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/a/a0/Copaxone_Injection_Site_Reaction.JPG 1.5x" data-file-width="315" data-file-height="456" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Copaxone_Injection_Site_Reaction.JPG" class="internal" title="Enlarge"></a></div>Irritation zone after injection of glatiramer acetate.</div></div></div>
<p>The <a href="/wiki/Disease-modifying_treatment" title="Disease-modifying treatment">disease-modifying treatments</a> have several adverse effects. One of the most common is irritation at the injection site for glatiramer acetate and the interferons (up to 90% with subcutaneous injections and 33% with intramuscular injections).<sup id="cite_ref-Rice2001_102-1" class="reference"><a href="#cite_note-Rice2001-102">&#91;102&#93;</a></sup><sup id="cite_ref-Balak2012_126-0" class="reference"><a href="#cite_note-Balak2012-126">&#91;126&#93;</a></sup> Over time, a visible dent at the injection site, due to the local destruction of fat tissue, known as <a href="/wiki/Lipoatrophy" title="Lipoatrophy">lipoatrophy</a>, may develop.<sup id="cite_ref-Balak2012_126-1" class="reference"><a href="#cite_note-Balak2012-126">&#91;126&#93;</a></sup> Interferons may produce <a href="/wiki/Flu-like_symptoms" class="mw-redirect" title="Flu-like symptoms">flu-like symptoms</a>;<sup id="cite_ref-pmid17131933_127-0" class="reference"><a href="#cite_note-pmid17131933-127">&#91;127&#93;</a></sup> some people taking glatiramer experience a post-injection reaction with flushing, chest tightness, heart palpitations, and anxiety, which usually lasts less than thirty minutes.<sup id="cite_ref-128" class="reference"><a href="#cite_note-128">&#91;128&#93;</a></sup> More dangerous but much less common are <a href="/wiki/Hepatotoxicity" title="Hepatotoxicity">liver damage</a> from interferons,<sup id="cite_ref-pmid15592724_129-0" class="reference"><a href="#cite_note-pmid15592724-129">&#91;129&#93;</a></sup> <a href="/wiki/Systolic_dysfunction" class="mw-redirect" title="Systolic dysfunction">systolic dysfunction</a> (12%), <a href="/wiki/Infertility" title="Infertility">infertility</a>, and <a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">acute myeloid leukemia</a> (0.8%) from mitoxantrone,<sup id="cite_ref-CochMit2013_118-1" class="reference"><a href="#cite_note-CochMit2013-118">&#91;118&#93;</a></sup><sup id="cite_ref-pmid19882365_130-0" class="reference"><a href="#cite_note-pmid19882365-130">&#91;130&#93;</a></sup> and <a href="/wiki/Progressive_multifocal_leukoencephalopathy" title="Progressive multifocal leukoencephalopathy">progressive multifocal leukoencephalopathy</a> occurring with natalizumab (occurring in 1 in 600 people treated).<sup id="cite_ref-Tsang2011_5-7" class="reference"><a href="#cite_note-Tsang2011-5">&#91;5&#93;</a></sup><sup id="cite_ref-131" class="reference"><a href="#cite_note-131">&#91;131&#93;</a></sup>
</p><p>Fingolimod may give rise to <a href="/wiki/Hypertension" title="Hypertension">hypertension</a> and <a href="/wiki/Bradycardia" title="Bradycardia">slowed heart rate</a>, <a href="/wiki/Macular_edema" title="Macular edema">macular edema</a>, elevated liver enzymes, or a <a href="/wiki/Lymphopenia" class="mw-redirect" title="Lymphopenia">reduction in lymphocyte levels</a>.<sup id="cite_ref-LaMantia2016_109-1" class="reference"><a href="#cite_note-LaMantia2016-109">&#91;109&#93;</a></sup><sup id="cite_ref-pmid22014437_111-1" class="reference"><a href="#cite_note-pmid22014437-111">&#91;111&#93;</a></sup> Tentative evidence supports the short-term safety of teriflunomide, with common side effects including: headaches, fatigue, nausea, hair loss, and limb pain.<sup id="cite_ref-He2016_101-1" class="reference"><a href="#cite_note-He2016-101">&#91;101&#93;</a></sup> There have also been reports of liver failure and PML with its use and it is <a href="/wiki/Teratology" title="Teratology">dangerous for fetal development</a>.<sup id="cite_ref-pmid22014437_111-2" class="reference"><a href="#cite_note-pmid22014437-111">&#91;111&#93;</a></sup> Most common side effects of dimethyl fumarate are flushing and gastrointestinal problems.<sup id="cite_ref-Xu2015_110-1" class="reference"><a href="#cite_note-Xu2015-110">&#91;110&#93;</a></sup><sup id="cite_ref-fumarate_132-0" class="reference"><a href="#cite_note-fumarate-132">&#91;132&#93;</a></sup><sup id="cite_ref-pmid22014437_111-3" class="reference"><a href="#cite_note-pmid22014437-111">&#91;111&#93;</a></sup> While dimethyl fumarate may lead to a <a href="/wiki/Neutropenia" title="Neutropenia">reduction in the white blood cell count</a> there were no reported cases of opportunistic infections during trials.<sup id="cite_ref-fumarateNDA_133-0" class="reference"><a href="#cite_note-fumarateNDA-133">&#91;133&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Associated_symptoms">Associated symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=23" title="Edit section: Associated symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Both medications and <a href="/wiki/Neurorehabilitation" title="Neurorehabilitation">neurorehabilitation</a> have been shown to improve some symptoms, though neither changes the course of the disease.<sup id="cite_ref-pmid16168933_134-0" class="reference"><a href="#cite_note-pmid16168933-134">&#91;134&#93;</a></sup> Some symptoms have a good response to medication, such as bladder <a href="/wiki/Spasticity" title="Spasticity">spasticity</a>, while others are little changed.<sup id="cite_ref-pmid18970977_1-42" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> Equipment such as <a href="/wiki/Catheter" title="Catheter">catheters</a> for neurogenic bladder dysfunction or mobility aids can be helpful in improving functional status.
</p><p>A <a href="/wiki/Multidisciplinary" class="mw-redirect" title="Multidisciplinary">multidisciplinary</a> approach is important for improving quality of life; however, it is difficult to specify a 'core team' as many health services may be needed at different points in time.<sup id="cite_ref-pmid18970977_1-43" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> Multidisciplinary rehabilitation programs increase activity and participation of people with MS but do not influence impairment level.<sup id="cite_ref-pmid17443610_135-0" class="reference"><a href="#cite_note-pmid17443610-135">&#91;135&#93;</a></sup> Studies investigating information provision in support of patient understanding and participation suggest that while interventions (written information, decision aids, coaching, educational programmes) may increase knowledge, the evidence of an effect on decision making and quality of life is mixed and low certainty.<sup id="cite_ref-136" class="reference"><a href="#cite_note-136">&#91;136&#93;</a></sup> There is limited evidence for the overall efficacy of individual therapeutic disciplines,<sup id="cite_ref-pmid15859525_137-0" class="reference"><a href="#cite_note-pmid15859525-137">&#91;137&#93;</a></sup><sup id="cite_ref-pmid12917976_138-0" class="reference"><a href="#cite_note-pmid12917976-138">&#91;138&#93;</a></sup> though there is good evidence that specific approaches, such as exercise,<sup id="cite_ref-139" class="reference"><a href="#cite_note-139">&#91;139&#93;</a></sup><sup id="cite_ref-140" class="reference"><a href="#cite_note-140">&#91;140&#93;</a></sup><sup id="cite_ref-pmid17482708_141-0" class="reference"><a href="#cite_note-pmid17482708-141">&#91;141&#93;</a></sup><sup id="cite_ref-142" class="reference"><a href="#cite_note-142">&#91;142&#93;</a></sup> and psychological therapies are effective.<sup id="cite_ref-143" class="reference"><a href="#cite_note-143">&#91;143&#93;</a></sup> Cognitive training, alone or combined with other neuropsychological interventions, may show positive effects for memory and attention though firm conclusions are not possible given small sample numbers, variable methodology, interventions and outcome measures.<sup id="cite_ref-144" class="reference"><a href="#cite_note-144">&#91;144&#93;</a></sup> The effectiveness of <a href="/wiki/Palliative_care" title="Palliative care">palliative approaches</a> in addition to standard care is uncertain, due to lack of evidence.<sup id="cite_ref-145" class="reference"><a href="#cite_note-145">&#91;145&#93;</a></sup> The effectiveness of interventions, including exercise, specifically for the prevention of falls in people with MS is uncertain, while there is some evidence of an effect on balance function and mobility.<sup id="cite_ref-146" class="reference"><a href="#cite_note-146">&#91;146&#93;</a></sup> <a href="/wiki/Cognitive_behavioral_therapy" title="Cognitive behavioral therapy">Cognitive behavioral therapy</a> has shown to be moderately effective for reducing MS fatigue.<sup id="cite_ref-147" class="reference"><a href="#cite_note-147">&#91;147&#93;</a></sup> The evidence for the effectiveness of non-pharmacological interventions for chronic pain is insufficient to recommend such interventions alone, however their use in combination with medications may be reasonable.<sup id="cite_ref-148" class="reference"><a href="#cite_note-148">&#91;148&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Non-pharmaceutical">Non-pharmaceutical</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=24" title="Edit section: Non-pharmaceutical">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>There is some evidence that <a href="/wiki/Aquatic_therapy" title="Aquatic therapy">aquatic therapy</a> is a beneficial intervention.<sup id="cite_ref-149" class="reference"><a href="#cite_note-149">&#91;149&#93;</a></sup>
</p><p>The spasticity associated with MS can be difficult to manage because of the progressive and fluctuating course of the disease.<sup id="cite_ref-150" class="reference"><a href="#cite_note-150">&#91;150&#93;</a></sup> Although there is no firm conclusion on the efficacy in reducing spasticity, PT interventions can be a safe and beneficial option for patients with multiple sclerosis. Physical therapy including vibration interventions, electrical stimulation, exercise therapy, standing therapy, and radial shock wave therapy (RSWT), were beneficial for limiting spasticity, helping limit excitability, or increasing range of motion.<sup id="cite_ref-151" class="reference"><a href="#cite_note-151">&#91;151&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Alternative_treatments">Alternative treatments</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=25" title="Edit section: Alternative treatments">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Over 50% of people with MS may use <a href="/wiki/Complementary_and_alternative_medicine" class="mw-redirect" title="Complementary and alternative medicine">complementary and alternative medicine</a>, although percentages vary depending on how alternative medicine is defined.<sup id="cite_ref-pmid16420779_18-1" class="reference"><a href="#cite_note-pmid16420779-18">&#91;18&#93;</a></sup> Regarding the characteristics of users, they are more frequently women, have had MS for a longer time, tend to be more disabled and have lower levels of satisfaction with conventional healthcare.<sup id="cite_ref-pmid16420779_18-2" class="reference"><a href="#cite_note-pmid16420779-18">&#91;18&#93;</a></sup> The evidence for the effectiveness for such treatments in most cases is weak or absent.<sup id="cite_ref-pmid16420779_18-3" class="reference"><a href="#cite_note-pmid16420779-18">&#91;18&#93;</a></sup><sup id="cite_ref-pmid19222053_152-0" class="reference"><a href="#cite_note-pmid19222053-152">&#91;152&#93;</a></sup> Treatments of unproven benefit used by people with MS include dietary supplementation and regimens,<sup id="cite_ref-pmid16420779_18-4" class="reference"><a href="#cite_note-pmid16420779-18">&#91;18&#93;</a></sup><sup id="cite_ref-153" class="reference"><a href="#cite_note-153">&#91;153&#93;</a></sup><sup id="cite_ref-pmid21965673_154-0" class="reference"><a href="#cite_note-pmid21965673-154">&#91;154&#93;</a></sup> vitamin D,<sup id="cite_ref-155" class="reference"><a href="#cite_note-155">&#91;155&#93;</a></sup> <a href="/wiki/Relaxation_technique" title="Relaxation technique">relaxation techniques</a> such as <a href="/wiki/Yoga_as_exercise" title="Yoga as exercise">yoga</a>,<sup id="cite_ref-pmid16420779_18-5" class="reference"><a href="#cite_note-pmid16420779-18">&#91;18&#93;</a></sup> <a href="/wiki/Herbal_medicine" title="Herbal medicine">herbal medicine</a> (including <a href="/wiki/Medical_cannabis" title="Medical cannabis">medical cannabis</a>),<sup id="cite_ref-pmid16420779_18-6" class="reference"><a href="#cite_note-pmid16420779-18">&#91;18&#93;</a></sup><sup id="cite_ref-156" class="reference"><a href="#cite_note-156">&#91;156&#93;</a></sup><sup id="cite_ref-157" class="reference"><a href="#cite_note-157">&#91;157&#93;</a></sup> <a href="/wiki/Hyperbaric_oxygen_therapy" class="mw-redirect" title="Hyperbaric oxygen therapy">hyperbaric oxygen therapy</a>,<sup id="cite_ref-pmid14974004_158-0" class="reference"><a href="#cite_note-pmid14974004-158">&#91;158&#93;</a></sup> <a href="/wiki/Helminthic_therapy" title="Helminthic therapy">self-infection with hookworms</a>, <a href="/wiki/Reflexology" title="Reflexology">reflexology</a>, <a href="/wiki/Acupuncture" title="Acupuncture">acupuncture</a>,<sup id="cite_ref-pmid16420779_18-7" class="reference"><a href="#cite_note-pmid16420779-18">&#91;18&#93;</a></sup><sup id="cite_ref-159" class="reference"><a href="#cite_note-159">&#91;159&#93;</a></sup> and <a href="/wiki/Mindfulness" title="Mindfulness">mindfulness</a>.<sup id="cite_ref-160" class="reference"><a href="#cite_note-160">&#91;160&#93;</a></sup> Evidence suggests vitamin D supplementation, irrespective of the form and dose, provides no benefit for people with MS; this includes for measures such as relapse recurrence, disability, and MRI lesions while effects on health‐related quality of life and fatigue are unclear.<sup id="cite_ref-161" class="reference"><a href="#cite_note-161">&#91;161&#93;</a></sup> There is insufficient evidence supporting high-dose <a href="/wiki/Biotin" title="Biotin">biotin</a><sup id="cite_ref-Motte2020_162-0" class="reference"><a href="#cite_note-Motte2020-162">&#91;162&#93;</a></sup><sup id="cite_ref-163" class="reference"><a href="#cite_note-163">&#91;163&#93;</a></sup><sup id="cite_ref-164" class="reference"><a href="#cite_note-164">&#91;164&#93;</a></sup> and some evidence for increased disease activity and higher risk of relapse with its use.<sup id="cite_ref-Goldschmidt2020_165-0" class="reference"><a href="#cite_note-Goldschmidt2020-165">&#91;165&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=26" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The availability of treatments that modify the course of multiple sclerosis beginning in the 1990s, known as disease-modifying therapies (DMTs), has improved prognosis. These treatments can reduce relapses and slow progression, but as of 2022 there is no cure.<sup id="cite_ref-McGinley2021_21-3" class="reference"><a href="#cite_note-McGinley2021-21">&#91;21&#93;</a></sup><sup id="cite_ref-Cree2022_166-0" class="reference"><a href="#cite_note-Cree2022-166">&#91;166&#93;</a></sup>
</p><p>The prognosis of MS depends on the subtype of the disease, and there is considerable individual variation in the progression of the disease.<sup id="cite_ref-Oh2018_167-0" class="reference"><a href="#cite_note-Oh2018-167">&#91;167&#93;</a></sup> In relapsing MS, the most common subtype, a 2016 cohort study found that after a median of 16.8 years from onset, one in ten needed a walking aid, and almost two in ten transitioned to secondary progressive MS, a form characterized by more progressive decline.<sup id="cite_ref-McGinley2021_21-4" class="reference"><a href="#cite_note-McGinley2021-21">&#91;21&#93;</a></sup> With treatments available in the 2020s, relapses can be eliminated or substantially reduced. However, "silent progression" of the disease still occurs.<sup id="cite_ref-Cree2022_166-1" class="reference"><a href="#cite_note-Cree2022-166">&#91;166&#93;</a></sup><sup id="cite_ref-168" class="reference"><a href="#cite_note-168">&#91;168&#93;</a></sup>
</p><p>In addition to secondary progressive MS (SPMS), a small proportion of people with MS (10–15%) experience progressive decline from the onset, known as primary progressive MS (PPMS). Most treatments have been approved for use in relapsing MS; there are fewer treatments with lower efficacy for progressive forms of MS.<sup id="cite_ref-Continuum_169-0" class="reference"><a href="#cite_note-Continuum-169">&#91;169&#93;</a></sup><sup id="cite_ref-Cree2022_166-2" class="reference"><a href="#cite_note-Cree2022-166">&#91;166&#93;</a></sup><sup id="cite_ref-McGinley2021_21-5" class="reference"><a href="#cite_note-McGinley2021-21">&#91;21&#93;</a></sup> The prognosis for progressive MS is worse, with faster accumulation of disability, though with considerable individual variation.<sup id="cite_ref-Continuum_169-1" class="reference"><a href="#cite_note-Continuum-169">&#91;169&#93;</a></sup> In untreated PPMS, the median time from onset to requiring a walking aid is estimated as seven years.<sup id="cite_ref-McGinley2021_21-6" class="reference"><a href="#cite_note-McGinley2021-21">&#91;21&#93;</a></sup> In SPMS, a 2014 cohort study reported that people required a walking aid after an average of five years from onset of SPMS, and were chair or bed-bound after an average of fifteen years.<sup id="cite_ref-170" class="reference"><a href="#cite_note-170">&#91;170&#93;</a></sup>
</p><p>After diagnosis of MS, characteristics that predict a worse course are male sex, older age, and greater disability at the time of diagnosis; female sex is associated with a higher relapse rate.<sup id="cite_ref-lancet2018_171-0" class="reference"><a href="#cite_note-lancet2018-171">&#91;171&#93;</a></sup> As of 2018, no biomarker can accurately predict disease progression in every patient.<sup id="cite_ref-Oh2018_167-1" class="reference"><a href="#cite_note-Oh2018-167">&#91;167&#93;</a></sup> Spinal cord lesions, abnormalities on MRI, and more <a href="/wiki/Cerebral_atrophy" title="Cerebral atrophy">brain atrophy</a> are predictive of a worse course, though brain atrophy as a predictor of disease course is experimental and not used in clinical practice as of 2018.<sup id="cite_ref-lancet2018_171-1" class="reference"><a href="#cite_note-lancet2018-171">&#91;171&#93;</a></sup> Early treatment leads to a better prognosis, but a higher relapse frequency when treated with DMTs is associated with a poorer prognosis.<sup id="cite_ref-Oh2018_167-2" class="reference"><a href="#cite_note-Oh2018-167">&#91;167&#93;</a></sup><sup id="cite_ref-lancet2018_171-2" class="reference"><a href="#cite_note-lancet2018-171">&#91;171&#93;</a></sup> A 60-year longitudinal population study conducted in Norway found a 7-year shorter <a href="/wiki/Life_expectancy" title="Life expectancy">life expectancy</a> in MS compared with the general population and a rise in survival in MS during the observation period. Median life expectancy for RRMS patients was 77.8 years and 71.4 years for PPMS, compared to 81.8 years for the general population. Life expectancy for men was 5 years shorter than for women.<sup id="cite_ref-172" class="reference"><a href="#cite_note-172">&#91;172&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=27" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1097763485"><table class="box-Update plainlinks metadata ambox ambox-content ambox-Update" role="presentation"><tbody><tr><td class="mbox-image"><div class="mbox-image-div"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/42px-Ambox_current_red_Americas.svg.png" decoding="async" width="42" height="34" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/63px-Ambox_current_red_Americas.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/84px-Ambox_current_red_Americas.svg.png 2x" data-file-width="360" data-file-height="290" /></div></td><td class="mbox-text"><div class="mbox-text-span">This section needs to be <b>updated</b>.<span class="hide-when-compact"> Please help update this article to reflect recent events or newly available information.</span>  <span class="date-container"><i>(<span class="date">July 2022</span>)</i></span></div></td></tr></tbody></table>
<div class="thumb tleft"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:Multiple_sclerosis_world_map-Deaths_per_million_persons-WHO2012.svg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1f/Multiple_sclerosis_world_map-Deaths_per_million_persons-WHO2012.svg/290px-Multiple_sclerosis_world_map-Deaths_per_million_persons-WHO2012.svg.png" decoding="async" width="290" height="128" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1f/Multiple_sclerosis_world_map-Deaths_per_million_persons-WHO2012.svg/435px-Multiple_sclerosis_world_map-Deaths_per_million_persons-WHO2012.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1f/Multiple_sclerosis_world_map-Deaths_per_million_persons-WHO2012.svg/580px-Multiple_sclerosis_world_map-Deaths_per_million_persons-WHO2012.svg.png 2x" data-file-width="940" data-file-height="415" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Multiple_sclerosis_world_map-Deaths_per_million_persons-WHO2012.svg" class="internal" title="Enlarge"></a></div>Deaths from multiple sclerosis per million persons in 2012 <style data-mw-deduplicate="TemplateStyles:r1054258005">.mw-parser-output .refbegin{font-size:90%;margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li{margin-left:0;padding-left:3.2em;text-indent:-3.2em}.mw-parser-output .refbegin-hanging-indents ul,.mw-parser-output .refbegin-hanging-indents ul li{list-style:none}@media(max-width:720px){.mw-parser-output .refbegin-hanging-indents>ul>li{padding-left:1.6em;text-indent:-1.6em}}.mw-parser-output .refbegin-columns{margin-top:0.3em}.mw-parser-output .refbegin-columns ul{margin-top:0}.mw-parser-output .refbegin-columns li{page-break-inside:avoid;break-inside:avoid-column}</style><div class="refbegin refbegin-columns references-column-count references-column-count-3" style="column-count: 3;"><style data-mw-deduplicate="TemplateStyles:r981673959">.mw-parser-output .legend{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .legend-color{display:inline-block;min-width:1.25em;height:1.25em;line-height:1.25;margin:1px 0;text-align:center;border:1px solid black;background-color:transparent;color:black}.mw-parser-output .legend-text{}</style><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#ffff20; color:black;">&#160;</span>&#160;0</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#ffc020; color:black;">&#160;</span>&#160;1</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#f08015; color:black;">&#160;</span>&#160;2</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#e06815; color:black;">&#160;</span>&#160;3–5</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#d85010; color:black;">&#160;</span>&#160;6–12</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#d02010; color:white;">&#160;</span>&#160;13–25</div></div></div></div></div>
<p>MS is the most common autoimmune disorder of the central nervous system.<sup id="cite_ref-pmid24746689_20-1" class="reference"><a href="#cite_note-pmid24746689-20">&#91;20&#93;</a></sup> The latest estimation of the total number of people with MS was 2.8&#160;million globally, with a <a href="/wiki/Prevalence" title="Prevalence">prevalence</a> of 36 per 100,000 people. Moreover, prevalence varies widely in different regions around the world.<sup id="cite_ref-Lane2022_22-1" class="reference"><a href="#cite_note-Lane2022-22">&#91;22&#93;</a></sup> In Africa, there are 5 people per 100,000 diagnosed with MS, compared to South East Asia where the prevalence is 9 per 100,000, 112 per 100,000 in the Americas, and 133 per 100,000 in Europe.<sup id="cite_ref-173" class="reference"><a href="#cite_note-173">&#91;173&#93;</a></sup>
</p><p>Increasing rates of MS may be explained simply by better diagnosis.<sup id="cite_ref-Milo2010_2-10" class="reference"><a href="#cite_note-Milo2010-2">&#91;2&#93;</a></sup> Studies on populational and <a href="#Geography">geographical patterns</a> have been common<sup id="cite_ref-pmid8269393_40-1" class="reference"><a href="#cite_note-pmid8269393-40">&#91;40&#93;</a></sup> and have led to a number of theories about the cause.<sup id="cite_ref-pmid17444504_16-4" class="reference"><a href="#cite_note-pmid17444504-16">&#91;16&#93;</a></sup><sup id="cite_ref-pmid15556803_54-4" class="reference"><a href="#cite_note-pmid15556803-54">&#91;54&#93;</a></sup><sup id="cite_ref-pmid17492755_55-2" class="reference"><a href="#cite_note-pmid17492755-55">&#91;55&#93;</a></sup>
</p><p>MS usually appears in adults in their late twenties or early thirties but it can rarely start in childhood and after 50 years of age.<sup id="cite_ref-Milo2010_2-11" class="reference"><a href="#cite_note-Milo2010-2">&#91;2&#93;</a></sup><sup id="cite_ref-Atlas2008_67-1" class="reference"><a href="#cite_note-Atlas2008-67">&#91;67&#93;</a></sup> The primary progressive subtype is more common in people in their fifties.<sup id="cite_ref-pmid17884680_87-1" class="reference"><a href="#cite_note-pmid17884680-87">&#91;87&#93;</a></sup> Similarly to many autoimmune disorders, the disease is more common in women, and the trend may be increasing.<sup id="cite_ref-pmid18970977_1-44" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid18606967_50-2" class="reference"><a href="#cite_note-pmid18606967-50">&#91;50&#93;</a></sup> As of 2020, globally it is about two times more common in women than in men, and the ratio of women to men with MS is as high as 4:1 in some countries.<sup id="cite_ref-174" class="reference"><a href="#cite_note-174">&#91;174&#93;</a></sup><sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag needs references to reliable medical sources. (May 2023)">medical citation needed</span></a></i>&#93;</sup> In children, it is even more common in females than males,<sup id="cite_ref-pmid18970977_1-45" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> while in people over fifty, it affects males and females almost equally.<sup id="cite_ref-pmid17884680_87-2" class="reference"><a href="#cite_note-pmid17884680-87">&#91;87&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=28" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Medical_discovery">Medical discovery</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=29" title="Edit section: Medical discovery">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Carswell-Multiple_Sclerosis2.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e5/Carswell-Multiple_Sclerosis2.jpg/220px-Carswell-Multiple_Sclerosis2.jpg" decoding="async" width="220" height="309" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/e/e5/Carswell-Multiple_Sclerosis2.jpg 1.5x" data-file-width="299" data-file-height="420" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Carswell-Multiple_Sclerosis2.jpg" class="internal" title="Enlarge"></a></div>Detail of Carswell's drawing of MS lesions in the <a href="/wiki/Brain_stem" class="mw-redirect" title="Brain stem">brain stem</a> and <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a> (1838)</div></div></div>
<p><a href="/wiki/Robert_Carswell_(pathologist)" title="Robert Carswell (pathologist)">Robert Carswell</a> (1793–1857), a British professor of <a href="/wiki/Pathology" title="Pathology">pathology</a>, and <a href="/wiki/Jean_Cruveilhier" title="Jean Cruveilhier">Jean Cruveilhier</a> (1791–1873), a French professor of pathologic anatomy, described and illustrated many of the disease's clinical details, but did not identify it as a separate disease.<sup id="cite_ref-pmid3066846_175-0" class="reference"><a href="#cite_note-pmid3066846-175">&#91;175&#93;</a></sup> Specifically, Carswell described the injuries he found as "a remarkable lesion of the spinal cord accompanied with atrophy".<sup id="cite_ref-pmid18970977_1-46" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> Under the microscope, Swiss pathologist <a href="/wiki/Georg_Eduard_Rindfleisch" class="mw-redirect" title="Georg Eduard Rindfleisch">Georg Eduard Rindfleisch</a> (1836–1908) noted in 1863 that the inflammation-associated lesions were distributed around blood vessels.<sup id="cite_ref-pmid10603616_176-0" class="reference"><a href="#cite_note-pmid10603616-176">&#91;176&#93;</a></sup><sup id="cite_ref-177" class="reference"><a href="#cite_note-177">&#91;177&#93;</a></sup>
</p><p>The French <a href="/wiki/Neurologist" class="mw-redirect" title="Neurologist">neurologist</a> <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a> (1825–1893) was the first person to recognize multiple sclerosis as a distinct disease in 1868.<sup id="cite_ref-pmid3066846_175-1" class="reference"><a href="#cite_note-pmid3066846-175">&#91;175&#93;</a></sup> Summarizing previous reports and adding his own clinical and pathological observations, Charcot called the disease <i>sclerose en plaques</i>.
</p>
<h3><span class="mw-headline" id="Diagnosis_history">Diagnosis history</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=30" title="Edit section: Diagnosis history">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The first attempt to establish a set of diagnostic criteria was also due to Charcot in 1868. He published what now is known as the "Charcot Triad", consisting in nystagmus, <a href="/wiki/Intention_tremor" title="Intention tremor">intention tremor</a>, and <a href="/wiki/Telegraphic_speech" title="Telegraphic speech">telegraphic speech</a> (scanning speech).<sup id="cite_ref-Milo_178-0" class="reference"><a href="#cite_note-Milo-178">&#91;178&#93;</a></sup> Charcot also observed cognition changes, describing his patients as having a "marked enfeeblement of the memory" and "conceptions that formed slowly".<sup id="cite_ref-Charcot1_23-2" class="reference"><a href="#cite_note-Charcot1-23">&#91;23&#93;</a></sup>
</p><p>Diagnosis was based on Charcot triad and clinical observation until Schumacher made the first attempt to standardize criteria in 1965 by introducing some fundamental requirements: Dissemination of the lesions in time (DIT) and space (DIS), and that "signs and symptoms cannot be explained better by another disease process".<sup id="cite_ref-Milo_178-1" class="reference"><a href="#cite_note-Milo-178">&#91;178&#93;</a></sup> The DIT and DIS requirement was later inherited by the Poser and McDonald criteria, whose 2017 revision is in use.<sup id="cite_ref-Milo_178-2" class="reference"><a href="#cite_note-Milo-178">&#91;178&#93;</a></sup><sup id="cite_ref-Oh2018_167-3" class="reference"><a href="#cite_note-Oh2018-167">&#91;167&#93;</a></sup>
</p><p>During the 20th century, theories about the cause and pathogenesis were developed and effective treatments began to appear in the 1990s.<sup id="cite_ref-pmid18970977_1-47" class="reference"><a href="#cite_note-pmid18970977-1">&#91;1&#93;</a></sup> Since the beginning of the 21st century, refinements of the concepts have taken place.  The 2010 revision of the McDonald criteria allowed for the diagnosis of MS with only one proved lesion (CIS).<sup id="cite_ref-mcdonald2010_179-0" class="reference"><a href="#cite_note-mcdonald2010-179">&#91;179&#93;</a></sup>
</p><p>In 1996, the US National Multiple Sclerosis Society (NMSS) (Advisory Committee on Clinical Trials) defined the first version of the clinical phenotypes that is in use. In this first version they provided standardized definitions for four MS clinical courses: relapsing-remitting (RR), secondary progressive (SP), primary progressive (PP), and progressive relapsing (PR). In 2010, PR was dropped and CIS was incorporated.<sup id="cite_ref-mcdonald2010_179-1" class="reference"><a href="#cite_note-mcdonald2010-179">&#91;179&#93;</a></sup> Three years later, the 2013 revision of the "phenotypes for the disease course" were forced to consider CIS as one of the phenotypes of MS, making obsolete some expressions like "conversion from CIS to MS".<sup id="cite_ref-180" class="reference"><a href="#cite_note-180">&#91;180&#93;</a></sup> Other organizations have proposed later new clinical phenotypes, like HAMS (Highly Active MS).<sup id="cite_ref-181" class="reference"><a href="#cite_note-181">&#91;181&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Historical_cases">Historical cases</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=31" title="Edit section: Historical cases">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tleft"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Animal_locomotion._Plate_541_(Boston_Public_Library).jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/8/85/Animal_locomotion._Plate_541_%28Boston_Public_Library%29.jpg/220px-Animal_locomotion._Plate_541_%28Boston_Public_Library%29.jpg" decoding="async" width="220" height="129" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/85/Animal_locomotion._Plate_541_%28Boston_Public_Library%29.jpg/330px-Animal_locomotion._Plate_541_%28Boston_Public_Library%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/85/Animal_locomotion._Plate_541_%28Boston_Public_Library%29.jpg/440px-Animal_locomotion._Plate_541_%28Boston_Public_Library%29.jpg 2x" data-file-width="4256" data-file-height="2492" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Animal_locomotion._Plate_541_(Boston_Public_Library).jpg" class="internal" title="Enlarge"></a></div>Photographic study of locomotion of a woman with MS with walking difficulties created in 1887 by <a href="/wiki/Muybridge" class="mw-redirect" title="Muybridge">Muybridge</a></div></div></div>
<p>There are several historical accounts of people who probably had MS and lived before or shortly after the disease was described by Charcot.
</p><p>A young woman called Halldora who lived in <a href="/wiki/Iceland" title="Iceland">Iceland</a> around 1200 suddenly lost her vision and mobility but recovered them seven days after. <a href="/wiki/Saint_Lidwina" class="mw-redirect" title="Saint Lidwina">Saint Lidwina</a> of <a href="/wiki/Schiedam" title="Schiedam">Schiedam</a> (1380–1433), a Dutch <a href="/wiki/Nun" title="Nun">nun</a>, may be one of the first clearly identifiable people with MS. From the age of 16 until her death at 53, she had intermittent pain, weakness of the legs and vision loss: symptoms typical of MS.<sup id="cite_ref-pmid390966_182-0" class="reference"><a href="#cite_note-pmid390966-182">&#91;182&#93;</a></sup> Both cases have led to the proposal of a "Viking gene" hypothesis for the dissemination of the disease.<sup id="cite_ref-pmid16479124_183-0" class="reference"><a href="#cite_note-pmid16479124-183">&#91;183&#93;</a></sup>
</p><p><a href="/wiki/Augustus_d%27Este" title="Augustus d&#39;Este">Augustus Frederick d'Este</a> (1794–1848), son of <a href="/wiki/Prince_Augustus_Frederick,_Duke_of_Sussex" title="Prince Augustus Frederick, Duke of Sussex">Prince Augustus Frederick, Duke of Sussex</a> and <a href="/wiki/Lady_Augusta_Murray" title="Lady Augusta Murray">Lady Augusta Murray</a> and a grandson of <a href="/wiki/George_III_of_the_United_Kingdom" class="mw-redirect" title="George III of the United Kingdom">George&#160;III of the United Kingdom</a>, almost certainly had MS. D'Este left a detailed diary describing his 22 years living with the disease. His diary began in 1822 and ended in 1846, although it remained unknown until 1948. His symptoms began at age 28 with a sudden transient visual loss (<a href="/wiki/Amaurosis_fugax" title="Amaurosis fugax">amaurosis fugax</a>) after the funeral of a friend. During his disease, he developed weakness of the legs, clumsiness of the hands, numbness, dizziness, bladder disturbance and <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>. In 1844, he began to use a wheelchair. Despite his illness, he kept an optimistic view of life.<sup id="cite_ref-184" class="reference"><a href="#cite_note-184">&#91;184&#93;</a></sup><sup id="cite_ref-pmid16103678_185-0" class="reference"><a href="#cite_note-pmid16103678-185">&#91;185&#93;</a></sup> Another early account of MS was kept by the British diarist <a href="/wiki/W._N._P._Barbellion" title="W. N. P. Barbellion">W. N. P. Barbellion</a>, pen name of Bruce Frederick Cummings (1889–1919), who maintained a detailed log of his diagnosis and struggle.<sup id="cite_ref-pmid16103678_185-1" class="reference"><a href="#cite_note-pmid16103678-185">&#91;185&#93;</a></sup> His diary was published in 1919 as <i><a href="/wiki/The_Journal_of_a_Disappointed_Man" title="The Journal of a Disappointed Man">The Journal of a Disappointed Man</a></i>.<sup id="cite_ref-186" class="reference"><a href="#cite_note-186">&#91;186&#93;</a></sup> <a href="/wiki/Charles_Dickens" title="Charles Dickens">Charles Dickens</a>, a keen observer, described possible bilateral <a href="/wiki/Optic_neuritis" title="Optic neuritis">optic neuritis</a> with reduced contrast vision and <a href="/wiki/Uhthoff%27s_phenomenon" title="Uhthoff&#39;s phenomenon">Uhthoff</a> phenomenon in the main female character of <i>Bleak House</i> (1852–1853), Esther Summerville.<sup id="cite_ref-187" class="reference"><a href="#cite_note-187">&#91;187&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=32" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Multiple_sclerosis_research" title="Multiple sclerosis research">Multiple sclerosis research</a></div>
<h3><span class="mw-headline" id="Epstein-Barr_virus_ongoing_studies">Epstein-Barr virus ongoing studies</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=33" title="Edit section: Epstein-Barr virus ongoing studies">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>As of 2022, the pathogenesis of MS as it relates to EBV is actively investigated, as are disease-modifying therapies; understanding of how risk factors combine with EBV to initiate MS is sought.  Whether EBV is the only cause of MS might be better understood if an EBV vaccine is developed and shown to prevent MS as well.<sup id="cite_ref-Aloisi2022_15-3" class="reference"><a href="#cite_note-Aloisi2022-15">&#91;15&#93;</a></sup>
</p><p>Even though a variety of studies showed the connection between an EBV infection and a later development of multiple sclerosis, the mechanisms behind this correlation are still not completely clear. Though there are some leading theories which are explaining the relationship between the two diseases closer. It is expected that the involvement of EBV-infected B-cells<sup id="cite_ref-188" class="reference"><a href="#cite_note-188">&#91;188&#93;</a></sup> and the involvement of anti-EBNA antibodies, which appear to be significantly higher in multiple sclerosis patients, play a crucial role in the development of the disease.<sup id="cite_ref-189" class="reference"><a href="#cite_note-189">&#91;189&#93;</a></sup> This is supported by the fact that with treatment against B-cells, e.g. through Ocrelizumab therapy, the course of multiple sclerosis symptoms will be improved. Annual relapses will appear in a minor rate and disability progression is slower.<sup id="cite_ref-190" class="reference"><a href="#cite_note-190">&#91;190&#93;</a></sup> A study led by a Stanford research unit which was published in 2022, has shown that during an EBV infection, molecular mimicry can occur, where the immune system will produce antibodies against the <a href="/wiki/EBNA" class="mw-redirect" title="EBNA">EBNA</a>1 protein, which at the same time is able to bind to GlialCAM in the myelin. Additionally, they observed a phenomenon which is uncommon in healthy individuals but often detected in multiple sclerosis patients – B-cells are trafficking to the brain and spinal cord, where they are producing oligoclonal antibody bands. A majority of these oligoclonal bands do have an affinity to the viral protein EBNA1, which is cross-reactive to GlialCAM. These antibodies are abundant in approximately 20–25% of multiple sclerosis patients and worsen the autoimmune demyelination which leads consequently to an pathophysiologocal exacerbation of the disease. Furthermore, the intrathecal oligoclonal expansion with a constant somatic hypermutation is unique in multiple sclerosis when compared to other neuroinflammatory diseases. In the study there was also the abundance of antibodies with IGHV 3–7 genes measured, which appears to be connected to the disease progress. Antibodies which are IGHV3–7-based are binding with a high affinity to EBNA1 and GlialCAM. This process is actively thriving the demyelination. It is probable that B-cells, expressing IGHV 3–7 genes entered the CSF and underwent affinity maturation after facing GlialCAM, which led consequently to the production of high affinity anti-GlialCAM antibodies. This was additionally shown in the EAE mouse model where immunization with EBNA1 lead to a strong B-cell response against GlialCAM, which worsened the EAE.<sup id="cite_ref-191" class="reference"><a href="#cite_note-191">&#91;191&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Human_endogenous_retroviruses">Human endogenous retroviruses</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=34" title="Edit section: Human endogenous retroviruses">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Two members of the human endogenous retroviruses-W (<a href="/wiki/HERV" class="mw-redirect" title="HERV">HERV</a>-W) family, namely, ERVWE1 and MS-associated retrovirus (MSRV), may be co-factors in MS immunopathogenesis. HERVs constitute up to 8% of the human genome; most are epignetically silent, but can be reactivated by exogenous viruses, proinflammatory conditions and/or oxidative stress.<sup id="cite_ref-192" class="reference"><a href="#cite_note-192">&#91;192&#93;</a></sup><sup id="cite_ref-193" class="reference"><a href="#cite_note-193">&#91;193&#93;</a></sup><sup id="cite_ref-194" class="reference"><a href="#cite_note-194">&#91;194&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Medications">Medications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=35" title="Edit section: Medications">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Medications that influence voltage-gated sodium ion channels are under investigation as a potential neuroprotective strategy because of hypothesized role of sodium in the pathological process leading to axonal injury and accumulating disability. There is insufficient evidence of an effect of sodium channel blockers for people with MS.<sup id="cite_ref-195" class="reference"><a href="#cite_note-195">&#91;195&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Pathogenesis">Pathogenesis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=36" title="Edit section: Pathogenesis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>MS is a clinically defined entity with several atypical presentations. Some auto-antibodies have been found in atypical MS cases, giving birth to separate disease families and restricting the previously wider concept of MS.
</p><p><a href="/wiki/Aquaporin_4" class="mw-redirect" title="Aquaporin 4">Anti-AQP4 autoantibodies</a> were found in <a href="/wiki/Neuromyelitis_optica" class="mw-redirect" title="Neuromyelitis optica">neuromyelitis optica</a> (NMO), which was previously considered a MS variant. A spectrum of diseases named NMOSD (NMO spectrum diseases) or anti-AQP4 diseases has been accepted.<sup id="cite_ref-Misu_196-0" class="reference"><a href="#cite_note-Misu-196">&#91;196&#93;</a></sup> Some cases of MS were presenting <a href="/wiki/Myelin_oligodendrocyte_glycoprotein" title="Myelin oligodendrocyte glycoprotein">anti-MOG autoantibodies</a>, mainly overlapping with the Marburg variant. Anti-MOG autoantibodies were found to be also present in ADEM, and a second spectrum of separated diseases is being considered. This spectrum is named inconsistently across different authors, but it is normally something similar to <a href="/wiki/Anti-MOG_associated_encephalomyelitis" class="mw-redirect" title="Anti-MOG associated encephalomyelitis">anti-MOG demyelinating diseases</a>.<sup id="cite_ref-Misu_196-1" class="reference"><a href="#cite_note-Misu-196">&#91;196&#93;</a></sup>
</p><p>A third kind of auto-antibodies is accepted. They are several <a href="/wiki/Neurofascin" class="mw-redirect" title="Neurofascin">anti-neurofascin</a> auto-antibodies which damage the Ranvier nodes of the neurons. These antibodies are more related to the peripheral nervous demyelination, but they were also found in chronic progressive PPMS and <a href="/wiki/Combined_central_and_peripheral_demyelination" class="mw-redirect" title="Combined central and peripheral demyelination">combined central and peripheral demyelination</a> (CCPD, which is considered another atypical MS presentation).<sup id="cite_ref-Kira_197-0" class="reference"><a href="#cite_note-Kira-197">&#91;197&#93;</a></sup>
</p><p>In addition to the significance of auto-antibodies in MS, four different patterns of demyelination have been reported, opening the door to consider MS as a <a href="/wiki/Heterogeneous_disease" class="mw-redirect" title="Heterogeneous disease">heterogeneous disease</a>.<sup id="cite_ref-pmid23917093_198-0" class="reference"><a href="#cite_note-pmid23917093-198">&#91;198&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Disease_biomarkers">Disease biomarkers</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=37" title="Edit section: Disease biomarkers">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:Journal.pone.0057573.g005_cropped.png" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/a/af/Journal.pone.0057573.g005_cropped.png/170px-Journal.pone.0057573.g005_cropped.png" decoding="async" width="170" height="203" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/af/Journal.pone.0057573.g005_cropped.png/255px-Journal.pone.0057573.g005_cropped.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/af/Journal.pone.0057573.g005_cropped.png/340px-Journal.pone.0057573.g005_cropped.png 2x" data-file-width="437" data-file-height="521" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Journal.pone.0057573.g005_cropped.png" class="internal" title="Enlarge"></a></div><a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">MRI</a> brain scan produced using a <i>Gradient-echo phase sequence</i> showing an iron deposit in a white matter lesion (inside green box in the middle of the image; enhanced and marked by red arrow top-left corner)<sup id="cite_ref-pmid23516409_199-0" class="reference"><a href="#cite_note-pmid23516409-199">&#91;199&#93;</a></sup></div></div></div>
<p>Since disease progression is the result of degeneration of neurons, the roles of proteins showing loss of nerve tissue such as <a href="/wiki/Neurofilament" title="Neurofilament">neurofilaments</a>, <a href="/wiki/Tau_protein" title="Tau protein">tau</a>, and <a href="/wiki/N-acetylaspartate" class="mw-redirect" title="N-acetylaspartate">N-acetylaspartate</a> are under investigation.<sup id="cite_ref-200" class="reference"><a href="#cite_note-200">&#91;200&#93;</a></sup><sup id="cite_ref-201" class="reference"><a href="#cite_note-201">&#91;201&#93;</a></sup>
</p><p>Improvement in neuroimaging techniques such as <a href="/wiki/Positron_emission_tomography" title="Positron emission tomography">positron emission tomography</a> (PET) or MRI carry a promise for better diagnosis and prognosis predictions. Regarding MRI, there are several techniques that have already shown some usefulness in research settings and could be introduced into clinical practice, such as double-inversion recovery sequences, <a href="/wiki/Magnetization_transfer" title="Magnetization transfer">magnetization transfer</a>, <a href="/wiki/Diffusion_MRI#Diffusion_tensor_imaging" title="Diffusion MRI">diffusion tensor</a>, and <a href="/wiki/Functional_magnetic_resonance_imaging" title="Functional magnetic resonance imaging">functional magnetic resonance imaging</a>.<sup id="cite_ref-pmid22159052_202-0" class="reference"><a href="#cite_note-pmid22159052-202">&#91;202&#93;</a></sup> These techniques are more specific for the disease than existing ones, but still lack some standardization of acquisition protocols and the creation of normative values.<sup id="cite_ref-pmid22159052_202-1" class="reference"><a href="#cite_note-pmid22159052-202">&#91;202&#93;</a></sup> This is particularly the case for <a href="/wiki/Proton_magnetic_resonance_spectroscopy" class="mw-redirect" title="Proton magnetic resonance spectroscopy">proton magnetic resonance spectroscopy</a>, for which a number of methodological variations observed in the literature may underlie continued inconsistencies in central nervous system metabolic abnormalities, particularly in <a href="/wiki/N-Acetylaspartic_acid" title="N-Acetylaspartic acid">N-acetyl aspartate</a>, <a href="/wiki/Inositol" title="Inositol">myoinositol</a>, <a href="/wiki/Choline" title="Choline">choline</a>, <a href="/wiki/Glutamate_(neurotransmitter)" title="Glutamate (neurotransmitter)">glutamate</a>, <a href="/wiki/Gamma-Aminobutyric_acid" class="mw-redirect" title="Gamma-Aminobutyric acid">GABA</a>, and <a href="/wiki/Glutathione" title="Glutathione">GSH</a>, observed for multiple sclerosis and its subtypes.<sup id="cite_ref-203" class="reference"><a href="#cite_note-203">&#91;203&#93;</a></sup> There are other techniques under development that include contrast agents capable of measuring levels of peripheral <a href="/wiki/Macrophage" title="Macrophage">macrophages</a>, inflammation, or neuronal dysfunction,<sup id="cite_ref-pmid22159052_202-2" class="reference"><a href="#cite_note-pmid22159052-202">&#91;202&#93;</a></sup> and techniques that measure iron deposition that could serve to determine the role of this feature in MS, or that of cerebral perfusion.<sup id="cite_ref-pmid22159052_202-3" class="reference"><a href="#cite_note-pmid22159052-202">&#91;202&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="COVID-19">COVID-19</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=38" title="Edit section: COVID-19">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The hospitalization rate was found to be higher among individuals with MS and COVID-19 infection, at 10%, while the pooled infection rate is estimated at 4%. The pooled prevalence of death in hospitalized individuals with MS is estimated as 4%.<sup id="cite_ref-204" class="reference"><a href="#cite_note-204">&#91;204&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Other_emerging_theories">Other emerging theories</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=39" title="Edit section: Other emerging theories">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>One emerging hypothesis, referred to as the hygiene hypothesis, suggests that early-life exposure to infectious agents helps to develop the immune system and reduces susceptibility to allergies and autoimmune disorders, including MS. Germ-free mice infected with transplanted fecal matter from MS patients exhibit an increased risk of developing EAE, an animal model of MS.<sup id="cite_ref-205" class="reference"><a href="#cite_note-205">&#91;205&#93;</a></sup><sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag needs references to reliable medical sources. (December 2022)">medical citation needed</span></a></i>&#93;</sup> It has also been proposed that certain bacteria found in the gut use molecular mimicry to infiltrate the brain via the <a href="/wiki/Gut%E2%80%93brain_axis" title="Gut–brain axis">gut-brain axis</a>, initiating an inflammatory response and increasing blood-brain barrier permeability. <a href="/wiki/Vitamin_D" title="Vitamin D">Vitamin D</a> levels have also been correlated with MS; lower levels of vitamin D correspond to an increased risk of MS, suggesting a reduced prevalence in the tropics – an area with more Vitamin D-rich sunlight – strengthening the impact of geographical location on MS development.<sup id="cite_ref-206" class="reference"><a href="#cite_note-206">&#91;206&#93;</a></sup> MS mechanisms begin when peripheral <a href="/wiki/Autoreactive_lymphocyte" class="mw-redirect" title="Autoreactive lymphocyte">autoreactive</a> effector <a href="/wiki/T_helper_cell" title="T helper cell">CD4+ T cells</a> get activated and move into the CNS. <a href="/wiki/Antigen-presenting_cell" title="Antigen-presenting cell">Antigen-presenting cells</a> localize the reactivation of autoreactive effector CD4-T cells once they have entered the CNS, attracting more T cells and macrophages to form the inflammatory lesion.<sup id="cite_ref-207" class="reference"><a href="#cite_note-207">&#91;207&#93;</a></sup><sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag needs references to reliable medical sources. (December 2022)">medical citation needed</span></a></i>&#93;</sup> In MS patients, macrophages and microglia assemble at locations where demyelination and neurodegeneration are actively occurring, and microglial activation is more apparent in the normal-appearing white matter of MS patients.<sup id="cite_ref-208" class="reference"><a href="#cite_note-208">&#91;208&#93;</a></sup> <a href="/wiki/Astrocyte" title="Astrocyte">Astrocytes</a> generate neurotoxic chemicals like <a href="/wiki/Nitric_oxide" title="Nitric oxide">nitric oxide</a> and <a href="/wiki/Tumor_necrosis_factor" title="Tumor necrosis factor">TNFα</a>, attract neurotoxic inflammatory <a href="/wiki/Monocyte" title="Monocyte">monocytes</a> to the CNS, and are responsible for <a href="/wiki/Astrogliosis" title="Astrogliosis">astrogliosis</a>, the scarring that prevents the spread of neuroinflammation and kills neurons inside the scarred area.<sup id="cite_ref-209" class="reference"><a href="#cite_note-209">&#91;209&#93;</a></sup><sup class="noprint Inline-Template noprint noexcerpt Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:NOTRS" class="mw-redirect" title="Wikipedia:NOTRS"><span title="Not very recent (December 2022)">better&#160;source&#160;needed</span></a></i>&#93;</sup>
</p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=40" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><a href="/wiki/List_of_multiple_sclerosis_organizations" title="List of multiple sclerosis organizations">List of multiple sclerosis organizations</a></li>
<li><a href="/wiki/List_of_people_with_multiple_sclerosis" title="List of people with multiple sclerosis">List of people with multiple sclerosis</a></li></ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=41" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1011085734">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist">
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-pmid18970977-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18970977_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-24"><sup><i><b>y</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-25"><sup><i><b>z</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-26"><sup><i><b>aa</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-27"><sup><i><b>ab</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-28"><sup><i><b>ac</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-29"><sup><i><b>ad</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-30"><sup><i><b>ae</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-31"><sup><i><b>af</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-32"><sup><i><b>ag</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-33"><sup><i><b>ah</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-34"><sup><i><b>ai</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-35"><sup><i><b>aj</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-36"><sup><i><b>ak</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-37"><sup><i><b>al</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-38"><sup><i><b>am</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-39"><sup><i><b>an</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-40"><sup><i><b>ao</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-41"><sup><i><b>ap</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-42"><sup><i><b>aq</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-43"><sup><i><b>ar</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-44"><sup><i><b>as</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-45"><sup><i><b>at</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-46"><sup><i><b>au</b></i></sup></a> <a href="#cite_ref-pmid18970977_1-47"><sup><i><b>av</b></i></sup></a></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1133582631">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite id="CITEREFCompstonColes2008" class="citation journal cs1"><a href="/wiki/Alastair_Compston" title="Alastair Compston">Compston A</a>, Coles A (October 2008). "Multiple sclerosis". <i>Lancet</i>. <b>372</b> (9648): 1502–1517. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2808%2961620-7">10.1016/S0140-6736(08)61620-7</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18970977">18970977</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:195686659">195686659</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Multiple+sclerosis&amp;rft.volume=372&amp;rft.issue=9648&amp;rft.pages=1502-1517&amp;rft.date=2008-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A195686659%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18970977&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2808%2961620-7&amp;rft.aulast=Compston&amp;rft.aufirst=A&amp;rft.au=Coles%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Milo2010-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Milo2010_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Milo2010_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Milo2010_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Milo2010_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Milo2010_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Milo2010_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Milo2010_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Milo2010_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Milo2010_2-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Milo2010_2-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Milo2010_2-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Milo2010_2-11"><sup><i><b>l</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMiloKahana2010" class="citation journal cs1">Milo R, Kahana E (March 2010). "Multiple sclerosis: geoepidemiology, genetics and the environment". <i>Autoimmunity Reviews</i>. <b>9</b> (5): A387-94. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.autrev.2009.11.010">10.1016/j.autrev.2009.11.010</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19932200">19932200</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Autoimmunity+Reviews&amp;rft.atitle=Multiple+sclerosis%3A+geoepidemiology%2C+genetics+and+the+environment&amp;rft.volume=9&amp;rft.issue=5&amp;rft.pages=A387-94&amp;rft.date=2010-03&amp;rft_id=info%3Adoi%2F10.1016%2Fj.autrev.2009.11.010&amp;rft_id=info%3Apmid%2F19932200&amp;rft.aulast=Milo&amp;rft.aufirst=R&amp;rft.au=Kahana%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-NIH2015-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-NIH2015_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NIH2015_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NIH2015_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NIH2015_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NIH2015_3-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160213025406/http://www.ninds.nih.gov/disorders/multiple_sclerosis/multiple_sclerosis.htm">"NINDS Multiple Sclerosis Information Page"</a>. <i>National Institute of Neurological Disorders and Stroke</i>. 19 November 2015. Archived from <a rel="nofollow" class="external text" href="http://www.ninds.nih.gov/disorders/multiple_sclerosis/multiple_sclerosis.htm">the original</a> on 13 February 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">6 March</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Institute+of+Neurological+Disorders+and+Stroke&amp;rft.atitle=NINDS+Multiple+Sclerosis+Information+Page&amp;rft.date=2015-11-19&amp;rft_id=http%3A%2F%2Fwww.ninds.nih.gov%2Fdisorders%2Fmultiple_sclerosis%2Fmultiple_sclerosis.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Nak2012-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nak2012_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nak2012_4-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFNakaharaMaedaAisoSuzuki2012" class="citation journal cs1">Nakahara J, Maeda M, Aiso S, Suzuki N (February 2012). "Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy". <i>Clinical Reviews in Allergy &amp; Immunology</i>. <b>42</b> (1): 26–34. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs12016-011-8287-6">10.1007/s12016-011-8287-6</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22189514">22189514</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:21058811">21058811</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Reviews+in+Allergy+%26+Immunology&amp;rft.atitle=Current+concepts+in+multiple+sclerosis%3A+autoimmunity+versus+oligodendrogliopathy&amp;rft.volume=42&amp;rft.issue=1&amp;rft.pages=26-34&amp;rft.date=2012-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A21058811%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22189514&amp;rft_id=info%3Adoi%2F10.1007%2Fs12016-011-8287-6&amp;rft.aulast=Nakahara&amp;rft.aufirst=J&amp;rft.au=Maeda%2C+M&amp;rft.au=Aiso%2C+S&amp;rft.au=Suzuki%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Tsang2011-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tsang2011_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tsang2011_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Tsang2011_5-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Tsang2011_5-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Tsang2011_5-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Tsang2011_5-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Tsang2011_5-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Tsang2011_5-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTsangMacdonell2011" class="citation journal cs1">Tsang BK, Macdonell R (December 2011). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20211005193936/https://www.racgp.org.au/afp/201112/45005">"Multiple sclerosis- diagnosis, management and prognosis"</a>. <i>Australian Family Physician</i>. <b>40</b> (12): 948–55. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22146321">22146321</a>. Archived from <a rel="nofollow" class="external text" href="http://www.racgp.org.au/afp/201112/45005">the original</a> on 5 October 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">5 October</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Australian+Family+Physician&amp;rft.atitle=Multiple+sclerosis-+diagnosis%2C+management+and+prognosis&amp;rft.volume=40&amp;rft.issue=12&amp;rft.pages=948-55&amp;rft.date=2011-12&amp;rft_id=info%3Apmid%2F22146321&amp;rft.aulast=Tsang&amp;rft.aufirst=BK&amp;rft.au=Macdonell%2C+R&amp;rft_id=http%3A%2F%2Fwww.racgp.org.au%2Fafp%2F201112%2F45005&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Liu_2021-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-Liu_2021_6-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLiuLiaoWenZhang2021" class="citation journal cs1">Liu Z, Liao Q, Wen H, Zhang Y (June 2021). "Disease modifying therapies in relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis". <i>Autoimmunity Reviews</i>. <b>20</b> (6): 102826. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.autrev.2021.102826">10.1016/j.autrev.2021.102826</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33878488">33878488</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:233325057">233325057</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Autoimmunity+Reviews&amp;rft.atitle=Disease+modifying+therapies+in+relapsing-remitting+multiple+sclerosis%3A+A+systematic+review+and+network+meta-analysis&amp;rft.volume=20&amp;rft.issue=6&amp;rft.pages=102826&amp;rft.date=2021-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A233325057%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F33878488&amp;rft_id=info%3Adoi%2F10.1016%2Fj.autrev.2021.102826&amp;rft.aulast=Liu&amp;rft.aufirst=Z&amp;rft.au=Liao%2C+Q&amp;rft.au=Wen%2C+H&amp;rft.au=Zhang%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Alphonsus_2019-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-Alphonsus_2019_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Alphonsus_2019_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Alphonsus_2019_7-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAlphonsusSuD&#39;Arcy2019" class="citation journal cs1">Alphonsus KB, Su Y, D'Arcy C (April 2019). "The effect of exercise, yoga and physiotherapy on the quality of life of people with multiple sclerosis: Systematic review and meta-analysis". <i>Complementary Therapies in Medicine</i>. <b>43</b>: 188–195. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ctim.2019.02.010">10.1016/j.ctim.2019.02.010</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30935529">30935529</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:86669723">86669723</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Complementary+Therapies+in+Medicine&amp;rft.atitle=The+effect+of+exercise%2C+yoga+and+physiotherapy+on+the+quality+of+life+of+people+with+multiple+sclerosis%3A+Systematic+review+and+meta-analysis&amp;rft.volume=43&amp;rft.pages=188-195&amp;rft.date=2019-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A86669723%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F30935529&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ctim.2019.02.010&amp;rft.aulast=Alphonsus&amp;rft.aufirst=KB&amp;rft.au=Su%2C+Y&amp;rft.au=D%27Arcy%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Leray2016Epidemiology-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-Leray2016Epidemiology_8-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLerayMoreauFromontEdan2016" class="citation journal cs1">Leray E, Moreau T, Fromont A, Edan G (January 2016). "Epidemiology of multiple sclerosis". <i>Revue Neurologique</i>. <b>172</b> (1): 3–13. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2015.10.006">10.1016/j.neurol.2015.10.006</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26718593">26718593</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=Epidemiology+of+multiple+sclerosis&amp;rft.volume=172&amp;rft.issue=1&amp;rft.pages=3-13&amp;rft.date=2016-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2015.10.006&amp;rft_id=info%3Apmid%2F26718593&amp;rft.aulast=Leray&amp;rft.aufirst=E&amp;rft.au=Moreau%2C+T&amp;rft.au=Fromont%2C+A&amp;rft.au=Edan%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid11955556-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid11955556_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11955556_9-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid11955556_9-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid11955556_9-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid11955556_9-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid11955556_9-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid11955556_9-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid11955556_9-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid11955556_9-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid11955556_9-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid11955556_9-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-pmid11955556_9-11"><sup><i><b>l</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCompstonColes2002" class="citation journal cs1">Compston A, Coles A (April 2002). "Multiple sclerosis". <i>Lancet</i>. <b>359</b> (9313): 1221–1231. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2802%2908220-X">10.1016/S0140-6736(02)08220-X</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11955556">11955556</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:14207583">14207583</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Multiple+sclerosis&amp;rft.volume=359&amp;rft.issue=9313&amp;rft.pages=1221-1231&amp;rft.date=2002-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A14207583%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11955556&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2802%2908220-X&amp;rft.aulast=Compston&amp;rft.aufirst=A&amp;rft.au=Coles%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMurrayButtnerPrice2012" class="citation book cs1">Murray ED, Buttner EA, Price BH (2012). "Depression and Psychosis in Neurological Practice".  In Daroff R, Fenichel G, Jankovic J, Mazziotta J (eds.). <i>Bradley's neurology in clinical practice</i> (6th&#160;ed.). Philadelphia, PA: Elsevier/Saunders. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-4377-0434-1" title="Special:BookSources/978-1-4377-0434-1"><bdi>978-1-4377-0434-1</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Depression+and+Psychosis+in+Neurological+Practice&amp;rft.btitle=Bradley%27s+neurology+in+clinical+practice.&amp;rft.place=Philadelphia%2C+PA&amp;rft.edition=6th&amp;rft.pub=Elsevier%2FSaunders&amp;rft.date=2012&amp;rft.isbn=978-1-4377-0434-1&amp;rft.aulast=Murray&amp;rft.aufirst=ED&amp;rft.au=Buttner%2C+EA&amp;rft.au=Price%2C+BH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Piryonesi-2021-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-Piryonesi-2021_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Piryonesi-2021_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Piryonesi-2021_11-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPiryonesiRostampourPiryonesi2021" class="citation journal cs1">Piryonesi SM, Rostampour S, Piryonesi SA (April 2021). "Predicting falls and injuries in people with multiple sclerosis using machine learning algorithms". <i>Multiple Sclerosis and Related Disorders</i>. <b>49</b>: 102740. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.msard.2021.102740">10.1016/j.msard.2021.102740</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33450500">33450500</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:231624230">231624230</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Multiple+Sclerosis+and+Related+Disorders&amp;rft.atitle=Predicting+falls+and+injuries+in+people+with+multiple+sclerosis+using+machine+learning+algorithms&amp;rft.volume=49&amp;rft.pages=102740&amp;rft.date=2021-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A231624230%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F33450500&amp;rft_id=info%3Adoi%2F10.1016%2Fj.msard.2021.102740&amp;rft.aulast=Piryonesi&amp;rft.aufirst=SM&amp;rft.au=Rostampour%2C+S&amp;rft.au=Piryonesi%2C+SA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMazumderMurchisonBourdetteCameron2014" class="citation journal cs1">Mazumder R, Murchison C, Bourdette D, Cameron M (25 September 2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177842">"Falls in people with multiple sclerosis compared with falls in healthy controls"</a>. <i>PLOS ONE</i>. <b>9</b> (9): e107620. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2014PLoSO...9j7620M">2014PLoSO...9j7620M</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0107620">10.1371/journal.pone.0107620</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177842">4177842</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25254633">25254633</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=Falls+in+people+with+multiple+sclerosis+compared+with+falls+in+healthy+controls&amp;rft.volume=9&amp;rft.issue=9&amp;rft.pages=e107620&amp;rft.date=2014-09-25&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4177842%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25254633&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0107620&amp;rft_id=info%3Abibcode%2F2014PLoSO...9j7620M&amp;rft.aulast=Mazumder&amp;rft.aufirst=R&amp;rft.au=Murchison%2C+C&amp;rft.au=Bourdette%2C+D&amp;rft.au=Cameron%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4177842&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBaecher-AllanKaskowWeiner2018" class="citation journal cs1">Baecher-Allan C, Kaskow BJ, Weiner HL (February 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neuron.2018.01.021">"Multiple Sclerosis: Mechanisms and Immunotherapy"</a>. <i>Neuron</i>. <b>97</b> (4): 742–768. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neuron.2018.01.021">10.1016/j.neuron.2018.01.021</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29470968">29470968</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3499974">3499974</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuron&amp;rft.atitle=Multiple+Sclerosis%3A+Mechanisms+and+Immunotherapy&amp;rft.volume=97&amp;rft.issue=4&amp;rft.pages=742-768&amp;rft.date=2018-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3499974%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29470968&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuron.2018.01.021&amp;rft.aulast=Baecher-Allan&amp;rft.aufirst=C&amp;rft.au=Kaskow%2C+BJ&amp;rft.au=Weiner%2C+HL&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.neuron.2018.01.021&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid8780061-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid8780061_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid8780061_14-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid8780061_14-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid8780061_14-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid8780061_14-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid8780061_14-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag needs references to reliable medical sources. (July 2022)">medical citation needed</span></a></i>&#93;</sup><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLublinReingold1996" class="citation journal cs1"><a href="/wiki/Fred_D._Lublin" title="Fred D. Lublin">Lublin FD</a>, Reingold SC (April 1996). "Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis". <i>Neurology</i>. <b>46</b> (4): 907–911. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.46.4.907">10.1212/WNL.46.4.907</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/8780061">8780061</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:40213123">40213123</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Defining+the+clinical+course+of+multiple+sclerosis%3A+results+of+an+international+survey.+National+Multiple+Sclerosis+Society+%28USA%29+Advisory+Committee+on+Clinical+Trials+of+New+Agents+in+Multiple+Sclerosis&amp;rft.volume=46&amp;rft.issue=4&amp;rft.pages=907-911&amp;rft.date=1996-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A40213123%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F8780061&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.46.4.907&amp;rft.aulast=Lublin&amp;rft.aufirst=FD&amp;rft.au=Reingold%2C+SC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Aloisi2022-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-Aloisi2022_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Aloisi2022_15-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Aloisi2022_15-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Aloisi2022_15-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAloisiCross2022" class="citation journal cs1">Aloisi F, Cross AH (October 2022). "MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis". <i>Journal of Neuroimmunology</i>. <b>371</b>: 577935. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jneuroim.2022.577935">10.1016/j.jneuroim.2022.577935</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35931008">35931008</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:251152784">251152784</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neuroimmunology&amp;rft.atitle=MINI-review+of+Epstein-Barr+virus+involvement+in+multiple+sclerosis+etiology+and+pathogenesis&amp;rft.volume=371&amp;rft.pages=577935&amp;rft.date=2022-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A251152784%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F35931008&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jneuroim.2022.577935&amp;rft.aulast=Aloisi&amp;rft.aufirst=F&amp;rft.au=Cross%2C+AH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17444504-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17444504_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17444504_16-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid17444504_16-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid17444504_16-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid17444504_16-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAscherioMunger2007" class="citation journal cs1">Ascherio A, Munger KL (April 2007). <a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fana.21117">"Environmental risk factors for multiple sclerosis. Part I: the role of infection"</a>. <i>Annals of Neurology</i>. <b>61</b> (4): 288–99. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fana.21117">10.1002/ana.21117</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17444504">17444504</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:7682774">7682774</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=Environmental+risk+factors+for+multiple+sclerosis.+Part+I%3A+the+role+of+infection&amp;rft.volume=61&amp;rft.issue=4&amp;rft.pages=288-99&amp;rft.date=2007-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7682774%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17444504&amp;rft_id=info%3Adoi%2F10.1002%2Fana.21117&amp;rft.aulast=Ascherio&amp;rft.aufirst=A&amp;rft.au=Munger%2C+KL&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fana.21117&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFQuinnHynes2021" class="citation journal cs1">Quinn É, Hynes SM (July 2021). "Occupational therapy interventions for multiple sclerosis: A scoping review". <i>Scandinavian Journal of Occupational Therapy</i>. <b>28</b> (5): 399–414. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F11038128.2020.1786160">10.1080/11038128.2020.1786160</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<a rel="nofollow" class="external text" href="https://hdl.handle.net/10379%2F16066">10379/16066</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32643486">32643486</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:220436640">220436640</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Scandinavian+Journal+of+Occupational+Therapy&amp;rft.atitle=Occupational+therapy+interventions+for+multiple+sclerosis%3A+A+scoping+review&amp;rft.volume=28&amp;rft.issue=5&amp;rft.pages=399-414&amp;rft.date=2021-07&amp;rft_id=info%3Ahdl%2F10379%2F16066&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A220436640%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F32643486&amp;rft_id=info%3Adoi%2F10.1080%2F11038128.2020.1786160&amp;rft.aulast=Quinn&amp;rft.aufirst=%C3%89&amp;rft.au=Hynes%2C+SM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid16420779-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid16420779_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16420779_18-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid16420779_18-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid16420779_18-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid16420779_18-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid16420779_18-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid16420779_18-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid16420779_18-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHuntley2006" class="citation journal cs1">Huntley A (January 2006). "A review of the evidence for efficacy of complementary and alternative medicines in MS". <i>International MS Journal</i>. <b>13</b> (1): 5–12, 4. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16420779">16420779</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+MS+Journal&amp;rft.atitle=A+review+of+the+evidence+for+efficacy+of+complementary+and+alternative+medicines+in+MS&amp;rft.volume=13&amp;rft.issue=1&amp;rft.pages=5-12%2C+4&amp;rft.date=2006-01&amp;rft_id=info%3Apmid%2F16420779&amp;rft.aulast=Huntley&amp;rft.aufirst=A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid8017890-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8017890_19-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWeinshenker1994" class="citation journal cs1">Weinshenker BG (1994). "Natural history of multiple sclerosis". <i>Annals of Neurology</i>. <b>36</b> (Suppl): S6-11. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fana.410360704">10.1002/ana.410360704</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/8017890">8017890</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:7140070">7140070</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=Natural+history+of+multiple+sclerosis&amp;rft.volume=36&amp;rft.issue=Suppl&amp;rft.pages=S6-11&amp;rft.date=1994&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7140070%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F8017890&amp;rft_id=info%3Adoi%2F10.1002%2Fana.410360704&amp;rft.aulast=Weinshenker&amp;rft.aufirst=BG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid24746689-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid24746689_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid24746689_20-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBererKrishnamoorthy2014" class="citation journal cs1">Berer K, Krishnamoorthy G (November 2014). "Microbial view of central nervous system autoimmunity". <i>FEBS Letters</i>. <b>588</b> (22): 4207–13. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.febslet.2014.04.007">10.1016/j.febslet.2014.04.007</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24746689">24746689</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:2772656">2772656</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FEBS+Letters&amp;rft.atitle=Microbial+view+of+central+nervous+system+autoimmunity&amp;rft.volume=588&amp;rft.issue=22&amp;rft.pages=4207-13&amp;rft.date=2014-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A2772656%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F24746689&amp;rft_id=info%3Adoi%2F10.1016%2Fj.febslet.2014.04.007&amp;rft.aulast=Berer&amp;rft.aufirst=K&amp;rft.au=Krishnamoorthy%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-McGinley2021-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-McGinley2021_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-McGinley2021_21-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-McGinley2021_21-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-McGinley2021_21-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-McGinley2021_21-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-McGinley2021_21-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-McGinley2021_21-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMcGinleyGoldschmidtRae-Grant2021" class="citation journal cs1">McGinley MP, Goldschmidt CH, Rae-Grant AD (February 2021). "Diagnosis and Treatment of Multiple Sclerosis: A Review". <i>JAMA</i>. <b>325</b> (8): 765–779. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.2020.26858">10.1001/jama.2020.26858</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33620411">33620411</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:232019589">232019589</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Diagnosis+and+Treatment+of+Multiple+Sclerosis%3A+A+Review&amp;rft.volume=325&amp;rft.issue=8&amp;rft.pages=765-779&amp;rft.date=2021-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A232019589%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F33620411&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2020.26858&amp;rft.aulast=McGinley&amp;rft.aufirst=MP&amp;rft.au=Goldschmidt%2C+CH&amp;rft.au=Rae-Grant%2C+AD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Lane2022-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lane2022_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lane2022_22-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLaneNgPoyserLucas2022" class="citation journal cs1">Lane J, Ng HS, Poyser C, Lucas RM, Tremlett H (July 2022). <a rel="nofollow" class="external text" href="https://linkinghub.elsevier.com/retrieve/pii/S2211-0348(22)00443-6">"Multiple sclerosis incidence: A systematic review of change over time by geographical region"</a>. <i>Mult Scler Relat Disord</i>. <b>63</b>: 103932. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.msard.2022.103932">10.1016/j.msard.2022.103932</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35667315">35667315</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:249188137">249188137</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230210212933/https://www.msard-journal.com/article/S2211-0348(22)00443-6/fulltext">Archived</a> from the original on 10 February 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">6 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mult+Scler+Relat+Disord&amp;rft.atitle=Multiple+sclerosis+incidence%3A+A+systematic+review+of+change+over+time+by+geographical+region&amp;rft.volume=63&amp;rft.pages=103932&amp;rft.date=2022-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A249188137%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F35667315&amp;rft_id=info%3Adoi%2F10.1016%2Fj.msard.2022.103932&amp;rft.aulast=Lane&amp;rft.aufirst=J&amp;rft.au=Ng%2C+HS&amp;rft.au=Poyser%2C+C&amp;rft.au=Lucas%2C+RM&amp;rft.au=Tremlett%2C+H&amp;rft_id=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211-0348%2822%2900443-6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Charcot1-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-Charcot1_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Charcot1_23-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Charcot1_23-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFClanet2008" class="citation journal cs1">Clanet M (June 2008). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190330210130/http://www.msforum.net/Site/ViewPDF/ViewPDF.aspx?ArticleID=E80DC748-5048-4BD2-9393-18BCAE0A1514&amp;doctype=Article">"Jean-Martin Charcot. 1825 to 1893"</a>. <i>International MS Journal</i>. <b>15</b> (2): 59–61. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18782501">18782501</a>. Archived from <a rel="nofollow" class="external text" href="http://www.msforum.net/Site/ViewPDF/ViewPDF.aspx?ArticleID=E80DC748-5048-4BD2-9393-18BCAE0A1514&amp;doctype=Article">the original</a> <span class="cs1-format">(PDF)</span> on 30 March 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">21 October</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+MS+Journal&amp;rft.atitle=Jean-Martin+Charcot.+1825+to+1893&amp;rft.volume=15&amp;rft.issue=2&amp;rft.pages=59-61&amp;rft.date=2008-06&amp;rft_id=info%3Apmid%2F18782501&amp;rft.aulast=Clanet&amp;rft.aufirst=M&amp;rft_id=http%3A%2F%2Fwww.msforum.net%2FSite%2FViewPDF%2FViewPDF.aspx%3FArticleID%3DE80DC748-5048-4BD2-9393-18BCAE0A1514%26doctype%3DArticle&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span><br />* <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCharcot1868" class="citation journal cs1">Charcot J (1868). "Histologie de la sclerose en plaques". <i>Gazette des Hopitaux, Paris</i>. <b>41</b>: 554–5.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gazette+des+Hopitaux%2C+Paris&amp;rft.atitle=Histologie+de+la+sclerose+en+plaques&amp;rft.volume=41&amp;rft.pages=554-5&amp;rft.date=1868&amp;rft.aulast=Charcot&amp;rft.aufirst=J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.webmd.com/multiple-sclerosis/">"MS Signs"</a>. <i><a href="/wiki/Webmd" class="mw-redirect" title="Webmd">Webmd</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160930181511/http://www.webmd.com/multiple-sclerosis/">Archived</a> from the original on 30 September 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Webmd&amp;rft.atitle=MS+Signs&amp;rft_id=http%3A%2F%2Fwww.webmd.com%2Fmultiple-sclerosis%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Petzold-2022-25"><span class="mw-cite-backlink">^ <a href="#cite_ref-Petzold-2022_25-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Petzold-2022_25-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Petzold-2022_25-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Petzold-2022_25-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Petzold-2022_25-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPetzoldFraserAbeggAlroughani2022" class="citation journal cs1">Petzold A, Fraser CL, Abegg M, Alroughani R, Alshowaeir D, Alvarenga R,  et&#160;al. (December 2022). <a rel="nofollow" class="external text" href="https://discovery.ucl.ac.uk/id/eprint/10156457/">"Diagnosis and classification of optic neuritis"</a>. <i>The Lancet. Neurology</i>. <b>21</b> (12): 1120–1134. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs1474-4422%2822%2900200-9">10.1016/s1474-4422(22)00200-9</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/36179757">36179757</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:252564095">252564095</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Diagnosis+and+classification+of+optic+neuritis&amp;rft.volume=21&amp;rft.issue=12&amp;rft.pages=1120-1134&amp;rft.date=2022-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A252564095%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F36179757&amp;rft_id=info%3Adoi%2F10.1016%2Fs1474-4422%2822%2900200-9&amp;rft.aulast=Petzold&amp;rft.aufirst=A&amp;rft.au=Fraser%2C+CL&amp;rft.au=Abegg%2C+M&amp;rft.au=Alroughani%2C+R&amp;rft.au=Alshowaeir%2C+D&amp;rft.au=Alvarenga%2C+R&amp;rft.au=Andris%2C+C&amp;rft.au=Asgari%2C+N&amp;rft.au=Barnett%2C+Y&amp;rft.au=Battistella%2C+R&amp;rft.au=Behbehani%2C+R&amp;rft.au=Berger%2C+T&amp;rft.au=Bikbov%2C+MM&amp;rft.au=Biotti%2C+D&amp;rft.au=Biousse%2C+V&amp;rft.au=Boschi%2C+A&amp;rft.au=Brazdil%2C+M&amp;rft.au=Brezhnev%2C+A&amp;rft.au=Calabresi%2C+PA&amp;rft.au=Cordonnier%2C+M&amp;rft.au=Costello%2C+F&amp;rft.au=Cruz%2C+FM&amp;rft.au=Cunha%2C+LP&amp;rft.au=Daoudi%2C+S&amp;rft.au=Deschamps%2C+R&amp;rft.au=de+Seze%2C+J&amp;rft.au=Diem%2C+R&amp;rft.au=Etemadifar%2C+M&amp;rft.au=Flores-Rivera%2C+J&amp;rft.au=Fonseca%2C+P&amp;rft.au=Frederiksen%2C+J&amp;rft.au=Frohman%2C+E&amp;rft.au=Frohman%2C+T&amp;rft.au=Tilikete%2C+CF&amp;rft.au=Fujihara%2C+K&amp;rft.au=G%C3%A1lvez%2C+A&amp;rft.au=Gouider%2C+R&amp;rft.au=Gracia%2C+F&amp;rft.au=Grigoriadis%2C+N&amp;rft.au=Guajardo%2C+JM&amp;rft.au=Habek%2C+M&amp;rft.au=Hawlina%2C+M&amp;rft.au=Mart%C3%ADnez-Lapiscina%2C+EH&amp;rft.au=Hooker%2C+J&amp;rft.au=Hor%2C+JY&amp;rft.au=Howlett%2C+W&amp;rft.au=Huang-Link%2C+Y&amp;rft.au=Idrissova%2C+Z&amp;rft.au=Illes%2C+Z&amp;rft.au=Jancic%2C+J&amp;rft.au=Jindahra%2C+P&amp;rft.au=Karussis%2C+D&amp;rft.au=Kerty%2C+E&amp;rft.au=Kim%2C+HJ&amp;rft.au=Lagr%C3%A8ze%2C+W&amp;rft.au=Leocani%2C+L&amp;rft.au=Levin%2C+N&amp;rft.au=Liskova%2C+P&amp;rft.au=Liu%2C+Y&amp;rft.au=Maiga%2C+Y&amp;rft.au=Marignier%2C+R&amp;rft.au=McGuigan%2C+C&amp;rft.au=Meira%2C+D&amp;rft.au=Merle%2C+H&amp;rft.au=Monteiro%2C+ML&amp;rft.au=Moodley%2C+A&amp;rft.au=Moura%2C+F&amp;rft.au=Mu%C3%B1oz%2C+S&amp;rft.au=Mustafa%2C+S&amp;rft.au=Nakashima%2C+I&amp;rft.au=Noval%2C+S&amp;rft.au=Oehninger%2C+C&amp;rft.au=Ogun%2C+O&amp;rft.au=Omoti%2C+A&amp;rft.au=Pandit%2C+L&amp;rft.au=Paul%2C+F&amp;rft.au=Rebolleda%2C+G&amp;rft.au=Reddel%2C+S&amp;rft.au=Rejdak%2C+K&amp;rft.au=Rejdak%2C+R&amp;rft.au=Rodriguez-Morales%2C+AJ&amp;rft.au=Rougier%2C+MB&amp;rft.au=Sa%2C+MJ&amp;rft.au=Sanchez-Dalmau%2C+B&amp;rft.au=Saylor%2C+D&amp;rft.au=Shatriah%2C+I&amp;rft.au=Siva%2C+A&amp;rft.au=Stiebel-Kalish%2C+H&amp;rft.au=Szatmary%2C+G&amp;rft.au=Ta%2C+L&amp;rft.au=Tenembaum%2C+S&amp;rft.au=Tran%2C+H&amp;rft.au=Trufanov%2C+Y&amp;rft.au=van+Pesch%2C+V&amp;rft.au=Wang%2C+AG&amp;rft.au=Wattjes%2C+MP&amp;rft.au=Willoughby%2C+E&amp;rft.au=Zakaria%2C+M&amp;rft.au=Zvornicanin%2C+J&amp;rft.au=Balcer%2C+L&amp;rft.au=Plant%2C+GT&amp;rft_id=https%3A%2F%2Fdiscovery.ucl.ac.uk%2Fid%2Feprint%2F10156457%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCameronNilsagard2018" class="citation journal cs1">Cameron MH, Nilsagard Y (2018). "Balance, gait, and falls in multiple sclerosis". <i>Handbook of Clinical Neurology</i>. <b>159</b>: 237–250. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fb978-0-444-63916-5.00015-x">10.1016/b978-0-444-63916-5.00015-x</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-444-63916-5" title="Special:BookSources/978-0-444-63916-5"><bdi>978-0-444-63916-5</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30482317">30482317</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Handbook+of+Clinical+Neurology&amp;rft.atitle=Balance%2C+gait%2C+and+falls+in+multiple+sclerosis&amp;rft.volume=159&amp;rft.pages=237-250&amp;rft.date=2018&amp;rft_id=info%3Apmid%2F30482317&amp;rft_id=info%3Adoi%2F10.1016%2Fb978-0-444-63916-5.00015-x&amp;rft.isbn=978-0-444-63916-5&amp;rft.aulast=Cameron&amp;rft.aufirst=MH&amp;rft.au=Nilsagard%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFOreja-GuevaraAyuso_BlancoBrieva_RuizHernández_Pérez2019" class="citation journal cs1">Oreja-Guevara C, Ayuso Blanco T, Brieva Ruiz L, Hernández Pérez MÁ, Meca-Lallana V, Ramió-Torrentà L (2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558141">"Cognitive Dysfunctions and Assessments in Multiple Sclerosis"</a>. <i>Frontiers in Neurology</i>. <b>10</b>: 581. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffneur.2019.00581">10.3389/fneur.2019.00581</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558141">6558141</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31214113">31214113</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Neurology&amp;rft.atitle=Cognitive+Dysfunctions+and+Assessments+in+Multiple+Sclerosis&amp;rft.volume=10&amp;rft.pages=581&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6558141%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31214113&amp;rft_id=info%3Adoi%2F10.3389%2Ffneur.2019.00581&amp;rft.aulast=Oreja-Guevara&amp;rft.aufirst=C&amp;rft.au=Ayuso+Blanco%2C+T&amp;rft.au=Brieva+Ruiz%2C+L&amp;rft.au=Hern%C3%A1ndez+P%C3%A9rez%2C+M%C3%81&amp;rft.au=Meca-Lallana%2C+V&amp;rft.au=Rami%C3%B3-Torrent%C3%A0%2C+L&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6558141&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKalbBeierBenedictCharvet2018" class="citation journal cs1">Kalb R, Beier M, Benedict RH, Charvet L, Costello K, Feinstein A,  et&#160;al. (November 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238181">"Recommendations for cognitive screening and management in multiple sclerosis care"</a>. <i>Multiple Sclerosis</i>. <b>24</b> (13): 1665–1680. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1352458518803785">10.1177/1352458518803785</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238181">6238181</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30303036">30303036</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Multiple+Sclerosis&amp;rft.atitle=Recommendations+for+cognitive+screening+and+management+in+multiple+sclerosis+care&amp;rft.volume=24&amp;rft.issue=13&amp;rft.pages=1665-1680&amp;rft.date=2018-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6238181%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30303036&amp;rft_id=info%3Adoi%2F10.1177%2F1352458518803785&amp;rft.aulast=Kalb&amp;rft.aufirst=R&amp;rft.au=Beier%2C+M&amp;rft.au=Benedict%2C+RH&amp;rft.au=Charvet%2C+L&amp;rft.au=Costello%2C+K&amp;rft.au=Feinstein%2C+A&amp;rft.au=Gingold%2C+J&amp;rft.au=Goverover%2C+Y&amp;rft.au=Halper%2C+J&amp;rft.au=Harris%2C+C&amp;rft.au=Kostich%2C+L&amp;rft.au=Krupp%2C+L&amp;rft.au=Lathi%2C+E&amp;rft.au=LaRocca%2C+N&amp;rft.au=Thrower%2C+B&amp;rft.au=DeLuca%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6238181&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBenedictAmatoDeLucaGeurts2020" class="citation journal cs1">Benedict RH, Amato MP, DeLuca J, Geurts JJ (October 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011205">"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues"</a>. <i>The Lancet. Neurology</i>. <b>19</b> (10): 860–871. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2820%2930277-5">10.1016/S1474-4422(20)30277-5</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011205">10011205</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32949546">32949546</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:221744328">221744328</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Cognitive+impairment+in+multiple+sclerosis%3A+clinical+management%2C+MRI%2C+and+therapeutic+avenues&amp;rft.volume=19&amp;rft.issue=10&amp;rft.pages=860-871&amp;rft.date=2020-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10011205%23id-name%3DPMC&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221744328%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F32949546&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2820%2930277-5&amp;rft.aulast=Benedict&amp;rft.aufirst=RH&amp;rft.au=Amato%2C+MP&amp;rft.au=DeLuca%2C+J&amp;rft.au=Geurts%2C+JJ&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10011205&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKurtzke1983" class="citation journal cs1"><a href="/wiki/John_F._Kurtzke" title="John F. Kurtzke">Kurtzke JF</a> (November 1983). <a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.33.11.1444">"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)"</a>. <i>Neurology</i>. <b>33</b> (11): 1444–52. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.33.11.1444">10.1212/WNL.33.11.1444</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/6685237">6685237</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Rating+neurologic+impairment+in+multiple+sclerosis%3A+an+expanded+disability+status+scale+%28EDSS%29&amp;rft.volume=33&amp;rft.issue=11&amp;rft.pages=1444-52&amp;rft.date=1983-11&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.33.11.1444&amp;rft_id=info%3Apmid%2F6685237&amp;rft.aulast=Kurtzke&amp;rft.aufirst=JF&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1212%252FWNL.33.11.1444&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid10467378-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10467378_31-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAmatoPonziani1999" class="citation journal cs1">Amato MP, Ponziani G (August 1999). "Quantification of impairment in MS: discussion of the scales in use". <i>Multiple Sclerosis</i>. <b>5</b> (4): 216–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1191%2F135245899678846113">10.1191/135245899678846113</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10467378">10467378</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Multiple+Sclerosis&amp;rft.atitle=Quantification+of+impairment+in+MS%3A+discussion+of+the+scales+in+use&amp;rft.volume=5&amp;rft.issue=4&amp;rft.pages=216-9&amp;rft.date=1999-08&amp;rft_id=info%3Adoi%2F10.1191%2F135245899678846113&amp;rft_id=info%3Apmid%2F10467378&amp;rft.aulast=Amato&amp;rft.aufirst=MP&amp;rft.au=Ponziani%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid12356200-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12356200_32-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRudickCutterReingold2002" class="citation journal cs1">Rudick RA, Cutter G, Reingold S (October 2002). "The multiple sclerosis functional composite: a new clinical outcome measure for multiple sderosis trials". <i>Multiple Sclerosis</i>. <b>8</b> (5): 359–65. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1191%2F1352458502ms845oa">10.1191/1352458502ms845oa</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12356200">12356200</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:31529508">31529508</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Multiple+Sclerosis&amp;rft.atitle=The+multiple+sclerosis+functional+composite%3A+a+new+clinical+outcome+measure+for+multiple+sderosis+trials&amp;rft.volume=8&amp;rft.issue=5&amp;rft.pages=359-65&amp;rft.date=2002-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A31529508%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12356200&amp;rft_id=info%3Adoi%2F10.1191%2F1352458502ms845oa&amp;rft.aulast=Rudick&amp;rft.aufirst=RA&amp;rft.au=Cutter%2C+G&amp;rft.au=Reingold%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFvan_MunsterUitdehaag2017" class="citation journal cs1">van Munster CE, Uitdehaag BM (March 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336539">"Outcome Measures in Clinical Trials for Multiple Sclerosis"</a>. <i>CNS Drugs</i>. <b>31</b> (3): 217–236. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40263-017-0412-5">10.1007/s40263-017-0412-5</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336539">5336539</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28185158">28185158</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drugs&amp;rft.atitle=Outcome+Measures+in+Clinical+Trials+for+Multiple+Sclerosis&amp;rft.volume=31&amp;rft.issue=3&amp;rft.pages=217-236&amp;rft.date=2017-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5336539%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28185158&amp;rft_id=info%3Adoi%2F10.1007%2Fs40263-017-0412-5&amp;rft.aulast=van+Munster&amp;rft.aufirst=CE&amp;rft.au=Uitdehaag%2C+BM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5336539&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid16804331-34"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid16804331_34-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16804331_34-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTataruVidalDecavelBerger2006" class="citation journal cs1">Tataru N, Vidal C, Decavel P, Berger E, Rumbach L (2006). "Limited impact of the summer heat wave in France (2003) on hospital admissions and relapses for multiple sclerosis". <i>Neuroepidemiology</i>. <b>27</b> (1): 28–32. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000094233">10.1159/000094233</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16804331">16804331</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20870484">20870484</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroepidemiology&amp;rft.atitle=Limited+impact+of+the+summer+heat+wave+in+France+%282003%29+on+hospital+admissions+and+relapses+for+multiple+sclerosis&amp;rft.volume=27&amp;rft.issue=1&amp;rft.pages=28-32&amp;rft.date=2006&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20870484%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16804331&amp;rft_id=info%3Adoi%2F10.1159%2F000094233&amp;rft.aulast=Tataru&amp;rft.aufirst=N&amp;rft.au=Vidal%2C+C&amp;rft.au=Decavel%2C+P&amp;rft.au=Berger%2C+E&amp;rft.au=Rumbach%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17439878-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17439878_35-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHeesenMohrHuitingaBergh2007" class="citation journal cs1">Heesen C, Mohr DC, Huitinga I, Bergh FT, Gaab J, Otte C, Gold SM (March 2007). "Stress regulation in multiple sclerosis: current issues and concepts". <i>Multiple Sclerosis</i>. <b>13</b> (2): 143–148. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1352458506070772">10.1177/1352458506070772</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17439878">17439878</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:8262595">8262595</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Multiple+Sclerosis&amp;rft.atitle=Stress+regulation+in+multiple+sclerosis%3A+current+issues+and+concepts&amp;rft.volume=13&amp;rft.issue=2&amp;rft.pages=143-148&amp;rft.date=2007-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A8262595%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17439878&amp;rft_id=info%3Adoi%2F10.1177%2F1352458506070772&amp;rft.aulast=Heesen&amp;rft.aufirst=C&amp;rft.au=Mohr%2C+DC&amp;rft.au=Huitinga%2C+I&amp;rft.au=Bergh%2C+FT&amp;rft.au=Gaab%2C+J&amp;rft.au=Otte%2C+C&amp;rft.au=Gold%2C+SM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFConfavreuxSuissaSaddierBourdès2001" class="citation journal cs1">Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S (February 2001). "Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group". <i>The New England Journal of Medicine</i>. <b>344</b> (5): 319–326. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJM200102013440501">10.1056/NEJM200102013440501</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11172162">11172162</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Vaccinations+and+the+risk+of+relapse+in+multiple+sclerosis.+Vaccines+in+Multiple+Sclerosis+Study+Group&amp;rft.volume=344&amp;rft.issue=5&amp;rft.pages=319-326&amp;rft.date=2001-02&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM200102013440501&amp;rft_id=info%3Apmid%2F11172162&amp;rft.aulast=Confavreux&amp;rft.aufirst=C&amp;rft.au=Suissa%2C+S&amp;rft.au=Saddier%2C+P&amp;rft.au=Bourd%C3%A8s%2C+V&amp;rft.au=Vukusic%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid11205361-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11205361_37-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMartinelli2000" class="citation journal cs1">Martinelli V (2000). "Trauma, stress and multiple sclerosis". <i>Neurological Sciences</i>. <b>21</b> (4 Suppl 2): S849–S852. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs100720070024">10.1007/s100720070024</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11205361">11205361</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:2376078">2376078</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurological+Sciences&amp;rft.atitle=Trauma%2C+stress+and+multiple+sclerosis&amp;rft.volume=21&amp;rft.issue=4+Suppl+2&amp;rft.pages=S849-S852&amp;rft.date=2000&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A2376078%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11205361&amp;rft_id=info%3Adoi%2F10.1007%2Fs100720070024&amp;rft.aulast=Martinelli&amp;rft.aufirst=V&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Makhani2021Prodrome-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-Makhani2021Prodrome_38-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMakhaniTremlett2021" class="citation journal cs1">Makhani N, Tremlett H (August 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324569">"The multiple sclerosis prodrome"</a>. <i>Nature Reviews. Neurology</i>. <b>17</b> (8): 515–521. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41582-021-00519-3">10.1038/s41582-021-00519-3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324569">8324569</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34155379">34155379</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neurology&amp;rft.atitle=The+multiple+sclerosis+prodrome&amp;rft.volume=17&amp;rft.issue=8&amp;rft.pages=515-521&amp;rft.date=2021-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8324569%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F34155379&amp;rft_id=info%3Adoi%2F10.1038%2Fs41582-021-00519-3&amp;rft.aulast=Makhani&amp;rft.aufirst=N&amp;rft.au=Tremlett%2C+H&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8324569&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Marrie2019_Prodrome-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-Marrie2019_Prodrome_39-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMarrie2019" class="citation journal cs1">Marrie RA (December 2019). "Mounting evidence for a multiple sclerosis prodrome". <i>Nature Reviews. Neurology</i>. <b>15</b> (12): 689–690. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41582-019-0283-0">10.1038/s41582-019-0283-0</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31654040">31654040</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:204887642">204887642</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neurology&amp;rft.atitle=Mounting+evidence+for+a+multiple+sclerosis+prodrome&amp;rft.volume=15&amp;rft.issue=12&amp;rft.pages=689-690&amp;rft.date=2019-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A204887642%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F31654040&amp;rft_id=info%3Adoi%2F10.1038%2Fs41582-019-0283-0&amp;rft.aulast=Marrie&amp;rft.aufirst=RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid8269393-40"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid8269393_40-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid8269393_40-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKurtzke1993" class="citation journal cs1">Kurtzke JF (October 1993). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC358295">"Epidemiologic evidence for multiple sclerosis as an infection"</a>. <i>Clinical Microbiology Reviews</i>. <b>6</b> (4): 382–427. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1128%2FCMR.6.4.382">10.1128/CMR.6.4.382</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC358295">358295</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/8269393">8269393</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Microbiology+Reviews&amp;rft.atitle=Epidemiologic+evidence+for+multiple+sclerosis+as+an+infection&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=382-427&amp;rft.date=1993-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC358295%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F8269393&amp;rft_id=info%3Adoi%2F10.1128%2FCMR.6.4.382&amp;rft.aulast=Kurtzke&amp;rft.aufirst=JF&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC358295&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid15721830-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15721830_41-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGilden2005" class="citation journal cs1">Gilden DH (March 2005). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129502">"Infectious causes of multiple sclerosis"</a>. <i>The Lancet. Neurology</i>. <b>4</b> (3): 195–202. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2805%2901017-3">10.1016/S1474-4422(05)01017-3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129502">7129502</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15721830">15721830</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Infectious+causes+of+multiple+sclerosis&amp;rft.volume=4&amp;rft.issue=3&amp;rft.pages=195-202&amp;rft.date=2005-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7129502%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15721830&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2805%2901017-3&amp;rft.aulast=Gilden&amp;rft.aufirst=DH&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7129502&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSoldanLieberman2023" class="citation journal cs1">Soldan SS, Lieberman PM (January 2023). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362539">"Epstein-Barr virus and multiple sclerosis"</a>. <i>Nature Reviews. Microbiology</i>. <b>21</b> (1): 51–64. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41579-022-00770-5">10.1038/s41579-022-00770-5</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362539">9362539</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35931816">35931816</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Microbiology&amp;rft.atitle=Epstein-Barr+virus+and+multiple+sclerosis&amp;rft.volume=21&amp;rft.issue=1&amp;rft.pages=51-64&amp;rft.date=2023-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9362539%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F35931816&amp;rft_id=info%3Adoi%2F10.1038%2Fs41579-022-00770-5&amp;rft.aulast=Soldan&amp;rft.aufirst=SS&amp;rft.au=Lieberman%2C+PM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9362539&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Bjornevik2022-43"><span class="mw-cite-backlink">^ <a href="#cite_ref-Bjornevik2022_43-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bjornevik2022_43-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBjornevikCorteseHealyKuhle2022" class="citation journal cs1">Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y,  et&#160;al. (January 2022). "Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis". <i>Science</i>. <b>375</b> (6578): 296–301. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2022Sci...375..296B">2022Sci...375..296B</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.abj8222">10.1126/science.abj8222</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35025605">35025605</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:245983763">245983763</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Longitudinal+analysis+reveals+high+prevalence+of+Epstein-Barr+virus+associated+with+multiple+sclerosis&amp;rft.volume=375&amp;rft.issue=6578&amp;rft.pages=296-301&amp;rft.date=2022-01&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.abj8222&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A245983763%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F35025605&amp;rft_id=info%3Abibcode%2F2022Sci...375..296B&amp;rft.aulast=Bjornevik&amp;rft.aufirst=K&amp;rft.au=Cortese%2C+M&amp;rft.au=Healy%2C+BC&amp;rft.au=Kuhle%2C+J&amp;rft.au=Mina%2C+MJ&amp;rft.au=Leng%2C+Y&amp;rft.au=Elledge%2C+SJ&amp;rft.au=Niebuhr%2C+DW&amp;rft.au=Scher%2C+AI&amp;rft.au=Munger%2C+KL&amp;rft.au=Ascherio%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span> See <a rel="nofollow" class="external text" href="https://www.bbc.com/news/health-61042598">BBC lay summary</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220425142547/https://www.bbc.com/news/health-61042598">Archived</a> 25 April 2022 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a> of 13 April 2022.</span>
</li>
<li id="cite_note-pmid14747002-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid14747002_44-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDymentEbersSadovnick2004" class="citation journal cs1">Dyment DA, Ebers GC, Sadovnick AD (February 2004). "Genetics of multiple sclerosis". <i>The Lancet. Neurology</i>. <b>3</b> (2): 104–10. <a href="/wiki/CiteSeerX_(identifier)" class="mw-redirect" title="CiteSeerX (identifier)">CiteSeerX</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.334.1312">10.1.1.334.1312</a></span>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2803%2900663-X">10.1016/S1474-4422(03)00663-X</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/14747002">14747002</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:16707321">16707321</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Genetics+of+multiple+sclerosis&amp;rft.volume=3&amp;rft.issue=2&amp;rft.pages=104-10&amp;rft.date=2004-02&amp;rft_id=https%3A%2F%2Fciteseerx.ist.psu.edu%2Fviewdoc%2Fsummary%3Fdoi%3D10.1.1.334.1312%23id-name%3DCiteSeerX&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A16707321%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F14747002&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2803%2900663-X&amp;rft.aulast=Dyment&amp;rft.aufirst=DA&amp;rft.au=Ebers%2C+GC&amp;rft.au=Sadovnick%2C+AD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-SkeneGrant2016-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-SkeneGrant2016_45-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSkeneGrant2016" class="citation journal cs1">Skene NG, Grant SG (2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730103">"Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment"</a>. <i>Frontiers in Neuroscience</i>. <b>10</b>: 16. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffnins.2016.00016">10.3389/fnins.2016.00016</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730103">4730103</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26858593">26858593</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Neuroscience&amp;rft.atitle=Identification+of+Vulnerable+Cell+Types+in+Major+Brain+Disorders+Using+Single+Cell+Transcriptomes+and+Expression+Weighted+Cell+Type+Enrichment&amp;rft.volume=10&amp;rft.pages=16&amp;rft.date=2016&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4730103%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26858593&amp;rft_id=info%3Adoi%2F10.3389%2Ffnins.2016.00016&amp;rft.aulast=Skene&amp;rft.aufirst=NG&amp;rft.au=Grant%2C+SG&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4730103&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHassan-SmithDouglas2011" class="citation journal cs1">Hassan-Smith G, Douglas MR (October 2011). "Epidemiology and diagnosis of multiple sclerosis". <i>British Journal of Hospital Medicine</i>. <b>72</b> (10): M146-51. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.12968%2Fhmed.2011.72.Sup10.M146">10.12968/hmed.2011.72.Sup10.M146</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22041658">22041658</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Hospital+Medicine&amp;rft.atitle=Epidemiology+and+diagnosis+of+multiple+sclerosis&amp;rft.volume=72&amp;rft.issue=10&amp;rft.pages=M146-51&amp;rft.date=2011-10&amp;rft_id=info%3Adoi%2F10.12968%2Fhmed.2011.72.Sup10.M146&amp;rft_id=info%3Apmid%2F22041658&amp;rft.aulast=Hassan-Smith&amp;rft.aufirst=G&amp;rft.au=Douglas%2C+MR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid11603614-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11603614_47-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRosati2001" class="citation journal cs1">Rosati G (April 2001). "The prevalence of multiple sclerosis in the world: an update". <i>Neurological Sciences</i>. <b>22</b> (2): 117–39. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs100720170011">10.1007/s100720170011</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11603614">11603614</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:207051545">207051545</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurological+Sciences&amp;rft.atitle=The+prevalence+of+multiple+sclerosis+in+the+world%3A+an+update&amp;rft.volume=22&amp;rft.issue=2&amp;rft.pages=117-39&amp;rft.date=2001-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A207051545%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11603614&amp;rft_id=info%3Adoi%2F10.1007%2Fs100720170011&amp;rft.aulast=Rosati&amp;rft.aufirst=G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid21247752-48"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid21247752_48-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid21247752_48-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid21247752_48-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBaranzini2011" class="citation journal cs1">Baranzini SE (June 2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105160">"Revealing the genetic basis of multiple sclerosis: are we there yet?"</a>. <i>Current Opinion in Genetics &amp; Development</i>. <b>21</b> (3): 317–24. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.gde.2010.12.006">10.1016/j.gde.2010.12.006</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105160">3105160</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21247752">21247752</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Genetics+%26+Development&amp;rft.atitle=Revealing+the+genetic+basis+of+multiple+sclerosis%3A+are+we+there+yet%3F&amp;rft.volume=21&amp;rft.issue=3&amp;rft.pages=317-24&amp;rft.date=2011-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3105160%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21247752&amp;rft_id=info%3Adoi%2F10.1016%2Fj.gde.2010.12.006&amp;rft.aulast=Baranzini&amp;rft.aufirst=SE&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3105160&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid31604244-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid31604244_49-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFInternational_Multiple_Sclerosis_Genetics_Consortium2019" class="citation journal cs1">International Multiple Sclerosis Genetics Consortium (2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241648">"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility"</a>. <i>Science</i>. <b>365</b> (6460). <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.aav7188">10.1126/science.aav7188</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241648">7241648</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31604244">31604244</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Multiple+sclerosis+genomic+map+implicates+peripheral+immune+cells+and+microglia+in+susceptibility.&amp;rft.volume=365&amp;rft.issue=6460&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7241648%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31604244&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.aav7188&amp;rft.au=International+Multiple+Sclerosis+Genetics+Consortium&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7241648&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18606967-50"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18606967_50-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18606967_50-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18606967_50-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAlonsoHernán2008" class="citation journal cs1">Alonso A, Hernán MA (July 2008). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109189">"Temporal trends in the incidence of multiple sclerosis: a systematic review"</a>. <i>Neurology</i>. <b>71</b> (2): 129–135. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2F01.wnl.0000316802.35974.34">10.1212/01.wnl.0000316802.35974.34</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109189">4109189</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18606967">18606967</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Temporal+trends+in+the+incidence+of+multiple+sclerosis%3A+a+systematic+review&amp;rft.volume=71&amp;rft.issue=2&amp;rft.pages=129-135&amp;rft.date=2008-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4109189%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18606967&amp;rft_id=info%3Adoi%2F10.1212%2F01.wnl.0000316802.35974.34&amp;rft.aulast=Alonso&amp;rft.aufirst=A&amp;rft.au=Hern%C3%A1n%2C+MA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4109189&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid12127652-51"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid12127652_51-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12127652_51-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPugliattiSotgiuRosati2002" class="citation journal cs1">Pugliatti M, Sotgiu S, Rosati G (July 2002). "The worldwide prevalence of multiple sclerosis". <i>Clinical Neurology and Neurosurgery</i>. <b>104</b> (3): 182–91. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0303-8467%2802%2900036-7">10.1016/S0303-8467(02)00036-7</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12127652">12127652</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:862001">862001</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Neurology+and+Neurosurgery&amp;rft.atitle=The+worldwide+prevalence+of+multiple+sclerosis&amp;rft.volume=104&amp;rft.issue=3&amp;rft.pages=182-91&amp;rft.date=2002-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A862001%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12127652&amp;rft_id=info%3Adoi%2F10.1016%2FS0303-8467%2802%2900036-7&amp;rft.aulast=Pugliatti&amp;rft.aufirst=M&amp;rft.au=Sotgiu%2C+S&amp;rft.au=Rosati%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGrimaldiSalemiGrimaldiRizzo2001" class="citation journal cs1">Grimaldi LM, Salemi G, Grimaldi G, Rizzo A, Marziolo R, Lo Presti C, Maimone D, Savettieri G (November 2001). "High incidence and increasing prevalence of MS in Enna (Sicily), southern Italy". <i>Neurology</i>. <b>57</b> (10): 1891–3. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2Fwnl.57.10.1891">10.1212/wnl.57.10.1891</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11723283">11723283</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34895995">34895995</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=High+incidence+and+increasing+prevalence+of+MS+in+Enna+%28Sicily%29%2C+southern+Italy&amp;rft.volume=57&amp;rft.issue=10&amp;rft.pages=1891-3&amp;rft.date=2001-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34895995%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11723283&amp;rft_id=info%3Adoi%2F10.1212%2Fwnl.57.10.1891&amp;rft.aulast=Grimaldi&amp;rft.aufirst=LM&amp;rft.au=Salemi%2C+G&amp;rft.au=Grimaldi%2C+G&amp;rft.au=Rizzo%2C+A&amp;rft.au=Marziolo%2C+R&amp;rft.au=Lo+Presti%2C+C&amp;rft.au=Maimone%2C+D&amp;rft.au=Savettieri%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid19897699-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19897699_53-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKulieGroffRedmerHounshell2009" class="citation journal cs1">Kulie T, Groff A, Redmer J, Hounshell J, Schrager S (2009). <a rel="nofollow" class="external text" href="https://doi.org/10.3122%2Fjabfm.2009.06.090037">"Vitamin D: an evidence-based review"</a>. <i>Journal of the American Board of Family Medicine</i>. <b>22</b> (6): 698–706. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3122%2Fjabfm.2009.06.090037">10.3122/jabfm.2009.06.090037</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19897699">19897699</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Board+of+Family+Medicine&amp;rft.atitle=Vitamin+D%3A+an+evidence-based+review&amp;rft.volume=22&amp;rft.issue=6&amp;rft.pages=698-706&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.3122%2Fjabfm.2009.06.090037&amp;rft_id=info%3Apmid%2F19897699&amp;rft.aulast=Kulie&amp;rft.aufirst=T&amp;rft.au=Groff%2C+A&amp;rft.au=Redmer%2C+J&amp;rft.au=Hounshell%2C+J&amp;rft.au=Schrager%2C+S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.3122%252Fjabfm.2009.06.090037&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid15556803-54"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid15556803_54-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15556803_54-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid15556803_54-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid15556803_54-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid15556803_54-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMarrie2004" class="citation journal cs1">Marrie RA (December 2004). "Environmental risk factors in multiple sclerosis aetiology". <i>The Lancet. Neurology</i>. <b>3</b> (12): 709–18. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2804%2900933-0">10.1016/S1474-4422(04)00933-0</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15556803">15556803</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:175786">175786</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Environmental+risk+factors+in+multiple+sclerosis+aetiology&amp;rft.volume=3&amp;rft.issue=12&amp;rft.pages=709-18&amp;rft.date=2004-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A175786%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15556803&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2804%2900933-0&amp;rft.aulast=Marrie&amp;rft.aufirst=RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17492755-55"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17492755_55-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17492755_55-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid17492755_55-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAscherioMunger2007" class="citation journal cs1">Ascherio A, Munger KL (June 2007). "Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors". <i>Annals of Neurology</i>. <b>61</b> (6): 504–13. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fana.21141">10.1002/ana.21141</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17492755">17492755</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:36999504">36999504</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=Environmental+risk+factors+for+multiple+sclerosis.+Part+II%3A+Noninfectious+factors&amp;rft.volume=61&amp;rft.issue=6&amp;rft.pages=504-13&amp;rft.date=2007-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A36999504%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17492755&amp;rft_id=info%3Adoi%2F10.1002%2Fana.21141&amp;rft.aulast=Ascherio&amp;rft.aufirst=A&amp;rft.au=Munger%2C+KL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHedströmHössjerKatsoulis2018" class="citation journal cs1">Hedström A, Hössjer O, Katsoulis M (September 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093765">"Organic solvents and MS susceptibility: Interaction with MS risk HLA genes"</a>. <i>Neurology</i>. <b>91</b> (5): 455–462. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0000000000005906">10.1212/WNL.0000000000005906</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093765">6093765</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29970406">29970406</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Organic+solvents+and+MS+susceptibility%3A+Interaction+with+MS+risk+HLA+genes&amp;rft.volume=91&amp;rft.issue=5&amp;rft.pages=455-462&amp;rft.date=2018-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6093765%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29970406&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0000000000005906&amp;rft.aulast=Hedstr%C3%B6m&amp;rft.aufirst=A&amp;rft.au=H%C3%B6ssjer%2C+O&amp;rft.au=Katsoulis%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6093765&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFStoweAndrewsMiller2020" class="citation journal cs1">Stowe J, Andrews N, Miller E (January 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224038">"Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and Narcolepsy"</a>. <i>CNS Drugs</i>. <b>34</b> (1): 1–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40263-019-00670-y">10.1007/s40263-019-00670-y</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224038">7224038</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31576507">31576507</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drugs&amp;rft.atitle=Do+Vaccines+Trigger+Neurological+Diseases%3F+Epidemiological+Evaluation+of+Vaccination+and+Neurological+Diseases+Using+Examples+of+Multiple+Sclerosis%2C+Guillain-Barr%C3%A9+Syndrome+and+Narcolepsy&amp;rft.volume=34&amp;rft.issue=1&amp;rft.pages=1-8&amp;rft.date=2020-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7224038%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31576507&amp;rft_id=info%3Adoi%2F10.1007%2Fs40263-019-00670-y&amp;rft.aulast=Stowe&amp;rft.aufirst=J&amp;rft.au=Andrews%2C+N&amp;rft.au=Miller%2C+E&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7224038&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18219824-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18219824_58-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSpitsinKoprowski2008" class="citation journal cs1">Spitsin S, Koprowski H (2008). "Role of uric acid in multiple sclerosis". <i>Current Topics in Microbiology and Immunology</i>. <b>318</b>: 325–342. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F978-3-540-73677-6_13">10.1007/978-3-540-73677-6_13</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-540-73676-9" title="Special:BookSources/978-3-540-73676-9"><bdi>978-3-540-73676-9</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18219824">18219824</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Topics+in+Microbiology+and+Immunology&amp;rft.atitle=Role+of+uric+acid+in+multiple+sclerosis&amp;rft.volume=318&amp;rft.pages=325-342&amp;rft.date=2008&amp;rft_id=info%3Apmid%2F18219824&amp;rft_id=info%3Adoi%2F10.1007%2F978-3-540-73677-6_13&amp;rft.isbn=978-3-540-73676-9&amp;rft.aulast=Spitsin&amp;rft.aufirst=S&amp;rft.au=Koprowski%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Nourbakhsh2019RisksPathogenesis-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-Nourbakhsh2019RisksPathogenesis_59-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFNourbakhshMowry2019" class="citation journal cs1">Nourbakhsh B, Mowry EM (June 2019). "Multiple Sclerosis Risk Factors and Pathogenesis". <i>Continuum</i>. <b>25</b> (3): 596–610. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FCON.0000000000000725">10.1212/CON.0000000000000725</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31162307">31162307</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:174806511">174806511</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Continuum&amp;rft.atitle=Multiple+Sclerosis+Risk+Factors+and+Pathogenesis&amp;rft.volume=25&amp;rft.issue=3&amp;rft.pages=596-610&amp;rft.date=2019-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A174806511%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F31162307&amp;rft_id=info%3Adoi%2F10.1212%2FCON.0000000000000725&amp;rft.aulast=Nourbakhsh&amp;rft.aufirst=B&amp;rft.au=Mowry%2C+EM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid29439228-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid29439228_60-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFChenPopko2018" class="citation journal cs1">Chen Y, Popko B (2018). "Cholesterol crystals impede nerve repair". <i><a href="/wiki/Science_(journal)" title="Science (journal)">Science</a></i>. <b>359</b> (6376): 635–636. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2018Sci...359..635C">2018Sci...359..635C</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.aar7369">10.1126/science.aar7369</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29439228">29439228</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3257111">3257111</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Cholesterol+crystals+impede+nerve+repair&amp;rft.volume=359&amp;rft.issue=6376&amp;rft.pages=635-636&amp;rft.date=2018&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.aar7369&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3257111%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29439228&amp;rft_id=info%3Abibcode%2F2018Sci...359..635C&amp;rft.aulast=Chen&amp;rft.aufirst=Y&amp;rft.au=Popko%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid29301957-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid29301957_61-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCantuti-CastelvetriFitznerBosch-QueraltWeil2018" class="citation journal cs1">Cantuti-Castelvetri L, Fitzner D, Bosch-Queralt M, Weil MT, Su M, Sen P, Ruhwedel T, Mitkovski M, Trendelenburg G, Lütjohann D, Möbius W, Simons M (2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.aan4183">"Defective cholesterol clearance limits remyelination in the aged central nervous system"</a>. <i><a href="/wiki/Science_(journal)" title="Science (journal)">Science</a></i>. <b>359</b> (6376): 684–688. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2018Sci...359..684C">2018Sci...359..684C</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.aan4183">10.1126/science.aan4183</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29301957">29301957</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Defective+cholesterol+clearance+limits+remyelination+in+the+aged+central+nervous+system&amp;rft.volume=359&amp;rft.issue=6376&amp;rft.pages=684-688&amp;rft.date=2018&amp;rft_id=info%3Apmid%2F29301957&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.aan4183&amp;rft_id=info%3Abibcode%2F2018Sci...359..684C&amp;rft.aulast=Cantuti-Castelvetri&amp;rft.aufirst=L&amp;rft.au=Fitzner%2C+D&amp;rft.au=Bosch-Queralt%2C+M&amp;rft.au=Weil%2C+MT&amp;rft.au=Su%2C+M&amp;rft.au=Sen%2C+P&amp;rft.au=Ruhwedel%2C+T&amp;rft.au=Mitkovski%2C+M&amp;rft.au=Trendelenburg%2C+G&amp;rft.au=L%C3%BCtjohann%2C+D&amp;rft.au=M%C3%B6bius%2C+W&amp;rft.au=Simons%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1126%252Fscience.aan4183&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17531860-62"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17531860_62-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17531860_62-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFChari2007" class="citation journal cs1">Chari DM (2007). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112255">"Remyelination in multiple sclerosis"</a>. <i>International Review of Neurobiology</i>. <b>79</b>: 589–620. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0074-7742%2807%2979026-8">10.1016/S0074-7742(07)79026-8</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-12-373736-6" title="Special:BookSources/978-0-12-373736-6"><bdi>978-0-12-373736-6</bdi></a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112255">7112255</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17531860">17531860</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Review+of+Neurobiology&amp;rft.atitle=Remyelination+in+multiple+sclerosis&amp;rft.volume=79&amp;rft.pages=589-620&amp;rft.date=2007&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7112255%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17531860&amp;rft_id=info%3Adoi%2F10.1016%2FS0074-7742%2807%2979026-8&amp;rft.isbn=978-0-12-373736-6&amp;rft.aulast=Chari&amp;rft.aufirst=DM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7112255&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17351524-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17351524_63-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPittockLucchinetti2007" class="citation journal cs1">Pittock SJ, Lucchinetti CF (March 2007). "The pathology of MS: new insights and potential clinical applications". <i>The Neurologist</i>. <b>13</b> (2): 45–56. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F01.nrl.0000253065.31662.37">10.1097/01.nrl.0000253065.31662.37</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17351524">17351524</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:2993523">2993523</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Neurologist&amp;rft.atitle=The+pathology+of+MS%3A+new+insights+and+potential+clinical+applications&amp;rft.volume=13&amp;rft.issue=2&amp;rft.pages=45-56&amp;rft.date=2007-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A2993523%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17351524&amp;rft_id=info%3Adoi%2F10.1097%2F01.nrl.0000253065.31662.37&amp;rft.aulast=Pittock&amp;rft.aufirst=SJ&amp;rft.au=Lucchinetti%2C+CF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHuangHussainChang2021" class="citation journal cs1">Huang X, Hussain B, Chang J (January 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804893">"Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms"</a>. <i>CNS Neuroscience &amp; Therapeutics</i>. <b>27</b> (1): 36–47. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fcns.13569">10.1111/cns.13569</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804893">7804893</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33381913">33381913</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Neuroscience+%26+Therapeutics&amp;rft.atitle=Peripheral+inflammation+and+blood-brain+barrier+disruption%3A+effects+and+mechanisms&amp;rft.volume=27&amp;rft.issue=1&amp;rft.pages=36-47&amp;rft.date=2021-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7804893%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F33381913&amp;rft_id=info%3Adoi%2F10.1111%2Fcns.13569&amp;rft.aulast=Huang&amp;rft.aufirst=X&amp;rft.au=Hussain%2C+B&amp;rft.au=Chang%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7804893&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid23088946-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23088946_65-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFerréShiroishiLaw2012" class="citation journal cs1">Ferré JC, Shiroishi MS, Law M (November 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479680">"Advanced techniques using contrast media in neuroimaging"</a>. <i>Magnetic Resonance Imaging Clinics of North America</i>. <b>20</b> (4): 699–713. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.mric.2012.07.007">10.1016/j.mric.2012.07.007</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479680">3479680</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23088946">23088946</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Magnetic+Resonance+Imaging+Clinics+of+North+America&amp;rft.atitle=Advanced+techniques+using+contrast+media+in+neuroimaging&amp;rft.volume=20&amp;rft.issue=4&amp;rft.pages=699-713&amp;rft.date=2012-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3479680%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23088946&amp;rft_id=info%3Adoi%2F10.1016%2Fj.mric.2012.07.007&amp;rft.aulast=Ferr%C3%A9&amp;rft.aufirst=JC&amp;rft.au=Shiroishi%2C+MS&amp;rft.au=Law%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3479680&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid11794488-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11794488_66-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTrojanoPaolicelli2001" class="citation journal cs1">Trojano M, Paolicelli D (November 2001). "The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes". <i>Neurological Sciences</i>. <b>22</b> (Suppl 2): S98-102. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs100720100044">10.1007/s100720100044</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11794488">11794488</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3057096">3057096</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurological+Sciences&amp;rft.atitle=The+differential+diagnosis+of+multiple+sclerosis%3A+classification+and+clinical+features+of+relapsing+and+progressive+neurological+syndromes&amp;rft.volume=22&amp;rft.issue=Suppl+2&amp;rft.pages=S98-102&amp;rft.date=2001-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3057096%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11794488&amp;rft_id=info%3Adoi%2F10.1007%2Fs100720100044&amp;rft.aulast=Trojano&amp;rft.aufirst=M&amp;rft.au=Paolicelli%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Atlas2008-67"><span class="mw-cite-backlink">^ <a href="#cite_ref-Atlas2008_67-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Atlas2008_67-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWorld_Health_Organization2008" class="citation book cs1">World Health Organization (2008). <i>Atlas: Multiple Sclerosis Resources in the World 2008</i>. Geneva: World Health Organization. pp.&#160;15–16. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/10665%2F43968">10665/43968</a></span>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-92-4-156375-8" title="Special:BookSources/978-92-4-156375-8"><bdi>978-92-4-156375-8</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Atlas%3A+Multiple+Sclerosis+Resources+in+the+World+2008&amp;rft.place=Geneva&amp;rft.pages=15-16&amp;rft.pub=World+Health+Organization&amp;rft.date=2008&amp;rft_id=info%3Ahdl%2F10665%2F43968&amp;rft.isbn=978-92-4-156375-8&amp;rft.au=World+Health+Organization&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid15177763-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15177763_68-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPoserBrinar2004" class="citation journal cs1">Poser CM, Brinar VV (June 2004). "Diagnostic criteria for multiple sclerosis: an historical review". <i>Clinical Neurology and Neurosurgery</i>. <b>106</b> (3): 147–58. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clineuro.2004.02.004">10.1016/j.clineuro.2004.02.004</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15177763">15177763</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:23452341">23452341</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Neurology+and+Neurosurgery&amp;rft.atitle=Diagnostic+criteria+for+multiple+sclerosis%3A+an+historical+review&amp;rft.volume=106&amp;rft.issue=3&amp;rft.pages=147-58&amp;rft.date=2004-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23452341%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15177763&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clineuro.2004.02.004&amp;rft.aulast=Poser&amp;rft.aufirst=CM&amp;rft.au=Brinar%2C+VV&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRovira2017" class="citation journal cs1">Rovira À (November 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.5334%2Fjbr-btr.1426">"Diagnosis of Multiple Sclerosis"</a>. <i>Journal of the Belgian Society of Radiology</i>. <b>101</b> (S1): 12. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.5334%2Fjbr-btr.1426">10.5334/jbr-btr.1426</a></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Belgian+Society+of+Radiology&amp;rft.atitle=Diagnosis+of+Multiple+Sclerosis&amp;rft.volume=101&amp;rft.issue=S1&amp;rft.pages=12&amp;rft.date=2017-11&amp;rft_id=info%3Adoi%2F10.5334%2Fjbr-btr.1426&amp;rft.aulast=Rovira&amp;rft.aufirst=%C3%80&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.5334%252Fjbr-btr.1426&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid11456302-70"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid11456302_70-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11456302_70-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMcDonaldCompstonEdanGoodkin2001" class="citation journal cs1"><a href="/wiki/W._Ian_McDonald" title="W. Ian McDonald">McDonald WI</a>, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, <a href="/wiki/Jerry_Wolinsky" title="Jerry Wolinsky">Wolinsky JS</a> (July 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". <i>Annals of Neurology</i>. <b>50</b> (1): 121–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fana.1032">10.1002/ana.1032</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11456302">11456302</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:13870943">13870943</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=Recommended+diagnostic+criteria+for+multiple+sclerosis%3A+guidelines+from+the+International+Panel+on+the+diagnosis+of+multiple+sclerosis&amp;rft.volume=50&amp;rft.issue=1&amp;rft.pages=121-7&amp;rft.date=2001-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13870943%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11456302&amp;rft_id=info%3Adoi%2F10.1002%2Fana.1032&amp;rft.aulast=McDonald&amp;rft.aufirst=WI&amp;rft.au=Compston%2C+A&amp;rft.au=Edan%2C+G&amp;rft.au=Goodkin%2C+D&amp;rft.au=Hartung%2C+HP&amp;rft.au=Lublin%2C+FD&amp;rft.au=McFarland%2C+HF&amp;rft.au=Paty%2C+DW&amp;rft.au=Polman%2C+CH&amp;rft.au=Reingold%2C+SC&amp;rft.au=Sandberg-Wollheim%2C+M&amp;rft.au=Sibley%2C+W&amp;rft.au=Thompson%2C+A&amp;rft.au=van+den+Noort%2C+S&amp;rft.au=Weinshenker%2C+BY&amp;rft.au=Wolinsky%2C+JS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18256986-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18256986_71-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRashidMiller2008" class="citation journal cs1">Rashid W, Miller DH (February 2008). "Recent advances in neuroimaging of multiple sclerosis". <i>Seminars in Neurology</i>. <b>28</b> (1): 46–55. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1055%2Fs-2007-1019127">10.1055/s-2007-1019127</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18256986">18256986</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seminars+in+Neurology&amp;rft.atitle=Recent+advances+in+neuroimaging+of+multiple+sclerosis&amp;rft.volume=28&amp;rft.issue=1&amp;rft.pages=46-55&amp;rft.date=2008-02&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2007-1019127&amp;rft_id=info%3Apmid%2F18256986&amp;rft.aulast=Rashid&amp;rft.aufirst=W&amp;rft.au=Miller%2C+DH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSinneckerClarkeMeierEnzinger2019" class="citation journal cs1">Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N,  et&#160;al. (MAGNIMS Study Group) (December 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704746">"Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis"</a>. <i>JAMA Neurology</i>. <b>76</b> (12): 1446–1456. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjamaneurol.2019.2478">10.1001/jamaneurol.2019.2478</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704746">6704746</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31424490">31424490</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA+Neurology&amp;rft.atitle=Evaluation+of+the+Central+Vein+Sign+as+a+Diagnostic+Imaging+Biomarker+in+Multiple+Sclerosis&amp;rft.volume=76&amp;rft.issue=12&amp;rft.pages=1446-1456&amp;rft.date=2019-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6704746%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31424490&amp;rft_id=info%3Adoi%2F10.1001%2Fjamaneurol.2019.2478&amp;rft.aulast=Sinnecker&amp;rft.aufirst=T&amp;rft.au=Clarke%2C+MA&amp;rft.au=Meier%2C+D&amp;rft.au=Enzinger%2C+C&amp;rft.au=Calabrese%2C+M&amp;rft.au=De+Stefano%2C+N&amp;rft.au=Pitiot%2C+A&amp;rft.au=Giorgio%2C+A&amp;rft.au=Schoonheim%2C+MM&amp;rft.au=Paul%2C+F&amp;rft.au=Pawlak%2C+MA&amp;rft.au=Schmidt%2C+R&amp;rft.au=Kappos%2C+L&amp;rft.au=Montalban%2C+X&amp;rft.au=Rovira%2C+%C3%80&amp;rft.au=Evangelou%2C+N&amp;rft.au=Wuerfel%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6704746&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBernitsas2020" class="citation journal cs1">Bernitsas E (February 2020). <a rel="nofollow" class="external text" href="https://practicalneurology.com/articles/2020-feb/the-central-vein-sign">"The Central Vein Sign"</a>. <i>Practical Neurology</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20211005141611/https://practicalneurology.com/articles/2020-feb/the-central-vein-sign">Archived</a> from the original on 5 October 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">5 October</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Practical+Neurology&amp;rft.atitle=The+Central+Vein+Sign&amp;rft.date=2020-02&amp;rft.aulast=Bernitsas&amp;rft.aufirst=E&amp;rft_id=https%3A%2F%2Fpracticalneurology.com%2Farticles%2F2020-feb%2Fthe-central-vein-sign&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCastellaroTamantiPisaniPizzini2020" class="citation journal cs1">Castellaro M, Tamanti A, Pisani AI, Pizzini FB, Crescenzo F, Calabrese M (November 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760678">"The Use of the Central Vein Sign in the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-analysis"</a>. <i>Diagnostics</i>. <b>10</b> (12): 1025. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fdiagnostics10121025">10.3390/diagnostics10121025</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760678">7760678</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33260401">33260401</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Diagnostics&amp;rft.atitle=The+Use+of+the+Central+Vein+Sign+in+the+Diagnosis+of+Multiple+Sclerosis%3A+A+Systematic+Review+and+Meta-analysis&amp;rft.volume=10&amp;rft.issue=12&amp;rft.pages=1025&amp;rft.date=2020-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7760678%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F33260401&amp;rft_id=info%3Adoi%2F10.3390%2Fdiagnostics10121025&amp;rft.aulast=Castellaro&amp;rft.aufirst=M&amp;rft.au=Tamanti%2C+A&amp;rft.au=Pisani%2C+AI&amp;rft.au=Pizzini%2C+FB&amp;rft.au=Crescenzo%2C+F&amp;rft.au=Calabrese%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7760678&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAl-ZandiFayadhAl-Waely2018" class="citation journal cs1">Al-Zandi SH, Fayadh NA, Al-Waely NK (1 March 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ejrnm.2017.09.003">"Central vein sign detected by SWI at 3 T MRI as a discriminator between multiple sclerosis and leukoaraiosis"</a>. <i>The Egyptian Journal of Radiology and Nuclear Medicine</i>. <b>49</b> (1): 158–164. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ejrnm.2017.09.003">10.1016/j.ejrnm.2017.09.003</a></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Egyptian+Journal+of+Radiology+and+Nuclear+Medicine&amp;rft.atitle=Central+vein+sign+detected+by+SWI+at+3+T+MRI+as+a+discriminator+between+multiple+sclerosis+and+leukoaraiosis&amp;rft.volume=49&amp;rft.issue=1&amp;rft.pages=158-164&amp;rft.date=2018-03-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ejrnm.2017.09.003&amp;rft.aulast=Al-Zandi&amp;rft.aufirst=SH&amp;rft.au=Fayadh%2C+NA&amp;rft.au=Al-Waely%2C+NK&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.ejrnm.2017.09.003&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGuissetLolliBugliPerrotta2021" class="citation journal cs1">Guisset F, Lolli V, Bugli C, Perrotta G, Absil J, Dachy B,  et&#160;al. (June 2021). <a rel="nofollow" class="external text" href="https://dipot.ulb.ac.be/dspace/bitstream/2013/312335/3/Guisset2020.pdf">"The central vein sign in multiple sclerosis patients with vascular comorbidities"</a> <span class="cs1-format">(PDF)</span>. <i>Multiple Sclerosis</i>. <b>27</b> (7): 1057–1065. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1352458520943785">10.1177/1352458520943785</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/2078.1%2F239849">2078.1/239849</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32749948">32749948</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:220976821">220976821</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210715222704/https://dipot.ulb.ac.be/dspace/bitstream/2013/312335/3/Guisset2020.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 15 July 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">5 October</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Multiple+Sclerosis&amp;rft.atitle=The+central+vein+sign+in+multiple+sclerosis+patients+with+vascular+comorbidities&amp;rft.volume=27&amp;rft.issue=7&amp;rft.pages=1057-1065&amp;rft.date=2021-06&amp;rft_id=info%3Ahdl%2F2078.1%2F239849&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A220976821%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F32749948&amp;rft_id=info%3Adoi%2F10.1177%2F1352458520943785&amp;rft.aulast=Guisset&amp;rft.aufirst=F&amp;rft.au=Lolli%2C+V&amp;rft.au=Bugli%2C+C&amp;rft.au=Perrotta%2C+G&amp;rft.au=Absil%2C+J&amp;rft.au=Dachy%2C+B&amp;rft.au=Pot%2C+C&amp;rft.au=Th%C3%A9audin%2C+M&amp;rft.au=Pasi%2C+M&amp;rft.au=van+Pesch%2C+V&amp;rft.au=Maggi%2C+P&amp;rft_id=https%3A%2F%2Fdipot.ulb.ac.be%2Fdspace%2Fbitstream%2F2013%2F312335%2F3%2FGuisset2020.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFChapman2020" class="citation news cs1">Chapman M (16 June 2020). <a rel="nofollow" class="external text" href="https://multiplesclerosisnewstoday.com/news-posts/2020/06/16/cleveland-clinic-given-7-million-nih-grant-study-diagnostic-cvs-biomarker/">"$7.2M NIH Grant Supports Study of MS Diagnostic Biomarker"</a>. BioNews Services. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20211005173348/https://multiplesclerosisnewstoday.com/news-posts/2020/06/16/cleveland-clinic-given-7-million-nih-grant-study-diagnostic-cvs-biomarker/">Archived</a> from the original on 5 October 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">5 October</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%247.2M+NIH+Grant+Supports+Study+of+MS+Diagnostic+Biomarker&amp;rft.date=2020-06-16&amp;rft.aulast=Chapman&amp;rft.aufirst=M&amp;rft_id=https%3A%2F%2Fmultiplesclerosisnewstoday.com%2Fnews-posts%2F2020%2F06%2F16%2Fcleveland-clinic-given-7-million-nih-grant-study-diagnostic-cvs-biomarker%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAndravizouDardiotisArtemiadisSokratous2019" class="citation journal cs1">Andravizou A, Dardiotis E, Artemiadis A, Sokratous M, Siokas V, Tsouris Z,  et&#160;al. (December 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065319">"Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options"</a>. <i>Auto- Immunity Highlights</i>. <b>10</b> (1): 7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs13317-019-0117-5">10.1186/s13317-019-0117-5</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065319">7065319</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32257063">32257063</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Auto-+Immunity+Highlights&amp;rft.atitle=Brain+atrophy+in+multiple+sclerosis%3A+mechanisms%2C+clinical+relevance+and+treatment+options&amp;rft.volume=10&amp;rft.issue=1&amp;rft.pages=7&amp;rft.date=2019-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7065319%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32257063&amp;rft_id=info%3Adoi%2F10.1186%2Fs13317-019-0117-5&amp;rft.aulast=Andravizou&amp;rft.aufirst=A&amp;rft.au=Dardiotis%2C+E&amp;rft.au=Artemiadis%2C+A&amp;rft.au=Sokratous%2C+M&amp;rft.au=Siokas%2C+V&amp;rft.au=Tsouris%2C+Z&amp;rft.au=Aloizou%2C+AM&amp;rft.au=Nikolaidis%2C+I&amp;rft.au=Bakirtzis%2C+C&amp;rft.au=Tsivgoulis%2C+G&amp;rft.au=Deretzi%2C+G&amp;rft.au=Grigoriadis%2C+N&amp;rft.au=Bogdanos%2C+DP&amp;rft.au=Hadjigeorgiou%2C+GM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7065319&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFJacobsenHagemeierMyhrNyland2014" class="citation journal cs1">Jacobsen C, Hagemeier J, Myhr KM, Nyland H, Lode K, Bergsland N,  et&#160;al. (October 2014). "Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study". <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>85</b> (10): 1109–1115. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2013-306906">10.1136/jnnp-2013-306906</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24554101">24554101</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:6144791">6144791</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Brain+atrophy+and+disability+progression+in+multiple+sclerosis+patients%3A+a+10-year+follow-up+study&amp;rft.volume=85&amp;rft.issue=10&amp;rft.pages=1109-1115&amp;rft.date=2014-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A6144791%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F24554101&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2013-306906&amp;rft.aulast=Jacobsen&amp;rft.aufirst=C&amp;rft.au=Hagemeier%2C+J&amp;rft.au=Myhr%2C+KM&amp;rft.au=Nyland%2C+H&amp;rft.au=Lode%2C+K&amp;rft.au=Bergsland%2C+N&amp;rft.au=Ramasamy%2C+DP&amp;rft.au=Dalaker%2C+TO&amp;rft.au=Larsen%2C+JP&amp;rft.au=Farbu%2C+E&amp;rft.au=Zivadinov%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid16945427-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16945427_80-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLinkHuang2006" class="citation journal cs1">Link H, Huang YM (November 2006). "Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness". <i>Journal of Neuroimmunology</i>. <b>180</b> (1–2): 17–28. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jneuroim.2006.07.006">10.1016/j.jneuroim.2006.07.006</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16945427">16945427</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22724352">22724352</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neuroimmunology&amp;rft.atitle=Oligoclonal+bands+in+multiple+sclerosis+cerebrospinal+fluid%3A+an+update+on+methodology+and+clinical+usefulness&amp;rft.volume=180&amp;rft.issue=1%E2%80%932&amp;rft.pages=17-28&amp;rft.date=2006-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22724352%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16945427&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jneuroim.2006.07.006&amp;rft.aulast=Link&amp;rft.aufirst=H&amp;rft.au=Huang%2C+YM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Loscalzo-2022-81"><span class="mw-cite-backlink">^ <a href="#cite_ref-Loscalzo-2022_81-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Loscalzo-2022_81-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Loscalzo-2022_81-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLoscalzoFauciKasperHauser2022" class="citation book cs1">Loscalzo J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (2022). <a rel="nofollow" class="external text" href="https://www.worldcat.org/oclc/1282172709"><i>Harrison's principles of internal medicine</i></a> (21st&#160;ed.). New York. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-264-26849-8" title="Special:BookSources/978-1-264-26849-8"><bdi>978-1-264-26849-8</bdi></a>. <a href="/wiki/OCLC_(identifier)" class="mw-redirect" title="OCLC (identifier)">OCLC</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/oclc/1282172709">1282172709</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Harrison%27s+principles+of+internal+medicine&amp;rft.place=New+York&amp;rft.edition=21st&amp;rft.date=2022&amp;rft_id=info%3Aoclcnum%2F1282172709&amp;rft.isbn=978-1-264-26849-8&amp;rft.aulast=Loscalzo&amp;rft.aufirst=J&amp;rft.au=Fauci%2C+AS&amp;rft.au=Kasper%2C+DL&amp;rft.au=Hauser%2C+SL&amp;rft.au=Longo%2C+DL&amp;rft.au=Jameson%2C+JL&amp;rft_id=https%3A%2F%2Fwww.worldcat.org%2Foclc%2F1282172709&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Saguil-2022-82"><span class="mw-cite-backlink">^ <a href="#cite_ref-Saguil-2022_82-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Saguil-2022_82-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Saguil-2022_82-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Saguil-2022_82-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSaguilFarnell_IvJordan2022" class="citation journal cs1">Saguil A, Farnell Iv EA, Jordan TS (August 2022). <a rel="nofollow" class="external text" href="https://www.aafp.org/pubs/afp/issues/2022/0800/multiple-sclerosis.html">"Multiple Sclerosis: A Primary Care Perspective"</a>. <i>American Family Physician</i>. <b>106</b> (2): 173–183. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35977131">35977131</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Family+Physician&amp;rft.atitle=Multiple+Sclerosis%3A+A+Primary+Care+Perspective&amp;rft.volume=106&amp;rft.issue=2&amp;rft.pages=173-183&amp;rft.date=2022-08&amp;rft_id=info%3Apmid%2F35977131&amp;rft.aulast=Saguil&amp;rft.aufirst=A&amp;rft.au=Farnell+Iv%2C+EA&amp;rft.au=Jordan%2C+TS&amp;rft_id=https%3A%2F%2Fwww.aafp.org%2Fpubs%2Fafp%2Fissues%2F2022%2F0800%2Fmultiple-sclerosis.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Solomon2019DiagnosisReview-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-Solomon2019DiagnosisReview_83-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSolomon2019" class="citation journal cs1">Solomon AJ (June 2019). "Diagnosis, Differential Diagnosis, and Misdiagnosis of Multiple Sclerosis". <i>Continuum</i>. <b>25</b> (3): 611–635. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FCON.0000000000000728">10.1212/CON.0000000000000728</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31162308">31162308</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:173991777">173991777</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Continuum&amp;rft.atitle=Diagnosis%2C+Differential+Diagnosis%2C+and+Misdiagnosis+of+Multiple+Sclerosis&amp;rft.volume=25&amp;rft.issue=3&amp;rft.pages=611-635&amp;rft.date=2019-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A173991777%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F31162308&amp;rft_id=info%3Adoi%2F10.1212%2FCON.0000000000000728&amp;rft.aulast=Solomon&amp;rft.aufirst=AJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Lublin-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lublin_84-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLublin2014" class="citation journal cs1">Lublin FD,  et&#160;al. (15 July 2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117366">"Defining the clinical course of multiple sclerosis, The 2013 revisions"</a>. <i>Neurology</i>. <b>83</b> (3): 278–286. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0000000000000560">10.1212/WNL.0000000000000560</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117366">4117366</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24871874">24871874</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Defining+the+clinical+course+of+multiple+sclerosis%2C+The+2013+revisions&amp;rft.volume=83&amp;rft.issue=3&amp;rft.pages=278-286&amp;rft.date=2014-07-15&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4117366%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24871874&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0000000000000560&amp;rft.aulast=Lublin&amp;rft.aufirst=FD&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4117366&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLublinCoetzeeCohenMarrie2020" class="citation journal cs1">Lublin FD, Coetzee T, Cohen JA, Marrie RA, Thompson AJ (June 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455332">"The 2013 clinical course descriptors for multiple sclerosis: A clarification"</a>. <i>Neurology</i>. <b>94</b> (24): 1088–1092. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0000000000009636">10.1212/WNL.0000000000009636</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455332">7455332</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32471886">32471886</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=The+2013+clinical+course+descriptors+for+multiple+sclerosis%3A+A+clarification&amp;rft.volume=94&amp;rft.issue=24&amp;rft.pages=1088-1092&amp;rft.date=2020-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7455332%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32471886&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0000000000009636&amp;rft.aulast=Lublin&amp;rft.aufirst=FD&amp;rft.au=Coetzee%2C+T&amp;rft.au=Cohen%2C+JA&amp;rft.au=Marrie%2C+RA&amp;rft.au=Thompson%2C+AJ&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7455332&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid15847841-86"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid15847841_86-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15847841_86-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMillerBarkhofMontalbanThompson2005" class="citation journal cs1">Miller D, Barkhof F, Montalban X, Thompson A, Filippi M (May 2005). "Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis". <i>The Lancet. Neurology</i>. <b>4</b> (5): 281–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2805%2970071-5">10.1016/S1474-4422(05)70071-5</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15847841">15847841</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:36401666">36401666</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Clinically+isolated+syndromes+suggestive+of+multiple+sclerosis%2C+part+I%3A+natural+history%2C+pathogenesis%2C+diagnosis%2C+and+prognosis&amp;rft.volume=4&amp;rft.issue=5&amp;rft.pages=281-8&amp;rft.date=2005-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A36401666%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15847841&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2805%2970071-5&amp;rft.aulast=Miller&amp;rft.aufirst=D&amp;rft.au=Barkhof%2C+F&amp;rft.au=Montalban%2C+X&amp;rft.au=Thompson%2C+A&amp;rft.au=Filippi%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17884680-87"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17884680_87-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17884680_87-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid17884680_87-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMillerLeary2007" class="citation journal cs1">Miller DH, Leary SM (October 2007). "Primary-progressive multiple sclerosis". <i>The Lancet. Neurology</i>. <b>6</b> (10): 903–12. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2807%2970243-0">10.1016/S1474-4422(07)70243-0</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/1871%2F24666">1871/24666</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17884680">17884680</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:31389841">31389841</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Primary-progressive+multiple+sclerosis&amp;rft.volume=6&amp;rft.issue=10&amp;rft.pages=903-12&amp;rft.date=2007-10&amp;rft_id=info%3Ahdl%2F1871%2F24666&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A31389841%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17884680&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2807%2970243-0&amp;rft.aulast=Miller&amp;rft.aufirst=DH&amp;rft.au=Leary%2C+SM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid16545751-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16545751_88-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRovarisConfavreuxFurlanKappos2006" class="citation journal cs1">Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M (April 2006). "Secondary progressive multiple sclerosis: current knowledge and future challenges". <i>The Lancet. Neurology</i>. <b>5</b> (4): 343–54. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2806%2970410-0">10.1016/S1474-4422(06)70410-0</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16545751">16545751</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:39503553">39503553</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Secondary+progressive+multiple+sclerosis%3A+current+knowledge+and+future+challenges&amp;rft.volume=5&amp;rft.issue=4&amp;rft.pages=343-54&amp;rft.date=2006-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39503553%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16545751&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2806%2970410-0&amp;rft.aulast=Rovaris&amp;rft.aufirst=M&amp;rft.au=Confavreux%2C+C&amp;rft.au=Furlan%2C+R&amp;rft.au=Kappos%2C+L&amp;rft.au=Comi%2C+G&amp;rft.au=Filippi%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-sorensen-89"><span class="mw-cite-backlink">^ <a href="#cite_ref-sorensen_89-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-sorensen_89-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSørensenCentonzeGiovannoni2020" class="citation journal cs1">Sørensen PS, Centonze D, Giovannoni G,  et&#160;al. (2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318823">"Expert opinion on the use of cladribine tablets in clinical practice"</a>. <i>Ther Adv Neurol Disord</i> (Review). <b>13</b>: 1756286420935019. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1756286420935019">10.1177/1756286420935019</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318823">7318823</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32636933">32636933</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ther+Adv+Neurol+Disord&amp;rft.atitle=Expert+opinion+on+the+use+of+cladribine+tablets+in+clinical+practice&amp;rft.volume=13&amp;rft.pages=1756286420935019&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7318823%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32636933&amp;rft_id=info%3Adoi%2F10.1177%2F1756286420935019&amp;rft.aulast=S%C3%B8rensen&amp;rft.aufirst=PS&amp;rft.au=Centonze%2C+D&amp;rft.au=Giovannoni%2C+G&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7318823&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-novartis.com-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-novartis.com_90-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease">"Novartis receives FDA approval for Mayzent® (siponimod), the first oral drug to treat secondary progressive MS with active disease"</a>. <i>Novartis.com</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201120002815/https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease">Archived</a> from the original on 20 November 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">12 November</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Novartis.com&amp;rft.atitle=Novartis+receives+FDA+approval+for+Mayzent%C2%AE+%28siponimod%29%2C+the+first+oral+drug+to+treat+secondary+progressive+MS+with+active+disease&amp;rft_id=https%3A%2F%2Fwww.novartis.com%2Fnews%2Fmedia-releases%2Fnovartis-receives-fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-91">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSaida2004" class="citation journal cs1 cs1-prop-foreign-lang-source">Saida T (November 2004). "[Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis]". <i>Rinsho Shinkeigaku</i> (Review) (in Japanese). <b>44</b> (11): 796–8. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15651294">15651294</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Rinsho+Shinkeigaku&amp;rft.atitle=%5BMultiple+sclerosis%3A+treatment+and+prevention+of+relapses+and+progression+in+multiple+sclerosis%5D&amp;rft.volume=44&amp;rft.issue=11&amp;rft.pages=796-8&amp;rft.date=2004-11&amp;rft_id=info%3Apmid%2F15651294&amp;rft.aulast=Saida&amp;rft.aufirst=T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18219812-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18219812_92-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPittockRodriguez2008" class="citation journal cs1">Pittock SJ, Rodriguez M (2008). "Benign multiple sclerosis: a distinct clinical entity with therapeutic implications". <i>Current Topics in Microbiology and Immunology</i>. <b>318</b>: 1–17. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F978-3-540-73677-6_1">10.1007/978-3-540-73677-6_1</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-540-73676-9" title="Special:BookSources/978-3-540-73676-9"><bdi>978-3-540-73676-9</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18219812">18219812</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Topics+in+Microbiology+and+Immunology&amp;rft.atitle=Benign+multiple+sclerosis%3A+a+distinct+clinical+entity+with+therapeutic+implications&amp;rft.volume=318&amp;rft.pages=1-17&amp;rft.date=2008&amp;rft_id=info%3Apmid%2F18219812&amp;rft_id=info%3Adoi%2F10.1007%2F978-3-540-73677-6_1&amp;rft.isbn=978-3-540-73676-9&amp;rft.aulast=Pittock&amp;rft.aufirst=SJ&amp;rft.au=Rodriguez%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFeinstein2007" class="citation book cs1">Feinstein A (2007). "1. Multiple sclerosis: diagnosis and definitions". <a rel="nofollow" class="external text" href="https://www.cambridge.org/core/books/clinical-neuropsychiatry-of-multiple-sclerosis/65B067C2165D447E44A103D8D2205CAC"><i>The Clinical Neuropsychiatry of Multiple Sclerosis</i></a>. Cambridge: Cambridge University Press. p.&#160;20. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1017%2FCBO9780511543760">10.1017/CBO9780511543760</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-521-85234-0" title="Special:BookSources/978-0-521-85234-0"><bdi>978-0-521-85234-0</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=1.+Multiple+sclerosis%3A+diagnosis+and+definitions&amp;rft.btitle=The+Clinical+Neuropsychiatry+of+Multiple+Sclerosis&amp;rft.place=Cambridge&amp;rft.pages=20&amp;rft.pub=Cambridge+University+Press&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1017%2FCBO9780511543760&amp;rft.isbn=978-0-521-85234-0&amp;rft.aulast=Feinstein&amp;rft.aufirst=A&amp;rft_id=https%3A%2F%2Fwww.cambridge.org%2Fcore%2Fbooks%2Fclinical-neuropsychiatry-of-multiple-sclerosis%2F65B067C2165D447E44A103D8D2205CAC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid15727225-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15727225_94-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFStadelmannBrück2004" class="citation journal cs1">Stadelmann C, Brück W (November 2004). "Lessons from the neuropathology of atypical forms of multiple sclerosis". <i>Neurological Sciences</i>. <b>25</b> (Suppl 4): S319–S322. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs10072-004-0333-1">10.1007/s10072-004-0333-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15727225">15727225</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:21212935">21212935</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurological+Sciences&amp;rft.atitle=Lessons+from+the+neuropathology+of+atypical+forms+of+multiple+sclerosis&amp;rft.volume=25&amp;rft.issue=Suppl+4&amp;rft.pages=S319-S322&amp;rft.date=2004-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A21212935%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15727225&amp;rft_id=info%3Adoi%2F10.1007%2Fs10072-004-0333-1&amp;rft.aulast=Stadelmann&amp;rft.aufirst=C&amp;rft.au=Br%C3%BCck%2C+W&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-95">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFujihara2019" class="citation journal cs1">Fujihara K (June 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522202">"Neuromyelitis optica spectrum disorders: still evolving and broadening"</a>. <i>Current Opinion in Neurology</i> (Review). <b>32</b> (3): 385–394. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FWCO.0000000000000694">10.1097/WCO.0000000000000694</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522202">6522202</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30893099">30893099</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Neurology&amp;rft.atitle=Neuromyelitis+optica+spectrum+disorders%3A+still+evolving+and+broadening&amp;rft.volume=32&amp;rft.issue=3&amp;rft.pages=385-394&amp;rft.date=2019-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6522202%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30893099&amp;rft_id=info%3Adoi%2F10.1097%2FWCO.0000000000000694&amp;rft.aulast=Fujihara&amp;rft.aufirst=K&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6522202&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Neurology2018-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-Neurology2018_96-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRae-GrantDayMarrieRabinstein2018" class="citation journal cs1">Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BA, Gronseth GS,  et&#160;al. (April 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0000000000005347">"Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology"</a>. <i>Neurology</i>. <b>90</b> (17): 777–788. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0000000000005347">10.1212/WNL.0000000000005347</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29686116">29686116</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Practice+guideline+recommendations+summary%3A+Disease-modifying+therapies+for+adults+with+multiple+sclerosis%3A+Report+of+the+Guideline+Development%2C+Dissemination%2C+and+Implementation+Subcommittee+of+the+American+Academy+of+Neurology&amp;rft.volume=90&amp;rft.issue=17&amp;rft.pages=777-788&amp;rft.date=2018-04&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0000000000005347&amp;rft_id=info%3Apmid%2F29686116&amp;rft.aulast=Rae-Grant&amp;rft.aufirst=A&amp;rft.au=Day%2C+GS&amp;rft.au=Marrie%2C+RA&amp;rft.au=Rabinstein%2C+A&amp;rft.au=Cree%2C+BA&amp;rft.au=Gronseth%2C+GS&amp;rft.au=Haboubi%2C+M&amp;rft.au=Halper%2C+J&amp;rft.au=Hosey%2C+JP&amp;rft.au=Jones%2C+DE&amp;rft.au=Lisak%2C+R&amp;rft.au=Pelletier%2C+D&amp;rft.au=Potrebic%2C+S&amp;rft.au=Sitcov%2C+C&amp;rft.au=Sommers%2C+R&amp;rft.au=Stachowiak%2C+J&amp;rft.au=Getchius%2C+TS&amp;rft.au=Merillat%2C+SA&amp;rft.au=Pringsheim%2C+T&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1212%252FWNL.0000000000005347&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-97">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBurtonO&#39;ConnorHoholBeyene2012" class="citation journal cs1">Burton JM, O'Connor PW, Hohol M, Beyene J (December 2012). "Oral versus intravenous steroids for treatment of relapses in multiple sclerosis". <i>The Cochrane Database of Systematic Reviews</i>. <b>12</b>: CD006921. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD006921.pub3">10.1002/14651858.CD006921.pub3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23235634">23235634</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Oral+versus+intravenous+steroids+for+treatment+of+relapses+in+multiple+sclerosis&amp;rft.volume=12&amp;rft.pages=CD006921&amp;rft.date=2012-12&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD006921.pub3&amp;rft_id=info%3Apmid%2F23235634&amp;rft.aulast=Burton&amp;rft.aufirst=JM&amp;rft.au=O%27Connor%2C+PW&amp;rft.au=Hohol%2C+M&amp;rft.au=Beyene%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFilippiniBrusaferriSibley2000" class="citation journal cs1">Filippini G, Brusaferri F, Sibley WA,  et&#160;al. (2000). "Corticosteroids or ACTH for acute exacerbations in multiple sclerosis". <i>Cochrane Database Syst Rev</i> (4): CD001331. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD001331">10.1002/14651858.CD001331</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11034713">11034713</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.atitle=Corticosteroids+or+ACTH+for+acute+exacerbations+in+multiple+sclerosis&amp;rft.issue=4&amp;rft.pages=CD001331&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD001331&amp;rft_id=info%3Apmid%2F11034713&amp;rft.aulast=Filippini&amp;rft.aufirst=G&amp;rft.au=Brusaferri%2C+F&amp;rft.au=Sibley%2C+WA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-RCOP_acute-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-RCOP_acute_99-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFThe_National_Collaborating_Centre_for_Chronic_Conditions2004" class="citation book cs1">The National Collaborating Centre for Chronic Conditions (2004). "Treatment of acute episodes". <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/books/NBK48921/"><i>Multiple sclerosis&#160;: national clinical guideline for diagnosis and management in primary and secondary care</i></a>. London: Royal College of Physicians. pp.&#160;54–58. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-86016-182-0" title="Special:BookSources/1-86016-182-0"><bdi>1-86016-182-0</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21290636">21290636</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230210212932/https://www.ncbi.nlm.nih.gov/books/NBK48921/">Archived</a> from the original on 10 February 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">5 October</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Treatment+of+acute+episodes&amp;rft.btitle=Multiple+sclerosis+%3A+national+clinical+guideline+for+diagnosis+and+management+in+primary+and+secondary+care&amp;rft.place=London&amp;rft.pages=54-58&amp;rft.pub=Royal+College+of+Physicians&amp;rft.date=2004&amp;rft_id=info%3Apmid%2F21290636&amp;rft.isbn=1-86016-182-0&amp;rft.au=The+National+Collaborating+Centre+for+Chronic+Conditions&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK48921%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPetzoldBraithwaitevan_Oosten2020" class="citation journal cs1">Petzold A, Braithwaite T, van Oosten BW (January 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952848">"Case for a new corticosteroid treatment trial in optic neuritis: review of updated evidence"</a>. <i>J. Neurol. Neurosurg. Psychiatry</i> (Review). <b>91</b> (1): 9–14. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2019-321653">10.1136/jnnp-2019-321653</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952848">6952848</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31740484">31740484</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatry&amp;rft.atitle=Case+for+a+new+corticosteroid+treatment+trial+in+optic+neuritis%3A+review+of+updated+evidence&amp;rft.volume=91&amp;rft.issue=1&amp;rft.pages=9-14&amp;rft.date=2020-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6952848%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31740484&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2019-321653&amp;rft.aulast=Petzold&amp;rft.aufirst=A&amp;rft.au=Braithwaite%2C+T&amp;rft.au=van+Oosten%2C+BW&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6952848&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-He2016-101"><span class="mw-cite-backlink">^ <a href="#cite_ref-He2016_101-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-He2016_101-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHeZhangZhaoZhang2016" class="citation journal cs1">He D, Zhang C, Zhao X, Zhang Y, Dai Q, Li Y, Chu L (March 2016). "Teriflunomide for multiple sclerosis". <i>The Cochrane Database of Systematic Reviews</i>. <b>3</b>: CD009882. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD009882.pub3">10.1002/14651858.CD009882.pub3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27003123">27003123</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Teriflunomide+for+multiple+sclerosis&amp;rft.volume=3&amp;rft.pages=CD009882&amp;rft.date=2016-03&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD009882.pub3&amp;rft_id=info%3Apmid%2F27003123&amp;rft.aulast=He&amp;rft.aufirst=D&amp;rft.au=Zhang%2C+C&amp;rft.au=Zhao%2C+X&amp;rft.au=Zhang%2C+Y&amp;rft.au=Dai%2C+Q&amp;rft.au=Li%2C+Y&amp;rft.au=Chu%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Rice2001-102"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rice2001_102-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rice2001_102-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRiceIncorvaiaMunari2001" class="citation journal cs1">Rice GP, Incorvaia B, Munari L,  et&#160;al. (2001). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017973">"Interferon in relapsing-remitting multiple sclerosis"</a>. <i>Cochrane Database Syst Rev</i>. <b>2001</b> (4): CD002002. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD002002">10.1002/14651858.CD002002</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017973">7017973</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11687131">11687131</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.atitle=Interferon+in+relapsing-remitting+multiple+sclerosis&amp;rft.volume=2001&amp;rft.issue=4&amp;rft.pages=CD002002&amp;rft.date=2001&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7017973%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11687131&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD002002&amp;rft.aulast=Rice&amp;rft.aufirst=GP&amp;rft.au=Incorvaia%2C+B&amp;rft.au=Munari%2C+L&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7017973&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Hassan2011-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hassan2011_103-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHassan-SmithDouglas2011" class="citation journal cs1">Hassan-Smith G, Douglas MR (November 2011). "Management and prognosis of multiple sclerosis". <i>British Journal of Hospital Medicine</i>. <b>72</b> (11): M174-6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.12968%2Fhmed.2011.72.Sup11.M174">10.12968/hmed.2011.72.Sup11.M174</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22082979">22082979</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Hospital+Medicine&amp;rft.atitle=Management+and+prognosis+of+multiple+sclerosis&amp;rft.volume=72&amp;rft.issue=11&amp;rft.pages=M174-6&amp;rft.date=2011-11&amp;rft_id=info%3Adoi%2F10.12968%2Fhmed.2011.72.Sup11.M174&amp;rft_id=info%3Apmid%2F22082979&amp;rft.aulast=Hassan-Smith&amp;rft.aufirst=G&amp;rft.au=Douglas%2C+MR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid21205679-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21205679_104-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFreedman2011" class="citation journal cs1">Freedman MS (January 2011). "Long-term follow-up of clinical trials of multiple sclerosis therapies". <i>Neurology</i>. <b>76</b> (1 Suppl 1): S26-34. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0b013e318205051d">10.1212/WNL.0b013e318205051d</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21205679">21205679</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:16929304">16929304</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Long-term+follow-up+of+clinical+trials+of+multiple+sclerosis+therapies&amp;rft.volume=76&amp;rft.issue=1+Suppl+1&amp;rft.pages=S26-34&amp;rft.date=2011-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A16929304%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21205679&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0b013e318205051d&amp;rft.aulast=Freedman&amp;rft.aufirst=MS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid22284996-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22284996_105-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFQizilbashMendezSanchez-de_la_Rosa2012" class="citation journal cs1">Qizilbash N, Mendez I, Sanchez-de la Rosa R (January 2012). "Benefit-risk analysis of glatiramer acetate for relapsing-remitting and clinically isolated syndrome multiple sclerosis". <i>Clinical Therapeutics</i>. <b>34</b> (1): 159–176.e5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clinthera.2011.12.006">10.1016/j.clinthera.2011.12.006</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22284996">22284996</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Therapeutics&amp;rft.atitle=Benefit-risk+analysis+of+glatiramer+acetate+for+relapsing-remitting+and+clinically+isolated+syndrome+multiple+sclerosis&amp;rft.volume=34&amp;rft.issue=1&amp;rft.pages=159-176.e5&amp;rft.date=2012-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clinthera.2011.12.006&amp;rft_id=info%3Apmid%2F22284996&amp;rft.aulast=Qizilbash&amp;rft.aufirst=N&amp;rft.au=Mendez%2C+I&amp;rft.au=Sanchez-de+la+Rosa%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid21205678-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21205678_106-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBates2011" class="citation journal cs1">Bates D (January 2011). "Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials". <i>Neurology</i>. <b>76</b> (1 Suppl 1): S14-25. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0b013e3182050388">10.1212/WNL.0b013e3182050388</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21205678">21205678</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:362182">362182</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Treatment+effects+of+immunomodulatory+therapies+at+different+stages+of+multiple+sclerosis+in+short-term+trials&amp;rft.volume=76&amp;rft.issue=1+Suppl+1&amp;rft.pages=S14-25&amp;rft.date=2011-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A362182%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21205678&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0b013e3182050388&amp;rft.aulast=Bates&amp;rft.aufirst=D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-107">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFClericoFaggianoPalace2008" class="citation journal cs1">Clerico M, Faggiano F, Palace J,  et&#160;al. (April 2008). "Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis". <i>Cochrane Database Syst Rev</i> (2): CD005278. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD005278.pub3">10.1002/14651858.CD005278.pub3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18425915">18425915</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.atitle=Recombinant+interferon+beta+or+glatiramer+acetate+for+delaying+conversion+of+the+first+demyelinating+event+to+multiple+sclerosis&amp;rft.issue=2&amp;rft.pages=CD005278&amp;rft.date=2008-04&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD005278.pub3&amp;rft_id=info%3Apmid%2F18425915&amp;rft.aulast=Clerico&amp;rft.aufirst=M&amp;rft.au=Faggiano%2C+F&amp;rft.au=Palace%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid22642799-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22642799_108-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFJohnstonSo2012" class="citation journal cs1">Johnston J, So TY (June 2012). "First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview". <i>Drugs</i>. <b>72</b> (9): 1195–211. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2165%2F11634010-000000000-00000">10.2165/11634010-000000000-00000</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22642799">22642799</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20323687">20323687</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drugs&amp;rft.atitle=First-line+disease-modifying+therapies+in+paediatric+multiple+sclerosis%3A+a+comprehensive+overview&amp;rft.volume=72&amp;rft.issue=9&amp;rft.pages=1195-211&amp;rft.date=2012-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20323687%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22642799&amp;rft_id=info%3Adoi%2F10.2165%2F11634010-000000000-00000&amp;rft.aulast=Johnston&amp;rft.aufirst=J&amp;rft.au=So%2C+TY&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-LaMantia2016-109"><span class="mw-cite-backlink">^ <a href="#cite_ref-LaMantia2016_109-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-LaMantia2016_109-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLa_MantiaTramacereFirwana2016" class="citation journal cs1">La Mantia L, Tramacere I, Firwana B,  et&#160;al. (April 2016). "Fingolimod for relapsing-remitting multiple sclerosis". <i>Cochrane Database Syst Rev</i>. <b>4</b>: CD009371. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD009371.pub2">10.1002/14651858.CD009371.pub2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27091121">27091121</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.atitle=Fingolimod+for+relapsing-remitting+multiple+sclerosis&amp;rft.volume=4&amp;rft.pages=CD009371&amp;rft.date=2016-04&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD009371.pub2&amp;rft_id=info%3Apmid%2F27091121&amp;rft.aulast=La+Mantia&amp;rft.aufirst=L&amp;rft.au=Tramacere%2C+I&amp;rft.au=Firwana%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Xu2015-110"><span class="mw-cite-backlink">^ <a href="#cite_ref-Xu2015_110-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Xu2015_110-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFXuZhangSun2015" class="citation journal cs1">Xu Z, Zhang F, Sun F,  et&#160;al. (April 2015). "Dimethyl fumarate for multiple sclerosis". <i>Cochrane Database Syst Rev</i> (4): CD011076. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD011076.pub2">10.1002/14651858.CD011076.pub2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25900414">25900414</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.atitle=Dimethyl+fumarate+for+multiple+sclerosis&amp;rft.issue=4&amp;rft.pages=CD011076&amp;rft.date=2015-04&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD011076.pub2&amp;rft_id=info%3Apmid%2F25900414&amp;rft.aulast=Xu&amp;rft.aufirst=Z&amp;rft.au=Zhang%2C+F&amp;rft.au=Sun%2C+F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid22014437-111"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid22014437_111-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid22014437_111-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid22014437_111-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid22014437_111-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKillesteinRudickPolman2011" class="citation journal cs1">Killestein J, Rudick RA, Polman CH (November 2011). "Oral treatment for multiple sclerosis". <i>The Lancet. Neurology</i>. <b>10</b> (11): 1026–34. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2811%2970228-9">10.1016/S1474-4422(11)70228-9</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22014437">22014437</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:206160178">206160178</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Oral+treatment+for+multiple+sclerosis&amp;rft.volume=10&amp;rft.issue=11&amp;rft.pages=1026-34&amp;rft.date=2011-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A206160178%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22014437&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2811%2970228-9&amp;rft.aulast=Killestein&amp;rft.aufirst=J&amp;rft.au=Rudick%2C+RA&amp;rft.au=Polman%2C+CH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFilippiniDel_GiovaneClerico2017" class="citation journal cs1">Filippini G, Del Giovane C, Clerico M,  et&#160;al. (April 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478290">"Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis"</a>. <i>Cochrane Database Syst Rev</i>. <b>2017</b> (4): CD012200. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD012200.pub2">10.1002/14651858.CD012200.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478290">6478290</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28440858">28440858</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.atitle=Treatment+with+disease-modifying+drugs+for+people+with+a+first+clinical+attack+suggestive+of+multiple+sclerosis&amp;rft.volume=2017&amp;rft.issue=4&amp;rft.pages=CD012200&amp;rft.date=2017-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6478290%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28440858&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD012200.pub2&amp;rft.aulast=Filippini&amp;rft.aufirst=G&amp;rft.au=Del+Giovane%2C+C&amp;rft.au=Clerico%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6478290&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Filippini2013-113"><span class="mw-cite-backlink">^ <a href="#cite_ref-Filippini2013_113-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Filippini2013_113-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Filippini2013_113-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Filippini2013_113-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFilippiniDel_GiovaneVacchi2013" class="citation journal cs1">Filippini G, Del Giovane C, Vacchi L,  et&#160;al. (June 2013). <a rel="nofollow" class="external text" href="https://researchonline.lshtm.ac.uk/id/eprint/992748/1/CD008933.pdf">"Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis"</a> <span class="cs1-format">(PDF)</span>. <i>Cochrane Database Syst Rev</i> (6): CD008933. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD008933.pub2">10.1002/14651858.CD008933.pub2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23744561">23744561</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20211005185528/https://researchonline.lshtm.ac.uk/id/eprint/992748/1/CD008933.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 5 October 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">5 October</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.atitle=Immunomodulators+and+immunosuppressants+for+multiple+sclerosis%3A+a+network+meta-analysis&amp;rft.issue=6&amp;rft.pages=CD008933&amp;rft.date=2013-06&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008933.pub2&amp;rft_id=info%3Apmid%2F23744561&amp;rft.aulast=Filippini&amp;rft.aufirst=G&amp;rft.au=Del+Giovane%2C+C&amp;rft.au=Vacchi%2C+L&amp;rft_id=https%3A%2F%2Fresearchonline.lshtm.ac.uk%2Fid%2Feprint%2F992748%2F1%2FCD008933.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLa_MantiaDi_PietrantonjRovaris2016" class="citation journal cs1">La Mantia L, Di Pietrantonj C, Rovaris M,  et&#160;al. (November 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464642">"Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis"</a>. <i>Cochrane Database Syst Rev</i>. <b>2016</b> (11): CD009333. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD009333.pub3">10.1002/14651858.CD009333.pub3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464642">6464642</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27880972">27880972</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.atitle=Interferons-beta+versus+glatiramer+acetate+for+relapsing-remitting+multiple+sclerosis&amp;rft.volume=2016&amp;rft.issue=11&amp;rft.pages=CD009333&amp;rft.date=2016-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6464642%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27880972&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD009333.pub3&amp;rft.aulast=La+Mantia&amp;rft.aufirst=L&amp;rft.au=Di+Pietrantonj%2C+C&amp;rft.au=Rovaris%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6464642&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Tramacere2015-115"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tramacere2015_115-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tramacere2015_115-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Tramacere2015_115-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTramacereDel_GiovaneSalantiD&#39;Amico2015" class="citation journal cs1">Tramacere I, Del Giovane C, Salanti G, D'Amico R, Filippini G (September 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235409">"Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis"</a>. <i>Cochrane Database Syst Rev</i>. <b>2015</b> (9): CD011381. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD011381.pub2">10.1002/14651858.CD011381.pub2</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/11380%2F1082490">11380/1082490</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235409">9235409</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26384035">26384035</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.atitle=Immunomodulators+and+immunosuppressants+for+relapsing-remitting+multiple+sclerosis%3A+a+network+meta-analysis&amp;rft.volume=2015&amp;rft.issue=9&amp;rft.pages=CD011381&amp;rft.date=2015-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9235409%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26384035&amp;rft_id=info%3Ahdl%2F11380%2F1082490&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD011381.pub2&amp;rft.aulast=Tramacere&amp;rft.aufirst=I&amp;rft.au=Del+Giovane%2C+C&amp;rft.au=Salanti%2C+G&amp;rft.au=D%27Amico%2C+R&amp;rft.au=Filippini%2C+G&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9235409&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.globenewswire.com/news-release/2022/12/28/2580377/8790/en/TG-Therapeutics-Announces-FDA-Approval-of-BRIUMVI-ublituximab-xiiy.html">"TG Therapeutics Announces FDA Approval of Briumvi (ublituximab-xiiy)"</a> (Press release). TG Therapeutics. 28 December 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221228194153/https://www.globenewswire.com/news-release/2022/12/28/2580377/8790/en/TG-Therapeutics-Announces-FDA-Approval-of-BRIUMVI-ublituximab-xiiy.html">Archived</a> from the original on 28 December 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">29 December</span> 2022</span> &#8211; via GlobeNewswire.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=TG+Therapeutics+Announces+FDA+Approval+of+Briumvi+%28ublituximab-xiiy%29&amp;rft.pub=TG+Therapeutics&amp;rft.date=2022-12-28&amp;rft_id=https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2022%2F12%2F28%2F2580377%2F8790%2Fen%2FTG-Therapeutics-Announces-FDA-Approval-of-BRIUMVI-ublituximab-xiiy.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-BopeKellerman2011-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-BopeKellerman2011_117-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBopeKellerman2011" class="citation book cs1">Bope ET, Kellerman RD (22 December 2011). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=pyKjGU5JdqQC&amp;pg=PT662"><i>Conn's Current Therapy 2012: Expert Consult – Online and Print</i></a>. Elsevier Health Sciences. pp.&#160;662–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-4557-0738-6" title="Special:BookSources/978-1-4557-0738-6"><bdi>978-1-4557-0738-6</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Conn%27s+Current+Therapy+2012%3A+Expert+Consult+%E2%80%93+Online+and+Print&amp;rft.pages=662-&amp;rft.pub=Elsevier+Health+Sciences&amp;rft.date=2011-12-22&amp;rft.isbn=978-1-4557-0738-6&amp;rft.aulast=Bope&amp;rft.aufirst=ET&amp;rft.au=Kellerman%2C+RD&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DpyKjGU5JdqQC%26pg%3DPT662&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-CochMit2013-118"><span class="mw-cite-backlink">^ <a href="#cite_ref-CochMit2013_118-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CochMit2013_118-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMartinelli_BoneschiVacchiRovarisCapra2013" class="citation journal cs1">Martinelli Boneschi F, Vacchi L, Rovaris M, Capra R, Comi G (May 2013). "Mitoxantrone for multiple sclerosis". <i>The Cochrane Database of Systematic Reviews</i>. <b>5</b> (5): CD002127. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD002127.pub3">10.1002/14651858.CD002127.pub3</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/2434%2F533488">2434/533488</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23728638">23728638</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Mitoxantrone+for+multiple+sclerosis&amp;rft.volume=5&amp;rft.issue=5&amp;rft.pages=CD002127&amp;rft.date=2013-05&amp;rft_id=info%3Ahdl%2F2434%2F533488&amp;rft_id=info%3Apmid%2F23728638&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD002127.pub3&amp;rft.aulast=Martinelli+Boneschi&amp;rft.aufirst=F&amp;rft.au=Vacchi%2C+L&amp;rft.au=Rovaris%2C+M&amp;rft.au=Capra%2C+R&amp;rft.au=Comi%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMarriottMiyasakiGronsethO&#39;Connor2010" class="citation journal cs1">Marriott JJ, Miyasaki JM, Gronseth G, O'Connor PW (May 2010). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871006">"Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology"</a>. <i>Neurology</i>. <b>74</b> (18): 1463–70. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0b013e3181dc1ae0">10.1212/WNL.0b013e3181dc1ae0</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871006">2871006</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20439849">20439849</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Evidence+Report%3A+The+efficacy+and+safety+of+mitoxantrone+%28Novantrone%29+in+the+treatment+of+multiple+sclerosis%3A+Report+of+the+Therapeutics+and+Technology+Assessment+Subcommittee+of+the+American+Academy+of+Neurology&amp;rft.volume=74&amp;rft.issue=18&amp;rft.pages=1463-70&amp;rft.date=2010-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2871006%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20439849&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0b013e3181dc1ae0&amp;rft.aulast=Marriott&amp;rft.aufirst=JJ&amp;rft.au=Miyasaki%2C+JM&amp;rft.au=Gronseth%2C+G&amp;rft.au=O%27Connor%2C+PW&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2871006&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid31598138-120"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid31598138_120-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid31598138_120-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFaissnerGold2019" class="citation journal cs1">Faissner S, Gold R (2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764045">"Progressive multiple sclerosis: latest therapeutic developments and future directions"</a>. <i>Therapeutic Advances in Neurological Disorders</i>. <b>12</b>: 1756286419878323. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1756286419878323">10.1177/1756286419878323</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764045">6764045</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31598138">31598138</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Therapeutic+Advances+in+Neurological+Disorders&amp;rft.atitle=Progressive+multiple+sclerosis%3A+latest+therapeutic+developments+and+future+directions&amp;rft.volume=12&amp;rft.pages=1756286419878323&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6764045%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31598138&amp;rft_id=info%3Adoi%2F10.1177%2F1756286419878323&amp;rft.aulast=Faissner&amp;rft.aufirst=S&amp;rft.au=Gold%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6764045&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-STATapproval-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-STATapproval_121-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWinslow2017" class="citation news cs1">Winslow R (28 March 2017). <a rel="nofollow" class="external text" href="https://www.statnews.com/2017/03/28/multiple-sclerosis-ms-drug-ocrelizumab/">"After 40-year odyssey, first drug for aggressive MS wins FDA approval"</a>. STAT. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170401151407/https://www.statnews.com/2017/03/28/multiple-sclerosis-ms-drug-ocrelizumab/">Archived</a> from the original on 1 April 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=After+40-year+odyssey%2C+first+drug+for+aggressive+MS+wins+FDA+approval&amp;rft.date=2017-03-28&amp;rft.aulast=Winslow&amp;rft.aufirst=R&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2017%2F03%2F28%2Fmultiple-sclerosis-ms-drug-ocrelizumab%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Ocrevus_FDA_label-122"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ocrevus_FDA_label_122-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ocrevus_FDA_label_122-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9da42362-3bb5-4b83-b4bb-b59fd4e55f0d">"Ocrevus- ocrelizumab injection"</a>. <i>DailyMed</i>. 13 December 2019. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200627100425/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9da42362-3bb5-4b83-b4bb-b59fd4e55f0d">Archived</a> from the original on 27 June 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">26 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=DailyMed&amp;rft.atitle=Ocrevus-+ocrelizumab+injection&amp;rft.date=2019-12-13&amp;rft_id=https%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fsetid%3D9da42362-3bb5-4b83-b4bb-b59fd4e55f0d&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-FDABLAapproval-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDABLAapproval_123-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/761053Orig1s000ltr.pdf">"BLA Approval Letter"</a> <span class="cs1-format">(PDF)</span>. FDA. 28 March 2017. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170402081250/https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/761053Orig1s000ltr.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 2 April 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=BLA+Approval+Letter&amp;rft.pub=FDA&amp;rft.date=2017-03-28&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fappletter%2F2017%2F761053Orig1s000ltr.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-124">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLinZhangZhangLuo2022" class="citation journal cs1">Lin M, Zhang J, Zhang Y, Luo J, Shi S,  et&#160;al. (Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group) (May 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115862">"Ocrelizumab for multiple sclerosis"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2022</b> (5): CD013247. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD013247.pub2">10.1002/14651858.CD013247.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115862">9115862</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35583174">35583174</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Ocrelizumab+for+multiple+sclerosis&amp;rft.volume=2022&amp;rft.issue=5&amp;rft.pages=CD013247&amp;rft.date=2022-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9115862%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F35583174&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD013247.pub2&amp;rft.aulast=Lin&amp;rft.aufirst=M&amp;rft.au=Zhang%2C+J&amp;rft.au=Zhang%2C+Y&amp;rft.au=Luo%2C+J&amp;rft.au=Shi%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9115862&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-125">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPennerSchreiber2023" class="citation book cs1">Penner IK, Schreiber H (2023). <i>Fatigue in Multiple Sclerosis</i>. Springer, Cham. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-031-13498-2" title="Special:BookSources/978-3-031-13498-2"><bdi>978-3-031-13498-2</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Fatigue+in+Multiple+Sclerosis&amp;rft.pub=Springer%2C+Cham&amp;rft.date=2023&amp;rft.isbn=978-3-031-13498-2&amp;rft.aulast=Penner&amp;rft.aufirst=IK&amp;rft.au=Schreiber%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Balak2012-126"><span class="mw-cite-backlink">^ <a href="#cite_ref-Balak2012_126-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Balak2012_126-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBalakHengstmanÇakmakThio2012" class="citation journal cs1">Balak DM, Hengstman GJ, Çakmak A, Thio HB (December 2012). <a rel="nofollow" class="external text" href="http://repub.eur.nl/pub/73097">"Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic review"</a>. <i>Multiple Sclerosis</i>. <b>18</b> (12): 1705–17. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1352458512438239">10.1177/1352458512438239</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/1765%2F73097">1765/73097</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22371220">22371220</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20343951">20343951</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210124034832/https://repub.eur.nl/pub/73097">Archived</a> from the original on 24 January 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">5 September</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Multiple+Sclerosis&amp;rft.atitle=Cutaneous+adverse+events+associated+with+disease-modifying+treatment+in+multiple+sclerosis%3A+a+systematic+review&amp;rft.volume=18&amp;rft.issue=12&amp;rft.pages=1705-17&amp;rft.date=2012-12&amp;rft_id=info%3Ahdl%2F1765%2F73097&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20343951%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22371220&amp;rft_id=info%3Adoi%2F10.1177%2F1352458512438239&amp;rft.aulast=Balak&amp;rft.aufirst=DM&amp;rft.au=Hengstman%2C+GJ&amp;rft.au=%C3%87akmak%2C+A&amp;rft.au=Thio%2C+HB&amp;rft_id=http%3A%2F%2Frepub.eur.nl%2Fpub%2F73097&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17131933-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17131933_127-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSládkováKostolanský2006" class="citation journal cs1">Sládková T, Kostolanský F (2006). "The role of cytokines in the immune response to influenza A virus infection". <i>Acta Virologica</i>. <b>50</b> (3): 151–62. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17131933">17131933</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Virologica&amp;rft.atitle=The+role+of+cytokines+in+the+immune+response+to+influenza+A+virus+infection&amp;rft.volume=50&amp;rft.issue=3&amp;rft.pages=151-62&amp;rft.date=2006&amp;rft_id=info%3Apmid%2F17131933&amp;rft.aulast=Sl%C3%A1dkov%C3%A1&amp;rft.aufirst=T&amp;rft.au=Kostolansk%C3%BD%2C+F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-128">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLa_MantiaMunariLovati2010" class="citation journal cs1">La Mantia L, Munari LM, Lovati R (May 2010). "Glatiramer acetate for multiple sclerosis". <i>The Cochrane Database of Systematic Reviews</i> (5): CD004678. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD004678.pub2">10.1002/14651858.CD004678.pub2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20464733">20464733</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Glatiramer+acetate+for+multiple+sclerosis&amp;rft.issue=5&amp;rft.pages=CD004678&amp;rft.date=2010-05&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004678.pub2&amp;rft_id=info%3Apmid%2F20464733&amp;rft.aulast=La+Mantia&amp;rft.aufirst=L&amp;rft.au=Munari%2C+LM&amp;rft.au=Lovati%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid15592724-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15592724_129-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTremlettOger2004" class="citation journal cs1">Tremlett H, Oger J (November 2004). "Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis". <i>Journal of Neurology</i>. <b>251</b> (11): 1297–303. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00415-004-0619-5">10.1007/s00415-004-0619-5</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15592724">15592724</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:12529733">12529733</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology&amp;rft.atitle=Hepatic+injury%2C+liver+monitoring+and+the+beta-interferons+for+multiple+sclerosis&amp;rft.volume=251&amp;rft.issue=11&amp;rft.pages=1297-303&amp;rft.date=2004-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A12529733%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15592724&amp;rft_id=info%3Adoi%2F10.1007%2Fs00415-004-0619-5&amp;rft.aulast=Tremlett&amp;rft.aufirst=H&amp;rft.au=Oger%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid19882365-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19882365_130-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFComi2009" class="citation journal cs1">Comi G (October 2009). "Treatment of multiple sclerosis: role of natalizumab". <i>Neurological Sciences</i>. 30. <b>30</b> (S2): S155-8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs10072-009-0147-2">10.1007/s10072-009-0147-2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19882365">19882365</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25910077">25910077</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurological+Sciences&amp;rft.atitle=Treatment+of+multiple+sclerosis%3A+role+of+natalizumab&amp;rft.volume=30&amp;rft.issue=S2&amp;rft.pages=S155-8&amp;rft.date=2009-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25910077%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19882365&amp;rft_id=info%3Adoi%2F10.1007%2Fs10072-009-0147-2&amp;rft.aulast=Comi&amp;rft.aufirst=G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-131">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHuntGiovannoni2012" class="citation journal cs1">Hunt D, Giovannoni G (February 2012). "Natalizumab-associated progressive multifocal leucoencephalopathy: a practical approach to risk profiling and monitoring". <i>Practical Neurology</i>. <b>12</b> (1): 25–35. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fpractneurol-2011-000092">10.1136/practneurol-2011-000092</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22258169">22258169</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:46326042">46326042</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Practical+Neurology&amp;rft.atitle=Natalizumab-associated+progressive+multifocal+leucoencephalopathy%3A+a+practical+approach+to+risk+profiling+and+monitoring&amp;rft.volume=12&amp;rft.issue=1&amp;rft.pages=25-35&amp;rft.date=2012-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A46326042%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22258169&amp;rft_id=info%3Adoi%2F10.1136%2Fpractneurol-2011-000092&amp;rft.aulast=Hunt&amp;rft.aufirst=D&amp;rft.au=Giovannoni%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-fumarate-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-fumarate_132-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130512021453/http://www.biogenidec.com/press_release_details.aspx?ID=5981&amp;ReqId=1801165">"Biogen Idec's TECFIDERA™ (Dimethyl Fumarate) Approved in US as a First-Line Oral Treatment for Multiple Sclerosis"</a> (Press release). Biogen Idec. 27 March 2013. Archived from <a rel="nofollow" class="external text" href="http://www.biogenidec.com/press_release_details.aspx?ID=5981&amp;ReqId=1801165">the original</a> on 12 May 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">4 June</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Biogen+Idec%27s+TECFIDERA%E2%84%A2+%28Dimethyl+Fumarate%29+Approved+in+US+as+a+First-Line+Oral+Treatment+for+Multiple+Sclerosis&amp;rft.pub=Biogen+Idec&amp;rft.date=2013-03-27&amp;rft_id=http%3A%2F%2Fwww.biogenidec.com%2Fpress_release_details.aspx%3FID%3D5981%26ReqId%3D1801165&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-fumarateNDA-133"><span class="mw-cite-backlink"><b><a href="#cite_ref-fumarateNDA_133-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204063lbl.pdf">"NDA 204063 – FDA Approved Labeling Text"</a> <span class="cs1-format">(PDF)</span>. US Food and Drug Agency. 27 March 2013. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20131004220910/http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204063lbl.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 4 October 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">5 April</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=NDA+204063+%E2%80%93+FDA+Approved+Labeling+Text&amp;rft.pub=US+Food+and+Drug+Agency&amp;rft.date=2013-03-27&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2013%2F204063lbl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span><br /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/204063Orig1s000ltr.pdf">"NDA Approval"</a> <span class="cs1-format">(PDF)</span>. US Food and Drug Agency. 27 March 2013. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20131004220451/http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/204063Orig1s000ltr.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 4 October 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">5 April</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=NDA+Approval&amp;rft.pub=US+Food+and+Drug+Agency&amp;rft.date=2013-03-27&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fappletter%2F2013%2F204063Orig1s000ltr.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid16168933-134"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16168933_134-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKesselringBeer2005" class="citation journal cs1">Kesselring J, Beer S (October 2005). "Symptomatic therapy and neurorehabilitation in multiple sclerosis". <i>The Lancet. Neurology</i>. <b>4</b> (10): 643–52. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2805%2970193-9">10.1016/S1474-4422(05)70193-9</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16168933">16168933</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:28253186">28253186</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Symptomatic+therapy+and+neurorehabilitation+in+multiple+sclerosis&amp;rft.volume=4&amp;rft.issue=10&amp;rft.pages=643-52&amp;rft.date=2005-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A28253186%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16168933&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2805%2970193-9&amp;rft.aulast=Kesselring&amp;rft.aufirst=J&amp;rft.au=Beer%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17443610-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17443610_135-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKhanTurner-StokesNgKilpatrick2007" class="citation journal cs1">Khan F, Turner-Stokes L, Ng L, Kilpatrick T (April 2007).  Khan F (ed.). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992048">"Multidisciplinary rehabilitation for adults with multiple sclerosis"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2011</b> (2): CD006036. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD006036.pub2">10.1002/14651858.CD006036.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992048">8992048</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17443610">17443610</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Multidisciplinary+rehabilitation+for+adults+with+multiple+sclerosis&amp;rft.volume=2011&amp;rft.issue=2&amp;rft.pages=CD006036&amp;rft.date=2007-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8992048%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17443610&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD006036.pub2&amp;rft.aulast=Khan&amp;rft.aufirst=F&amp;rft.au=Turner-Stokes%2C+L&amp;rft.au=Ng%2C+L&amp;rft.au=Kilpatrick%2C+T&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8992048&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-136">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKöpkeSolariRahnKhan2018" class="citation journal cs1">Köpke S, Solari A, Rahn A, Khan F, Heesen C, Giordano A (October 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517040">"Information provision for people with multiple sclerosis"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>10</b> (10): CD008757. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD008757.pub3">10.1002/14651858.CD008757.pub3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517040">6517040</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30317542">30317542</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Information+provision+for+people+with+multiple+sclerosis&amp;rft.volume=10&amp;rft.issue=10&amp;rft.pages=CD008757&amp;rft.date=2018-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6517040%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30317542&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008757.pub3&amp;rft.aulast=K%C3%B6pke&amp;rft.aufirst=S&amp;rft.au=Solari%2C+A&amp;rft.au=Rahn%2C+A&amp;rft.au=Khan%2C+F&amp;rft.au=Heesen%2C+C&amp;rft.au=Giordano%2C+A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6517040&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid15859525-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15859525_137-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSteultjensDekkerBouterLeemrijse2005" class="citation journal cs1">Steultjens EM, Dekker J, Bouter LM, Leemrijse CJ, van den Ende CH (May 2005). <a rel="nofollow" class="external text" href="https://research.vu.nl/ws/files/2109363/187018.pdf">"Evidence of the efficacy of occupational therapy in different conditions: an overview of systematic reviews"</a> <span class="cs1-format">(PDF)</span>. <i>Clinical Rehabilitation</i>. <b>19</b> (3): 247–54. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1191%2F0269215505cr870oa">10.1191/0269215505cr870oa</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<a rel="nofollow" class="external text" href="https://hdl.handle.net/1871%2F26505">1871/26505</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15859525">15859525</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:18785849">18785849</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200804123616/https://research.vu.nl/ws/files/2109363/187018.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 4 August 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">24 September</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Rehabilitation&amp;rft.atitle=Evidence+of+the+efficacy+of+occupational+therapy+in+different+conditions%3A+an+overview+of+systematic+reviews&amp;rft.volume=19&amp;rft.issue=3&amp;rft.pages=247-54&amp;rft.date=2005-05&amp;rft_id=info%3Ahdl%2F1871%2F26505&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A18785849%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15859525&amp;rft_id=info%3Adoi%2F10.1191%2F0269215505cr870oa&amp;rft.aulast=Steultjens&amp;rft.aufirst=EM&amp;rft.au=Dekker%2C+J&amp;rft.au=Bouter%2C+LM&amp;rft.au=Leemrijse%2C+CJ&amp;rft.au=van+den+Ende%2C+CH&amp;rft_id=https%3A%2F%2Fresearch.vu.nl%2Fws%2Ffiles%2F2109363%2F187018.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid12917976-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12917976_138-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSteultjensDekkerBouterCardol2003" class="citation journal cs1">Steultjens EM, Dekker J, Bouter LM, Cardol M, Van de Nes JC, Van den Ende CH (2003).  Steultjens EE (ed.). <a rel="nofollow" class="external text" href="https://research.vumc.nl/ws/files/787274/271238.pdf">"Occupational therapy for multiple sclerosis"</a> <span class="cs1-format">(PDF)</span>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2010</b> (3): CD003608. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD003608">10.1002/14651858.CD003608</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022193">9022193</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12917976">12917976</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220428081347/https://research.vumc.nl/ws/files/787274/271238.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 28 April 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">5 October</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Occupational+therapy+for+multiple+sclerosis&amp;rft.volume=2010&amp;rft.issue=3&amp;rft.pages=CD003608&amp;rft.date=2003&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9022193%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12917976&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD003608&amp;rft.aulast=Steultjens&amp;rft.aufirst=EM&amp;rft.au=Dekker%2C+J&amp;rft.au=Bouter%2C+LM&amp;rft.au=Cardol%2C+M&amp;rft.au=Van+de+Nes%2C+JC&amp;rft.au=Van+den+Ende%2C+CH&amp;rft_id=https%3A%2F%2Fresearch.vumc.nl%2Fws%2Ffiles%2F787274%2F271238.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-139">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAmatyaKhanGalea2019" class="citation journal cs1">Amatya B, Khan F, Galea M (January 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353175">"Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>1</b> (1): CD012732. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD012732.pub2">10.1002/14651858.CD012732.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353175">6353175</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30637728">30637728</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Rehabilitation+for+people+with+multiple+sclerosis%3A+an+overview+of+Cochrane+Reviews&amp;rft.volume=1&amp;rft.issue=1&amp;rft.pages=CD012732&amp;rft.date=2019-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6353175%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30637728&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD012732.pub2&amp;rft.aulast=Amatya&amp;rft.aufirst=B&amp;rft.au=Khan%2C+F&amp;rft.au=Galea%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6353175&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-140">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHeinevan_de_PortRietbergvan_Wegen2015" class="citation journal cs1">Heine M, van de Port I, Rietberg MB, van Wegen EE, Kwakkel G (September 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554249">"Exercise therapy for fatigue in multiple sclerosis"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2015</b> (9): CD009956. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD009956.pub2">10.1002/14651858.CD009956.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554249">9554249</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26358158">26358158</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Exercise+therapy+for+fatigue+in+multiple+sclerosis&amp;rft.volume=2015&amp;rft.issue=9&amp;rft.pages=CD009956&amp;rft.date=2015-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9554249%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26358158&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD009956.pub2&amp;rft.aulast=Heine&amp;rft.aufirst=M&amp;rft.au=van+de+Port%2C+I&amp;rft.au=Rietberg%2C+MB&amp;rft.au=van+Wegen%2C+EE&amp;rft.au=Kwakkel%2C+G&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9554249&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17482708-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17482708_141-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGallienNicolasRobineauPétrilli2007" class="citation journal cs1">Gallien P, Nicolas B, Robineau S, Pétrilli S, Houedakor J, Durufle A (July 2007). "Physical training and multiple sclerosis". <i>Annales de Réadaptation et de Médecine Physique</i>. <b>50</b> (6): 373–6, 369–72. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.annrmp.2007.04.004">10.1016/j.annrmp.2007.04.004</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17482708">17482708</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annales+de+R%C3%A9adaptation+et+de+M%C3%A9decine+Physique&amp;rft.atitle=Physical+training+and+multiple+sclerosis&amp;rft.volume=50&amp;rft.issue=6&amp;rft.pages=373-6%2C+369-72&amp;rft.date=2007-07&amp;rft_id=info%3Adoi%2F10.1016%2Fj.annrmp.2007.04.004&amp;rft_id=info%3Apmid%2F17482708&amp;rft.aulast=Gallien&amp;rft.aufirst=P&amp;rft.au=Nicolas%2C+B&amp;rft.au=Robineau%2C+S&amp;rft.au=P%C3%A9trilli%2C+S&amp;rft.au=Houedakor%2C+J&amp;rft.au=Durufle%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-142">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRietbergBrooksUitdehaagKwakkel2005" class="citation journal cs1">Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G (January 2005).  Kwakkel G (ed.). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485797">"Exercise therapy for multiple sclerosis"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2005</b> (1): CD003980. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD003980.pub2">10.1002/14651858.CD003980.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485797">6485797</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15674920">15674920</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Exercise+therapy+for+multiple+sclerosis&amp;rft.volume=2005&amp;rft.issue=1&amp;rft.pages=CD003980&amp;rft.date=2005-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6485797%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15674920&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD003980.pub2&amp;rft.aulast=Rietberg&amp;rft.aufirst=MB&amp;rft.au=Brooks%2C+D&amp;rft.au=Uitdehaag%2C+BM&amp;rft.au=Kwakkel%2C+G&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6485797&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-143"><span class="mw-cite-backlink"><b><a href="#cite_ref-143">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFThomasThomasHillierGalvin2006" class="citation journal cs1">Thomas PW, Thomas S, Hillier C, Galvin K, Baker R (January 2006).  Thomas PW (ed.). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406851">"Psychological interventions for multiple sclerosis"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2010</b> (1): CD004431. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD004431.pub2">10.1002/14651858.CD004431.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406851">8406851</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16437487">16437487</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Psychological+interventions+for+multiple+sclerosis&amp;rft.volume=2010&amp;rft.issue=1&amp;rft.pages=CD004431&amp;rft.date=2006-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8406851%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F16437487&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004431.pub2&amp;rft.aulast=Thomas&amp;rft.aufirst=PW&amp;rft.au=Thomas%2C+S&amp;rft.au=Hillier%2C+C&amp;rft.au=Galvin%2C+K&amp;rft.au=Baker%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8406851&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-144"><span class="mw-cite-backlink"><b><a href="#cite_ref-144">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRosti-OtajärviHämäläinen2014" class="citation journal cs1">Rosti-Otajärvi EM, Hämäläinen PI (February 2014). "Neuropsychological rehabilitation for multiple sclerosis". <i>The Cochrane Database of Systematic Reviews</i> (2): CD009131. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD009131.pub3">10.1002/14651858.CD009131.pub3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24515630">24515630</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Neuropsychological+rehabilitation+for+multiple+sclerosis&amp;rft.issue=2&amp;rft.pages=CD009131&amp;rft.date=2014-02&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD009131.pub3&amp;rft_id=info%3Apmid%2F24515630&amp;rft.aulast=Rosti-Otaj%C3%A4rvi&amp;rft.aufirst=EM&amp;rft.au=H%C3%A4m%C3%A4l%C3%A4inen%2C+PI&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-145"><span class="mw-cite-backlink"><b><a href="#cite_ref-145">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLatorracaMartimbiancoPachitoTorloni2019" class="citation journal cs1">Latorraca CO, Martimbianco AL, Pachito DV, Torloni MR, Pacheco RL, Pereira JG, Riera R (October 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803560">"Palliative care interventions for people with multiple sclerosis"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2019</b> (10): CD012936. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD012936.pub2">10.1002/14651858.CD012936.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803560">6803560</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31637711">31637711</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Palliative+care+interventions+for+people+with+multiple+sclerosis&amp;rft.volume=2019&amp;rft.issue=10&amp;rft.pages=CD012936&amp;rft.date=2019-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6803560%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31637711&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD012936.pub2&amp;rft.aulast=Latorraca&amp;rft.aufirst=CO&amp;rft.au=Martimbianco%2C+AL&amp;rft.au=Pachito%2C+DV&amp;rft.au=Torloni%2C+MR&amp;rft.au=Pacheco%2C+RL&amp;rft.au=Pereira%2C+JG&amp;rft.au=Riera%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6803560&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-146"><span class="mw-cite-backlink"><b><a href="#cite_ref-146">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHayesGalvinKennedyFinlayson2019" class="citation journal cs1">Hayes S, Galvin R, Kennedy C, Finlayson M, McGuigan C, Walsh CD, Coote S (November 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953359">"Interventions for preventing falls in people with multiple sclerosis"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>11</b> (11): CD012475. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD012475.pub2">10.1002/14651858.CD012475.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953359">6953359</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31778221">31778221</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Interventions+for+preventing+falls+in+people+with+multiple+sclerosis&amp;rft.volume=11&amp;rft.issue=11&amp;rft.pages=CD012475&amp;rft.date=2019-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6953359%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31778221&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD012475.pub2&amp;rft.aulast=Hayes&amp;rft.aufirst=S&amp;rft.au=Galvin%2C+R&amp;rft.au=Kennedy%2C+C&amp;rft.au=Finlayson%2C+M&amp;rft.au=McGuigan%2C+C&amp;rft.au=Walsh%2C+CD&amp;rft.au=Coote%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6953359&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-147"><span class="mw-cite-backlink"><b><a href="#cite_ref-147">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFvan_den_AkkerBeckermanColletteEijssen2016" class="citation journal cs1">van den Akker LE, Beckerman H, Collette EH, Eijssen IC, Dekker J, de Groot V (November 2016). "Effectiveness of cognitive behavioral therapy for the treatment of fatigue in patients with multiple sclerosis: A systematic review and meta-analysis". <i>Journal of Psychosomatic Research</i>. <b>90</b>: 33–42. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jpsychores.2016.09.002">10.1016/j.jpsychores.2016.09.002</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27772557">27772557</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Psychosomatic+Research&amp;rft.atitle=Effectiveness+of+cognitive+behavioral+therapy+for+the+treatment+of+fatigue+in+patients+with+multiple+sclerosis%3A+A+systematic+review+and+meta-analysis&amp;rft.volume=90&amp;rft.pages=33-42&amp;rft.date=2016-11&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jpsychores.2016.09.002&amp;rft_id=info%3Apmid%2F27772557&amp;rft.aulast=van+den+Akker&amp;rft.aufirst=LE&amp;rft.au=Beckerman%2C+H&amp;rft.au=Collette%2C+EH&amp;rft.au=Eijssen%2C+IC&amp;rft.au=Dekker%2C+J&amp;rft.au=de+Groot%2C+V&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-148"><span class="mw-cite-backlink"><b><a href="#cite_ref-148">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAmatyaYoungKhan2018" class="citation journal cs1">Amatya B, Young J, Khan F (December 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516893">"Non-pharmacological interventions for chronic pain in multiple sclerosis"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>12</b> (12): CD012622. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD012622.pub2">10.1002/14651858.CD012622.pub2</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516893">6516893</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30567012">30567012</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Non-pharmacological+interventions+for+chronic+pain+in+multiple+sclerosis&amp;rft.volume=12&amp;rft.issue=12&amp;rft.pages=CD012622&amp;rft.date=2018-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6516893%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30567012&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD012622.pub2&amp;rft.aulast=Amatya&amp;rft.aufirst=B&amp;rft.au=Young%2C+J&amp;rft.au=Khan%2C+F&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6516893&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-149"><span class="mw-cite-backlink"><b><a href="#cite_ref-149">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCorvilloVarelaArmijoAlvarez-Badillo2017" class="citation journal cs1">Corvillo I, Varela E, Armijo F, Alvarez-Badillo A, Armijo O, Maraver F (December 2017). "Efficacy of aquatic therapy for multiple sclerosis: a systematic review". <i>Eur J Phys Rehabil Med</i> (Review). <b>53</b> (6): 944–952. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.23736%2FS1973-9087.17.04570-1">10.23736/S1973-9087.17.04570-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28215060">28215060</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Eur+J+Phys+Rehabil+Med&amp;rft.atitle=Efficacy+of+aquatic+therapy+for+multiple+sclerosis%3A+a+systematic+review&amp;rft.volume=53&amp;rft.issue=6&amp;rft.pages=944-952&amp;rft.date=2017-12&amp;rft_id=info%3Adoi%2F10.23736%2FS1973-9087.17.04570-1&amp;rft_id=info%3Apmid%2F28215060&amp;rft.aulast=Corvillo&amp;rft.aufirst=I&amp;rft.au=Varela%2C+E&amp;rft.au=Armijo%2C+F&amp;rft.au=Alvarez-Badillo%2C+A&amp;rft.au=Armijo%2C+O&amp;rft.au=Maraver%2C+F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-150"><span class="mw-cite-backlink"><b><a href="#cite_ref-150">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKhanAmatyaBensmailYelnik2019" class="citation journal cs1">Khan F, Amatya B, Bensmail D, Yelnik A (July 2019). "Non-pharmacological interventions for spasticity in adults: An overview of systematic reviews". <i>Ann Phys Rehabil Med</i>. <b>62</b> (4): 265–273. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.rehab.2017.10.001">10.1016/j.rehab.2017.10.001</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29042299">29042299</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:207497395">207497395</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ann+Phys+Rehabil+Med&amp;rft.atitle=Non-pharmacological+interventions+for+spasticity+in+adults%3A+An+overview+of+systematic+reviews&amp;rft.volume=62&amp;rft.issue=4&amp;rft.pages=265-273&amp;rft.date=2019-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A207497395%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29042299&amp;rft_id=info%3Adoi%2F10.1016%2Fj.rehab.2017.10.001&amp;rft.aulast=Khan&amp;rft.aufirst=F&amp;rft.au=Amatya%2C+B&amp;rft.au=Bensmail%2C+D&amp;rft.au=Yelnik%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-151"><span class="mw-cite-backlink"><b><a href="#cite_ref-151">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFEtoomKhraiweshLena2018" class="citation journal cs1">Etoom M, Khraiwesh Y, Lena F,  et&#160;al. (November 2018). "Effectiveness of Physiotherapy Interventions on Spasticity in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis". <i>Am J Phys Med Rehabil</i>. <b>97</b> (11): 793–807. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FPHM.0000000000000970">10.1097/PHM.0000000000000970</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29794531">29794531</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:44156766">44156766</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+J+Phys+Med+Rehabil&amp;rft.atitle=Effectiveness+of+Physiotherapy+Interventions+on+Spasticity+in+People+With+Multiple+Sclerosis%3A+A+Systematic+Review+and+Meta-Analysis&amp;rft.volume=97&amp;rft.issue=11&amp;rft.pages=793-807&amp;rft.date=2018-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A44156766%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29794531&amp;rft_id=info%3Adoi%2F10.1097%2FPHM.0000000000000970&amp;rft.aulast=Etoom&amp;rft.aufirst=M&amp;rft.au=Khraiwesh%2C+Y&amp;rft.au=Lena%2C+F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid19222053-152"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19222053_152-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFOlsen2009" class="citation journal cs1">Olsen SA (2009). "A review of complementary and alternative medicine (CAM) by people with multiple sclerosis". <i>Occupational Therapy International</i>. <b>16</b> (1): 57–70. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Foti.266">10.1002/oti.266</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19222053">19222053</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Occupational+Therapy+International&amp;rft.atitle=A+review+of+complementary+and+alternative+medicine+%28CAM%29+by+people+with+multiple+sclerosis&amp;rft.volume=16&amp;rft.issue=1&amp;rft.pages=57-70&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1002%2Foti.266&amp;rft_id=info%3Apmid%2F19222053&amp;rft.aulast=Olsen&amp;rft.aufirst=SA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-153"><span class="mw-cite-backlink"><b><a href="#cite_ref-153">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFParksJackson-TarltonVacchiMerdad2020" class="citation journal cs1">Parks NE, Jackson-Tarlton CS, Vacchi L, Merdad R, Johnston BC (May 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388136">"Dietary interventions for multiple sclerosis-related outcomes"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2020</b> (5): CD004192. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD004192.pub4">10.1002/14651858.CD004192.pub4</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388136">7388136</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32428983">32428983</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Dietary+interventions+for+multiple+sclerosis-related+outcomes&amp;rft.volume=2020&amp;rft.issue=5&amp;rft.pages=CD004192&amp;rft.date=2020-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7388136%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32428983&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004192.pub4&amp;rft.aulast=Parks&amp;rft.aufirst=NE&amp;rft.au=Jackson-Tarlton%2C+CS&amp;rft.au=Vacchi%2C+L&amp;rft.au=Merdad%2C+R&amp;rft.au=Johnston%2C+BC&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7388136&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid21965673-154"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21965673_154-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGrigorianAraujoNaiduPlace2011" class="citation journal cs1">Grigorian A, Araujo L, Naidu NN, Place DJ, Choudhury B, Demetriou M (November 2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220534">"N-acetylglucosamine inhibits T-helper 1 (Th1)/T-helper 17 (Th17) cell responses and treats experimental autoimmune encephalomyelitis"</a>. <i>The Journal of Biological Chemistry</i>. <b>286</b> (46): 40133–41. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1074%2Fjbc.M111.277814">10.1074/jbc.M111.277814</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220534">3220534</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21965673">21965673</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Biological+Chemistry&amp;rft.atitle=N-acetylglucosamine+inhibits+T-helper+1+%28Th1%29%2FT-helper+17+%28Th17%29+cell+responses+and+treats+experimental+autoimmune+encephalomyelitis&amp;rft.volume=286&amp;rft.issue=46&amp;rft.pages=40133-41&amp;rft.date=2011-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3220534%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21965673&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M111.277814&amp;rft.aulast=Grigorian&amp;rft.aufirst=A&amp;rft.au=Araujo%2C+L&amp;rft.au=Naidu%2C+NN&amp;rft.au=Place%2C+DJ&amp;rft.au=Choudhury%2C+B&amp;rft.au=Demetriou%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3220534&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-155"><span class="mw-cite-backlink"><b><a href="#cite_ref-155">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPozuelo-MoyanoBenito-LeónMitchellHernández-Gallego2013" class="citation journal cs1">Pozuelo-Moyano B, Benito-León J, Mitchell AJ, Hernández-Gallego J (2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649517">"A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis"</a>. <i>Neuroepidemiology</i> (Systematic review). <b>40</b> (3): 147–53. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000345122">10.1159/000345122</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649517">3649517</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23257784">23257784</a>. <q>the available evidence substantiates neither clinically significant benefit nor harm from vitamin D in the treatment of patients with MS</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroepidemiology&amp;rft.atitle=A+systematic+review+of+randomized%2C+double-blind%2C+placebo-controlled+trials+examining+the+clinical+efficacy+of+vitamin+D+in+multiple+sclerosis&amp;rft.volume=40&amp;rft.issue=3&amp;rft.pages=147-53&amp;rft.date=2013&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3649517%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23257784&amp;rft_id=info%3Adoi%2F10.1159%2F000345122&amp;rft.aulast=Pozuelo-Moyano&amp;rft.aufirst=B&amp;rft.au=Benito-Le%C3%B3n%2C+J&amp;rft.au=Mitchell%2C+AJ&amp;rft.au=Hern%C3%A1ndez-Gallego%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3649517&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-156"><span class="mw-cite-backlink"><b><a href="#cite_ref-156">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFChongWolffWiseTanton2006" class="citation journal cs1">Chong MS, Wolff K, Wise K, Tanton C, Winstock A, Silber E (October 2006). "Cannabis use in patients with multiple sclerosis". <i>Multiple Sclerosis</i>. <b>12</b> (5): 646–51. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1352458506070947">10.1177/1352458506070947</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17086912">17086912</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34692470">34692470</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Multiple+Sclerosis&amp;rft.atitle=Cannabis+use+in+patients+with+multiple+sclerosis&amp;rft.volume=12&amp;rft.issue=5&amp;rft.pages=646-51&amp;rft.date=2006-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34692470%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17086912&amp;rft_id=info%3Adoi%2F10.1177%2F1352458506070947&amp;rft.aulast=Chong&amp;rft.aufirst=MS&amp;rft.au=Wolff%2C+K&amp;rft.au=Wise%2C+K&amp;rft.au=Tanton%2C+C&amp;rft.au=Winstock%2C+A&amp;rft.au=Silber%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-157"><span class="mw-cite-backlink"><b><a href="#cite_ref-157">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTorres-MorenoPapaseitTorrensFarré2018" class="citation journal cs1">Torres-Moreno MC, Papaseit E, Torrens M, Farré M (October 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324456">"Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis"</a>. <i>JAMA Network Open</i>. <b>1</b> (6): e183485. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjamanetworkopen.2018.3485">10.1001/jamanetworkopen.2018.3485</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324456">6324456</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30646241">30646241</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA+Network+Open&amp;rft.atitle=Assessment+of+Efficacy+and+Tolerability+of+Medicinal+Cannabinoids+in+Patients+With+Multiple+Sclerosis%3A+A+Systematic+Review+and+Meta-analysis&amp;rft.volume=1&amp;rft.issue=6&amp;rft.pages=e183485&amp;rft.date=2018-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6324456%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30646241&amp;rft_id=info%3Adoi%2F10.1001%2Fjamanetworkopen.2018.3485&amp;rft.aulast=Torres-Moreno&amp;rft.aufirst=MC&amp;rft.au=Papaseit%2C+E&amp;rft.au=Torrens%2C+M&amp;rft.au=Farr%C3%A9%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6324456&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid14974004-158"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid14974004_158-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBennettHeard2004" class="citation journal cs1">Bennett M, Heard R (2004).  Bennett MH (ed.). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407327">"Hyperbaric oxygen therapy for multiple sclerosis"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2011</b> (1): CD003057. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD003057.pub2">10.1002/14651858.CD003057.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407327">8407327</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/14974004">14974004</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Hyperbaric+oxygen+therapy+for+multiple+sclerosis&amp;rft.volume=2011&amp;rft.issue=1&amp;rft.pages=CD003057&amp;rft.date=2004&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8407327%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F14974004&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD003057.pub2&amp;rft.aulast=Bennett&amp;rft.aufirst=M&amp;rft.au=Heard%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8407327&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-159"><span class="mw-cite-backlink"><b><a href="#cite_ref-159">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAdams2010" class="citation news cs1">Adams T (23 May 2010). <a rel="nofollow" class="external text" href="https://www.theguardian.com/lifeandstyle/2010/may/23/parasitic-hookworm-jasper-lawrence-tim-adams">"Gut instinct: the miracle of the parasitic hookworm"</a>. <i>The Observer</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20141024051021/http://www.theguardian.com/lifeandstyle/2010/may/23/parasitic-hookworm-jasper-lawrence-tim-adams">Archived</a> from the original on 24 October 2014.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Observer&amp;rft.atitle=Gut+instinct%3A+the+miracle+of+the+parasitic+hookworm&amp;rft.date=2010-05-23&amp;rft.aulast=Adams&amp;rft.aufirst=T&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Flifeandstyle%2F2010%2Fmay%2F23%2Fparasitic-hookworm-jasper-lawrence-tim-adams&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-160"><span class="mw-cite-backlink"><b><a href="#cite_ref-160">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSimpsonBoothLawrenceByrne2014" class="citation journal cs1">Simpson R, Booth J, Lawrence M, Byrne S, Mair F, Mercer S (January 2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900731">"Mindfulness based interventions in multiple sclerosis—a systematic review"</a>. <i>BMC Neurology</i>. <b>14</b>: 15. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2F1471-2377-14-15">10.1186/1471-2377-14-15</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900731">3900731</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24438384">24438384</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Neurology&amp;rft.atitle=Mindfulness+based+interventions+in+multiple+sclerosis%E2%80%94a+systematic+review&amp;rft.volume=14&amp;rft.pages=15&amp;rft.date=2014-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3900731%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24438384&amp;rft_id=info%3Adoi%2F10.1186%2F1471-2377-14-15&amp;rft.aulast=Simpson&amp;rft.aufirst=R&amp;rft.au=Booth%2C+J&amp;rft.au=Lawrence%2C+M&amp;rft.au=Byrne%2C+S&amp;rft.au=Mair%2C+F&amp;rft.au=Mercer%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3900731&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-161"><span class="mw-cite-backlink"><b><a href="#cite_ref-161">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFJagannathFilippiniDi_PietrantonjAsokan2018" class="citation journal cs1">Jagannath VA, Filippini G, Di Pietrantonj C, Asokan GV, Robak EW, Whamond L, Robinson SA (September 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513642">"Vitamin D for the management of multiple sclerosis"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>9</b> (9): CD008422. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD008422.pub3">10.1002/14651858.CD008422.pub3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513642">6513642</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30246874">30246874</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Vitamin+D+for+the+management+of+multiple+sclerosis&amp;rft.volume=9&amp;rft.issue=9&amp;rft.pages=CD008422&amp;rft.date=2018-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6513642%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30246874&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008422.pub3&amp;rft.aulast=Jagannath&amp;rft.aufirst=VA&amp;rft.au=Filippini%2C+G&amp;rft.au=Di+Pietrantonj%2C+C&amp;rft.au=Asokan%2C+GV&amp;rft.au=Robak%2C+EW&amp;rft.au=Whamond%2C+L&amp;rft.au=Robinson%2C+SA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6513642&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Motte2020-162"><span class="mw-cite-backlink"><b><a href="#cite_ref-Motte2020_162-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMotteGold2020" class="citation journal cs1">Motte J, Gold R (December 2020). "High-dose biotin in multiple sclerosis: the end of the road". <i>Lancet Neurol</i>. <b>19</b> (12): 965–966. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2820%2930353-7">10.1016/S1474-4422(20)30353-7</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33222766">33222766</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:225049079">225049079</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet+Neurol&amp;rft.atitle=High-dose+biotin+in+multiple+sclerosis%3A+the+end+of+the+road&amp;rft.volume=19&amp;rft.issue=12&amp;rft.pages=965-966&amp;rft.date=2020-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A225049079%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F33222766&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2820%2930353-7&amp;rft.aulast=Motte&amp;rft.aufirst=J&amp;rft.au=Gold%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-163"><span class="mw-cite-backlink"><b><a href="#cite_ref-163">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTryfonosMantzorouFotiouVrizas2019" class="citation journal cs1">Tryfonos C, Mantzorou M, Fotiou D, Vrizas M, Vadikolias K, Pavlidou E, Giaginis C (September 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789617">"Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives"</a>. <i>Medicines</i>. <b>6</b> (3): 95. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fmedicines6030095">10.3390/medicines6030095</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789617">6789617</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31547410">31547410</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medicines&amp;rft.atitle=Dietary+Supplements+on+Controlling+Multiple+Sclerosis+Symptoms+and+Relapses%3A+Current+Clinical+Evidence+and+Future+Perspectives&amp;rft.volume=6&amp;rft.issue=3&amp;rft.pages=95&amp;rft.date=2019-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6789617%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31547410&amp;rft_id=info%3Adoi%2F10.3390%2Fmedicines6030095&amp;rft.aulast=Tryfonos&amp;rft.aufirst=C&amp;rft.au=Mantzorou%2C+M&amp;rft.au=Fotiou%2C+D&amp;rft.au=Vrizas%2C+M&amp;rft.au=Vadikolias%2C+K&amp;rft.au=Pavlidou%2C+E&amp;rft.au=Giaginis%2C+C&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6789617&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-164"><span class="mw-cite-backlink"><b><a href="#cite_ref-164">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSedelBernardMockTourbah2016" class="citation journal cs1">Sedel F, Bernard D, Mock DM, Tourbah A (November 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neuropharm.2015.08.028">"Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis"</a>. <i>Neuropharmacology</i>. <b>110</b> (Pt B): 644–653. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neuropharm.2015.08.028">10.1016/j.neuropharm.2015.08.028</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26327679">26327679</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropharmacology&amp;rft.atitle=Targeting+demyelination+and+virtual+hypoxia+with+high-dose+biotin+as+a+treatment+for+progressive+multiple+sclerosis&amp;rft.volume=110&amp;rft.issue=Pt+B&amp;rft.pages=644-653&amp;rft.date=2016-11&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuropharm.2015.08.028&amp;rft_id=info%3Apmid%2F26327679&amp;rft.aulast=Sedel&amp;rft.aufirst=F&amp;rft.au=Bernard%2C+D&amp;rft.au=Mock%2C+DM&amp;rft.au=Tourbah%2C+A&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.neuropharm.2015.08.028&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Goldschmidt2020-165"><span class="mw-cite-backlink"><b><a href="#cite_ref-Goldschmidt2020_165-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGoldschmidtCohen2020" class="citation journal cs1">Goldschmidt CH, Cohen JA (July 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609671">"The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis"</a>. <i>Neurotherapeutics</i>. <b>17</b> (3): 968–970. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs13311-020-00907-5">10.1007/s13311-020-00907-5</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609671">7609671</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32761325">32761325</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurotherapeutics&amp;rft.atitle=The+Rise+and+Fall+of+High-Dose+Biotin+to+Treat+Progressive+Multiple+Sclerosis&amp;rft.volume=17&amp;rft.issue=3&amp;rft.pages=968-970&amp;rft.date=2020-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7609671%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32761325&amp;rft_id=info%3Adoi%2F10.1007%2Fs13311-020-00907-5&amp;rft.aulast=Goldschmidt&amp;rft.aufirst=CH&amp;rft.au=Cohen%2C+JA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7609671&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Cree2022-166"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cree2022_166-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cree2022_166-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Cree2022_166-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCreeHartungBarnett2022" class="citation journal cs1">Cree BA, Hartung HP, Barnett M (June 2022). "New drugs for multiple sclerosis: new treatment algorithms". <i>Curr Opin Neurol</i>. <b>35</b> (3): 262–270. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FWCO.0000000000001063">10.1097/WCO.0000000000001063</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35674067">35674067</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:249438715">249438715</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Curr+Opin+Neurol&amp;rft.atitle=New+drugs+for+multiple+sclerosis%3A+new+treatment+algorithms&amp;rft.volume=35&amp;rft.issue=3&amp;rft.pages=262-270&amp;rft.date=2022-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A249438715%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F35674067&amp;rft_id=info%3Adoi%2F10.1097%2FWCO.0000000000001063&amp;rft.aulast=Cree&amp;rft.aufirst=BA&amp;rft.au=Hartung%2C+HP&amp;rft.au=Barnett%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Oh2018-167"><span class="mw-cite-backlink">^ <a href="#cite_ref-Oh2018_167-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Oh2018_167-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Oh2018_167-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Oh2018_167-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFOhVidal-JordanaMontalban2018" class="citation journal cs1">Oh J, Vidal-Jordana A, Montalban X (December 2018). "Multiple sclerosis: clinical aspects". <i>Curr Opin Neurol</i>. <b>31</b> (6): 752–759. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FWCO.0000000000000622">10.1097/WCO.0000000000000622</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30300239">30300239</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:6103857">6103857</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Curr+Opin+Neurol&amp;rft.atitle=Multiple+sclerosis%3A+clinical+aspects&amp;rft.volume=31&amp;rft.issue=6&amp;rft.pages=752-759&amp;rft.date=2018-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A6103857%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F30300239&amp;rft_id=info%3Adoi%2F10.1097%2FWCO.0000000000000622&amp;rft.aulast=Oh&amp;rft.aufirst=J&amp;rft.au=Vidal-Jordana%2C+A&amp;rft.au=Montalban%2C+X&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-168"><span class="mw-cite-backlink"><b><a href="#cite_ref-168">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHauserCree2020" class="citation journal cs1">Hauser SL, Cree BA (December 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704606">"Treatment of Multiple Sclerosis: A Review"</a>. <i>Am J Med</i>. <b>133</b> (12): 1380–1390.e2. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.amjmed.2020.05.049">10.1016/j.amjmed.2020.05.049</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704606">7704606</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32682869">32682869</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+J+Med&amp;rft.atitle=Treatment+of+Multiple+Sclerosis%3A+A+Review&amp;rft.volume=133&amp;rft.issue=12&amp;rft.pages=1380-1390.e2&amp;rft.date=2020-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7704606%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32682869&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjmed.2020.05.049&amp;rft.aulast=Hauser&amp;rft.aufirst=SL&amp;rft.au=Cree%2C+BA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7704606&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Continuum-169"><span class="mw-cite-backlink">^ <a href="#cite_ref-Continuum_169-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Continuum_169-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFOntaneda2019" class="citation journal cs1">Ontaneda D (June 2019). "Progressive Multiple Sclerosis". <i>Continuum (Minneap Minn)</i>. <b>25</b> (3): 736–752. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FCON.0000000000000727">10.1212/CON.0000000000000727</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31162314">31162314</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:174808956">174808956</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Continuum+%28Minneap+Minn%29&amp;rft.atitle=Progressive+Multiple+Sclerosis&amp;rft.volume=25&amp;rft.issue=3&amp;rft.pages=736-752&amp;rft.date=2019-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A174808956%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F31162314&amp;rft_id=info%3Adoi%2F10.1212%2FCON.0000000000000727&amp;rft.aulast=Ontaneda&amp;rft.aufirst=D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-170"><span class="mw-cite-backlink"><b><a href="#cite_ref-170">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFInojosaProschmannAkgünZiemssen2021" class="citation journal cs1">Inojosa H, Proschmann U, Akgün K, Ziemssen T (April 2021). "A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition". <i>J Neurol</i>. <b>268</b> (4): 1210–1221. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00415-019-09489-5">10.1007/s00415-019-09489-5</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31363847">31363847</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:198999832">198999832</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Neurol&amp;rft.atitle=A+focus+on+secondary+progressive+multiple+sclerosis+%28SPMS%29%3A+challenges+in+diagnosis+and+definition&amp;rft.volume=268&amp;rft.issue=4&amp;rft.pages=1210-1221&amp;rft.date=2021-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A198999832%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F31363847&amp;rft_id=info%3Adoi%2F10.1007%2Fs00415-019-09489-5&amp;rft.aulast=Inojosa&amp;rft.aufirst=H&amp;rft.au=Proschmann%2C+U&amp;rft.au=Akg%C3%BCn%2C+K&amp;rft.au=Ziemssen%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span> <a href="/wiki/Expanded_Disability_Status_Scale" title="Expanded Disability Status Scale">Expanded Disability Status Scale</a> (EDSS) 6.0 is equivalent to requiring a walking aid, and EDSS 8.0 equivalent to chair or bedbound</span>
</li>
<li id="cite_note-lancet2018-171"><span class="mw-cite-backlink">^ <a href="#cite_ref-lancet2018_171-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-lancet2018_171-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-lancet2018_171-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFThompsonBaranziniGeurtsHemmer2018" class="citation journal cs1">Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O (April 2018). "Multiple sclerosis". <i>Lancet</i>. <b>391</b> (10130): 1622–1636. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2818%2930481-1">10.1016/S0140-6736(18)30481-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29576504">29576504</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4313310">4313310</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Multiple+sclerosis&amp;rft.volume=391&amp;rft.issue=10130&amp;rft.pages=1622-1636&amp;rft.date=2018-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4313310%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29576504&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2818%2930481-1&amp;rft.aulast=Thompson&amp;rft.aufirst=AJ&amp;rft.au=Baranzini%2C+SE&amp;rft.au=Geurts%2C+J&amp;rft.au=Hemmer%2C+B&amp;rft.au=Ciccarelli%2C+O&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-172"><span class="mw-cite-backlink"><b><a href="#cite_ref-172">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLundeAssmusMyhrBø2017" class="citation journal cs1">Lunde HM, Assmus J, Myhr KM, Bø L, Grytten N (August 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537547">"Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>88</b> (8): 621–625. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2016-315238">10.1136/jnnp-2016-315238</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537547">5537547</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28365589">28365589</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Survival+and+cause+of+death+in+multiple+sclerosis%3A+a+60-year+longitudinal+population+study&amp;rft.volume=88&amp;rft.issue=8&amp;rft.pages=621-625&amp;rft.date=2017-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5537547%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28365589&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2016-315238&amp;rft.aulast=Lunde&amp;rft.aufirst=HM&amp;rft.au=Assmus%2C+J&amp;rft.au=Myhr%2C+KM&amp;rft.au=B%C3%B8%2C+L&amp;rft.au=Grytten%2C+N&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5537547&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-173"><span class="mw-cite-backlink"><b><a href="#cite_ref-173">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.msif.org/wp-content/uploads/2020/12/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf">"Atlas of MS"</a> <span class="cs1-format">(PDF)</span>. <i>Multiple Sclerosis International Federation</i>. September 2020.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Multiple+Sclerosis+International+Federation&amp;rft.atitle=Atlas+of+MS&amp;rft.date=2020-09&amp;rft_id=https%3A%2F%2Fwww.msif.org%2Fwp-content%2Fuploads%2F2020%2F12%2FAtlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-174"><span class="mw-cite-backlink"><b><a href="#cite_ref-174">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWaltonKingRechtmanKaye2020" class="citation journal cs1">Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA,  et&#160;al. (December 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720355">"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition"</a>. <i>Multiple Sclerosis</i>. <b>26</b> (14): 1816–1821. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1352458520970841">10.1177/1352458520970841</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720355">7720355</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33174475">33174475</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Multiple+Sclerosis&amp;rft.atitle=Rising+prevalence+of+multiple+sclerosis+worldwide%3A+Insights+from+the+Atlas+of+MS%2C+third+edition&amp;rft.volume=26&amp;rft.issue=14&amp;rft.pages=1816-1821&amp;rft.date=2020-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7720355%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F33174475&amp;rft_id=info%3Adoi%2F10.1177%2F1352458520970841&amp;rft.aulast=Walton&amp;rft.aufirst=C&amp;rft.au=King%2C+R&amp;rft.au=Rechtman%2C+L&amp;rft.au=Kaye%2C+W&amp;rft.au=Leray%2C+E&amp;rft.au=Marrie%2C+RA&amp;rft.au=Robertson%2C+N&amp;rft.au=La+Rocca%2C+N&amp;rft.au=Uitdehaag%2C+B&amp;rft.au=van+der+Mei%2C+I&amp;rft.au=Wallin%2C+M&amp;rft.au=Helme%2C+A&amp;rft.au=Angood+Napier%2C+C&amp;rft.au=Rijke%2C+N&amp;rft.au=Baneke%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7720355&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid3066846-175"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid3066846_175-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid3066846_175-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCompston1988" class="citation journal cs1">Compston A (October 1988). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1032909">"The 150th anniversary of the first depiction of the lesions of multiple sclerosis"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>51</b> (10): 1249–52. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp.51.10.1249">10.1136/jnnp.51.10.1249</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1032909">1032909</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/3066846">3066846</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=The+150th+anniversary+of+the+first+depiction+of+the+lesions+of+multiple+sclerosis&amp;rft.volume=51&amp;rft.issue=10&amp;rft.pages=1249-52&amp;rft.date=1988-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1032909%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F3066846&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.51.10.1249&amp;rft.aulast=Compston&amp;rft.aufirst=A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1032909&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid10603616-176"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10603616_176-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLassmann1999" class="citation journal cs1">Lassmann H (October 1999). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1692680">"The pathology of multiple sclerosis and its evolution"</a>. <i>Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences</i>. <b>354</b> (1390): 1635–40. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1098%2Frstb.1999.0508">10.1098/rstb.1999.0508</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1692680">1692680</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10603616">10603616</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Philosophical+Transactions+of+the+Royal+Society+of+London.+Series+B%2C+Biological+Sciences&amp;rft.atitle=The+pathology+of+multiple+sclerosis+and+its+evolution&amp;rft.volume=354&amp;rft.issue=1390&amp;rft.pages=1635-40&amp;rft.date=1999-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1692680%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10603616&amp;rft_id=info%3Adoi%2F10.1098%2Frstb.1999.0508&amp;rft.aulast=Lassmann&amp;rft.aufirst=H&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1692680&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-177"><span class="mw-cite-backlink"><b><a href="#cite_ref-177">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLassmann2005" class="citation journal cs1">Lassmann H (July 2005). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095927">"Multiple sclerosis pathology: evolution of pathogenetic concepts"</a>. <i>Brain Pathology</i>. <b>15</b> (3): 217–22. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1750-3639.2005.tb00523.x">10.1111/j.1750-3639.2005.tb00523.x</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095927">8095927</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16196388">16196388</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:8342303">8342303</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain+Pathology&amp;rft.atitle=Multiple+sclerosis+pathology%3A+evolution+of+pathogenetic+concepts&amp;rft.volume=15&amp;rft.issue=3&amp;rft.pages=217-22&amp;rft.date=2005-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8095927%23id-name%3DPMC&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A8342303%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16196388&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1750-3639.2005.tb00523.x&amp;rft.aulast=Lassmann&amp;rft.aufirst=H&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8095927&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Milo-178"><span class="mw-cite-backlink">^ <a href="#cite_ref-Milo_178-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Milo_178-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Milo_178-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMiloMiller2014" class="citation journal cs1">Milo R, Miller A (April 2014). "Revised diagnostic criteria of multiple sclerosis". <i>Autoimmunity Reviews</i>. <b>13</b> (4–5): 518–524. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.autrev.2014.01.012">10.1016/j.autrev.2014.01.012</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24424194">24424194</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Autoimmunity+Reviews&amp;rft.atitle=Revised+diagnostic+criteria+of+multiple+sclerosis&amp;rft.volume=13&amp;rft.issue=4%E2%80%935&amp;rft.pages=518-524&amp;rft.date=2014-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.autrev.2014.01.012&amp;rft_id=info%3Apmid%2F24424194&amp;rft.aulast=Milo&amp;rft.aufirst=R&amp;rft.au=Miller%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-mcdonald2010-179"><span class="mw-cite-backlink">^ <a href="#cite_ref-mcdonald2010_179-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-mcdonald2010_179-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPolmanReingoldBanwellClanet2011" class="citation journal cs1">Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (February 2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084507">"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria"</a>. <i>Annals of Neurology</i>. <b>69</b> (2): 292–302. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fana.22366">10.1002/ana.22366</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084507">3084507</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21387374">21387374</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=Diagnostic+criteria+for+multiple+sclerosis%3A+2010+revisions+to+the+McDonald+criteria&amp;rft.volume=69&amp;rft.issue=2&amp;rft.pages=292-302&amp;rft.date=2011-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3084507%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21387374&amp;rft_id=info%3Adoi%2F10.1002%2Fana.22366&amp;rft.aulast=Polman&amp;rft.aufirst=CH&amp;rft.au=Reingold%2C+SC&amp;rft.au=Banwell%2C+B&amp;rft.au=Clanet%2C+M&amp;rft.au=Cohen%2C+JA&amp;rft.au=Filippi%2C+M&amp;rft.au=Fujihara%2C+K&amp;rft.au=Havrdova%2C+E&amp;rft.au=Hutchinson%2C+M&amp;rft.au=Kappos%2C+L&amp;rft.au=Lublin%2C+FD&amp;rft.au=Montalban%2C+X&amp;rft.au=O%27Connor%2C+P&amp;rft.au=Sandberg-Wollheim%2C+M&amp;rft.au=Thompson%2C+AJ&amp;rft.au=Waubant%2C+E&amp;rft.au=Weinshenker%2C+B&amp;rft.au=Wolinsky%2C+JS&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3084507&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-180"><span class="mw-cite-backlink"><b><a href="#cite_ref-180">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLublinReingoldCohenCutter2014" class="citation journal cs1">Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH (July 2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117366">"Defining the clinical course of multiple sclerosis: the 2013 revisions"</a>. <i>Neurology</i>. <b>83</b> (3): 278–86. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0000000000000560">10.1212/WNL.0000000000000560</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117366">4117366</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24871874">24871874</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Defining+the+clinical+course+of+multiple+sclerosis%3A+the+2013+revisions&amp;rft.volume=83&amp;rft.issue=3&amp;rft.pages=278-86&amp;rft.date=2014-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4117366%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24871874&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0000000000000560&amp;rft.aulast=Lublin&amp;rft.aufirst=FD&amp;rft.au=Reingold%2C+SC&amp;rft.au=Cohen%2C+JA&amp;rft.au=Cutter%2C+GR&amp;rft.au=S%C3%B8rensen%2C+PS&amp;rft.au=Thompson%2C+AJ&amp;rft.au=Wolinsky%2C+JS&amp;rft.au=Balcer%2C+LJ&amp;rft.au=Banwell%2C+B&amp;rft.au=Barkhof%2C+F&amp;rft.au=Bebo%2C+B&amp;rft.au=Calabresi%2C+PA&amp;rft.au=Clanet%2C+M&amp;rft.au=Comi%2C+G&amp;rft.au=Fox%2C+RJ&amp;rft.au=Freedman%2C+MS&amp;rft.au=Goodman%2C+AD&amp;rft.au=Inglese%2C+M&amp;rft.au=Kappos%2C+L&amp;rft.au=Kieseier%2C+BC&amp;rft.au=Lincoln%2C+JA&amp;rft.au=Lubetzki%2C+C&amp;rft.au=Miller%2C+AE&amp;rft.au=Montalban%2C+X&amp;rft.au=O%27Connor%2C+PW&amp;rft.au=Petkau%2C+J&amp;rft.au=Pozzilli%2C+C&amp;rft.au=Rudick%2C+RA&amp;rft.au=Sormani%2C+MP&amp;rft.au=St%C3%BCve%2C+O&amp;rft.au=Waubant%2C+E&amp;rft.au=Polman%2C+CH&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4117366&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-181"><span class="mw-cite-backlink"><b><a href="#cite_ref-181">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSørensenCentonzeGiovannoniMontalban2020" class="citation journal cs1">Sørensen PS, Centonze D, Giovannoni G, Montalban X, Selchen D, Vermersch P,  et&#160;al. (24 June 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318823">"Expert opinion on the use of cladribine tablets in clinical practice"</a>. <i>Therapeutic Advances in Neurological Disorders</i>. <b>13</b>: 1756286420935019. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1756286420935019">10.1177/1756286420935019</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318823">7318823</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32636933">32636933</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Therapeutic+Advances+in+Neurological+Disorders&amp;rft.atitle=Expert+opinion+on+the+use+of+cladribine+tablets+in+clinical+practice&amp;rft.volume=13&amp;rft.pages=1756286420935019&amp;rft.date=2020-06-24&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7318823%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32636933&amp;rft_id=info%3Adoi%2F10.1177%2F1756286420935019&amp;rft.aulast=S%C3%B8rensen&amp;rft.aufirst=PS&amp;rft.au=Centonze%2C+D&amp;rft.au=Giovannoni%2C+G&amp;rft.au=Montalban%2C+X&amp;rft.au=Selchen%2C+D&amp;rft.au=Vermersch%2C+P&amp;rft.au=Wiendl%2C+H&amp;rft.au=Yamout%2C+B&amp;rft.au=Salloukh%2C+H&amp;rft.au=Rieckmann%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7318823&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid390966-182"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid390966_182-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMedaer1979" class="citation journal cs1">Medaer R (September 1979). "Does the history of multiple sclerosis go back as far as the 14th century?". <i>Acta Neurologica Scandinavica</i>. <b>60</b> (3): 189–92. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1600-0447.1979.tb08970.x">10.1111/j.1600-0447.1979.tb08970.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/390966">390966</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:221422840">221422840</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Neurologica+Scandinavica&amp;rft.atitle=Does+the+history+of+multiple+sclerosis+go+back+as+far+as+the+14th+century%3F&amp;rft.volume=60&amp;rft.issue=3&amp;rft.pages=189-92&amp;rft.date=1979-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221422840%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F390966&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0447.1979.tb08970.x&amp;rft.aulast=Medaer&amp;rft.aufirst=R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid16479124-183"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16479124_183-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHolmøy2006" class="citation journal cs1">Holmøy T (2006). <a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000091431">"A Norse contribution to the history of neurological diseases"</a>. <i>European Neurology</i>. <b>55</b> (1): 57–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000091431">10.1159/000091431</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16479124">16479124</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Neurology&amp;rft.atitle=A+Norse+contribution+to+the+history+of+neurological+diseases&amp;rft.volume=55&amp;rft.issue=1&amp;rft.pages=57-8&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1159%2F000091431&amp;rft_id=info%3Apmid%2F16479124&amp;rft.aulast=Holm%C3%B8y&amp;rft.aufirst=T&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1159%252F000091431&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-184"><span class="mw-cite-backlink"><b><a href="#cite_ref-184">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFirth1948" class="citation book cs1">Firth D (1948). <i>The Case of August D'Esté</i>. Cambridge: Cambridge University Press.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Case+of+August+D%27Est%C3%A9&amp;rft.place=Cambridge&amp;rft.pub=Cambridge+University+Press&amp;rft.date=1948&amp;rft.aulast=Firth&amp;rft.aufirst=D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid16103678-185"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid16103678_185-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16103678_185-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPearce2005" class="citation journal cs1">Pearce JM (2005). <a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000087387">"Historical descriptions of multiple sclerosis"</a>. <i>European Neurology</i>. <b>54</b> (1): 49–53. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000087387">10.1159/000087387</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16103678">16103678</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Neurology&amp;rft.atitle=Historical+descriptions+of+multiple+sclerosis&amp;rft.volume=54&amp;rft.issue=1&amp;rft.pages=49-53&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1159%2F000087387&amp;rft_id=info%3Apmid%2F16103678&amp;rft.aulast=Pearce&amp;rft.aufirst=JM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1159%252F000087387&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-186"><span class="mw-cite-backlink"><b><a href="#cite_ref-186">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBarbellion1919" class="citation book cs1">Barbellion WN (1919). <a rel="nofollow" class="external text" href="https://archive.org/details/journaladisappo00wellgoog"><i>The Journal of a Disappointed Man</i></a>. New York: George H. Doran. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7012-1906-8" title="Special:BookSources/0-7012-1906-8"><bdi>0-7012-1906-8</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Journal+of+a+Disappointed+Man&amp;rft.place=New+York&amp;rft.pub=George+H.+Doran&amp;rft.date=1919&amp;rft.isbn=0-7012-1906-8&amp;rft.aulast=Barbellion&amp;rft.aufirst=WN&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Fjournaladisappo00wellgoog&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-187"><span class="mw-cite-backlink"><b><a href="#cite_ref-187">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPetzold2013" class="citation journal cs1">Petzold A (2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291069">"Optic Neuritis: Another Dickensian Diagnosis"</a>. <i>Neuro-Ophthalmology</i>. <b>37</b> (6): 247–250. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F01658107.2013.830313">10.3109/01658107.2013.830313</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291069">5291069</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28167994">28167994</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuro-Ophthalmology&amp;rft.atitle=Optic+Neuritis%3A+Another+Dickensian+Diagnosis&amp;rft.volume=37&amp;rft.issue=6&amp;rft.pages=247-250&amp;rft.date=2013&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5291069%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28167994&amp;rft_id=info%3Adoi%2F10.3109%2F01658107.2013.830313&amp;rft.aulast=Petzold&amp;rft.aufirst=A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5291069&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-188"><span class="mw-cite-backlink"><b><a href="#cite_ref-188">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBar-OrPenderKhannaSteinman2020" class="citation journal cs1">Bar-Or A, Pender MP, Khanna R, Steinman L, Hartung HP, Maniar T,  et&#160;al. (March 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106557">"Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies"</a>. <i>Trends in Molecular Medicine</i>. <b>26</b> (3): 296–310. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.molmed.2019.11.003">10.1016/j.molmed.2019.11.003</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106557">7106557</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31862243">31862243</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Molecular+Medicine&amp;rft.atitle=Epstein-Barr+Virus+in+Multiple+Sclerosis%3A+Theory+and+Emerging+Immunotherapies&amp;rft.volume=26&amp;rft.issue=3&amp;rft.pages=296-310&amp;rft.date=2020-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7106557%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31862243&amp;rft_id=info%3Adoi%2F10.1016%2Fj.molmed.2019.11.003&amp;rft.aulast=Bar-Or&amp;rft.aufirst=A&amp;rft.au=Pender%2C+MP&amp;rft.au=Khanna%2C+R&amp;rft.au=Steinman%2C+L&amp;rft.au=Hartung%2C+HP&amp;rft.au=Maniar%2C+T&amp;rft.au=Croze%2C+E&amp;rft.au=Aftab%2C+BT&amp;rft.au=Giovannoni%2C+G&amp;rft.au=Joshi%2C+MA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7106557&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-189"><span class="mw-cite-backlink"><b><a href="#cite_ref-189">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDeLorenzeMungerLennetteOrentreich2006" class="citation journal cs1">DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A (June 2006). "Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up". <i>Archives of Neurology</i>. <b>63</b> (6): 839–844. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchneur.63.6.noc50328">10.1001/archneur.63.6.noc50328</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16606758">16606758</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Neurology&amp;rft.atitle=Epstein-Barr+virus+and+multiple+sclerosis%3A+evidence+of+association+from+a+prospective+study+with+long-term+follow-up&amp;rft.volume=63&amp;rft.issue=6&amp;rft.pages=839-844&amp;rft.date=2006-06&amp;rft_id=info%3Adoi%2F10.1001%2Farchneur.63.6.noc50328&amp;rft_id=info%3Apmid%2F16606758&amp;rft.aulast=DeLorenze&amp;rft.aufirst=GN&amp;rft.au=Munger%2C+KL&amp;rft.au=Lennette%2C+ET&amp;rft.au=Orentreich%2C+N&amp;rft.au=Vogelman%2C+JH&amp;rft.au=Ascherio%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-190"><span class="mw-cite-backlink"><b><a href="#cite_ref-190">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHauserBar-OrComiGiovannoni2017" class="citation journal cs1">Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B,  et&#160;al. (January 2017). "Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis". <i>The New England Journal of Medicine</i>. <b>376</b> (3): 221–234. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa1601277">10.1056/NEJMoa1601277</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28002679">28002679</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:205099904">205099904</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Ocrelizumab+versus+Interferon+Beta-1a+in+Relapsing+Multiple+Sclerosis&amp;rft.volume=376&amp;rft.issue=3&amp;rft.pages=221-234&amp;rft.date=2017-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A205099904%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28002679&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1601277&amp;rft.aulast=Hauser&amp;rft.aufirst=SL&amp;rft.au=Bar-Or%2C+A&amp;rft.au=Comi%2C+G&amp;rft.au=Giovannoni%2C+G&amp;rft.au=Hartung%2C+HP&amp;rft.au=Hemmer%2C+B&amp;rft.au=Lublin%2C+F&amp;rft.au=Montalban%2C+X&amp;rft.au=Rammohan%2C+KW&amp;rft.au=Selmaj%2C+K&amp;rft.au=Traboulsee%2C+A&amp;rft.au=Wolinsky%2C+JS&amp;rft.au=Arnold%2C+DL&amp;rft.au=Klingelschmitt%2C+G&amp;rft.au=Masterman%2C+D&amp;rft.au=Fontoura%2C+P&amp;rft.au=Belachew%2C+S&amp;rft.au=Chin%2C+P&amp;rft.au=Mairon%2C+N&amp;rft.au=Garren%2C+H&amp;rft.au=Kappos%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-191"><span class="mw-cite-backlink"><b><a href="#cite_ref-191">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLanzBrewerHoMoon2022" class="citation journal cs1">Lanz TV, Brewer RC, Ho PP, Moon JS, Jude KM, Fernandez D,  et&#160;al. (March 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382663">"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM"</a>. <i>Nature</i>. <b>603</b> (7900): 321–327. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2022Natur.603..321L">2022Natur.603..321L</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41586-022-04432-7">10.1038/s41586-022-04432-7</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382663">9382663</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35073561">35073561</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Clonally+expanded+B+cells+in+multiple+sclerosis+bind+EBV+EBNA1+and+GlialCAM&amp;rft.volume=603&amp;rft.issue=7900&amp;rft.pages=321-327&amp;rft.date=2022-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9382663%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F35073561&amp;rft_id=info%3Adoi%2F10.1038%2Fs41586-022-04432-7&amp;rft_id=info%3Abibcode%2F2022Natur.603..321L&amp;rft.aulast=Lanz&amp;rft.aufirst=TV&amp;rft.au=Brewer%2C+RC&amp;rft.au=Ho%2C+PP&amp;rft.au=Moon%2C+JS&amp;rft.au=Jude%2C+KM&amp;rft.au=Fernandez%2C+D&amp;rft.au=Fernandes%2C+RA&amp;rft.au=Gomez%2C+AM&amp;rft.au=Nadj%2C+GS&amp;rft.au=Bartley%2C+CM&amp;rft.au=Schubert%2C+RD&amp;rft.au=Hawes%2C+IA&amp;rft.au=Vazquez%2C+SE&amp;rft.au=Iyer%2C+M&amp;rft.au=Zuchero%2C+JB&amp;rft.au=Teegen%2C+B&amp;rft.au=Dunn%2C+JE&amp;rft.au=Lock%2C+CB&amp;rft.au=Kipp%2C+LB&amp;rft.au=Cotham%2C+VC&amp;rft.au=Ueberheide%2C+BM&amp;rft.au=Aftab%2C+BT&amp;rft.au=Anderson%2C+MS&amp;rft.au=DeRisi%2C+JL&amp;rft.au=Wilson%2C+MR&amp;rft.au=Bashford-Rogers%2C+RJ&amp;rft.au=Platten%2C+M&amp;rft.au=Garcia%2C+KC&amp;rft.au=Steinman%2C+L&amp;rft.au=Robinson%2C+WH&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9382663&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-192"><span class="mw-cite-backlink"><b><a href="#cite_ref-192">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMorandiTanasescuTarlintonConstantinescu2017" class="citation journal cs1">Morandi E, Tanasescu R, Tarlinton RE, Constantinescu CS, Zhang W, Tench C, Gran B (16 February 2017).  Ruprecht K (ed.). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313176">"The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis"</a>. <i>PloS One</i>. <b>12</b> (2): e0172415. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0172415">10.1371/journal.pone.0172415</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313176">5313176</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28207850">28207850</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PloS+One&amp;rft.atitle=The+association+between+human+endogenous+retroviruses+and+multiple+sclerosis%3A+A+systematic+review+and+meta-analysis&amp;rft.volume=12&amp;rft.issue=2&amp;rft.pages=e0172415&amp;rft.date=2017-02-16&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5313176%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28207850&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0172415&amp;rft.aulast=Morandi&amp;rft.aufirst=E&amp;rft.au=Tanasescu%2C+R&amp;rft.au=Tarlinton%2C+RE&amp;rft.au=Constantinescu%2C+CS&amp;rft.au=Zhang%2C+W&amp;rft.au=Tench%2C+C&amp;rft.au=Gran%2C+B&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5313176&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-193"><span class="mw-cite-backlink"><b><a href="#cite_ref-193">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLiFanCui2022" class="citation journal cs1">Li Y, Fan T, Cui J (March 2022). "Human endogenous retroviruses in viral disease and therapy". <i>Clinical and Translational Discovery</i>. <b>2</b> (1). <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fctd2.38">10.1002/ctd2.38</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/2768-0622">2768-0622</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+and+Translational+Discovery&amp;rft.atitle=Human+endogenous+retroviruses+in+viral+disease+and+therapy&amp;rft.volume=2&amp;rft.issue=1&amp;rft.date=2022-03&amp;rft_id=info%3Adoi%2F10.1002%2Fctd2.38&amp;rft.issn=2768-0622&amp;rft.aulast=Li&amp;rft.aufirst=Y&amp;rft.au=Fan%2C+T&amp;rft.au=Cui%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-194"><span class="mw-cite-backlink"><b><a href="#cite_ref-194">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRangelda_Silvada_SilvaDos_Santos2022" class="citation journal cs1">Rangel SC, da Silva MD, da Silva AL, Dos Santos JM, Neves LM, Pedrosa A,  et&#160;al. (23 November 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744114">"Human endogenous retroviruses and the inflammatory response: A vicious circle associated with health and illness"</a>. <i>Frontiers in Immunology</i>. <b>13</b>: 1057791. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffimmu.2022.1057791">10.3389/fimmu.2022.1057791</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744114">9744114</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/36518758">36518758</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Immunology&amp;rft.atitle=Human+endogenous+retroviruses+and+the+inflammatory+response%3A+A+vicious+circle+associated+with+health+and+illness&amp;rft.volume=13&amp;rft.pages=1057791&amp;rft.date=2022-11-23&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9744114%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F36518758&amp;rft_id=info%3Adoi%2F10.3389%2Ffimmu.2022.1057791&amp;rft.aulast=Rangel&amp;rft.aufirst=SC&amp;rft.au=da+Silva%2C+MD&amp;rft.au=da+Silva%2C+AL&amp;rft.au=Dos+Santos%2C+JM&amp;rft.au=Neves%2C+LM&amp;rft.au=Pedrosa%2C+A&amp;rft.au=Rodrigues%2C+FM&amp;rft.au=Trettel%2C+CD&amp;rft.au=Furtado%2C+GE&amp;rft.au=de+Barros%2C+MP&amp;rft.au=Bachi%2C+AL&amp;rft.au=Romano%2C+CM&amp;rft.au=Nali%2C+LH&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9744114&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-195"><span class="mw-cite-backlink"><b><a href="#cite_ref-195">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFYangHaoZhangZeng2015" class="citation journal cs1">Yang C, Hao Z, Zhang L, Zeng L, Wen J (October 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242538">"Sodium channel blockers for neuroprotection in multiple sclerosis"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2015</b> (10): CD010422. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD010422.pub2">10.1002/14651858.CD010422.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242538">9242538</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26486929">26486929</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Sodium+channel+blockers+for+neuroprotection+in+multiple+sclerosis&amp;rft.volume=2015&amp;rft.issue=10&amp;rft.pages=CD010422&amp;rft.date=2015-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9242538%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26486929&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD010422.pub2&amp;rft.aulast=Yang&amp;rft.aufirst=C&amp;rft.au=Hao%2C+Z&amp;rft.au=Zhang%2C+L&amp;rft.au=Zeng%2C+L&amp;rft.au=Wen%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9242538&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Misu-196"><span class="mw-cite-backlink">^ <a href="#cite_ref-Misu_196-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Misu_196-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMisuFujihara2019" class="citation journal cs1">Misu T, Fujihara K (February 2019). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fcen3.12491">"Neuromyelitis optica spectrum and myelin oligodendrocyte glycoprotein antibody‐related disseminated encephalomyelitis"</a>. <i>Clinical and Experimental Neuroimmunology</i>. <b>10</b> (1): 9–17. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fcen3.12491">10.1111/cen3.12491</a></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+and+Experimental+Neuroimmunology&amp;rft.atitle=Neuromyelitis+optica+spectrum+and+myelin+oligodendrocyte+glycoprotein+antibody%E2%80%90related+disseminated+encephalomyelitis.&amp;rft.volume=10&amp;rft.issue=1&amp;rft.pages=9-17&amp;rft.date=2019-02&amp;rft_id=info%3Adoi%2F10.1111%2Fcen3.12491&amp;rft.aulast=Misu&amp;rft.aufirst=T&amp;rft.au=Fujihara%2C+K&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1111%252Fcen3.12491&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Kira-197"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kira_197-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKiraYamasakiOgata2019" class="citation journal cs1">Kira JI, Yamasaki R, Ogata H (2019). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neuint.2018.12.011">"Anti-neurofascin autoantibody and demyelination"</a>. <i>Neurochemistry International</i>. <b>130</b>: 104360. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neuint.2018.12.011">10.1016/j.neuint.2018.12.011</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30582947">30582947</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurochemistry+International&amp;rft.atitle=Anti-neurofascin+autoantibody+and+demyelination&amp;rft.volume=130&amp;rft.pages=104360&amp;rft.date=2019&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuint.2018.12.011&amp;rft_id=info%3Apmid%2F30582947&amp;rft.aulast=Kira&amp;rft.aufirst=JI&amp;rft.au=Yamasaki%2C+R&amp;rft.au=Ogata%2C+H&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.neuint.2018.12.011&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid23917093-198"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23917093_198-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPopescuPirkoLucchinetti2013" class="citation journal cs1">Popescu BF, Pirko I, Lucchinetti CF (August 2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915566">"Pathology of multiple sclerosis: where do we stand?"</a>. <i>Continuum (Minneapolis, Minn.)</i>. <b>19</b> (4 Multiple Sclerosis): 901–21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2F01.CON.0000433291.23091.65">10.1212/01.CON.0000433291.23091.65</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915566">3915566</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23917093">23917093</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Continuum+%28Minneapolis%2C+Minn.%29&amp;rft.atitle=Pathology+of+multiple+sclerosis%3A+where+do+we+stand%3F&amp;rft.volume=19&amp;rft.issue=4+Multiple+Sclerosis&amp;rft.pages=901-21&amp;rft.date=2013-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3915566%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23917093&amp;rft_id=info%3Adoi%2F10.1212%2F01.CON.0000433291.23091.65&amp;rft.aulast=Popescu&amp;rft.aufirst=BF&amp;rft.au=Pirko%2C+I&amp;rft.au=Lucchinetti%2C+CF&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3915566&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid23516409-199"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23516409_199-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMehtaPeiYangLi2013" class="citation journal cs1">Mehta V, Pei W, Yang G, Li S, Swamy E, Boster A, Schmalbrock P, Pitt D (2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597727">"Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions"</a>. <i>PLOS ONE</i>. <b>8</b> (3): e57573. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2013PLoSO...857573M">2013PLoSO...857573M</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0057573">10.1371/journal.pone.0057573</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597727">3597727</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23516409">23516409</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=Iron+is+a+sensitive+biomarker+for+inflammation+in+multiple+sclerosis+lesions&amp;rft.volume=8&amp;rft.issue=3&amp;rft.pages=e57573&amp;rft.date=2013&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3597727%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23516409&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0057573&amp;rft_id=info%3Abibcode%2F2013PLoSO...857573M&amp;rft.aulast=Mehta&amp;rft.aufirst=V&amp;rft.au=Pei%2C+W&amp;rft.au=Yang%2C+G&amp;rft.au=Li%2C+S&amp;rft.au=Swamy%2C+E&amp;rft.au=Boster%2C+A&amp;rft.au=Schmalbrock%2C+P&amp;rft.au=Pitt%2C+D&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3597727&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-200"><span class="mw-cite-backlink"><b><a href="#cite_ref-200">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKhalilTeunissenOttoPiehl2018" class="citation journal cs1">Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T,  et&#160;al. (October 2018). <a rel="nofollow" class="external text" href="https://discovery.ucl.ac.uk/id/eprint/10057189/1/Petzold_Horne_Fig1%20DLD-18-450.pdf">"Neurofilaments as biomarkers in neurological disorders"</a> <span class="cs1-format">(PDF)</span>. <i>Nature Reviews. Neurology</i>. <b>14</b> (10): 577–589. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41582-018-0058-z">10.1038/s41582-018-0058-z</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30171200">30171200</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:52140127">52140127</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210124190131/https://discovery.ucl.ac.uk/id/eprint/10057189/1/Petzold_Horne_Fig1%20DLD-18-450.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 24 January 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">19 September</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neurology&amp;rft.atitle=Neurofilaments+as+biomarkers+in+neurological+disorders&amp;rft.volume=14&amp;rft.issue=10&amp;rft.pages=577-589&amp;rft.date=2018-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A52140127%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F30171200&amp;rft_id=info%3Adoi%2F10.1038%2Fs41582-018-0058-z&amp;rft.aulast=Khalil&amp;rft.aufirst=M&amp;rft.au=Teunissen%2C+CE&amp;rft.au=Otto%2C+M&amp;rft.au=Piehl%2C+F&amp;rft.au=Sormani%2C+MP&amp;rft.au=Gattringer%2C+T&amp;rft.au=Barro%2C+C&amp;rft.au=Kappos%2C+L&amp;rft.au=Comabella%2C+M&amp;rft.au=Fazekas%2C+F&amp;rft.au=Petzold%2C+A&amp;rft.au=Blennow%2C+K&amp;rft.au=Zetterberg%2C+H&amp;rft.au=Kuhle%2C+J&amp;rft_id=https%3A%2F%2Fdiscovery.ucl.ac.uk%2Fid%2Feprint%2F10057189%2F1%2FPetzold_Horne_Fig1%2520DLD-18-450.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-201"><span class="mw-cite-backlink"><b><a href="#cite_ref-201">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPetzold2005" class="citation journal cs1">Petzold A (June 2005). <a rel="nofollow" class="external text" href="http://discovery.ucl.ac.uk/18928/1/18928.pdf">"Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss"</a> <span class="cs1-format">(PDF)</span>. <i>Journal of the Neurological Sciences</i>. <b>233</b> (1–2): 183–98. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jns.2005.03.015">10.1016/j.jns.2005.03.015</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15896809">15896809</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:18311152">18311152</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170922054542/http://discovery.ucl.ac.uk/18928/1/18928.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 22 September 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">19 September</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Neurological+Sciences&amp;rft.atitle=Neurofilament+phosphoforms%3A+surrogate+markers+for+axonal+injury%2C+degeneration+and+loss&amp;rft.volume=233&amp;rft.issue=1%E2%80%932&amp;rft.pages=183-98&amp;rft.date=2005-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A18311152%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15896809&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jns.2005.03.015&amp;rft.aulast=Petzold&amp;rft.aufirst=A&amp;rft_id=http%3A%2F%2Fdiscovery.ucl.ac.uk%2F18928%2F1%2F18928.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid22159052-202"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid22159052_202-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid22159052_202-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid22159052_202-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid22159052_202-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFilippiRoccaDe_StefanoEnzinger2011" class="citation journal cs1">Filippi M, Rocca MA, De Stefano N, Enzinger C, Fisher E, Horsfield MA, Inglese M, Pelletier D, Comi G (December 2011). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchneurol.2011.914">"Magnetic resonance techniques in multiple sclerosis: the present and the future"</a>. <i>Archives of Neurology</i>. <b>68</b> (12): 1514–20. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchneurol.2011.914">10.1001/archneurol.2011.914</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22159052">22159052</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Neurology&amp;rft.atitle=Magnetic+resonance+techniques+in+multiple+sclerosis%3A+the+present+and+the+future&amp;rft.volume=68&amp;rft.issue=12&amp;rft.pages=1514-20&amp;rft.date=2011-12&amp;rft_id=info%3Adoi%2F10.1001%2Farchneurol.2011.914&amp;rft_id=info%3Apmid%2F22159052&amp;rft.aulast=Filippi&amp;rft.aufirst=M&amp;rft.au=Rocca%2C+MA&amp;rft.au=De+Stefano%2C+N&amp;rft.au=Enzinger%2C+C&amp;rft.au=Fisher%2C+E&amp;rft.au=Horsfield%2C+MA&amp;rft.au=Inglese%2C+M&amp;rft.au=Pelletier%2C+D&amp;rft.au=Comi%2C+G&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1001%252Farchneurol.2011.914&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-203"><span class="mw-cite-backlink"><b><a href="#cite_ref-203">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSwanbergLandheerPittJuchem2019" class="citation journal cs1">Swanberg KM, Landheer K, Pitt D, Juchem C (2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876616">"Quantifying the Metabolic Signature of Multiple Sclerosis by <i>in vivo</i> Proton Magnetic Resonance Spectroscopy: Current Challenges and Future Outlook in the Translation From Proton Signal to Diagnostic Biomarker"</a>. <i>Frontiers in Neurology</i>. <b>10</b>: 1173. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffneur.2019.01173">10.3389/fneur.2019.01173</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876616">6876616</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31803127">31803127</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Neurology&amp;rft.atitle=Quantifying+the+Metabolic+Signature+of+Multiple+Sclerosis+by+in+vivo+Proton+Magnetic+Resonance+Spectroscopy%3A+Current+Challenges+and+Future+Outlook+in+the+Translation+From+Proton+Signal+to+Diagnostic+Biomarker&amp;rft.volume=10&amp;rft.pages=1173&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6876616%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31803127&amp;rft_id=info%3Adoi%2F10.3389%2Ffneur.2019.01173&amp;rft.aulast=Swanberg&amp;rft.aufirst=KM&amp;rft.au=Landheer%2C+K&amp;rft.au=Pitt%2C+D&amp;rft.au=Juchem%2C+C&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6876616&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-204"><span class="mw-cite-backlink"><b><a href="#cite_ref-204">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMoghadasiMirmosayyebBarzegarSahraian2021" class="citation journal cs1">Moghadasi AN, Mirmosayyeb O, Barzegar M, Sahraian MA, Ghajarzadeh M (August 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184129">"The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis"</a>. <i>Neurol Sci</i>. <b>42</b> (8): 3093–3099. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs10072-021-05373-1">10.1007/s10072-021-05373-1</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184129">8184129</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34100130">34100130</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurol+Sci&amp;rft.atitle=The+prevalence+of+COVID-19+infection+in+patients+with+multiple+sclerosis+%28MS%29%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=42&amp;rft.issue=8&amp;rft.pages=3093-3099&amp;rft.date=2021-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8184129%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F34100130&amp;rft_id=info%3Adoi%2F10.1007%2Fs10072-021-05373-1&amp;rft.aulast=Moghadasi&amp;rft.aufirst=AN&amp;rft.au=Mirmosayyeb%2C+O&amp;rft.au=Barzegar%2C+M&amp;rft.au=Sahraian%2C+MA&amp;rft.au=Ghajarzadeh%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8184129&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-205"><span class="mw-cite-backlink"><b><a href="#cite_ref-205">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPrinz2017" class="citation journal cs1">Prinz M (3 November 2017). "Faculty Opinions recommendation of Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice". <i>Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature</i>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3410%2Ff.731077576.793538553">10.3410/f.731077576.793538553</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Faculty+Opinions+%E2%80%93+Post-Publication+Peer+Review+of+the+Biomedical+Literature&amp;rft.atitle=Faculty+Opinions+recommendation+of+Gut+microbiota+from+multiple+sclerosis+patients+enables+spontaneous+autoimmune+encephalomyelitis+in+mice.&amp;rft.date=2017-11-03&amp;rft_id=info%3Adoi%2F10.3410%2Ff.731077576.793538553&amp;rft.aulast=Prinz&amp;rft.aufirst=M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-206"><span class="mw-cite-backlink"><b><a href="#cite_ref-206">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAranow2011" class="citation journal cs1">Aranow C (August 2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166406">"Vitamin D and the immune system"</a>. <i>Journal of Investigative Medicine</i>. <b>59</b> (6): 881–886. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2310%2Fjim.0b013e31821b8755">10.2310/jim.0b013e31821b8755</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166406">3166406</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21527855">21527855</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Investigative+Medicine&amp;rft.atitle=Vitamin+D+and+the+immune+system&amp;rft.volume=59&amp;rft.issue=6&amp;rft.pages=881-886&amp;rft.date=2011-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3166406%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21527855&amp;rft_id=info%3Adoi%2F10.2310%2Fjim.0b013e31821b8755&amp;rft.aulast=Aranow&amp;rft.aufirst=C&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3166406&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-207"><span class="mw-cite-backlink"><b><a href="#cite_ref-207">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTadaTakemoriOkumuraNonaka1978" class="citation journal cs1">Tada T, Takemori T, Okumura K, Nonaka M, Tokuhisa T (February 1978). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2184496">"Two distinct types of helper T cells involved in the secondary antibody response: independent and synergistic effects of Ia- and Ia+ helper T cells"</a>. <i>The Journal of Experimental Medicine</i>. <b>147</b> (2): 446–458. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1084%2Fjem.147.2.446">10.1084/jem.147.2.446</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2184496">2184496</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/415110">415110</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Experimental+Medicine&amp;rft.atitle=Two+distinct+types+of+helper+T+cells+involved+in+the+secondary+antibody+response%3A+independent+and+synergistic+effects+of+Ia-+and+Ia%2B+helper+T+cells&amp;rft.volume=147&amp;rft.issue=2&amp;rft.pages=446-458&amp;rft.date=1978-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2184496%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F415110&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.147.2.446&amp;rft.aulast=Tada&amp;rft.aufirst=T&amp;rft.au=Takemori%2C+T&amp;rft.au=Okumura%2C+K&amp;rft.au=Nonaka%2C+M&amp;rft.au=Tokuhisa%2C+T&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2184496&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-208"><span class="mw-cite-backlink"><b><a href="#cite_ref-208">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLassmann2018" class="citation journal cs1">Lassmann H (March 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830904">"Multiple Sclerosis Pathology"</a>. <i>Cold Spring Harbor Perspectives in Medicine</i>. <b>8</b> (3): a028936. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1101%2Fcshperspect.a028936">10.1101/cshperspect.a028936</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830904">5830904</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29358320">29358320</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cold+Spring+Harbor+Perspectives+in+Medicine&amp;rft.atitle=Multiple+Sclerosis+Pathology&amp;rft.volume=8&amp;rft.issue=3&amp;rft.pages=a028936&amp;rft.date=2018-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5830904%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29358320&amp;rft_id=info%3Adoi%2F10.1101%2Fcshperspect.a028936&amp;rft.aulast=Lassmann&amp;rft.aufirst=H&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5830904&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-209"><span class="mw-cite-backlink"><b><a href="#cite_ref-209">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation cs2">"Pathogenesis of HIV-Associated Dementia and Multiple Sclerosis: Role of Microglia and Astrocytes", <i>The Role of Glia in Neurotoxicity</i>, CRC Press, pp.&#160;283–298, 28 December 2004, <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1201%2F9781420039740-21">10.1201/9781420039740-21</a>, <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780429128608" title="Special:BookSources/9780429128608"><bdi>9780429128608</bdi></a></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Role+of+Glia+in+Neurotoxicity&amp;rft.atitle=Pathogenesis+of+HIV-Associated+Dementia+and+Multiple+Sclerosis%3A+Role+of+Microglia+and+Astrocytes&amp;rft.pages=283-298&amp;rft.date=2004-12-28&amp;rft_id=info%3Adoi%2F10.1201%2F9781420039740-21&amp;rft.isbn=9780429128608&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMultiple+sclerosis" class="Z3988"></span></span>
</li>
</ol></div></div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=42" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1134653256">.mw-parser-output .side-box{margin:4px 0;box-sizing:border-box;border:1px solid #aaa;font-size:88%;line-height:1.25em;background-color:#f9f9f9;display:flow-root}.mw-parser-output .side-box-abovebelow,.mw-parser-output .side-box-text{padding:0.25em 0.9em}.mw-parser-output .side-box-image{padding:2px 0 2px 0.9em;text-align:center}.mw-parser-output .side-box-imageright{padding:2px 0.9em 2px 0;text-align:center}@media(min-width:500px){.mw-parser-output .side-box-flex{display:flex;align-items:center}.mw-parser-output .side-box-text{flex:1}}@media(min-width:720px){.mw-parser-output .side-box{width:238px}.mw-parser-output .side-box-right{clear:right;float:right;margin-left:1em}.mw-parser-output .side-box-left{margin-right:1em}}</style><div class="side-box side-box-right plainlinks sistersitebox"><style data-mw-deduplicate="TemplateStyles:r1126788409">.mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}</style>
<div class="side-box-flex">
<div class="side-box-image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png" decoding="async" width="30" height="40" class="noviewer" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x" data-file-width="1024" data-file-height="1376" /></div>
<div class="side-box-text plainlist">Wikimedia Commons has media related to <span style="font-weight: bold; font-style: italic;"><a href="https://commons.wikimedia.org/wiki/Category:Multiple_sclerosis" class="extiw" title="commons:Category:Multiple sclerosis">Multiple sclerosis</a></span>.</div></div>
</div>
<ul><li><a rel="nofollow" class="external text" href="https://curlie.org/Health/Conditions_and_Diseases/Neurological_Disorders/Demyelinating_Diseases/Multiple_Sclerosis/">Multiple sclerosis</a> at <a href="/wiki/Curlie" class="mw-redirect" title="Curlie">Curlie</a></li>
<li><a rel="nofollow" class="external text" href="http://www.atlasofms.org/">Database for analysis and comparison of global data on the epidemiology of MS</a></li></ul>
<div class="navbox-styles"><style data-mw-deduplicate="TemplateStyles:r1061467846">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style><style data-mw-deduplicate="TemplateStyles:r1129693374">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}</style><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"></div><div role="navigation" class="navbox" aria-label="Navbox" style="width:100%; margin:0.5em 0 0.5em 0;;padding:3px"><table class="nowraplinks navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;background: #EAECF0">Classification</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"><div style="position:relative; float:right; font-size:0.8em;"><a href="https://www.wikidata.org/wiki/Q8277" class="extiw" title="d:Q8277">D</a></div><div class="hlist" style="text-align:left;"><ul><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></b>: <a rel="nofollow" class="external text" href="https://icd.who.int/browse10/2019/en#/G35">G35</a></li><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></b>: <a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=340">340</a></li><li><b><a href="/wiki/Online_Mendelian_Inheritance_in_Man" title="Online Mendelian Inheritance in Man">OMIM</a></b>: <a rel="nofollow" class="external text" href="https://omim.org/entry/126200">126200</a></li><li><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b>: <a rel="nofollow" class="external text" href="https://meshb.nlm.nih.gov/record/ui?ui=D009103">D009103</a></li><li><b><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></b>: <a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb8412.htm">8412</a></li></ul></div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;background: #EAECF0">External resources</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"><div class="hlist" style="text-align:left;"><ul><li><b><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></b>: <a rel="nofollow" class="external text" href="https://www.nlm.nih.gov/medlineplus/ency/article/000737.htm">000737</a></li><li><b><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></b>: <a rel="nofollow" class="external text" href="https://emedicine.medscape.com/neuro/228-overview">neuro/228</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/oph/topic179.htm#">oph/179</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/emerg/topic321.htm#">emerg/321</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/pmr/topic82.htm#">pmr/82</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/radio/topic461.htm#">radio/461</a></li><li><b><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></b>: <a rel="nofollow" class="external text" href="https://patient.info/doctor/multiple-sclerosis-pro">Multiple sclerosis</a></li><li><b><a href="/wiki/GeneReviews" title="GeneReviews">GeneReviews</a></b>: <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/books/NBK1316/">Overview</a></li></ul></div></div></td></tr></tbody></table></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"></div><div role="navigation" class="navbox" aria-labelledby="Demyelinating_diseases_of_the_central_nervous_system" style="padding:3px"><table class="nowraplinks hlist mw-collapsible expanded navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><style data-mw-deduplicate="TemplateStyles:r1063604349">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Demyelinating_diseases_of_CNS" title="Template:Demyelinating diseases of CNS"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Demyelinating_diseases_of_CNS" title="Template talk:Demyelinating diseases of CNS"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Demyelinating_diseases_of_CNS&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Demyelinating_diseases_of_the_central_nervous_system" style="font-size:114%;margin:0 4em">Demyelinating diseases of the <a href="/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Multiple_sclerosis_signs_and_symptoms" title="Multiple sclerosis signs and symptoms">Signs and symptoms</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Ataxia" title="Ataxia">Ataxia</a></li>
<li><a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">Depression</a></li>
<li><a href="/wiki/Diplopia" title="Diplopia">Diplopia</a></li>
<li><a href="/wiki/Dysarthria" title="Dysarthria">Dysarthria</a></li>
<li><a href="/wiki/Dysphagia" title="Dysphagia">Dysphagia</a></li>
<li><a href="/wiki/Fatigue" title="Fatigue">Fatigue</a></li>
<li><a href="/wiki/Urinary_incontinence" title="Urinary incontinence">Incontinence</a></li>
<li><a href="/wiki/Nystagmus" title="Nystagmus">Nystagmus</a></li>
<li><a href="/wiki/Optic_neuritis" title="Optic neuritis">Optic neuritis</a></li>
<li><a href="/wiki/Pain" title="Pain">Pain</a></li>
<li><a href="/wiki/Uhthoff%27s_phenomenon" title="Uhthoff&#39;s phenomenon">Uhthoff's phenomenon</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Investigations and diagnosis</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Multiple_sclerosis_diagnosis" title="Multiple sclerosis diagnosis">Multiple sclerosis diagnosis</a>
<ul><li><a href="/wiki/McDonald_criteria" title="McDonald criteria">McDonald criteria</a></li></ul></li>
<li><a href="/wiki/Poser_criteria" title="Poser criteria">Poser criteria</a></li></ul>
<ul><li>Clinical
<ul><li><a href="/wiki/Clinically_isolated_syndrome" title="Clinically isolated syndrome">Clinically isolated syndrome</a></li>
<li><a href="/wiki/Expanded_Disability_Status_Scale" title="Expanded Disability Status Scale">Expanded Disability Status Scale</a></li></ul></li>
<li>Serological and CSF
<ul><li><a href="/wiki/Oligoclonal_band" title="Oligoclonal band">Oligoclonal bands</a></li></ul></li>
<li>Radiological
<ul><li><a href="/wiki/Radiologically_isolated_syndrome" title="Radiologically isolated syndrome">Radiologically isolated syndrome</a></li>
<li><a href="/wiki/Lesional_demyelinations_of_the_central_nervous_system" title="Lesional demyelinations of the central nervous system">Lesional demyelinations of the central nervous system</a></li>
<li><a href="/wiki/Dawson%27s_fingers" class="mw-redirect" title="Dawson&#39;s fingers">Dawson's fingers</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Approved treatment</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Management_of_multiple_sclerosis" title="Management of multiple sclerosis">Management of multiple sclerosis</a></li>
<li><a href="/wiki/Alemtuzumab" title="Alemtuzumab">Alemtuzumab</a></li>
<li><a href="/wiki/Cladribine" title="Cladribine">Cladribine</a></li>
<li><a href="/wiki/Dimethyl_fumarate" title="Dimethyl fumarate">Dimethyl fumarate</a></li>
<li><a href="/wiki/Diroximel_fumarate" title="Diroximel fumarate">Diroximel fumarate</a></li>
<li><a href="/wiki/Fingolimod" title="Fingolimod">Fingolimod</a></li>
<li><a href="/wiki/Glatiramer_acetate" title="Glatiramer acetate">Glatiramer acetate</a></li>
<li><a href="/wiki/Interferon_beta-1a" title="Interferon beta-1a">Interferon beta-1a</a></li>
<li><a href="/wiki/Interferon_beta-1b" title="Interferon beta-1b">Interferon beta-1b</a></li>
<li><a href="/wiki/Laquinimod" title="Laquinimod">Laquinimod</a></li>
<li><a href="/wiki/Mitoxantrone" title="Mitoxantrone">Mitoxantrone</a></li>
<li><a href="/wiki/Monomethyl_fumarate" title="Monomethyl fumarate">Monomethyl fumarate</a></li>
<li><a href="/wiki/Natalizumab" title="Natalizumab">Natalizumab</a></li>
<li><a href="/wiki/Ocrelizumab" title="Ocrelizumab">Ocrelizumab</a></li>
<li><a href="/wiki/Ozanimod" title="Ozanimod">Ozanimod</a></li>
<li><a href="/wiki/Ponesimod" title="Ponesimod">Ponesimod</a></li>
<li><a href="/wiki/Siponimod" title="Siponimod">Siponimod</a></li>
<li><a href="/wiki/Teriflunomide" title="Teriflunomide">Teriflunomide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other treatments</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li>Former
<ul><li><a href="/wiki/Daclizumab" title="Daclizumab">Daclizumab</a></li></ul></li>
<li><a href="/wiki/Multiple_sclerosis_research" title="Multiple sclerosis research">Multiple sclerosis research</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Demyelinating diseases</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/CNS_demyelinating_autoimmune_diseases" title="CNS demyelinating autoimmune diseases">Autoimmune</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Neuromyelitis_optica" class="mw-redirect" title="Neuromyelitis optica">Neuromyelitis optica</a></li>
<li><a href="/wiki/Diffuse_myelinoclastic_sclerosis" title="Diffuse myelinoclastic sclerosis">Diffuse myelinoclastic sclerosis</a></li>
<li><a href="/wiki/MOG_antibody_disease" title="MOG antibody disease">MOG antibody disease</a></li>
<li><a class="mw-selflink selflink">Multiple sclerosis</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Inflammatory_demyelinating_diseases_of_the_central_nervous_system" title="Inflammatory demyelinating diseases of the central nervous system">Inflammatory</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Acute_disseminated_encephalomyelitis" title="Acute disseminated encephalomyelitis">Acute disseminated encephalomyelitis</a></li>
<li><a href="/wiki/Balo_concentric_sclerosis" title="Balo concentric sclerosis">Balo concentric sclerosis</a></li>
<li><a href="/wiki/Marburg_acute_multiple_sclerosis" title="Marburg acute multiple sclerosis">Marburg acute multiple sclerosis</a></li>
<li><a href="/wiki/Neuromyelitis_optica" class="mw-redirect" title="Neuromyelitis optica">Neuromyelitis optica</a></li>
<li><a href="/wiki/Diffuse_myelinoclastic_sclerosis" title="Diffuse myelinoclastic sclerosis">Diffuse myelinoclastic sclerosis</a></li>
<li><a href="/wiki/Tumefactive_multiple_sclerosis" title="Tumefactive multiple sclerosis">Tumefactive multiple sclerosis</a></li>
<li><a href="/wiki/Experimental_autoimmune_encephalomyelitis" title="Experimental autoimmune encephalomyelitis">Experimental autoimmune encephalomyelitis</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Hereditary_CNS_demyelinating_disease" title="Hereditary CNS demyelinating disease">Hereditary</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Adrenoleukodystrophy" title="Adrenoleukodystrophy">Adrenoleukodystrophy</a></li>
<li><a href="/wiki/Alexander_disease" title="Alexander disease">Alexander disease</a></li>
<li><a href="/wiki/Canavan_disease" title="Canavan disease">Canavan disease</a></li>
<li><a href="/wiki/Krabbe_disease" title="Krabbe disease">Krabbe disease</a></li>
<li><a href="/wiki/Metachromatic_leukodystrophy" title="Metachromatic leukodystrophy">Metachromatic leukodystrophy</a></li>
<li><a href="/wiki/Pelizaeus%E2%80%93Merzbacher_disease" title="Pelizaeus–Merzbacher disease">Pelizaeus–Merzbacher disease</a></li>
<li><a href="/wiki/Leukoencephalopathy_with_vanishing_white_matter" title="Leukoencephalopathy with vanishing white matter">Leukoencephalopathy with vanishing white matter</a></li>
<li><a href="/wiki/Megalencephalic_leukoencephalopathy_with_subcortical_cysts" title="Megalencephalic leukoencephalopathy with subcortical cysts">Megalencephalic leukoencephalopathy with subcortical cysts</a></li>
<li><a href="/wiki/CAMFAK_syndrome" title="CAMFAK syndrome">CAMFAK syndrome</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Central_pontine_myelinolysis" title="Central pontine myelinolysis">Central pontine myelinolysis</a></li>
<li><a href="/wiki/Marchiafava%E2%80%93Bignami_disease" title="Marchiafava–Bignami disease">Marchiafava–Bignami disease</a></li>
<li><a href="/wiki/Mitochondrial_DNA_depletion_syndrome" title="Mitochondrial DNA depletion syndrome">Mitochondrial DNA depletion syndrome</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/List_of_multiple_sclerosis_organizations" title="List of multiple sclerosis organizations">List of multiple sclerosis organizations</a></li>
<li><a href="/wiki/List_of_people_with_multiple_sclerosis" title="List of people with multiple sclerosis">List of people with multiple sclerosis</a></li>
<li><a href="/wiki/Multiple_sclerosis_drug_pipeline" title="Multiple sclerosis drug pipeline">Multiple sclerosis drug pipeline</a></li>
<li><a href="/wiki/Pathophysiology_of_multiple_sclerosis" title="Pathophysiology of multiple sclerosis">Pathophysiology</a></li></ul>
</div></td></tr></tbody></table></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"></div><div role="navigation" class="navbox" aria-labelledby="Diseases_of_the_nervous_system,_primarily_CNS" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Central_nervous_system_disease" title="Template:Central nervous system disease"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Central_nervous_system_disease" title="Template talk:Central nervous system disease"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Central_nervous_system_disease&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Diseases_of_the_nervous_system,_primarily_CNS" style="font-size:114%;margin:0 4em">Diseases of the <a href="/wiki/Nervous_system" title="Nervous system">nervous system</a>, primarily <a href="/wiki/Central_nervous_system_disease" title="Central nervous system disease">CNS</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Inflammation" title="Inflammation">Inflammation</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Brain" scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Human_brain" title="Human brain">Brain</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Encephalitis" title="Encephalitis">Encephalitis</a>
<ul><li><a href="/wiki/Viral_encephalitis" title="Viral encephalitis">Viral encephalitis</a></li>
<li><a href="/wiki/Herpesviral_encephalitis" title="Herpesviral encephalitis">Herpesviral encephalitis</a></li>
<li><a href="/wiki/Limbic_encephalitis" title="Limbic encephalitis">Limbic encephalitis</a></li>
<li><a href="/wiki/Encephalitis_lethargica" title="Encephalitis lethargica">Encephalitis lethargica</a></li></ul></li>
<li><a href="/wiki/Cavernous_sinus_thrombosis" title="Cavernous sinus thrombosis">Cavernous sinus thrombosis</a></li>
<li><a href="/wiki/Brain_abscess" title="Brain abscess">Brain abscess</a>
<ul><li><a href="/wiki/Amoebic_brain_abscess" title="Amoebic brain abscess">Amoebic</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Brain and <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Encephalomyelitis" title="Encephalomyelitis">Encephalomyelitis</a>
<ul><li><a href="/wiki/Acute_disseminated_encephalomyelitis" title="Acute disseminated encephalomyelitis">Acute disseminated</a></li></ul></li>
<li><a href="/wiki/Meningitis" title="Meningitis">Meningitis</a></li>
<li><a href="/wiki/Meningoencephalitis" title="Meningoencephalitis">Meningoencephalitis</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Human_brain" title="Human brain">Brain</a>/<br /><a href="/wiki/Encephalopathy" title="Encephalopathy">encephalopathy</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Neurodegenerative_disease" title="Neurodegenerative disease">Degenerative</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Extrapyramidal_system" title="Extrapyramidal system">Extrapyramidal</a> and<br /><a href="/wiki/Movement_disorders" class="mw-redirect" title="Movement disorders">movement disorders</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Basal_ganglia_disease" title="Basal ganglia disease">Basal ganglia disease</a>
<ul><li><a href="/wiki/Parkinsonism" title="Parkinsonism">Parkinsonism</a>
<ul><li><a href="/wiki/Parkinson%27s_disease" title="Parkinson&#39;s disease">PD</a></li>
<li><a href="/wiki/Postencephalitic_parkinsonism" class="mw-redirect" title="Postencephalitic parkinsonism">Postencephalitic</a></li>
<li><a href="/wiki/Neuroleptic_malignant_syndrome" title="Neuroleptic malignant syndrome">NMS</a></li></ul></li>
<li><a href="/wiki/Neurodegeneration_with_brain_iron_accumulation" title="Neurodegeneration with brain iron accumulation">NBIA</a>
<ul><li><a href="/wiki/Pantothenate_kinase-associated_neurodegeneration" title="Pantothenate kinase-associated neurodegeneration">PKAN</a></li></ul></li>
<li><a href="/wiki/Tauopathy" title="Tauopathy">Tauopathy</a>
<ul><li><a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">PSP</a></li></ul></li>
<li><a href="/wiki/Multiple_system_atrophy" title="Multiple system atrophy">Striatonigral degeneration</a></li>
<li><a href="/wiki/Hemiballismus" title="Hemiballismus">Hemiballismus</a></li>
<li><a href="/wiki/Huntington%27s_disease" title="Huntington&#39;s disease">HD</a></li>
<li><a href="/wiki/Olivopontocerebellar_atrophy" title="Olivopontocerebellar atrophy">OA</a></li></ul></li></ul>
<ul><li><a href="/wiki/Dyskinesia" title="Dyskinesia">Dyskinesia</a>
<ul><li><a href="/wiki/Dystonia" title="Dystonia">Dystonia</a>
<ul><li><a href="/wiki/Status_dystonicus" title="Status dystonicus">Status dystonicus</a></li>
<li><a href="/wiki/Spasmodic_torticollis" title="Spasmodic torticollis">Spasmodic torticollis</a></li>
<li><a href="/wiki/Meige%27s_syndrome" title="Meige&#39;s syndrome">Meige's</a></li>
<li><a href="/wiki/Blepharospasm" title="Blepharospasm">Blepharospasm</a></li></ul></li>
<li><a href="/wiki/Athetosis" title="Athetosis">Athetosis</a></li>
<li><a href="/wiki/Chorea" title="Chorea">Chorea</a>
<ul><li><a href="/wiki/Choreoathetosis" title="Choreoathetosis">Choreoathetosis</a></li></ul></li>
<li><a href="/wiki/Myoclonus" title="Myoclonus">Myoclonus</a>
<ul><li><a href="/wiki/Myoclonic_epilepsy" title="Myoclonic epilepsy">Myoclonic epilepsy</a></li></ul></li>
<li><a href="/wiki/Akathisia" title="Akathisia">Akathisia</a></li></ul></li></ul>
<ul><li><a href="/wiki/Tremor" title="Tremor">Tremor</a>
<ul><li><a href="/wiki/Essential_tremor" title="Essential tremor">Essential tremor</a></li>
<li><a href="/wiki/Intention_tremor" title="Intention tremor">Intention tremor</a></li></ul></li>
<li><a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">Restless legs</a></li>
<li><a href="/wiki/Stiff-person_syndrome" title="Stiff-person syndrome">Stiff-person</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Dementia" title="Dementia">Dementia</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Tauopathy" title="Tauopathy">Tauopathy</a>
<ul><li><a href="/wiki/Alzheimer%27s_disease" title="Alzheimer&#39;s disease">Alzheimer's</a>
<ul><li><a href="/wiki/Early-onset_Alzheimer%27s_disease" title="Early-onset Alzheimer&#39;s disease">Early-onset</a></li></ul></li>
<li><a href="/wiki/Primary_progressive_aphasia" title="Primary progressive aphasia">Primary progressive aphasia</a></li></ul></li>
<li><a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">Frontotemporal dementia</a>/<a href="/wiki/Frontotemporal_lobar_degeneration" title="Frontotemporal lobar degeneration">Frontotemporal lobar degeneration</a>
<ul><li><a href="/wiki/Pick%27s_disease" class="mw-redirect" title="Pick&#39;s disease">Pick's</a></li></ul></li>
<li><a href="/wiki/Lewy_bodies_dementia" class="mw-redirect" title="Lewy bodies dementia">Lewy bodies dementia</a></li>
<li><a href="/wiki/Posterior_cortical_atrophy" title="Posterior cortical atrophy">Posterior cortical atrophy</a></li></ul>
<ul><li><a href="/wiki/Vascular_dementia" title="Vascular dementia">Vascular dementia</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Mitochondrial_disease" title="Mitochondrial disease">Mitochondrial disease</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Leigh_syndrome" title="Leigh syndrome">Leigh syndrome</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Demyelinating_disease" title="Demyelinating disease">Demyelinating</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/CNS_demyelinating_autoimmune_diseases" title="CNS demyelinating autoimmune diseases">Autoimmune</a></li>
<li><a href="/wiki/Inflammatory_demyelinating_diseases_of_the_central_nervous_system" title="Inflammatory demyelinating diseases of the central nervous system">Inflammatory</a></li>
<li><a class="mw-selflink selflink">Multiple sclerosis</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Demyelinating_diseases_of_CNS" title="Template:Demyelinating diseases of CNS">Template:Demyelinating diseases of CNS</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Episodic/<br /><a href="/wiki/Paroxysmal_attack" title="Paroxysmal attack">paroxysmal</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Epileptic_seizure" class="mw-redirect" title="Epileptic seizure">Seizures</a> and <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Focal_seizure" title="Focal seizure">Focal</a></li>
<li><a href="/wiki/Generalized_epilepsy" title="Generalized epilepsy">Generalised</a></li>
<li><a href="/wiki/Status_epilepticus" title="Status epilepticus">Status epilepticus</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Epilepsy" class="mw-redirect" title="Template:Epilepsy">Template:Epilepsy</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Headache" title="Headache">Headache</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Migraine" title="Migraine">Migraine</a></li>
<li><a href="/wiki/Cluster_headache" title="Cluster headache">Cluster</a></li>
<li><a href="/wiki/Tension_headache" title="Tension headache">Tension</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Headache" title="Template:Headache">Template:Headache</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Cerebrovascular_disease" title="Cerebrovascular disease">Cerebrovascular</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Transient_ischemic_attack" title="Transient ischemic attack">TIA</a></li>
<li><a href="/wiki/Stroke" title="Stroke">Stroke</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Cerebrovascular_diseases" title="Template:Cerebrovascular diseases">Template:Cerebrovascular diseases</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Sleep_disorders" class="mw-redirect" title="Sleep disorders">Sleep disorders</a>
<ul><li>For more detailed coverage, see <a href="/wiki/Template:Sleep" title="Template:Sleep">Template:Sleep</a></li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Cerebrospinal_fluid" title="Cerebrospinal fluid">CSF</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Intracranial_pressure" title="Intracranial pressure">Intracranial hypertension</a>
<ul><li><a href="/wiki/Hydrocephalus" title="Hydrocephalus">Hydrocephalus</a></li>
<li><a href="/wiki/Normal_pressure_hydrocephalus" title="Normal pressure hydrocephalus">Normal pressure hydrocephalus</a></li>
<li><a href="/wiki/Choroid_plexus_papilloma" title="Choroid plexus papilloma">Choroid plexus papilloma</a></li>
<li><a href="/wiki/Idiopathic_intracranial_hypertension" title="Idiopathic intracranial hypertension">Idiopathic intracranial hypertension</a></li></ul></li>
<li><a href="/wiki/Cerebral_edema" title="Cerebral edema">Cerebral edema</a></li>
<li><a href="/wiki/Spontaneous_cerebrospinal_fluid_leak" class="mw-redirect" title="Spontaneous cerebrospinal fluid leak">Intracranial hypotension</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Brain_herniation" title="Brain herniation">Brain herniation</a></li>
<li><a href="/wiki/Reye_syndrome" title="Reye syndrome">Reye syndrome</a></li>
<li><a href="/wiki/Hepatic_encephalopathy" title="Hepatic encephalopathy">Hepatic encephalopathy</a></li>
<li><a href="/wiki/Toxic_encephalopathy" title="Toxic encephalopathy">Toxic encephalopathy</a></li>
<li><a href="/wiki/Hashimoto%27s_encephalopathy" title="Hashimoto&#39;s encephalopathy">Hashimoto's encephalopathy</a></li>
<li><a href="/wiki/Fetal_alcohol_spectrum_disorder" title="Fetal alcohol spectrum disorder">Static Encephalopathy</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Both/either</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Degenerative" scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Neurodegenerative_disease" title="Neurodegenerative disease">Degenerative</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Spinocerebellar_ataxia" title="Spinocerebellar ataxia">SA</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Friedreich%27s_ataxia" title="Friedreich&#39;s ataxia">Friedreich's ataxia</a></li>
<li><a href="/wiki/Ataxia%E2%80%93telangiectasia" title="Ataxia–telangiectasia">Ataxia–telangiectasia</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Motor_neuron_disease" class="mw-redirect" title="Motor neuron disease">MND</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Upper_motor_neuron" title="Upper motor neuron">UMN</a> only:</i>
<ul><li><a href="/wiki/Primary_lateral_sclerosis" title="Primary lateral sclerosis">Primary lateral sclerosis</a></li>
<li><a href="/wiki/Pseudobulbar_palsy" title="Pseudobulbar palsy">Pseudobulbar palsy</a></li>
<li><a href="/wiki/Hereditary_spastic_paraplegia" title="Hereditary spastic paraplegia">Hereditary spastic paraplegia</a></li></ul></li></ul>
<ul><li><i><a href="/wiki/Lower_motor_neuron" title="Lower motor neuron">LMN</a> only:</i>
<ul><li><a href="/wiki/Distal_hereditary_motor_neuronopathies" title="Distal hereditary motor neuronopathies">Distal hereditary motor neuronopathies</a></li>
<li><a href="/wiki/Spinal_muscular_atrophies" title="Spinal muscular atrophies">Spinal muscular atrophies</a>
<ul><li><a href="/wiki/Spinal_muscular_atrophy" title="Spinal muscular atrophy">SMA</a></li>
<li><a href="/wiki/Spinal_and_bulbar_muscular_atrophy" title="Spinal and bulbar muscular atrophy">SMAX1</a></li>
<li><a href="/wiki/X-linked_spinal_muscular_atrophy_type_2" title="X-linked spinal muscular atrophy type 2">SMAX2</a></li>
<li><a href="/wiki/Distal_spinal_muscular_atrophy_type_1" title="Distal spinal muscular atrophy type 1">DSMA1</a></li>
<li><a href="/wiki/Congenital_distal_spinal_muscular_atrophy" title="Congenital distal spinal muscular atrophy">Congenital DSMA</a></li>
<li>Spinal muscular atrophy with lower extremity predominance (SMALED)
<ul><li><a href="/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_1" title="Spinal muscular atrophy with lower extremity predominance 1">SMALED1</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_2A" title="Spinal muscular atrophy with lower extremity predominance 2A">SMALED2A</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_2B" title="Spinal muscular atrophy with lower extremity predominance 2B">SMALED2B</a></li></ul></li>
<li><a href="/wiki/Pontocerebellar_hypoplasia" title="Pontocerebellar hypoplasia">SMA-PCH</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_progressive_myoclonic_epilepsy" title="Spinal muscular atrophy with progressive myoclonic epilepsy">SMA-PME</a></li></ul></li>
<li><a href="/wiki/Progressive_muscular_atrophy" title="Progressive muscular atrophy">Progressive muscular atrophy</a></li>
<li><a href="/wiki/Progressive_bulbar_palsy" title="Progressive bulbar palsy">Progressive bulbar palsy</a>
<ul><li><a href="/wiki/Fazio%E2%80%93Londe_disease" title="Fazio–Londe disease">Fazio–Londe</a></li>
<li><a href="/wiki/Infantile_progressive_bulbar_palsy" title="Infantile progressive bulbar palsy">Infantile progressive bulbar palsy</a></li></ul></li></ul></li></ul>
<ul><li><i>both:</i>
<ul><li><a href="/wiki/Amyotrophic_lateral_sclerosis" class="mw-redirect" title="Amyotrophic lateral sclerosis">Amyotrophic lateral sclerosis</a></li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"></div><div role="navigation" class="navbox" aria-labelledby="Hypersensitivity_and_autoimmune_diseases" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Hypersensitivity_disease_by_cause" title="Template:Hypersensitivity disease by cause"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Hypersensitivity_disease_by_cause" title="Template talk:Hypersensitivity disease by cause"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Hypersensitivity_disease_by_cause&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Hypersensitivity_and_autoimmune_diseases" style="font-size:114%;margin:0 4em"><a href="/wiki/Hypersensitivity" title="Hypersensitivity">Hypersensitivity</a> and <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diseases</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Type_I_hypersensitivity" title="Type I hypersensitivity">Type I</a>/<a href="/wiki/Allergy" title="Allergy">allergy</a>/<a href="/wiki/Atopy" title="Atopy">atopy</a><br />(<a href="/wiki/Immunoglobulin_E" title="Immunoglobulin E">IgE</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Foreign</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Atopic_dermatitis" title="Atopic dermatitis">Atopic dermatitis</a></li>
<li><a href="/wiki/Allergic_urticaria" class="mw-redirect" title="Allergic urticaria">Allergic urticaria</a></li>
<li><a href="/wiki/Allergic_rhinitis" title="Allergic rhinitis">Allergic rhinitis</a> (Hay fever)</li>
<li><a href="/wiki/Allergic_asthma" class="mw-redirect" title="Allergic asthma">Allergic asthma</a></li>
<li><a href="/wiki/Anaphylaxis" title="Anaphylaxis">Anaphylaxis</a></li>
<li><a href="/wiki/Food_allergy" title="Food allergy">Food allergy</a>
<ul><li>common allergies include: <a href="/wiki/Milk_allergy" title="Milk allergy">Milk</a></li>
<li><a href="/wiki/Egg_allergy" title="Egg allergy">Egg</a></li>
<li><a href="/wiki/Peanut_allergy" title="Peanut allergy">Peanut</a></li>
<li><a href="/wiki/Tree_nut_allergy" title="Tree nut allergy">Tree nut</a></li>
<li><a href="/wiki/Seafood_allergy" class="mw-redirect" title="Seafood allergy">Seafood</a></li>
<li><a href="/wiki/Soy_allergy" title="Soy allergy">Soy</a></li>
<li><a href="/wiki/Wheat_allergy" title="Wheat allergy">Wheat</a></li></ul></li>
<li><a href="/wiki/Side_effects_of_penicillin" title="Side effects of penicillin">Penicillin allergy</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Autoimmune</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Eosinophilic_esophagitis" title="Eosinophilic esophagitis">Eosinophilic esophagitis</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Type_II_hypersensitivity" title="Type II hypersensitivity">Type II</a>/<a href="/wiki/Antibody-dependent_cellular_cytotoxicity" title="Antibody-dependent cellular cytotoxicity">ADCC</a><br />
<ul><li><ul><li><a href="/wiki/Immunoglobulin_M" title="Immunoglobulin M">IgM</a></li>
<li><a href="/wiki/Immunoglobulin_G" title="Immunoglobulin G">IgG</a></li></ul></li></ul></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Foreign</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<li><a href="/wiki/Hemolytic_disease_of_the_newborn" title="Hemolytic disease of the newborn">Hemolytic disease of the newborn</a></li>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Autoimmune</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Cytotoxicity" title="Cytotoxicity">Cytotoxic</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Autoimmune_hemolytic_anemia" title="Autoimmune hemolytic anemia">Autoimmune hemolytic anemia</a></li>
<li><a href="/wiki/Immune_thrombocytopenic_purpura" title="Immune thrombocytopenic purpura">Immune thrombocytopenic purpura</a></li>
<li><a href="/wiki/Bullous_pemphigoid" title="Bullous pemphigoid">Bullous pemphigoid</a></li>
<li><a href="/wiki/Pemphigus_vulgaris" title="Pemphigus vulgaris">Pemphigus vulgaris</a></li>
<li><a href="/wiki/Rheumatic_fever" title="Rheumatic fever">Rheumatic fever</a></li>
<li><a href="/wiki/Goodpasture_syndrome" title="Goodpasture syndrome">Goodpasture syndrome</a></li>
<li><a href="/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome" title="Guillain–Barré syndrome">Guillain–Barré syndrome</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">"<a href="/wiki/Hypersensitivity#Type_V" title="Hypersensitivity">Type V</a>"/<a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptor</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Graves%27_disease" title="Graves&#39; disease">Graves' disease</a></li>
<li><a href="/wiki/Myasthenia_gravis" title="Myasthenia gravis">Myasthenia gravis</a></li>
<li><a href="/wiki/Pernicious_anemia" title="Pernicious anemia">Pernicious anemia</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Type_III_hypersensitivity" title="Type III hypersensitivity">Type III</a><br />(<a href="/wiki/Immune_complex" title="Immune complex">Immune complex</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Foreign</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Henoch%E2%80%93Sch%C3%B6nlein_purpura" title="Henoch–Schönlein purpura">Henoch–Schönlein purpura</a></li>
<li><a href="/wiki/Cutaneous_small-vessel_vasculitis" title="Cutaneous small-vessel vasculitis">Hypersensitivity vasculitis</a></li>
<li><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a></li>
<li><a href="/wiki/Farmer%27s_lung" title="Farmer&#39;s lung">Farmer's lung</a></li>
<li><a href="/wiki/Acute_proliferative_glomerulonephritis" title="Acute proliferative glomerulonephritis">Post-streptococcal glomerulonephritis</a></li>
<li><a href="/wiki/Serum_sickness" title="Serum sickness">Serum sickness</a></li>
<li><a href="/wiki/Arthus_reaction" title="Arthus reaction">Arthus reaction</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Autoimmune</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Lupus" title="Lupus">Lupus</a></li>
<li><a href="/wiki/Subacute_bacterial_endocarditis" title="Subacute bacterial endocarditis">Subacute bacterial endocarditis</a></li>
<li><a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">Rheumatoid arthritis</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Type_IV_hypersensitivity" title="Type IV hypersensitivity">Type IV</a>/<a href="/wiki/Cell-mediated_immunity" title="Cell-mediated immunity">cell-mediated</a><br />(<a href="/wiki/T_cell" title="T cell">T cells</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Foreign</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Allergic_contact_dermatitis" title="Allergic contact dermatitis">Allergic contact dermatitis</a></li>
<li><a href="/wiki/Mantoux_test" title="Mantoux test">Mantoux test</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Autoimmune</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Type_1_diabetes" title="Type 1 diabetes">Type 1 diabetes</a></li>
<li><a href="/wiki/Hashimoto%27s_thyroiditis" title="Hashimoto&#39;s thyroiditis">Hashimoto's thyroiditis</a></li>
<li><a class="mw-selflink selflink">Multiple sclerosis</a></li>
<li><a href="/wiki/Coeliac_disease" title="Coeliac disease">Coeliac disease</a></li>
<li><a href="/wiki/Giant_cell_arteritis" title="Giant cell arteritis">Giant cell arteritis</a></li>
<li><a href="/wiki/Postorgasmic_illness_syndrome" title="Postorgasmic illness syndrome">Postorgasmic illness syndrome</a></li>
<li><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Graft-versus-host_disease" title="Graft-versus-host disease">GVHD</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Transfusion-associated_graft-versus-host_disease" title="Transfusion-associated graft-versus-host disease">Transfusion-associated graft-versus-host disease</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Unknown/<br />multiple</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Foreign</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Hypersensitivity_pneumonitis" title="Hypersensitivity pneumonitis">Hypersensitivity pneumonitis</a>
<ul><li><a href="/wiki/Allergic_bronchopulmonary_aspergillosis" title="Allergic bronchopulmonary aspergillosis">Allergic bronchopulmonary aspergillosis</a></li></ul></li>
<li><a href="/wiki/Transplant_rejection" title="Transplant rejection">Transplant rejection</a></li>
<li><a href="/wiki/Latex_allergy" title="Latex allergy">Latex allergy</a> (I+IV)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Autoimmune</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Sj%C3%B6gren_syndrome" title="Sjögren syndrome">Sjögren syndrome</a></li>
<li><a href="/wiki/Autoimmune_hepatitis" title="Autoimmune hepatitis">Autoimmune hepatitis</a></li>
<li><a href="/wiki/Autoimmune_polyendocrine_syndrome" title="Autoimmune polyendocrine syndrome">Autoimmune polyendocrine syndrome</a>
<ul><li><a href="/wiki/Autoimmune_polyendocrine_syndrome_type_1" title="Autoimmune polyendocrine syndrome type 1">APS1</a></li>
<li><a href="/wiki/Autoimmune_polyendocrine_syndrome_type_2" title="Autoimmune polyendocrine syndrome type 2">APS2</a></li></ul></li>
<li><a href="/wiki/Addison%27s_disease" title="Addison&#39;s disease">Autoimmune adrenalitis</a></li>
<li><a href="/wiki/Autoimmune_disease" title="Autoimmune disease">Systemic autoimmune disease</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"><style data-mw-deduplicate="TemplateStyles:r1038841319">.mw-parser-output .tooltip-dotted{border-bottom:1px dotted;cursor:help}</style><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1038841319"></div><div role="navigation" class="navbox authority-control" aria-label="Navbox" style="padding:3px"><table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control</a>: National <a href="https://www.wikidata.org/wiki/Q8277#identifiers" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" class="noprint" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><span class="uid"><a rel="nofollow" class="external text" href="https://catalogue.bnf.fr/ark:/12148/cb119384088">France</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://data.bnf.fr/ark:/12148/cb119384088">BnF data</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://d-nb.info/gnd/4040693-3">Germany</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="http://uli.nli.org.il/F/?func=find-b&amp;local_base=NLX10&amp;find_code=UID&amp;request=987007550961205171">Israel</a></span></li>
<li><span class="uid"><span class="rt-commentedText tooltip tooltip-dotted" title="Multiple sclerosis"><a rel="nofollow" class="external text" href="https://id.loc.gov/authorities/sh85088374">United States</a></span></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://id.ndl.go.jp/auth/ndlna/00572494">Japan</a></span></li>
<li><span class="uid"><span class="rt-commentedText tooltip tooltip-dotted" title="roztroušená skleróza"><a rel="nofollow" class="external text" href="https://aleph.nkp.cz/F/?func=find-c&amp;local_base=aut&amp;ccl_term=ica=ph180724&amp;CON_LNG=ENG">Czech Republic</a></span></span></li></ul>
</div></td></tr></tbody></table></div>
<!-- 
NewPP limit report
Parsed by mw1374
Cached time: 20230626163609
Cache expiry: 1814400
Reduced expiry: false
Complications: [vary‐revision‐sha1, show‐toc]
CPU time usage: 3.387 seconds
Real time usage: 3.619 seconds
Preprocessor visited node count: 14323/1000000
Post‐expand include size: 721890/2097152 bytes
Template argument size: 9551/2097152 bytes
Highest expansion depth: 14/100
Expensive parser function count: 21/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 793027/5000000 bytes
Lua time usage: 2.039/10.000 seconds
Lua memory usage: 10538840/52428800 bytes
Lua Profile:
    ?                                                                280 ms       13.5%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::find      200 ms        9.6%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::callParserFunction      160 ms        7.7%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::gsub      160 ms        7.7%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::getEntityStatements      120 ms        5.8%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::anchorEncode      120 ms        5.8%
    <mw.lua:694>                                                     100 ms        4.8%
    type                                                             100 ms        4.8%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::match      100 ms        4.8%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::preprocess       80 ms        3.8%
    [others]                                                         660 ms       31.7%
Number of Wikibase entities loaded: 1/400
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 3061.743      1 -total
 69.37% 2124.027      1 Template:Reflist
 51.70% 1582.783    188 Template:Cite_journal
  6.04%  184.882     17 Template:Navbox
  4.01%  122.755      1 Template:Infobox_medical_condition_(new)
  3.55%  108.844      1 Template:Infobox
  3.44%  105.193      2 Template:Ambox
  3.32%  101.560      1 Template:More_medical_citations_needed
  3.20%   98.074      1 Template:Medical_condition_classification_and_resources
  2.17%   66.540      9 Template:Cite_book
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:50603-0!canonical and timestamp 20230626163617 and revision id 1162037993. Rendering was triggered because: edit-page
 -->
</div><!--esi <esi:include src="/esitest-fa8a495983347898/content" /> --><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript>
<div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Multiple_sclerosis&amp;oldid=1162037993">https://en.wikipedia.org/w/index.php?title=Multiple_sclerosis&amp;oldid=1162037993</a>"</div></div>
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Multiple_sclerosis" title="Category:Multiple sclerosis">Multiple sclerosis</a></li><li><a href="/wiki/Category:Ailments_of_unknown_cause" title="Category:Ailments of unknown cause">Ailments of unknown cause</a></li><li><a href="/wiki/Category:Epstein%E2%80%93Barr_virus%E2%80%93associated_diseases" title="Category:Epstein–Barr virus–associated diseases">Epstein–Barr virus–associated diseases</a></li><li><a href="/wiki/Category:Myelin_disorders" title="Category:Myelin disorders">Myelin disorders</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_July_2022" title="Category:Articles with unsourced statements from July 2022">Articles with unsourced statements from July 2022</a></li><li><a href="/wiki/Category:Webarchive_template_wayback_links" title="Category:Webarchive template wayback links">Webarchive template wayback links</a></li><li><a href="/wiki/Category:CS1_Japanese-language_sources_(ja)" title="Category:CS1 Japanese-language sources (ja)">CS1 Japanese-language sources (ja)</a></li><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_is_different_from_Wikidata" title="Category:Short description is different from Wikidata">Short description is different from Wikidata</a></li><li><a href="/wiki/Category:Articles_needing_additional_medical_references_from_July_2022" title="Category:Articles needing additional medical references from July 2022">Articles needing additional medical references from July 2022</a></li><li><a href="/wiki/Category:All_articles_needing_additional_references" title="Category:All articles needing additional references">All articles needing additional references</a></li><li><a href="/wiki/Category:Articles_requiring_reliable_medical_sources" title="Category:Articles requiring reliable medical sources">Articles requiring reliable medical sources</a></li><li><a href="/wiki/Category:Use_dmy_dates_from_March_2023" title="Category:Use dmy dates from March 2023">Use dmy dates from March 2023</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_May_2023" title="Category:Articles with unsourced statements from May 2023">Articles with unsourced statements from May 2023</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2017" title="Category:Articles containing potentially dated statements from 2017">Articles containing potentially dated statements from 2017</a></li><li><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></li><li><a href="/wiki/Category:Wikipedia_articles_in_need_of_updating_from_July_2022" title="Category:Wikipedia articles in need of updating from July 2022">Wikipedia articles in need of updating from July 2022</a></li><li><a href="/wiki/Category:All_Wikipedia_articles_in_need_of_updating" title="Category:All Wikipedia articles in need of updating">All Wikipedia articles in need of updating</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_December_2022" title="Category:Articles with unsourced statements from December 2022">Articles with unsourced statements from December 2022</a></li><li><a href="/wiki/Category:All_articles_lacking_reliable_references" title="Category:All articles lacking reliable references">All articles lacking reliable references</a></li><li><a href="/wiki/Category:Articles_lacking_reliable_references_from_December_2022" title="Category:Articles lacking reliable references from December 2022">Articles lacking reliable references from December 2022</a></li><li><a href="/wiki/Category:Commons_category_link_is_on_Wikidata" title="Category:Commons category link is on Wikidata">Commons category link is on Wikidata</a></li><li><a href="/wiki/Category:Articles_with_Curlie_links" title="Category:Articles with Curlie links">Articles with Curlie links</a></li><li><a href="/wiki/Category:Articles_with_BNF_identifiers" title="Category:Articles with BNF identifiers">Articles with BNF identifiers</a></li><li><a href="/wiki/Category:Articles_with_BNFdata_identifiers" title="Category:Articles with BNFdata identifiers">Articles with BNFdata identifiers</a></li><li><a href="/wiki/Category:Articles_with_GND_identifiers" title="Category:Articles with GND identifiers">Articles with GND identifiers</a></li><li><a href="/wiki/Category:Articles_with_J9U_identifiers" title="Category:Articles with J9U identifiers">Articles with J9U identifiers</a></li><li><a href="/wiki/Category:Articles_with_LCCN_identifiers" title="Category:Articles with LCCN identifiers">Articles with LCCN identifiers</a></li><li><a href="/wiki/Category:Articles_with_NDL_identifiers" title="Category:Articles with NDL identifiers">Articles with NDL identifiers</a></li><li><a href="/wiki/Category:Articles_with_NKC_identifiers" title="Category:Articles with NKC identifiers">Articles with NKC identifiers</a></li><li><a href="/wiki/Category:Wikipedia_neurology_articles_ready_to_translate" title="Category:Wikipedia neurology articles ready to translate">Wikipedia neurology articles ready to translate</a></li><li><a href="/wiki/Category:Wikipedia_medicine_articles_ready_to_translate_(full)" title="Category:Wikipedia medicine articles ready to translate (full)">Wikipedia medicine articles ready to translate (full)</a></li></ul></div></div>
				</div>
			</main>
			
		</div>
		<div class="mw-footer-container">
			
<footer id="footer" class="mw-footer" role="contentinfo" >
	<ul id="footer-info">
	<li id="footer-info-lastmod"> This page was last edited on 26 June 2023, at 16:36<span class="anonymous-show">&#160;(UTC)</span>.</li>
	<li id="footer-info-copyright">Text is available under the <a rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons Attribution-ShareAlike License 4.0</a><a rel="license" href="//creativecommons.org/licenses/by-sa/4.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//foundation.wikimedia.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//foundation.wikimedia.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>

	<ul id="footer-places">
	<li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li>
	<li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li>
	<li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li>
	<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
	<li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Universal_Code_of_Conduct">Code of Conduct</a></li>
	<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Multiple_sclerosis&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
	<li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li>
	<li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li>
	<li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li>
</ul>

	<ul id="footer-icons" class="noprint">
	<li id="footer-copyrightico"><a href="https://wikimediafoundation.org/"><img src="/static/images/footer/wikimedia-button.png" srcset="/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation" loading="lazy" /></a></li>
	<li id="footer-poweredbyico"><a href="https://www.mediawiki.org/"><img src="/static/images/footer/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"></a></li>
</ul>

</footer>

		</div>
	</div> 
</div> 
<div class='vector-settings'>
	
<button
	id=""
	class="cdx-button cdx-button--icon-only vector-limited-width-toggle"
	><span class="vector-icon mw-ui-icon-fullScreen mw-ui-icon-wikimedia-fullScreen"></span>

<span>Toggle limited content width</span>

</button>

</div>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw1370","wgBackendResponseTime":140,"wgPageParseReport":{"limitreport":{"cputime":"3.387","walltime":"3.619","ppvisitednodes":{"value":14323,"limit":1000000},"postexpandincludesize":{"value":721890,"limit":2097152},"templateargumentsize":{"value":9551,"limit":2097152},"expansiondepth":{"value":14,"limit":100},"expensivefunctioncount":{"value":21,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":793027,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00% 3061.743      1 -total"," 69.37% 2124.027      1 Template:Reflist"," 51.70% 1582.783    188 Template:Cite_journal","  6.04%  184.882     17 Template:Navbox","  4.01%  122.755      1 Template:Infobox_medical_condition_(new)","  3.55%  108.844      1 Template:Infobox","  3.44%  105.193      2 Template:Ambox","  3.32%  101.560      1 Template:More_medical_citations_needed","  3.20%   98.074      1 Template:Medical_condition_classification_and_resources","  2.17%   66.540      9 Template:Cite_book"]},"scribunto":{"limitreport-timeusage":{"value":"2.039","limit":"10.000"},"limitreport-memusage":{"value":10538840,"limit":52428800},"limitreport-profile":[["?","280","13.5"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::find","200","9.6"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::callParserFunction","160","7.7"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::gsub","160","7.7"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::getEntityStatements","120","5.8"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::anchorEncode","120","5.8"],["\u003Cmw.lua:694\u003E","100","4.8"],["type","100","4.8"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::match","100","4.8"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::preprocess","80","3.8"],["[others]","660","31.7"]]},"cachereport":{"origin":"mw1374","timestamp":"20230626163609","ttl":1814400,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Multiple sclerosis","url":"https:\/\/en.wikipedia.org\/wiki\/Multiple_sclerosis","sameAs":"http:\/\/www.wikidata.org\/entity\/Q8277","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q8277","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2001-10-20T21:49:14Z","dateModified":"2023-06-26T16:36:05Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/5\/59\/MS_Demyelinisation_CD68_10xv2.jpg","headline":"disease that damages the myelin sheaths around nerve axons"}</script><script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Multiple sclerosis","url":"https:\/\/en.wikipedia.org\/wiki\/Multiple_sclerosis","sameAs":"http:\/\/www.wikidata.org\/entity\/Q8277","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q8277","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2001-10-20T21:49:14Z","dateModified":"2023-06-26T16:36:05Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/5\/59\/MS_Demyelinisation_CD68_10xv2.jpg","headline":"disease that damages the myelin sheaths around nerve axons"}</script>
</body>
</html>